Form 8-K

8-K — Cartesian Growth Corp II

Accession: 0001104659-26-086861

Filed: 2026-07-27

Period: 2026-07-24

CIK: 0001889112

SIC: 6770 (BLANK CHECKS)

Item: Entry into a Material Definitive Agreement

Item: Unregistered Sales of Equity Securities

Item: Regulation FD Disclosure

Item: Financial Statements and Exhibits

Documents

8-K — tm2621302d1_8k.htm (Primary)

EX-2.1 — EXHIBIT 2.1 (tm2621302d1_ex2-1.htm)

EX-10.1 — EXHIBIT 10.1 (tm2621302d1_ex10-1.htm)

EX-10.2 — EXHIBIT 10.2 (tm2621302d1_ex10-2.htm)

EX-10.3 — EXHIBIT 10.3 (tm2621302d1_ex10-3.htm)

EX-99.1 — EXHIBIT 99.1 (tm2621302d1_ex99-1.htm)

GRAPHIC (tm2621302d1_ex10-3sp3img001.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — FORM 8-K

8-K (Primary)

Filename: tm2621302d1_8k.htm · Sequence: 1

false

0001889112

00-0000000

0001889112

2026-07-24

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported):

July 24, 2026

Cartesian Growth Corporation II

(Exact name of registrant as specified in its

charter)

Cayman Islands

001-41378

N/A

(State or other jurisdiction

of incorporation)

(Commission File

Number)

(I.R.S. Employer

Identification No.)

505 Fifth Avenue, 15th Floor

New York, New York

10017

(Address of principal executive

offices)

(Zip Code)

(212) 461-6363

(Registrant’s telephone number, including

area code)

Not Applicable

(Former name or former address, if changed since

last report)

Check the appropriate box below if the Form 8-K

filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the

Act: None.

Indicate by check mark whether the registrant is an emerging growth

company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities

Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company x

If an emerging growth company, indicate by check mark if the registrant

has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant

to Section 13(a) of the Exchange Act. ¨

Item 1.01

Entry Into A Material Definitive Agreement

On July 24, 2026, Cartesian

Growth Corporation II, a Cayman Islands exempted company (“CGC”), and InoBat AS, a private limited company (aksjeselskap)

organized under the Laws of Norway (“InoBat”), entered into a Business Combination Agreement (as it may be amended,

supplemented or otherwise modified from time to time, the “Business Combination Agreement”). The Business Combination

Agreement provides for a business combination transaction that values InoBat at an aggregate amount of $1,265,000,000, consisting of upfront

consideration equal to $575,000,000 and potential earn-out consideration equal to $690,000,000. The Business Combination Agreement and

the transactions contemplated thereby (the “Business Combination”) were unanimously approved by the boards of directors of

each of CGC and InoBat. The closing of the Business Combination (the “Closing”, and the date on which the Closing occurs,

the “Closing Date”) is expected to occur in the fourth quarter of 2026, following the receipt of the requisite approvals

of CGC’s shareholders and the fulfillment of other customary closing conditions. Capitalized terms used but not expressly defined

in this Current Report on Form 8-K shall have the meanings ascribed to them in the Business Combination Agreement.

Business Combination Agreement

The Exchange

The Business Combination Agreement

provides, among other things, that prior to the Closing, (i) InoBat will form InoBat B.V., a private company with limited liability

(besloten vennootschap met beperkte aansprakelijkheid) to be incorporated and existing under the laws of the Netherlands (“ListCo”);

(ii) ListCo will cause the formation of InoBat Cayman Merger Sub, a Cayman Islands exempted company and a wholly-owned subsidiary

of ListCo (“Merger Sub” and, together with InoBat, CGC, and ListCo, the “Parties”), (iii) ListCo

will convert into a public limited liability company (naamloze vennootschap) under the laws of the Netherlands to be named InoBat

N.V.; (iv) shareholders of InoBat holding at least 90% of the outstanding shares of InoBat (including shares issuable upon conversion

of InoBat’s convertible notes and shares underlying InoBat options) will contribute their shares of InoBat to ListCo in exchange

for common shares of ListCo (“ListCo Common Shares”) at the Exchange Ratio (as defined in the Business Combination

Agreement) (the “Exchange”).

At the time the Exchange becomes

effective (the “Exchange Effective Time”), each option issued by InoBat (whether vested or unvested) will cease to

represent the right to purchase shares of InoBat and will be canceled in exchange for options to purchase ListCo Common Shares under a

new incentive equity plan to be agreed among the Parties in an amount equal to the product (rounded down to the nearest whole number)

of (x) the number of shares of InoBat subject to such option immediately prior to the Exchange Effective Time, multiplied by (y) the

Exchange Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to the quotient of (i) the exercise price

per share of such option immediately prior to the Exchange Effective Time, divided by (ii) the Exchange Ratio, and generally subject

to the same terms and conditions (including applicable vesting, expiration and forfeiture provisions) that applied to the corresponding

option immediately prior to the Exchange Effective Time. Immediately prior to the Exchange Effective Time, all outstanding convertible

notes of InoBat will be converted into shares of InoBat pursuant to their terms.

Earn-Out Consideration

In addition to the upfront

consideration, InoBat shareholders who execute the irrevocable shareholder undertaking contemplated by the Business Combination Agreement

(the “InoBat Shareholder Undertaking”) will be entitled to receive additional ListCo Common Shares (the “Earn-Out

Shares”) upon the achievement of certain milestones. The Earn-Out Shares represent consideration equal to $690,000,000 and will

be issued across three tranches: (i) ListCo Common Shares representing $115,000,000 of value, based on a deemed value of $10.20 per

ListCo Common Share, upon the start of commissioning of Project Kamzik, including the production line in Project Kamzik’s facility

in Šurany, Slovakia, before December 31, 2027 (the “Earn-Out 1 Shares”); (ii) ListCo Common Shares

representing $287,500,000 of value, based on a deemed value of $10.20 per ListCo Common Share, if the EBITDA of ListCo for either fiscal

year 2026 or fiscal year 2027 exceeds €47,000,000 (the “Earn-Out 2 Shares”); and (iii) ListCo Common Shares

representing $287,500,000 of value, based on a deemed value of $10.20 per ListCo Common Share, if the EBITDA of ListCo for either fiscal

year 2027 or fiscal year 2028 exceeds €87,000,000, in each case subject to the terms and conditions set forth in the Business Combination

Agreement and the applicable Earn-Out Agreement (the “Earn-Out 3 Shares”).

At or prior to the Closing,

ListCo, InoBat, CGC and the applicable InoBat shareholders will enter into earn-out agreements, pursuant to which the recipients

of the Earn-Out Shares will agree, among other things, that the Earn-Out Shares will not vest unless and until the applicable earn-out

target has been achieved and will be forfeited if the applicable earn-out target is not achieved by the applicable deadline. The Earn-Out

Shares will also be subject to transfer restrictions prior to vesting. In addition, any unvested Earn-Out Shares that have not been forfeited

will become vested upon the occurrence of a qualifying change of control of ListCo, subject to the terms and conditions set forth in the

applicable Earn-Out Agreement.

CGC Shareholder Redemptions

CGC will provide the holders

of Class A ordinary shares of CGC, par value $0.0001 per share (the “CGC Class A Shares”) the right to have

all or a portion of their CGC Class A Shares redeemed for cash in connection with the Business Combination, in accordance with CGC’s

governing documents, for a per-share price equal to the pro rata portion of the funds then in CGC’s trust account (including interest

not previously released to pay taxes). Any such redemptions will occur immediately prior to the consummation of the Merger (as defined

below).

The Merger

Subject to the terms and conditions

of the Business Combination Agreement, on the Closing Date, Merger Sub will merge with and into CGC (the “Merger”),

with CGC surviving the Merger as a wholly-owned subsidiary of ListCo. At the time the Merger becomes effective (the “Merger Effective

Time”), (a) each ordinary share of CGC issued and outstanding as of immediately prior to the Merger Effective Time will

be automatically converted into the right to receive one ListCo Common Share and (b) each warrant of CGC, exercisable to purchase

one CGC Class A Share at $11.50 per share, will be automatically converted into a warrant to purchase one ListCo Common Share at

$11.50 per share. The Parties intend that, for U.S. federal income tax purposes, the Exchange and the Merger, taken together with the

PIPE Financing and any third-party financing, will constitute an integrated transaction that qualifies as a tax-free capital contribution

pursuant to Section 351(a) of the Internal Revenue Code of 1986, as amended (the “Code”), and that the conversion

of ListCo from a Dutch private company with limited liability to a Dutch public limited liability company will qualify as a reorganization

within the meaning of Section 368(a)(1)(F) of the Code. The Business Combination Agreement is intended to constitute a “plan

of reorganization” for purposes of Section 368(a) of the Code and the Treasury Regulations promulgated thereunder.

Representations and Warranties; Covenants

The Business Combination Agreement

contains representations, warranties and covenants of each of the Parties that are customary for transactions of this type, including

with respect to the operations of CGC and InoBat prior to the Closing and the preparation and filing of a registration statement on Form F-4

relating to the Business Combination containing a prospectus and proxy statement of CGC (the “Registration Statement / Proxy

Statement”) with the Securities and Exchange Commission (the “SEC”). The Parties have also undertaken to

procure clearance under applicable antitrust and foreign direct investment laws from all applicable governmental entities.

Governance

CGC has agreed to take all

action within its power as may be necessary or appropriate such that, effective immediately after the Merger Effective Time, the ListCo

board of directors will initially consist of seven directors. Two individuals designated by the Sponsor (as defined below) shall be appointed

as observers to the ListCo board of directors (with no power to vote on any matter before the ListCo board of directors).

Conditions to Closing

The obligation of CGC and

InoBat to consummate the Business Combination is subject to certain closing conditions, including, but not limited to, (i) the receipt

of all required approvals, decisions or clearances under applicable antitrust and foreign direct investment laws from each applicable

governmental entity, (ii) no legal restraint or prohibition issued by any governmental entity enjoining, prohibiting or preventing

the consummation of the Business Combination being in effect, (iii) the effectiveness of the Registration Statement / Proxy Statement,

(iv) receipt of the requisite approvals and consents of CGC’s shareholders, and (v) the approval for listing of the ListCo

Common Shares (including, for the avoidance of doubt, the ListCo Common Shares to be issued pursuant to the Merger) on Nasdaq.

The obligation of CGC to consummate

the Business Combination is also subject to the fulfillment of other customary closing conditions, including, but not limited to, there

having been no Company Material Adverse Effect since the date of the Business Combination Agreement that is continuing.

The obligation of InoBat to

consummate the Business Combination is also subject to the fulfillment of other customary closing conditions, including, but not limited

to, (i) there having been no CGC Material Adverse Effect since the date of the Business Combination Agreement that is continuing,

(ii) the consummation of the Exchange, and (iii) each PIPE Investor (as defined below) having funded their respective investments

pursuant to the applicable Investor Subscription Agreement (as defined below).

Termination

The Business Combination Agreement

may be terminated under certain customary and limited circumstances prior to the Closing, including, but not limited to, (i) by mutual

written consent of CGC and InoBat, (ii) by CGC if the representations and warranties of InoBat are not true and correct or if InoBat

fails to perform any pre-closing covenant or agreement set forth in the Business Combination Agreement such that certain conditions to

closing cannot be satisfied and the breach or breaches of such representations or warranties or the failure to perform such covenant or

agreement, as applicable, are not cured or cannot be cured within certain specified time periods, (iii) by InoBat if the representations

and warranties of CGC are not true and correct or if CGC fails to perform any covenant or agreement set forth in the Business Combination

Agreement such that certain conditions to closing cannot be satisfied and the breach or breaches of such representations or warranties

or the failure to perform such covenant or agreement, as applicable, are not cured or cannot be cured within certain specified time periods,

(iv) by either CGC or InoBat if the Business Combination is not consummated by December 31, 2026, (v) by either CGC or

InoBat if the requisite CGC shareholder approvals are not obtained after the conclusion of the meeting at which CGC’s shareholders

voted on such matters, (vi) by either CGC or InoBat, if any governmental entity has issued a final and non-appealable order prohibiting

the Business Combination, (vii) by CGC if InoBat has not delivered the InoBat Shareholder Undertaking (executed by shareholders of

InoBat holding at least 90% of the outstanding shares of InoBat, including shares issuable upon conversion of InoBat’s convertible

notes and options) on or prior to August 31, 2026, or (viii) by CGC if InoBat fails to comply with certain consent obligations

relating to National Development Fund II, a.s. (“NDF II”) and NDF II or any of its affiliates objects to the Business

Combination or notifies InoBat in writing of its intention to impose any penalty on InoBat or any of its subsidiaries arising therefrom.

If the Business Combination

Agreement is validly terminated, none of the Parties will have any liability or any further obligation under the Business Combination

Agreement other than customary confidentiality obligations, except in the case of willful breach or fraud. Notwithstanding the foregoing,

if the Business Combination Agreement is terminated by CGC due to a breach by InoBat and InoBat enters into a definitive agreement for

a competing transaction within twelve months thereafter, InoBat will be required to pay CGC and the Sponsor an aggregate break fee

of $10,000,000. If the Business Combination Agreement is terminated by InoBat due to a breach by CGC and CGC enters into a definitive

agreement for an alternative acquisition within 12 months thereafter, CGC will be required to pay InoBat an aggregate break fee of $10,000,000.

In addition, if CGC terminates the Business Combination Agreement due to certain specified breaches by InoBat relating to NDF II consent

obligations, InoBat will be required to pay CGC and the Sponsor an aggregate specified breach break fee of $500,000.

The foregoing description

of the Business Combination Agreement and the Business Combination does not purport to be complete and is qualified in its entirety by

the terms and conditions of the Business Combination Agreement and any related agreements. The Business Combination Agreement contains

representations, warranties and covenants that the respective Parties made to each other as of the date of such agreement or other specific

dates. The assertions embodied in those representations, warranties and covenants were made for purposes of the contract among the respective

Parties and are subject to important qualifications and limitations agreed to by the Parties in connection with negotiating such agreement.

It is not intended to provide any other factual information about CGC, InoBat, or any other Party to the Business Combination Agreement

or any related agreement. In particular, the representations, warranties, covenants and agreements contained in the Business Combination

Agreement, which were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the Parties, are

subject to limitations agreed upon by the Parties (including being qualified by confidential disclosures made for the purposes of allocating

contractual risk between the Parties instead of establishing these matters as facts) and are subject to standards of materiality applicable

to the Parties that may differ from those applicable to investors and security holders. Investors and security holders are not third-party

beneficiaries under the Business Combination Agreement and should not rely on the representations, warranties, covenants and agreements,

or any descriptions thereof, as characterizations of the actual state of facts or condition of any Party to the Business Combination Agreement.

Moreover, information concerning the subject matter of the representations and warranties may change after the date of the Business Combination

Agreement, which subsequent information may or may not be fully reflected in CGC’s public disclosures.

The foregoing description

of the Business Combination Agreement is qualified in its entirety by reference to the Business Combination Agreement filed as Exhibit 2.1

to this Current Report on Form 8-K.

Related Agreements

The Business Combination Agreement

contemplates the execution of various additional agreements and instruments, on or before the Closing, including, among others, the following:

Sponsor Support Agreement

Concurrently with the execution

of the Business Combination Agreement, CGC II Sponsor LLC, a Cayman Islands limited liability company (the “Sponsor”),

and InoBat entered into the Sponsor Support Agreement (the “Sponsor Support Agreement”), pursuant to which the Sponsor

has agreed to, among other things, (i) vote in favor of the Business Combination Agreement and the Business Combination, (ii) waive

any adjustment to the conversion ratio set forth in the governing documents of CGC or any other anti-dilution or similar protection with

respect to the CGC’s Class B ordinary shares, par value $0.0001 per share (whether resulting from the transactions contemplated

by the Business Combination Agreement or otherwise), (iii) forfeit and surrender to CGC all of its CGC Private Warrants (as defined

in the Business Combination Agreement), (iv) transfer 800,000 CGC Class A Shares to an institutional PIPE Investor (the “Institutional

PIPE Investor”) or its designee, (v) cancel $1,800,000 of obligations under the promissory notes evidencing loans made

to CGC by the Sponsor or its affiliates (the “Sponsor Loans”) and exchange $9,200,000 of obligations under the Sponsor

Loans into 90,196 ListCo Series B Preference Shares (as defined below) and 901,961 PIPE Warrants (as defined below), (vi) be

bound by certain other covenants and agreements related to the Business Combination, (vii) be bound by certain transfer restrictions

with respect to its shares in CGC prior to the Closing, and (viii) waive redemption rights with respect to any CGC Class A Shares

held by the Sponsor, in each case, on the terms and subject to the conditions set forth in the Sponsor Support Agreement. No affiliate

of the Sponsor shall be a director on the ListCo board of directors.

A copy of the Sponsor Support

Agreement is filed with this Current Report on Form 8-K as Exhibit 10.1 and is incorporated herein by reference, and the foregoing

description of the Sponsor Support Agreement is qualified in its entirety by reference thereto.

Shareholder Support Agreements

Concurrently with the execution

of the Business Combination Agreement, CGC and each Key Supporting Company Shareholder listed on Annex A to the Business Combination Agreement

entered into a shareholder support agreement (collectively, the “Shareholder Support Agreements”), pursuant to which

each such Key Supporting Company Shareholder has agreed to, among other things, (i) support and vote in favor of the Business Combination

Agreement and the transactions contemplated thereby (including agreeing to enter into a Company Shareholder Undertaking), (ii) take,

or cause to be taken, any actions necessary or advisable to cause certain agreements to be terminated effective as of the Closing, and

(iii) release claims against InoBat, CGC and Merger Sub.

A copy of the

Shareholder Support Agreement is filed with this Current Report on Form 8-K as Exhibit 10.2 and is incorporated herein by

reference, and the foregoing description of the Shareholder Support Agreements is qualified in its entirety by reference

thereto.

PIPE Financing (Private Placement)

Concurrently with the execution

of the Business Combination Agreement, CGC, InoBat, the Sponsor and certain investors (collectively, the “PIPE Investors”)

entered into securities purchase agreements (collectively, the “Investor Subscription Agreements”). Pursuant to the

Investor Subscription Agreements:

· the Institutional PIPE Investor agreed to subscribe

for and purchase, and InoBat agreed to cause ListCo to issue and sell to the Institutional PIPE Investor on the Closing Date, 490,196

shares of 12.0% Series A Cumulative Convertible Preference Shares of ListCo (the “ListCo Series A Preference Shares”)

and warrants (the “PIPE Warrants”) to purchase an amount of ListCo Common Shares equal to the number of shares of ListCo

Common Shares into which such shares of ListCo Series A Preference Shares are initially convertible, for an aggregate purchase price

of $50 million; and

· the PIPE Investors other than the Institutional

PIPE Investor (including an affiliate of the Sponsor) agreed to subscribe for and purchase, and InoBat agreed to cause ListCo to issue

and sell to each such PIPE Investor on the Closing Date, 269,608 shares of Series B Convertible Preference Shares of ListCo (the

“ListCo Series B Preference Shares” and, together with the ListCo Series A Preference Shares, the “ListCo

Preference Shares”) and PIPE Warrants to purchase an amount of ListCo Common Shares equal to 75% of the number of shares of

ListCo Common Shares into which such shares of ListCo Series B Preference Shares are initially convertible, for an aggregate purchase

price of $27.5 million.

Each ListCo Preference Share

will have a stated value of $120.00, and will have the rights, preferences and privileges set forth in the Amended and Restated Articles

of Association of ListCo to be effective as of the Closing Date (the “Articles”).

The obligations of each party

to consummate the PIPE Financing are conditioned upon, among other things, (i) the ListCo Common Shares (including the ListCo Common

Shares issuable to the PIPE Investors pursuant to the Investor Subscription Agreements) having been approved for listing on Nasdaq or

the New York Stock Exchange; (ii) all conditions precedent to the Closing shall have been satisfied or waived and the closing of

the Business Combination shall be scheduled to occur substantially concurrently with the closing of the PIPE Financing; and (iii) the

absence of specified adverse judgments, orders, laws, rules or regulations enjoining or otherwise prohibiting the consummation of

the transactions contemplated by the Investor Subscription Agreements.

The obligations of CGC to

consummate the PIPE Financing are further subject to additional conditions, including, among other things: (i) material truth and

accuracy of the representations and warranties of the PIPE Investors, subject to customary bringdown standards; and (ii) material

compliance by the PIPE Investors with their covenants, agreements and conditions under the Investor Subscription Agreements.

The obligations of the PIPE

Investors to consummate the PIPE Financing are further subject to additional conditions, including, among other things: (i) the material

truth and accuracy of the representations and warranties of CGC and InoBat in the Investor Subscription Agreements, subject to customary

bringdown standards; and (ii) material compliance by CGC and InoBat with their covenants, agreements and conditions under the Investor

Subscription Agreements.

The Investor Subscription

Agreements provide that CGC, ListCo and InoBat will grant the PIPE Investors certain customary registration rights.

The foregoing description

of the Investor Subscription Agreements and the PIPE Financing is subject to and qualified in its entirety by reference to the full text

of the form of Investor Subscription Agreement, a copy of which is attached as Exhibit 10.3 hereto, and the terms of which are incorporated

herein by reference.

Registration Rights Agreement

In connection with the Closing,

ListCo, the Sponsor, certain members of the Sponsor, the PIPE Investors and certain shareholders of InoBat will enter into an amended

and restated registration rights agreement (the “Registration Rights Agreement”). Pursuant to the Registration Rights

Agreement, among other things, ListCo will agree that ListCo will file with the SEC (at ListCo’s sole cost and expense) a registration

statement registering the resale of certain ListCo shares held by or issuable to the parties thereto (the “Resale Registration

Statement”), and ListCo will use its commercially reasonable efforts to have the Resale Registration Statement declared effective

as soon as reasonably practicable after the filing thereof. Such holders will be entitled to customary piggyback registration rights and

demand registration rights, including underwritten demands.

The Registration Rights Agreement

amends and restates the registration rights agreement that was entered into by CGC, the Sponsor and certain other parties in connection

with CGC’s initial public offering. The Registration Rights Agreement will terminate on the earlier of (a) the tenth anniversary

of the date of the Registration Rights Agreement or (b) with respect to any holder party thereto, on the date that such holder no

longer holds any registrable securities (as defined therein).

Lock-Up Agreement

In connection with the Closing,

ListCo, the Sponsor, certain members of the Sponsor and certain shareholders of InoBat will enter into a lock-up agreement (the “Lock-up

Agreement”). Pursuant to the Lock-up Agreement, the Sponsor and certain shareholders of InoBat will be prohibited from transferring

(except for certain permitted transfers) certain ListCo Common Shares held by such holder beginning on the Closing Date (the “Lock-Up

Shares”). Ten percent (10%) of the ListCo Common Shares issued to such parties pursuant to the Business Combination Agreement

will not be subject to a lock-up. Forty percent (40%) of the Upfront Consideration Shares held by certain InoBat shareholders will be

subject to an Orderly Disposition Agreement in lieu of a lock-up (as described below). The remaining Lock-Up Shares will be subject to

transfer restrictions, subject to release in three equal tranches (i) at 12 months following the Closing (or earlier if the 20-day

VWAP (as defined in the Business Combination Agreement) exceeds $14.00 per ListCo Common Share), (ii) at 15 months following the

Closing (or earlier if the 20-day VWAP exceeds $16.00 per ListCo Common Share) and (iii) at 18 months following the Closing (or earlier

if the 20-day VWAP exceeds $18.00 per ListCo Common Share). Earn-Out 1 Shares and Earn-Out 2 Shares will be subject to transfer restrictions

following issuance, subject to release in three equal tranches at 6 months, 9 months and 12 months after issuance, or earlier if the 20-day

VWAP exceeds $14.00, $16.00 and $18.00 per ListCo Common Share, respectively. Earn-Out 3 Shares will not be subject to a lock-up.

Orderly Disposition Agreements

At the Closing, CGC, ListCo

and each ODA Holder (as defined in the Business Combination Agreement) will enter into an orderly disposition agreement (each, an “Orderly

Disposition Agreement”) pursuant to which, among other things, for a period of 12 months following the Closing, each ODA Holder

will agree not to sell, on a daily basis, more than 30% of the 20-day average daily volume of ListCo Common Shares, and not to sell ListCo

Common Shares at a price per share less than $10.20, in each case, on the terms and subject to the conditions set forth in the applicable

Orderly Disposition Agreement.

ListCo Equity Incentive Plan

Prior to the effectiveness

of the Registration Statement / Proxy Statement, the ListCo board of directors will approve and adopt an equity incentive plan (the “ListCo

Equity Incentive Plan”), the form of which will be mutually agreed between CGC and InoBat prior to the initial filing of the

Registration Statement / Proxy Statement, effective as of one day prior to the Closing Date. The ListCo Equity Incentive Plan will reserve

an agreed upon percentage of the issued and outstanding ListCo Common Shares on a fully-diluted basis, determined as of the effective

date of such plan, for grant thereunder, which shall include (and not be in addition to) the ListCo Common Shares issuable upon the exercise

or conversion of InoBat’s options.

Articles of Association

At the Closing, immediately

after giving effect to the Exchange, ListCo will convert its legal form from a private company with limited liability (besloten vennootschap

met beperkte aansprakelijkheid) to a public limited liability company (naamloze vennootschap) and will amend and restate its

articles of association (the Articles), which will govern the rights, privileges and preferences of the holders of ListCo securities after

the Closing, including the rights, preferences and privileges of the ListCo Preference Shares.

Item 3.02

Unregistered Sales of Equity Securities.

The disclosure set forth above

in Item 1.01 of this Current Report on Form 8-K with respect to the issuance of ListCo Preference Shares and PIPE Warrants in connection

with the transactions contemplated by the Investor Subscription Agreements is incorporated by reference herein. The ListCo Preference

Shares and PIPE Warrants issuable to the PIPE Investors pursuant to the Investor Subscription Agreements will not be registered under

the Securities Act of 1933, as amended (the “Securities Act”), in reliance on the exemption from registration provided

in Section 4(a)(2) of the Securities Act.

Item 7.01

Regulation FD Disclosure.

On July 27, 2026, CGC

and InoBat issued a press release announcing the Business Combination. The press release is attached hereto as Exhibit 99.1 and incorporated

by reference herein.

The information in this Item

7.01, including Exhibit 99.1, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities

Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to liabilities under that section, and

shall not be deemed to be incorporated by reference into the filings of CGC under the Securities Act or the Exchange Act, regardless of

any general incorporation language in such filings. This Current Report on Form 8-K will not be deemed an admission as to the materiality

of any information in this Item 7.01, including Exhibit 99.1.

Additional Information about the Proposed Business Combination and

Where to Find It

The proposed Business Combination will be submitted

to shareholders of CGC for their consideration. CGC intends to file a registration statement on Form F-4 with the SEC, which will

include preliminary and definitive proxy statements to be distributed to CGC’s shareholders in connection with CGC’s solicitations

of proxies from CGC’s shareholders with respect to the proposed business combination and other matters to be described in the registration

statement, as well as the prospectus relating to the offer of the securities to be issued to the shareholders of InoBat in connection

with the completion of the proposed Business Combination. After the registration statement has been filed and declared effective, CGC

will mail a definitive proxy statement/prospectus and other relevant documents relating to the proposed Business Combination and other

matters to be described in the registration statement to InoBat shareholders and CGC shareholders as of a record date to be established

for voting on the proposed Business Combination. Before making any voting or investment decision, CGC shareholders, InoBat shareholders,

and other interested persons are urged to read these documents and any amendments thereto, as well as any other relevant documents filed

with the SEC by CGC in connection with the proposed Business Combination and other matters to be described in the registration statement,

when they become available because they will contain important information about CGC, InoBat and the proposed Business Combination.

Shareholders will also be able to obtain free copies of the preliminary proxy statement/prospectus, the definitive proxy statement/prospectus

and other documents filed by CGC with the SEC, once available, without charge, at the SEC’s website located at www.sec.gov, or by

directing a written request to Cartesian Growth Corporation II, 505 Fifth Avenue, 15th Floor, New York, New York 10017.

Forward-Looking Statements

This Current Report on Form 8-K includes

forward-looking statements. Forward-looking statements generally are accompanied by words such as “believe,” “may,”

“will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,”

“should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,”

“future,” “outlook” and similar expressions that predict or indicate future events or trends or that are not statements

of historical matters. These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts

of other financial and performance metrics and projections of market opportunity; financing and other business milestones; potential benefits

of the proposed Business Combination and other related transactions; and expectations relating to the proposed Business Combination and

other related transactions. These statements are based on various assumptions, whether or not identified in this Current Report on Form 8-K,

and on the current expectations of InoBat’s and CGC’s management and are not predictions of actual performance. These forward-looking

statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by an investor as a

guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are difficult

or impossible to predict and may differ from assumptions. Many actual events and circumstances are beyond the control of InoBat and CGC.

These forward-looking statements are subject to a number of risks and uncertainties, including but not limited to changes in domestic

and foreign business, market, financial, political, and legal conditions; the inability of the Parties to successfully or timely consummate

the proposed Business Combination and other related transactions, including the risk that any regulatory approvals are not obtained, are

delayed or are subject to unanticipated conditions that could adversely affect the combined company or the expected benefits of the proposed

Business Combination and other related transactions; failure to realize the anticipated benefits of the proposed Business Combination

and other related transactions; ability to successfully consummate the PIPE Financing, or obtain additional financing; ability to attract

and retain qualified personnel; global economic and political conditions; the occurrence of any event, change or other circumstance that

could give rise to the termination of the Business Combination Agreement; legal and regulatory changes; the outcome of any legal proceedings

that may be instituted against CGC or InoBat related to the proposed Business Combination; the effects of competition on InoBat’s

future business; the approval by CGC’s public shareholders of the Business Combination and related transactions, the amount of redemption

requests made by CGC’s public shareholders. Additional risks related to InoBat’s business include, but are not limited to:

The development of battery technology is complex and the timing of development cannot be assured. Delays in the development of InoBat’s

batteries could adversely affect InoBat’s business and prospects; InoBat may be unable to adequately control the costs associated

with its operations and the components necessary to develop and commercialize its battery technology; InoBat may not be able to accurately

estimate the future supply and demand for its batteries, which could result in a variety of inefficiencies in its business and hinder

its ability to generate revenue and profits; InoBat’s expectations and targets regarding when it will achieve various technical,

pre-production and production objectives depend in large part upon assumptions and analyses developed by InoBat. If these assumptions

or analyses prove to be incorrect, InoBat may not achieve these milestones when expected or at all; if InoBat’s existing customers

do not make subsequent purchases from it, InoBat will not receive revenue from such customers, and its results of operations would

be adversely impacted; InoBat is an early-stage company with a history of financial losses and expects to incur significant expenses and

continuing losses from operations; InoBat’s business plan has yet to be tested, and it may not succeed in executing on its strategic

plans, including commercialization; InoBat relies heavily on its intellectual property portfolio. If it is unable to protect its intellectual

property rights, InoBat’s business and competitive position would be harmed; InoBat’s patent applications may not result

in issued patents or its patent rights may be contested, circumvented, invalidated or limited in scope, any of which could have a material

adverse effect on its ability to prevent others from interfering with its commercialization of its products; governmental trade controls,

including export and import controls, sanctions, customs requirements and related regimes, could subject InoBat to liability or loss of

contracting privileges, limit its ability to transfer technology or compete in certain markets and affect its ability to hire qualified

personnel; and changes in government policy, including the imposition of or increases in tariffs and changes to existing trade agreements,

could have a material adverse effect on global economic conditions and InoBat’s business, financial condition, results of operations

and prospects. Additional risks related to CGC include those factors set forth in the section entitled “Risk Factors” and

“Cautionary Note Regarding Forward-Looking Statements” in CGC’s annual report on Form 10-K for the year ended December 31,

2025, and in those documents that CGC has filed, or will file, with the SEC.

If any of these risks materialize or CGC’s

or InoBat’s assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking

statements. There may be additional risks that neither CGC nor InoBat presently know or that CGC and InoBat currently believe are immaterial

that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements

reflect CGC’s and InoBat’s expectations, plans, or forecasts of future events and views as of the date of this Current Report

on Form 8-K and are qualified in their entirety by reference to the cautionary statements herein. CGC and InoBat anticipate that

subsequent events and developments will cause CGC’s and InoBat’s assessments to change. These forward-looking statements should

not be relied upon as representing CGC’s and InoBat’s assessments as of any date subsequent to the date of this Current Report

on Form 8-K. Accordingly, undue reliance should not be placed upon the forward-looking statements. Neither CGC, InoBat nor any

of their respective affiliates undertake any obligation to update these forward-looking statements, except as required by law.

Participants in the Solicitation

CGC, InoBat, and their respective directors

and executive officers may be deemed to be participants in the solicitations of proxies from CGC’s shareholders with respect to

the proposed Business Combination and the other matters set forth in the registration statement. Information regarding CGC’s directors

and executive officers, and a description of their interests in CGC is contained in CGC’s annual report on Form 10-K for the

year ended December 31, 2025, which was filed with the SEC and is available free of charge at the SEC’s website located at

www.sec.gov, or by directing a request to Cartesian Growth Corporation II, 505 Fifth Avenue, 15th Floor, New York, New York 10017. Additional

information regarding the interests of such participants in the proxy solicitation and a description of their direct and indirect interests,

will be contained in the proxy statement/prospectus relating to the proposed Business Combination when it becomes available. Shareholders,

potential investors and other interested persons should read the proxy statement/prospectus carefully when it becomes available before

making any voting or investment decisions. You may obtain free copies of these documents from the sources described above.

This Current Report on Form 8-K is not a

substitute for the registration statement or for any other document that CGC and InoBat may file with the SEC in connection with the proposed

Business Combination. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY

WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Investors and security holders may obtain free copies of other

documents filed with the SEC by CGC, without charge, at the SEC’s website located at www.sec.gov.

No Offer or Solicitation

This Current Report on Form 8-K shall not

constitute an offer to sell, or the solicitation of an offer to buy, or a recommendation to purchase, any securities, in any jurisdiction,

or the solicitation of any vote, consent or approval in any jurisdiction in connection with the proposed Business Combination or any related

transactions, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would

be unlawful. This Current Report on Form 8-K is not, and under no circumstances is to be construed as, a prospectus, an advertisement

or a public offering of the securities described herein in the United States or any other jurisdiction. No offer of securities shall be

made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act, or exemptions therefrom. INVESTMENT

IN ANY SECURITIES DESCRIBED HEREIN HAS NOT BEEN APPROVED BY THE SEC OR ANY OTHER REGULATORY AUTHORITY NOR HAS ANY AUTHORITY PASSED UPON

OR ENDORSED THE MERITS OF THE OFFERING OR THE ACCURACY OR ADEQUACY OF THE INFORMATION CONTAINED HEREIN. ANY REPRESENTATION TO THE CONTRARY

IS A CRIMINAL OFFENSE.

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

Exhibit

Number

Description

2.1†

Business Combination Agreement, dated as of July 24, 2026, by and between Cartesian Growth Corporation II and InoBat AS.

10.1

Sponsor Support Agreement, dated as of July 24, 2026, by and between CGC II Sponsor LLC and InoBat AS.

10.2

Shareholder Support Agreement.

10.3†

Form of Securities Purchase Agreement.

99.1

Press Release, dated July 27, 2026.

104

Cover Page Interactive Data File, formatted in Inline XBRL

†

Certain of the exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The registrant agrees to furnish a copy of all omitted exhibits and schedules to the SEC upon its request.

SIGNATURE

Pursuant to the requirements

of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto

duly authorized.

Cartesian Growth Corporation II

By:

/s/ Peter Yu

Name: Peter Yu

Title: Chief Executive Officer

Date: July 27, 2026

EX-2.1 — EXHIBIT 2.1

EX-2.1

Filename: tm2621302d1_ex2-1.htm · Sequence: 2

Exhibit 2.1

BUSINESS COMBINATION AGREEMENT

BY AND BETWEEN

CARTESIAN GROWTH CORPORATION II

AND

INOBAT AS

DATED AS OF JULY 24, 2026

Table

of Contents

Page

Article 1 CERTAIN DEFINITIONS

Section 1.1

Definitions

Article 2 MERGER AND EXCHANGE

Section 2.1

Closing Transactions

Section 2.2

Closing of the Transactions Contemplated by this Agreement

Section 2.3

Allocation Schedule

Section 2.4

Treatment of Company Equity Awards, Company Convertible Notes

Section 2.5

Treatment of CGC Securities

Section 2.6

Deliverables

Section 2.7

Withholding

Article 3 REPRESENTATIONS AND WARRANTIES RELATING TO THE GROUP COMPANIES

Section 3.1

Organization and Qualification

Section 3.2

Capitalization of the Group Companies

Section 3.3

Authority

Section 3.4

Financial Statements; Undisclosed Liabilities

Section 3.5

Consents and Requisite Governmental Approvals; No Violations

Section 3.6

Permits

Section 3.7

Material Contracts

Section 3.8

Absence of Changes

Section 3.9

Litigation

Section 3.10

Compliance with Applicable Law

Section 3.11

Employee Plans

Section 3.12

Environmental Matters

Section 3.13

Intellectual Property

Section 3.14

Employee Matters

Section 3.15

Insurance

Section 3.16

Tax Matters

Section 3.17

Brokers

Section 3.18

Real and Personal Property

Section 3.19

Transactions with Affiliates

Section 3.20

Data Privacy and Security

Section 3.21

Compliance with International Trade & Anti-Corruption Laws

Section 3.22

Information Supplied

Section 3.23

Investigation; No Other Representations

Section 3.24

EXCLUSIVITY OF REPRESENTATIONS AND WARRANTIES

Article 4 REPRESENTATIONS AND WARRANTIES RELATING TO CGC

Section 4.1

Organization and Qualification

Section 4.2

Authority

Section 4.3

Consents and Requisite Governmental Approvals; No Violations

Section 4.4

Brokers

Section 4.5

Information Supplied

Section 4.6

Capitalization of CGC

Section 4.7

SEC Filings

Section 4.8

Trust Account

Section 4.9

Transactions with Affiliates

Section 4.10

Litigation

Section 4.11

Compliance with Applicable Law

Section 4.12

Business Activities

Section 4.13

Internal Controls; Listing; Financial Statements

-i-

Table

of Contents

(continued)

Page

Section 4.14

No Undisclosed Liabilities

Section 4.15

Tax Matters

Section 4.16

Investigation; No Other Representations

Section 4.17

Compliance with International Trade & Anti-Corruption Laws

Section 4.18

EXCLUSIVITY OF REPRESENTATIONS AND WARRANTIES

Article 5 COVENANTS

Section 5.1

Conduct of Business of the Company

Section 5.2

Efforts to Consummate; Litigation

Section 5.3

Confidentiality and Access to Information

Section 5.4

Public Announcements

Section 5.5

Tax Matters

Section 5.6

Exclusive Dealing

Section 5.7

Preparation of Registration Statement / Proxy Statement

Section 5.8

CGC Shareholder Approval

Section 5.9

Joinder Amendment; ListCo and Merger Sub Shareholder Approval

Section 5.10

Conduct of Business of CGC

Section 5.11

Nasdaq Listing

Section 5.12

Trust Account

Section 5.13

Company Shareholder Undertaking

Section 5.14

PIPE Financing

Section 5.15

Indemnification; Directors’ and Officers’ Insurance

Section 5.16

Post-Closing Directors and Officers

Section 5.17

PCAOB Financials

Section 5.18

Equity Incentive Plan; Key Person Employment Agreements

Section 5.19

Registration Rights Agreement and Lock-up Agreement

Section 5.20

Assignment and Assumption Agreement

Section 5.21

Company Indebtedness

Section 5.22

Agricultural Land Fund

Section 5.23

Ministry of Economy Notification

Section 5.24

Lot Size Support

Section 5.25

Waivers

Section 5.26

NDF II Consent

Article 6 CONDITIONS TO CONSUMMATION OF THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT

Section 6.1

Conditions to the Obligations of the Parties

Section 6.2

Other Conditions to the Obligations of CGC

Section 6.3

Other Conditions to the Obligations of the Company

Section 6.4

Frustration of Closing Conditions

Article 7 TERMINATION

Section 7.1

Termination

Section 7.2

Effect of Termination

Article 8 MISCELLANEOUS

Section 8.1

Non-Survival

Section 8.2

Entire Agreement; Assignment

Section 8.3

Amendment

Section 8.4

Notices

Section 8.5

Governing Law

Section 8.6

Fees and Expenses

-ii-

Table

of Contents

(continued)

Page

Section 8.7

Construction; Interpretation

Section 8.8

Exhibits and Schedules

Section 8.9

Parties in Interest

Section 8.10

Severability

Section 8.11

Counterparts; Electronic Signatures

Section 8.12

Knowledge of Company; Knowledge of CGC

Section 8.13

No Recourse

Section 8.14

Extension; Waiver

Section 8.15

Waiver of Jury Trial

Section 8.16

Submission to Jurisdiction

Section 8.17

Remedies

Section 8.18

Trust Account Waiver

Section 8.19

Legal Representation; Privilege

ANNEXES

Annex A

Key Supporting Company Shareholders

Annex B

Key Persons

-iii-

BUSINESS COMBINATION AGREEMENT

This

BUSINESS COMBINATION AGREEMENT (this “Agreement”), dated as of July 24, 2026, is made by and between Cartesian

Growth Corporation II, a Cayman Islands exempted company (“CGC”) and InoBat AS, a private limited company (aksjeselskap)

organized under the Laws of Norway and registered with registration number 927 439 948 in the Norwegian Register of Business Enterprises

(the “Company”). CGC and the Company shall be referred to herein from time to time collectively as the “Parties”.

Capitalized terms used but not otherwise defined herein have the meanings set forth in Section 1.1.

WHEREAS, CGC is a blank check

company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share

purchase, reorganization or similar business combination with one or more businesses;

WHEREAS, pursuant to the Governing

Documents of CGC, CGC is required to provide an opportunity for its shareholders to have their outstanding CGC Class A Shares redeemed

on the terms and subject to the conditions set forth therein in connection with obtaining the CGC Shareholder Approval;

WHEREAS,

as of the date of this Agreement, CGC II Sponsor LLC, a Cayman Islands limited liability company (the “Sponsor”),

owns 5,649,999 CGC Class A Shares and 1 CGC Class B Share;

WHEREAS, it is contemplated

that (i) the Company will cause the formation of InoBat B.V., a private company with limited liability (besloten vennootschap

met beperkte aansprakelijkheid) incorporated under the laws of the Netherlands (“ListCo”) and (ii) ListCo

will cause the formation of InoBat Cayman Merger Sub, a Cayman Islands exempted company and a wholly-owned subsidiary of ListCo (“Merger

Sub”), in each case for the purpose of consummating the transactions contemplated by this Agreement and the Ancillary Documents;

WHEREAS, the Transaction Share

Consideration (which includes the maximum number of Upfront Consideration Shares and the maximum number of Earn-Out Shares) values the

Company at an aggregate amount equal to $1,265,000,000;

WHEREAS, it is contemplated

that, promptly following the formation of ListCo, Company Shareholders who hold at least 90% of the outstanding Company Shares, Company

Shares to be issued upon conversion of the Company Convertible Notes, and Company Shares underlying Company Options will enter into an

irrevocable shareholder undertaking (the Company Shareholders that enter into such undertaking prior to the Closing, collectively, the

“Company Undertaking Shareholders”; and such undertaking, collectively, the “Company Shareholder

Undertaking”), to be executed by and among ListCo, the Company, and the Undertaking Company Shareholders, pursuant to which,

among other things, each Undertaking Company Shareholder: (a) will grant one or more powers of attorney permitting and directing

the respective authorized persons identified in such powers of attorney (acting on behalf of such Undertaking Company Shareholder) and

the proxyholders under such powers of attorney to, as applicable, execute (i) the Dutch Deeds of Issue, (ii) a notarized contribution

and transfer agreement or other share transfer agreement, in each case governed by Norwegian law, in a form and substance reasonably satisfactory

to CGC (the “Norwegian Share Transfer Deed”) or one or more alternative agreements which will cause ListCo to

own directly at least 90% of the outstanding Company Shares, Company Shares to be issued upon conversion of the Company Convertible Notes,

and Company Shares underlying Company Options at the Closing, and (iii) any Ancillary Documents to which such Undertaking Company

Shareholder is or will be a party (including an Earn-Out Agreement), (b) undertake to take all necessary or desirable actions in

connection with the transactions contemplated by this Agreement and the other Ancillary Documents, and (c) agree to certain covenants

to support the transactions contemplated by this Agreement and the other Ancillary Documents (including restrictions on the sale, disposition

or transfer of the Company Shares held by such Undertaking Company Shareholder (the “Undertaking Company Shares”)),

in each case, on the terms and subject to the conditions set forth in the Company Shareholder Undertaking;

WHEREAS, prior to the CGC

Merger, in accordance with this Agreement and the Company Shareholder Undertaking, the Undertaking Company Shareholders and ListCo shall

effect the Exchange;

WHEREAS, on the Closing Date,

(i) Merger Sub will merge with and into CGC (the “CGC Merger”), with CGC surviving the CGC Merger as a

wholly-owned Subsidiary of ListCo, and (ii) pursuant to the CGC Merger, each CGC Share shall be automatically converted as of the

CGC Merger Effective Time into the right to receive one (1) ListCo Common Share, in each case, on the terms and subject to the conditions

set forth in this Agreement;

WHEREAS,

concurrently with the execution of this Agreement, the Sponsor, CGC and the Company are entering into the sponsor support agreement

(the “Sponsor Support Agreement”), pursuant to which, among other things, the Sponsor shall agree to (a) vote

in favor of this Agreement and the transactions contemplated hereby (including the CGC Merger), (b) waive any adjustment to the conversion

ratio set forth in the Governing Documents of CGC, any other anti-dilution or similar protections with respect to the CGC Class B

Shares (whether resulting from the transactions contemplated by the Investor Subscription Agreements or otherwise), (c) not exercise

its right to convert the Sponsor Loans into CGC Private Warrants in connection with the Closing, and (d) amend the terms of the Sponsor

Loans such that, in connection with the Closing, the Sponsor Loans shall convert into ListCo Series B Preference Shares and ListCo

Warrants; in each case as set forth therein;

WHEREAS,

concurrently with the execution of this Agreement, each Company Shareholder listed on Annex A attached hereto (collectively,

the “Key Supporting Company Shareholders”) will duly execute and deliver to CGC a shareholder support

agreement (collectively, the “Shareholder Support Agreements”), pursuant to which, among other things, each

such Key Supporting Company Shareholder will agree to, among other things, (a) support and vote in favor of this Agreement, such

other Ancillary Documents to which the Company is or will be a party and the transactions contemplated hereby and thereby (including agreeing

to enter into a Company Shareholder Undertaking), (b) take, or cause to be taken, any actions necessary or advisable to cause certain

agreements to be terminated effective as of the Closing, and (c) a release of claims against the Company, CGC and Merger Sub;

WHEREAS, pursuant to the Assignment

and Assumption Agreement (as defined below) to be entered into in connection with the Closing by and among ListCo, CGC and Continental

in accordance with this Agreement, CGC shall assign to ListCo all of its rights, interests, and obligations in and under the CGC Warrant

Agreement, in each case with effect from the CGC Merger Effective Time;

WHEREAS,

at or prior to the Closing, CGC, the Sponsor and certain other investors, if applicable, may enter into one or more non-redemption

agreements (collectively, the “Non-Redemption Agreements”), pursuant to which Sponsor and such investors have

committed to hold or acquire, as applicable, and to not exercise redemption rights with respect to, certain CGC Shares in connection with

the transactions contemplated hereby;

WHEREAS, concurrently with

the execution of this Agreement, CGC, a certain institutional investor (the “Institutional PIPE Investor”) and

certain investors (together with the Institutional PIPE Investor, the “PIPE Investors”) are each entering into

securities purchase agreements (collectively, the “Investor Subscription Agreements”), pursuant to which, among

other things, each PIPE Investor has agreed to subscribe for on the Closing Date, and the Company has agreed to cause ListCo to issue

to each such PIPE Investor on the Closing Date, the number of ListCo Shares and ListCo Warrants set forth in the applicable Investor Subscription

Agreement in exchange for the purchase price set forth therein (the aggregate purchase price under all Investor Subscription Agreements,

collectively, the “PIPE Financing Amount”, and the financing under all Investor Subscription Agreements, collectively,

hereinafter referred to as, the “PIPE Financing”), on the terms and subject to the conditions set forth in the

applicable Investor Subscription Agreement;

WHEREAS, the Company has agreed

to form ListCo and to cause ListCo to become a party to this Agreement and the Investor Subscription Agreements promptly after the date

of this Agreement;

WHEREAS, at the Closing, the

Company or ListCo shall enter into employment agreements, in form and substance agreed to by the Company, CGC and the Key Persons (the

“Key Person Employment Agreements”) with each of the individuals set forth on Annex B (the “Key

Persons”);

WHEREAS, at the Closing, ListCo,

certain CGC Shareholders, and certain shareholders of the Company will enter into a Registration Rights Agreement, in a form to be mutually

agreed by the Company and CGC (the “Registration Rights Agreement”), pursuant to which, among other things,

the CGC Shareholders and the Company Shareholders party thereto will be granted certain registration rights with respect to their respective

Equity Securities of ListCo, in each case, on the terms and subject to the conditions therein;

WHEREAS, at the Closing, ListCo,

certain CGC Shareholders, and certain shareholders of the Company will enter into a Lock-up Agreement, in a form to be mutually agreed

by the Company and CGC (the “Lock-up Agreement”), pursuant to which, among other things, the CGC Shareholders

and the Company Shareholders party thereto will agree not to effect any sale or distribution of any Equity Securities of ListCo held by

any of them in accordance with the terms and conditions described in Schedule I hereto;

WHEREAS, at the Closing, CGC,

ListCo and each ODA Holder (as defined in Schedule I hereto) will enter into an orderly disposition agreement, in a form to be

mutually agreed by the Company and CGC (each, an “Orderly Disposition Agreement”), pursuant to which, among

other things, for the period of time specified in the Orderly Disposition Agreement, each ODA Holder shall agree to not sell ListCo Shares

in accordance with the terms and conditions described in Schedule I hereto;

WHEREAS, at or prior to the

Closing, the Company, CGC, ListCo and each Undertaking Company Shareholder shall enter into an earn-out agreement (each, an “Earn-Out

Agreement”) pursuant to which, among other things, the Undertaking Company Shareholders shall agree (i) that their

Earn-Out Shares shall not vest unless and until the respective Earn-Out Target has been achieved, (ii) to forfeit their Earn-Out

Shares if the relevant Earn-Out Target has not been achieved by the last date on which it could be achieved, (iii) not to directly

or indirectly transfer, subject to any Lien or otherwise dispose of their Earn-Out Shares unless and until they have vested, (iv) that

the Earn-Out Shares and Earn-Out Targets shall be adjusted to reflect appropriately the effect of any stock split, reverse stock split,

stock dividend (including any dividend or distribution of securities convertible into ListCo Common Shares), reorganization, recapitalization,

reclassification, combination, exchange of shares or other like change with respect to ListCo Common Shares occurring on or after the

Closing, (v) that any dividends or distributions payable on their Earn-Out Shares shall be set aside by ListCo and shall only be

paid upon the vesting, if any, of the respective Earn-Out Shares and (vi) that any unvested Earn-Out Shares that have not been forfeited

will become vested upon a Qualifying ListCo Change of Control;

WHEREAS, the CGC Board has

(a) approved this Agreement, such other Ancillary Documents to which CGC is or will be a party and the transactions contemplated

hereby and thereby (including the CGC Merger) and (b) recommended, among other things, approval of this Agreement and the transactions

contemplated by this Agreement (including the CGC Merger) by the holders of CGC Shares entitled to vote thereon;

WHEREAS, the board of directors

of the Company (the “Company Board”) has (a) approved this Agreement, such other Ancillary Documents to

which the Company is or will be a party and the transactions contemplated hereby and thereby and (b) recommended, among other things,

the approval of this Agreement, such other Ancillary Documents to which the Company is or will be a party and the transactions contemplated

hereby and thereby (including the CGC Merger and the Exchange) by the holders of Company Shares entitled to vote thereon;

WHEREAS, each of the Parties

intends that the Exchange shall, to the extent legally and factually possible, qualify as a tax neutral roll-over for tax purposes pursuant

to applicable Law; and

WHEREAS, for U.S. federal

(and applicable state or local) income tax purposes, each of the Parties hereby intends that (i) the Exchange and the CGC Merger,

taken together with the PIPE Financing and any third party financing, will constitute an integrated transaction that qualifies as a tax

free capital contribution pursuant to Section 351(a) of the Code, (ii) the Dutch Conversion will qualify as a “reorganization”

within the meaning of Section 368(a)(1)(F) of the Code, and (iii) this Agreement be, and hereby is, adopted as a “plan

of reorganization” pursuant to Section 368(a) of the Code and Treasury Regulations Section 1.368-2(g) (collectively

(i)-(iii) the “Intended Tax Treatment”).

NOW, THEREFORE, in consideration

of the premises and the mutual promises set forth herein and for other good and valuable consideration, the receipt and sufficiency of

which are hereby acknowledged, the Parties, each intending to be legally bound, hereby agree as follows:

Article 1

CERTAIN DEFINITIONS

Section 1.1           Definitions.

As used in this Agreement, the following terms have the respective meanings set forth below.

“Additional CGC

SEC Reports” has the meaning set forth in Section 4.7.

“Affiliate”

means, with respect to any Person, any other Person who directly or indirectly, through one or more intermediaries, controls, is controlled

by, or is under common control with, such Person. The term “control” means the possession, directly or indirectly, of the

power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities,

by contract or otherwise, and the terms “controlled” and “controlling” have meanings correlative thereto.

“Agreement”

has the meaning set forth in the introductory paragraph to this Agreement.

“Allocation Schedule”

has the meaning set forth in Section 2.3.

“Alternative Transaction

Break Fee” has the meaning set forth in Section 7.2(b).

“Ancillary

Documents” means the (a) Registration Rights Agreement, (b) Lock-up Agreement, (c) Sponsor Support

Agreement, (d) Shareholder Support Agreements, (e) Assignment and Assumption Agreement, (f) Investor Subscription Agreements,

(g) Non-Redemption Agreements, (h) Earn-Out Agreements, (i) Orderly Disposition Agreements and (j) each other agreement,

document, instrument and/or certificate contemplated by this Agreement executed or to be executed in connection with the transactions

contemplated hereby.

“Anti-Corruption

Laws” means, collectively, (a) the U.S. Foreign Corrupt Practices Act of 1977, as amended (FCPA), (b) the UK Bribery

Act 2010 and (c) any other applicable anti-bribery or anti-corruption Laws related to combatting bribery, corruption and money laundering.

“Business”

means the business of, directly or indirectly, developing, manufacturing, and commercializing lithium-ion (Li-ion) and sodium-ion

(Na-ion) battery cells and integrated battery energy storage systems (BESS) for the energy storage and mobility sectors.

“Business Combination

Proposal” has the meaning set forth in Section 5.8.

“Business Day”

means a day, other than a Saturday or Sunday, on which commercial banks in New York, New York; Bratislava, Slovak Republic; Oslo, Norway;

and the Cayman Islands; are open for the general transaction of business.

“Cayman Act”

means the Companies Act (As Revised) of the Cayman Islands.

“CGC”

has the meaning set forth in the introductory paragraph to this Agreement.

“CGC Acquisition

Proposal” means any transaction or series of related transactions under which CGC or any of its controlled Affiliates, directly

or indirectly, (i) acquires or otherwise purchases any other Person(s), (ii) engages in a business combination with any other

Person(s) or (iii) acquires or otherwise purchases all or a material portion of the assets or businesses of any other Person(s) (in

the case of each of clause (i), (ii) and (iii), whether by merger, consolidation, recapitalization, purchase or issuance of equity

securities, tender offer or otherwise). Notwithstanding the foregoing or anything to the contrary herein, none of this Agreement, the

Ancillary Documents or the transactions contemplated hereby or thereby shall constitute a CGC Acquisition Proposal.

“CGC Board”

has the meaning set forth in the recitals to this Agreement.

“CGC Board Recommendation”

has the meaning set forth in Section 5.8.

“CGC Bylaws”

has the meaning set forth in Section 2.1(a).

“CGC Certificate

of Incorporation” has the meaning set forth in Section 2.1(a).

“CGC Class A

Shares” means CGC’s Class A ordinary shares.

“CGC Class B

Shares” means CGC’s Class B ordinary shares.

“CGC Disclosure

Schedules” means the disclosure schedules to this Agreement delivered to the Company by CGC on the date of this Agreement.

“CGC

Expenses” means, as of any determination time, the aggregate amount of fees, expenses, commissions or other amounts incurred

by or on behalf of, or otherwise payable by, whether or not due, CGC in connection with the negotiation, preparation or execution of this

Agreement or any Ancillary Documents, the performance of its covenants or agreements in this Agreement or any Ancillary Document or the

consummation of the transactions contemplated hereby or thereby, including the fees and expenses of outside legal counsel, accountants,

advisors, brokers, investment bankers, consultants, or other agents or service providers of CGC, and any other fees, expenses, commissions

or other amounts that are expressly allocated to CGC pursuant to this Agreement or any Ancillary Document; provided that the

obligations of CGC to the Sponsor evidenced by the Sponsor Loans shall not be treated as CGC Expenses and, instead, shall be converted

as set forth in the Sponsor Support Agreement. Notwithstanding the foregoing or anything to the contrary herein, CGC Expenses shall not

include any Company Expenses.

“CGC Financial

Statements” means all of the financial statements of CGC included in the CGC SEC Reports.

“CGC Fundamental

Representations” means the representations and warranties set forth in Section 4.1 (Organization and Qualification),

Section 4.2 (Authority), Section 4.4 (Brokers) and Section 4.6(a) and Section 4.6(b) (Capitalization

of CGC).

“CGC Material

Adverse Effect” means any change, event, effect or occurrence that, individually or in the aggregate with any other change,

event, effect or occurrence, has had or would reasonably be expected to have a material adverse effect on the ability of CGC to consummate

the CGC Merger in accordance with the terms of this Agreement; provided, however, that none of the following shall be taken

into account in determining whether a CGC Material Adverse Effect has occurred or is reasonably likely to occur: any adverse change, event,

effect or occurrence arising after the date of this Agreement from or related to (i) general business or economic conditions in or

affecting Europe, or changes therein, or the global economy generally, (ii) any national or international political or social conditions

in Europe or any other country, including the engagement by Europe or any other country in hostilities, whether or not pursuant to the

declaration of a national emergency or war, or the occurrence in any place of any military or terrorist attack, sabotage or cyberterrorism,

(iii) changes in conditions of the financial, banking, capital or securities markets generally in Europe or any other country or

region in the world, or changes therein, including changes in interest rates in Europe or any other country and changes in exchange rates

for the currencies of any countries, (iv) changes in any applicable Laws, (v) any change, event, effect or occurrence that is

generally applicable to the industries or markets in which CGC operates, (vi) the execution or public announcement of this Agreement

or the pendency or consummation of the transactions contemplated by this Agreement, including the impact thereof on the relationships,

contractual or otherwise, of CGC with investors, contractors, lenders, suppliers, vendors, partners, licensors, licensees, payors or other

third parties related thereto (provided that the exception in this clause (vi) shall not apply to the representations and warranties

set forth in Section 4.3(b) to the extent that its purpose is to address the consequences resulting from the public announcement

or pendency or consummation of the transactions contemplated by this Agreement or the condition set forth in Section 6.2(a) to

the extent it relates to such representations and warranties); provided, however, that any change, event, effect or occurrence

resulting from a matter described in any of the foregoing clauses (i) through (v) may be taken into account in determining whether

a CGC Material Adverse Effect has occurred or is reasonably likely to occur to the extent such change, event, effect or occurrence has

or would reasonably be expected to have a disproportionate adverse effect on CGC, relative to other similarly situated SPACs operating

in the industries in which CGC operate.

“CGC Merger”

has the meaning set forth in the recitals to this Agreement.

“CGC Merger Surviving

Company” has the meaning set forth in Section 2.1(c)(ii).

“CGC Non-Party

Affiliates” means, collectively, each CGC Related Party and each of the former, current or future Affiliates, Representatives,

successors or permitted assigns of any CGC Related Party (other than, for the avoidance of doubt, CGC).

“CGC Private Placement

Warrants Purchase Agreements” means, the (a) Private Placement Warrants Purchase Agreement, dated as of May 10,

2022, by and between CGC and the Sponsor, and (b) Private Placement Warrants Purchase Agreement, dated as of May 10, 2022, by

and between CGC, Cantor Fitzgerald & Co. and Piper Sandler & Co.

“CGC Private Warrants”

means the 8,900,000 CGC Warrants that were issued by CGC pursuant to the CGC Private Placement Warrants Purchase Agreements.

“CGC

Public Warrants” means the 7,666,666 CGC Warrants that were issued by CGC in connection with its initial public offering.

“CGC Related Parties”

has the meaning set forth in Section 4.9.

“CGC Related Party

Transactions” has the meaning set forth in Section 4.9.

“CGC SEC Reports”

has the meaning set forth in Section 4.7.

“CGC Shareholder”

means each holder of CGC Class A Shares and each holder of CGC Class B Shares, in its capacity as holder.

“CGC Shareholder

Approval” means, collectively, the Required CGC Shareholder Approval and the Other CGC Shareholder Approval.

“CGC Shareholder

Redemption” means the right of the holders of CGC Class A Shares to redeem all or a portion of their CGC Class A

Shares (in connection with the transactions contemplated by this Agreement or otherwise) as set forth in Governing Documents of CGC.

“CGC Shareholders

Meeting” has the meaning set forth in Section 5.8.

“CGC Shares”

means, collectively, the CGC Class A Shares and CGC Class B Shares.

“CGC

Units” means units of CGC consisting of one CGC Class A Share and one-third of one CGC Public Warrant.

“CGC

Warrant Agreement” means that certain Warrant Agreement, dated as of May 10, 2022, by and between CGC and Continental,

as warrant agent.

“CGC

Warrants” means warrants to purchase CGC Class A Share as contemplated under the CGC Warrant Agreement, with

each warrant exercisable for one CGC Class A Share at an exercise price of $11.50.

“Change of Control

Payment” means (a) any success, change of control, retention, transaction bonus or other similar payment or amount

to any Person solely as a result of this Agreement, any Ancillary Document or the transactions contemplated hereby or thereby or (b) any

payments made or required to be made pursuant to or in connection with or upon termination of, and any fees, expenses or other payments

owing or that will become owing in respect of, any Company Related Party Transaction (in the case of this clause (b), regardless of whether

paid or payable prior to, at or after the Closing or in connection with or otherwise related to this Agreement or any Ancillary Document

or one or more circumstances, matters, transactions or events unrelated to this Agreement or the Ancillary Documents). Notwithstanding

the foregoing or anything to the contrary herein, Change of Control Payments shall not include (i) the ListCo Common Shares to be

issued in respect of or that will become subject to, as applicable, the Rollover Options at the Exchange Effective Time on the terms and

subject to the conditions of this Agreement, (ii) any payments made in the ordinary course of business consistent with past practice

and not accelerated, increased or enhanced as a result of the transactions contemplated hereby, (iii) any payments required under

existing Contracts entered into prior to the date of this Agreement in the ordinary course of business and not in contemplation of the

transactions contemplated hereby, (iv) any severance payments made pursuant to existing severance policies or agreements in effect

prior to the date of this Agreement that are triggered solely by termination of employment without cause or resignation for good reason

(and not by the consummation of the transactions contemplated hereby), and (v) any retention payments made to employees below the

level of vice president that do not exceed $50,000 per individual in the aggregate.

“Closing”

has the meaning set forth in Section 2.2.

“Closing Company

Audited Financial Statements” has the meaning set forth in Section 3.4(a).

“Closing Date”

has the meaning set forth in Section 2.2.

“Closing Filing”

has the meaning set forth in Section 5.4(b).

“Closing Press

Release” has the meaning set forth in Section 5.4(b).

“Code”

means the U.S. Internal Revenue Code of 1986, as amended.

“Company”

has the meaning set forth in the introductory paragraph to this Agreement.

“Company Acquisition

Proposal” means (a) any transaction or series of related transactions under which any Person(s), directly or indirectly,

(i) acquires or otherwise purchases the Company and its controlled Affiliates, taken as a whole, or a majority of the voting power

of Equity Securities of the Company, or (ii) acquires, is granted, leased or licensed or otherwise purchases all or a material portion

of assets, properties or businesses of the Company and its controlled Affiliates, taken as a whole (in the case of each of clause (i) and

(ii), whether by merger, consolidation, liquidation, dissolution, recapitalization, reorganization, amalgamation, scheme of arrangement,

purchase of assets, share exchange, business combination, purchase or issuance of Equity Securities, tender offer or otherwise), or (b) any

issuance, sale or acquisition of any portion of the Equity Securities or voting power or similar investment in the Company or any of its

Subsidiaries (other than the issuance of the applicable class of shares of the Company upon the exercise or conversion of any Company

Options outstanding on the date of this Agreement in accordance with the terms of the Company Equity Plan and the underlying grant, award

or similar agreement, or the Company Convertible Notes (as applicable)). Notwithstanding the foregoing or anything to the contrary herein,

none of this Agreement, the Ancillary Documents or the transactions contemplated hereby or thereby shall constitute a Company Acquisition

Proposal.

“Company Board”

has the meaning set forth in the recitals to this Agreement.

“Company

Convertible Notes” means the convertible notes identified in Section 3.2(a) of the Company Disclosure

Schedules.

“Company Convertible

Notes Conversion” has the meaning set forth in Section 2.4(b).

“Company Designees”

has the meaning set forth in Section 5.16(b).

“Company Disclosure

Schedules” means the disclosure schedules to this Agreement delivered to CGC by the Company on the date of this Agreement.

“Company Equity

Award” means, as of any determination time, each outstanding Company Option and each other outstanding award to any current

or former director, manager, officer, employee, individual independent contractor or other service provider of any Group Company of rights

of any kind to receive any Equity Security of any Group Company under any Company Equity Plan or otherwise that is outstanding.

“Company Equity

Plan” means, collectively, any plan that provides for the award to any current or former director, manager, officer, employee,

individual independent contractor or other service provider of any Group Company of rights of any kind to receive Equity Securities of

any Group Company or benefits measured in whole or in part by reference to Equity Securities of any Group Company.

“Company Expenses”

means, as of any determination time, the aggregate amount of fees, expenses, commissions or other amounts incurred by or on behalf of,

or otherwise payable by, whether or not due and payable, any Group Company in connection with, or as a result of, the negotiation, preparation

or execution of this Agreement or any Ancillary Documents, the performance of its covenants or agreements in this Agreement or any Ancillary

Document, or the consummation of the transactions contemplated hereby or thereby, including (a) the fees and expenses of outside

legal counsel, accountants, advisors, brokers, investment bankers, consultants, or other agents or service providers of any Group Company,

(b) any other fees, expenses, commissions or other amounts that are expressly allocated to any Group Company pursuant to this Agreement

or any Ancillary Document, and (c) any costs, fees and expenses incurred in connection with the preparation and audit of the PCAOB

Financials. Notwithstanding the foregoing or anything to the contrary herein, Company Expenses shall not include any CGC Expenses.

“Company Fundamental

Representations” means the representations and warranties set forth in Section 3.1(a) and Section 3.1(b) (Organization

and Qualification), Section 3.2(a), Section 3.2(c) and Section 3.2(h) (Capitalization

of the Group Companies), Section 3.3 (Authority), Section 3.8(a) (Absence of Changes),

and Section 3.17 (Brokers).

“Company Intellectual

Property” means all Intellectual Property Rights owned by the Group Companies.

“Company Licensed

Intellectual Property” means Intellectual Property Rights owned by any Person (other than a Group Company) that is licensed

to any Group Company.

“Company Material

Adverse Effect” means any change, event, effect or occurrence that, individually or in the aggregate with any other change,

event, effect or occurrence, has had or would reasonably be expected to have a material adverse effect on (a) the business, results

of operations or financial condition of the Group Companies, taken as a whole, or (b) the ability of the Company to consummate the

transactions contemplated hereunder in accordance with the terms of this Agreement; provided, however, that, in the case of clause

(a), none of the following shall be taken into account in determining whether a Company Material Adverse Effect has occurred or is reasonably

likely to occur: any adverse change, event, effect or occurrence arising after the date of this Agreement from or related to (i) general

business or economic conditions in or affecting Europe, or changes therein, or the global economy generally, (ii) any national or

international political or social conditions in Europe or any other country, including the engagement by Europe or any other country in

hostilities, whether or not pursuant to the declaration of a national emergency or war, or the occurrence in any place of any military

or terrorist attack, sabotage or cyberterrorism, (iii) changes in conditions of the financial, banking, capital or securities markets

generally in Europe or any other country or region in the world, or changes therein, including changes in interest rates in Europe or

any other country and changes in exchange rates for the currencies of any countries, (iv) changes in any applicable Laws or the interpretation

or enforcement thereof by any Governmental Entity, (v) any change, event, effect or occurrence that is generally applicable to the

industries or markets in which any Group Company operates, (vi) the execution or public announcement of this Agreement or the pendency

or consummation of the transactions contemplated by this Agreement, including the impact thereof on the relationships, contractual or

otherwise, of any Group Company with employees, customers, investors, contractors, lenders, suppliers, vendors, partners, licensors, licensees,

payors or other third parties related thereto (provided that the exception in this clause (vi) shall not apply to the representations

and warranties set forth in Section 3.5(b) to the extent that its purpose is to address the consequences resulting from

the public announcement or pendency or consummation of the transactions contemplated by this Agreement or the condition set forth in Section 6.2(a) to

the extent it relates to such representations and warranties), (vii) any failure by any Group Company to meet, or changes to, any

internal or published budgets, projections, forecasts, estimates or predictions (although the underlying facts and circumstances resulting

in such failure may be taken into account to the extent not otherwise excluded from this definition pursuant to clauses (i) through

(vi) or (viii)), or (viii) any hurricane, tornado, flood, earthquake, tsunami, natural disaster, mudslides, wild fires, epidemics,

pandemics or quarantines, acts of God or other natural disasters or comparable events in Europe or any other country or region in the

world, or any escalation of the foregoing, (ix) any actions taken or omitted to be taken by any Group Companies at the written request

or with the written consent of CGC, (x) any changes in IFRS or other applicable accounting standards or the interpretation thereof,

(xi) any loss of employees, customers, suppliers, distributors, licensors, licensees or other business partners to the extent resulting

from the public announcement or pendency of the transactions contemplated by this Agreement, or (xii) any litigation arising from

or relating to this Agreement or the transactions contemplated hereby; provided, however, that any change, event, effect or occurrence

resulting from a matter described in any of the foregoing clauses (i) through (v) or (viii) through (xii) may be taken

into account in determining whether a Company Material Adverse Effect has occurred or is reasonably likely to occur to the extent such

change, event, effect or occurrence has had or would reasonably be expected to have a disproportionate adverse effect on the Group Companies,

taken as a whole, relative to other participants operating in the industries or markets in which the Group Companies operate.

“Company Non-Party

Affiliates” means, collectively, each Company Related Party and each former, current or future Affiliates, Representatives,

successors or permitted assigns of any Company Related Party (other than, for the avoidance of doubt, the Company).

“Company Option”

means, as of any determination time, each option to purchase Company Shares that is outstanding and unexercised, whether granted under

a Company Equity Plan or otherwise.

“Company Option

Share Amount” means the aggregate number of Company Shares issuable upon the full exercise, exchange or conversion of Company

Options that are outstanding at the Exchange Effective Time, calculated using the treasury stock method.

“Company Product”

means each platform, service, existing product or product candidate that is being researched, tested, developed or manufactured by or

on behalf of the Group Companies.

“Company Related

Party” has the meaning set forth in Section 3.19.

“Company Related

Party Transactions” has the meaning set forth in Section 3.19.

“Company

Shareholder” means the holders of Company Shares as of any determination time prior to the Exchange Effective Time. For

the avoidance of doubt, the holders of the Company Convertible Notes will become Company Shareholders immediately prior to Closing,

upon conversion of the Company Convertible Notes pursuant to Section 2.4(b).

“Company Shareholder

Undertaking” has the meaning set forth in the recitals to this Agreement.

“Company

Shares” means the shares, par value NOK 0.01 per share, of the Company.

“Competing Transaction”

means an alternative business combination, transfer of a material portion of the Company’s direct or indirect assets, transfer,

issuance, or acquisition of more than 25% of the share capital of the Company or any of its material subsidiaries (or of securities convertible

or exchangeable into more than 25% of the share capital of the Company or any of its material subsidiaries), a merger, or any similar

transaction. Competing Transaction shall not include a good faith transaction undertaken solely to change domicile or corporate form so

long as there is no change in any of the ultimate beneficial ownership of the Company, its direct and indirect assets, and its business

and that of its subsidiaries.

“Confidentiality

Agreement” means that certain Confidentiality Agreement, dated as of February 11, 2026, by and between the Company

and CGC.

“Consent”

means any notice, authorization, qualification, registration, filing, notification, waiver, order, consent or approval to be obtained

from, filed with or delivered to, a Governmental Entity or other Person.

“Continental”

means Continental Stock Transfer & Trust Company.

“Contract”

or “Contracts” means any written agreement, contract, license, lease, obligation, undertaking or other commitment

or arrangement that is legally binding upon a Person or any of his, her or its properties or assets.

“D&O Persons”

has the meaning set forth in Section 5.15(a).

“Dutch Conversion”

has the meaning set forth in the recitals to this Agreement.

“Dutch Deeds of

Issue” means each deed governed by Dutch law in form and substance reasonably satisfactory to CGC and the Company, pursuant

to which ListCo will issue, as applicable, (i) ListCo Common Shares to the Undertaking Company Shareholders in accordance with Section 2.1(a),

or (ii) ListCo Common Shares to the Exchange Agent, acting solely for the account and benefit of the CGC Shareholders as of immediately

prior to the CGC Merger Effective Time (after giving effect to the PIPE Financing) in accordance with Section 2.1(c)(i).

“Earn-Out 1 Shares”

means a number of ListCo Common Shares equal to the product of (a) the quotient of (i) $115,000,000 and (ii) $10.20 and

(b) the Undertaking Company Percentage.

“Earn-Out 1 Target”

means the start of commissioning of Project Kamzik, including the production line in the Project Kamzik’s facility in Šurany,

Slovakia before December 31, 2027. For the avoidance of doubt, the start of commissioning for purposes of the Earn-Out 1 Target means

the time when the pilot production line in Project Kamzik is operational and starts to produce lithium-ion battery cells.

“Earn-Out 2 Shares”

means a number of ListCo Common Shares equal to the product of (a) the quotient of (i) $287,500,000 and (ii) $10.20 and

(b) the Undertaking Company Percentage.

“Earn-Out

2 Target” means the EBITDA of ListCo for either of fiscal years 2026 or 2027 being greater than €47,000,000.

“Earn-Out 3 Shares”

means a number of ListCo Common Shares equal to the product of (a) the quotient of (i) $287,500,000 and (ii) $10.20 and

(b) the Undertaking Company Percentage.

“Earn-Out

3 Target” means the EBITDA of ListCo for either of fiscal years 2027 or 2028 being greater than €87,000,000.

“Earn-Out Agreements”

has the meaning set forth in the recitals to this Agreement.

“Earn-Out Shares”

means, collectively, the Earn-Out 1 Shares, the Earn-Out 2 Shares and the Earn-Out 3 Shares.

“Earn-Out Targets”

means, collectively, the Earn-Out 1 Target, the Earn-Out 2 Target and the Earn-Out 3 Target.

“EBITDA”

means, for any period, the net income (or, if applicable, net loss) as reported in ListCo’s audited financials, as filed with the

SEC, on a consolidated basis for such period plus (or minus), in each case if and to the extent deducted in (or added in) computing net

income (or, if applicable, net loss) for such period: (a) interest or financial expense or income; (b) income tax expenses,

benefits or credits; (c) depreciation; and (d) amortization, in each case calculated in accordance with IFRS and audited by

ListCo’s auditors in accordance with the standards of the PCAOB.

“Employee Benefit

Plan” means each “employee benefit plan” and each other benefit or compensatory plan, program,

policy or Contract that any Group Company maintains, sponsors or contributes to, or under or with respect to which any Group Company has

any Liability, other than any plan sponsored or maintained by a Governmental Entity.

“Environmental

Laws” means any federal, state, local, municipal, foreign, international, or multinational law, regulation, or other applicable

requirement, policy, guidance or treaty relating to (a) releases or threatened release of Hazardous Substance; (b) pollution

or protection of employee health or safety, public health or the environment; or (c) the manufacture, handling, transport, use, treatment,

storage, or disposal of Hazardous Substances.

“Equity Securities”

means any share, share capital, capital stock, partnership, membership, joint venture or similar interest in any Person (including any

stock appreciation, phantom stock, profit participation or similar rights), and any option, warrant, right or security (including debt

securities) convertible, exchangeable or exercisable therefor.

“Exchange”

has the meaning set forth in Section 2.1(a)(i).

“Exchange Act”

means the Securities Exchange Act of 1934.

“Exchange Agent”

has the meaning set forth in Section 2.6(a).

“Exchange Agent

Agreement” has the meaning set forth in Section 2.6(a).

“Exchange Effective

Time” has the meaning set forth in Section 2.1(a)(i).

“Exchange Fund”

has the meaning set forth in Section 2.6(b).

“Exchange Ratio”

means the quotient obtained by dividing (a) the Transaction Share Consideration, by (b) the number of Fully-Diluted Shares.

“FDI

Authorities” means, collectively, the Ministry of Economy of the Slovak Republic, if competent under Slovak foreign

direct investment laws, and any other Governmental Entity competent under foreign direct investment laws of the applicable jurisdiction

to conduct investigations concerning a screening of foreign investments in respect of the transactions contemplated hereby.

“Federal Securities

Laws” means the Exchange Act, the Securities Act and the other U.S. federal securities laws and the rules and regulations

of the SEC promulgated thereunder or otherwise.

“Financial Statements”

has the meaning set forth in Section 3.4(a).

“Fraud”

means an act or omission by a Party, and requires: (a) a false or incorrect representation or warranty expressly set forth in this

Agreement, (b) with actual knowledge (as opposed to constructive, imputed or implied knowledge) by the Party making such representation

or warranty that such representation or warranty expressly set forth in this Agreement is false or incorrect, (c) an intention to

deceive another Party, to induce such Party to enter into this Agreement, (d) an intention to deceive another Party, in justifiable

or reasonable reliance upon such false or incorrect representation or warranty expressly set forth in this Agreement, causing such Party

to enter into this Agreement, and (e) an intention to deceive another Party to suffer damage by reason of such reliance. For the

avoidance of doubt, “Fraud” does not include any claim for equitable fraud, promissory fraud, unfair dealings

fraud or any torts (including a claim for fraud or alleged fraud) based on negligence or recklessness.

“Fully-Diluted

Shares” means an amount equal to, without duplication, (a) the aggregate number of Company Shares that are issued and

outstanding as of immediately prior to the Exchange Effective Time (after the conversion of the Company Convertible Notes), plus

(b) the Company Option Share Amount, plus (c) the aggregate number of Company Shares issuable upon the full exercise,

exchange or conversion of any other Equity Securities of the Company outstanding as of immediately prior to the Exchange Effective Time.

“GAAP”

means United States generally accepted accounting principles.

“Governing Document

Proposals” has the meaning set forth in Section 5.8.

“Governing Documents”

means the legal document(s) by which any Person (other than an individual) establishes its legal existence or which govern its internal

affairs. For example, the “Governing Documents” of a U.S. corporation are its certificate or articles of incorporation

and by-laws, the “Governing Documents” of a U.S. limited partnership are its limited partnership agreement and

certificate of limited partnership, the “Governing Documents” of a U.S. limited liability company are its operating

or limited liability company agreement and certificate of formation and the “Governing Documents” of a Cayman

Islands exempted company are its memorandum and articles of association.

“Governmental

Entity” means any United States or non-United States (a) federal, state, local, municipal or other government, (b) governmental

or quasi-governmental entity of any nature (including any governmental agency, branch, department, official, or entity and any court or

other tribunal) or (c) body exercising or entitled to exercise any administrative, executive, judicial, legislative, police, regulatory,

or taxing authority or power of any nature, including any arbitral tribunal (public or private).

“Group Company”

and “Group Companies” means, collectively, the Company and its Subsidiaries.

“Hazardous Substance”

means any pollutant, contaminant or toxic or hazardous material, substance or waste or petroleum, or any fraction thereof.

“IFRS”

means the International Financial Reporting Standards as issued by the International Accounting Standards Board.

“Indebtedness”

means, as of any time, without duplication, with respect to any Person, the outstanding principal amount of, accrued and unpaid interest

on, fees and expenses arising under or in respect of (a) indebtedness for borrowed money, (b) other obligations evidenced by

any note, bond, debenture or other debt security (including, for the avoidance of doubt, the Company Convertible Notes), (c) obligations

for the deferred purchase price of property or assets, including “earn-outs” and “seller notes”

(but excluding any trade payables arising in the ordinary course of business), (d) reimbursement and other obligations with respect

to letters of credit, bank guarantees, bankers’ acceptances or other similar instruments, in each case, solely to the extent drawn,

(e) leases required to be capitalized under GAAP or IFRS, as applicable, (f) derivative, hedging, swap, foreign exchange or

similar arrangements, including swaps, caps, collars, hedges or similar arrangements, and (g) any of the obligations of any other

Person of the type referred to in clauses (a) through (f) above directly or indirectly guaranteed by such Person or secured

by any assets of such Person, whether or not such Indebtedness has been assumed by such Person.

“Initial Company

Designee” has the meaning set forth in Section 5.16(b).

“Intellectual

Property Rights” means all intellectual property rights and related priority rights protected, created or arising under

the Laws of Slovakia or the European Union or any other jurisdiction or under any international convention, including all (a) patents

and patent applications, industrial designs and design patent rights, including any continuations, divisionals, continuations-in-part

and provisional applications and statutory invention registrations, and any patents issuing on any of the foregoing and any reissues,

reexaminations, substitutes, supplementary protection certificates, extensions of any of the foregoing; (b) trademarks, service marks,

trade names, service names, brand names, trade dress rights, logos, Internet domain names, corporate names and other source or business

identifiers, together with the goodwill associated with any of the foregoing, and all applications, registrations, extensions and renewals

of any of the foregoing; (c) copyrights and works of authorship, database and design rights, mask work rights and moral rights, whether

or not registered or published, and all registrations, applications, renewals, extensions and reversions of any of any of the foregoing;

(d) trade secrets, know-how and confidential and proprietary information, including invention disclosures, inventions and formulae,

whether patentable or not; and (e) rights in or to Software or other technology.

“Intended Tax

Treatment” has the meaning set forth in the recitals to this Agreement.

“Investment Company

Act” means the Investment Company Act of 1940.

“Investor Subscription

Agreements” has the meaning set forth in the recitals to this Agreement.

“IPO”

has the meaning set forth in Section 8.18.

“JOBS Act”

means the Jumpstart Our Business Startups Act of 2012.

“Key Supporting

Company Shareholders” has the meaning set forth in the recitals to this Agreement.

“Law”

means any federal, state, local, foreign, national or supranational statute, law (including common law, and, if applicable, fiduciary

or similar duties), act, statute, ordinance, treaty, rule, code, regulation or other binding directive or guidance issued, promulgated

or enforced by a Governmental Entity having jurisdiction over a given matter.

“Leased Real Property”

has the meaning set forth in Section 3.18(b).

“Liability”

or “liability” means any and all debts, liabilities and obligations, whether accrued or fixed, absolute or contingent,

known or unknown, matured or unmatured or determined or determinable, including those arising under any Law (including any Environmental

Law), Proceeding or Order and those arising under any Contract, agreement, arrangement, commitment or undertaking.

“Lien”

means any mortgage, pledge, security interest, encumbrance, lien, license or sub-license, charge, or other similar encumbrance or interest

(including, in the case of any Equity Securities, any voting, transfer or similar restrictions).

“ListCo Board”

means, at any time after the Exchange Effective Time, the duly constituted board of directors of ListCo.

“ListCo Common

Shares” means the common shares, par value twelve eurocents per share, of ListCo.

“ListCo Preference

Shares” means, collectively, the ListCo Series A Preference Share and the ListCo Series B Preference Shares.

“ListCo Series A

Preference Shares” means the 12.0% Series A Cumulative Convertible Preference Shares of ListCo.

“ListCo Series B

Preference Shares” means the Series B Convertible Preference Shares of ListCo.

“ListCo Shares”

means (a) prior to the consummation of the CGC Merger, collectively, the nominal placeholder shares; and (b) after the

consummation of the Exchange, collectively, the ListCo Common Shares and the ListCo Preference Shares. Any reference to ListCo Shares

in this Agreement or any Ancillary Document shall be deemed to refer to clause (a) or clause (b) of this definition, as the

context so requires.

“ListCo Warrants”

means the warrants to purchase ListCo Common Shares, each ListCo Warrant exercisable for one ListCo Common Share at an exercise price

of $12.00 per share.

“Material Contracts”

has the meaning set forth in Section 3.7(a).

“Material Permits”

has the meaning set forth in Section 3.6.

“Merger Sub”

has the meaning set forth in the introductory paragraph to this Agreement.

“Nasdaq”

means the Nasdaq Capital Market.

“Nasdaq Proposal”

has the meaning set forth in Section 5.8.

“NDF II”

means National Development Fund II, a.s., a joint-stock company (akciová spoločnosť) incorporated and existing

under the laws of the Slovak Republic, with its registered seat at Grosslingova 44, 811 09 Bratislava, Slovak Republic, registered in

the Commercial Register of the Municipal Court Bratislava III, Section Sa, Insert 5948/B.

“NOK”

means the Norwegian krone, the currency of the Kingdom of Norway.

“Non-Party Affiliate”

has the meaning set forth in Section 8.13.

“Norwegian Share

Transfer Deed” has the meaning set forth in the recitals to this Agreement.

“Off-the-Shelf

Software” means any Software that is made generally and widely available to the public on a commercial basis and is licensed

to any of the Group Companies on a non-exclusive basis under standard terms and conditions for a one-time license fee of less than $100,000

per license or an ongoing licensee fee of less than $50,000 per year.

“Officers”

has the meaning set forth in Section 5.16(a).

“Order”

means any outstanding writ, order, judgment, injunction, decision, determination, award, ruling, subpoena, verdict or decree entered,

issued or rendered by any Governmental Entity.

“Orderly Disposition

Agreement” has the meaning set forth in the recitals to this Agreement.

“Other CGC Shareholder

Approval” means the approval of each Other Transaction Proposal by the affirmative vote of the holders of the requisite

number of CGC Shares entitled to vote thereon, whether in person or by proxy at the CGC Shareholders Meeting (or any adjournment thereof),

in accordance with the Governing Documents of CGC and applicable Law.

“Other Transaction

Proposal” means each Transaction Proposal, other than the Required Transaction Proposals.

“Outside Shareholder”

means a holder of ListCo Shares who did not receive Earn-Out Shares in connection with the Closing; provided, for the avoidance of doubt,

that any Company Shareholder who did not execute a Company Shareholder Undertaking prior to the Closing shall not be an Outside Shareholder.

“Parties”

has the meaning set forth in the introductory paragraph to this Agreement.

“PCAOB”

means the Public Company Accounting Oversight Board.

“Permits”

means any approvals, authorizations, clearances, declarations of conformity, licenses, registrations, permits or certificates of a Governmental

Entity.

“Permitted Liens”

means (a) mechanic’s, materialmen’s, carriers’, repairers’ and other similar statutory Liens arising or incurred

in the ordinary course of business for amounts that are not yet due and payable or are being contested in good faith by appropriate proceedings

and for which sufficient reserves have been established in accordance with GAAP or IFRS, as applicable, (b) Liens for Taxes, assessments

or other governmental charges not yet due and payable as of the Closing Date or which are being contested in good faith by appropriate

proceedings and for which sufficient reserves have been established in accordance with GAAP or IFRS, as applicable, (c) encumbrances

and restrictions on real property (including easements, covenants, conditions, rights of way and similar restrictions) that do not prohibit

or materially interfere with any of the Group Companies’ use or occupancy of such real property, (d) zoning, building codes

and other land use Laws regulating the use or occupancy of real property or the activities conducted thereon which are imposed by any

Governmental Entity having jurisdiction over such real property and which are not violated by the use or occupancy of such real property

or the operation of the businesses of the Group Company and do not prohibit or materially interfere with any of the Group Companies’

use or occupancy of such real property, (e) cash deposits or cash pledges to secure the payment of workers’ compensation, unemployment

insurance, social security benefits or obligations arising under similar Laws or to secure the performance of public or statutory obligations,

surety or appeal bonds, and other obligations of a like nature, in each case in the ordinary course of business and which are not yet

due and payable, (f) grants by any Group Company of non-exclusive rights in non-material Intellectual Property Rights in the ordinary

course of business consistent with past practice, (g) grants by any Group Company of Liens in connection with any Indebtedness described

in Section 5.1(b)(vi) of the Company Disclosure Schedule, and (h) other Liens that do not materially and adversely

affect the value, use or operation of the asset subject thereto.

“Person”

means an individual, partnership, corporation, limited liability company, joint stock company, unincorporated organization or association,

trust, joint venture or other similar entity, whether or not a legal entity or Governmental Entity.

“Personal Data”

means any data or information relating to an identified natural person that is regulated by the Privacy Laws.

“PIPE Financing”

has the meaning set forth in the recitals to this Agreement.

“PIPE Financing

Amount” has the meaning set forth in the recitals to this Agreement.

“PIPE Investors”

has the meaning set forth in the recitals to this Agreement.

“Plan of Merger”

has the meaning set forth in Section 2.1(c)(i).

“Privacy and Data

Security Policies” has the meaning set forth in Section 3.20(a).

“Privacy Laws”

means Laws relating to the Processing or protection of Personal Data that apply to the Group Companies.

“Proceeding”

means any lawsuit, litigation, action, audit, examination, claim, complaint, charge, proceeding, suit or arbitration (in each case, whether

civil, criminal or administrative and whether public or private) pending by or before or otherwise involving any Governmental Entity.

“Process”

(or “Processing” or “Processes”) means the collection, use, storage, processing, recording,

distribution, transfer, import, export, protection (including security measures), disposal or disclosure or other activity regarding data

(whether electronically or in any other form or medium).

“Project

Kamzik” means the development of a lithium-ion battery “gigafactory” in joint venture with Gotion GmbH in Šurany,

Slovakia.

“Prospectus”

has the meaning set forth in Section 8.18.

“Public Financial

Aid Scheme” means any and all present or past aid, grant, subsidy, incentive, contribution, allowance, benefit, support,

loan, guarantee, indemnity, preferential arrangement, comfort, relief, exemption, deferral, waiver or other financial or non-financial

advantage of any kind, whether repayable or non-repayable, conditional or unconditional, direct or indirect, in cash or in kind, received,

approved, applied for, committed, notified or which the Company or any Group Company is entitled to receive or apply for, from or by virtue

of: (a) any Governmental Entity, state body, public authority, public institution, regional or municipal authority, state-owned enterprise

or any other entity exercising public functions or acting on behalf of the Slovak Republic, any other member state of the European Union

or any other state or supranational entity; (b) any scheme, programme, measure or instrument not covered in paragraph (a) above

but which constitutes, or may constitute, state aid, de minimis aid, public support or a financial benefit within the

meaning of any applicable EU or Slovak law; (c) any amendment, extension, renewal, top-up, novation, replacement or successor of

any scheme or measure falling within paragraphs (a) or (b) above; and (d) any indirect benefit received by virtue of the

Group Company being part of a group of companies which has received any of the foregoing, to the extent such benefit is attributable to

the relevant Group Company; in each case regardless of (i) whether such aid, benefit or support has been formally notified to or

approved by the European Commission or any other relevant authority, (ii) whether such aid, benefit or support is subject to any

repayment obligation, clawback, recovery order, retention condition, maintenance of investment condition or other condition, and (iii) whether

such aid, benefit or support has been fully drawn, partially drawn, committed but undrawn, conditionally approved or subject to any pending

application or notification.

“Public Shareholders”

has the meaning set forth in Section 8.18.

“Public Software”

means any Software that contains, includes, incorporates, or has instantiated therein, or is derived in any manner (in whole or in part)

from, any Software that is distributed as free software, open source software (e.g., Linux) or similar licensing or distribution models,

including under any terms or conditions that impose any requirement that any Software using, linked with, incorporating, distributed with

or derived from such Public Software (a) be made available or distributed in source code form; (b) be licensed for purposes

of making derivative works; or (c) be redistributable at no, or a nominal, charge.

“Qualifying ListCo

Change of Control” means a bona fide transaction, including a series of related transactions, pursuant to which both (a) Outside

Shareholders receive cash consideration of the greater of (x) the pro rata consideration payable per share to each holder of ListCo

Common Shares and (y) $20.00 per ListCo Common Share (such $20.00 amount to be adjusted to reflect any share consolidations or combinations

or similar events) and (b) either or both: (i) all of the material assets of ListCo are acquired in a transaction by a person

(natural or legal) who, together with its affiliates, did not previously own more than 10% of the ListCo Common Shares or (ii) a

person (natural or legal) who, together with its affiliates, did not previously own more than 10% of the ListCo Common Shares, acquiring

at least 50% of ListCo Common Shares (as measured by value); in each case, so long as each holder of ListCo Preference Shares is entitled

to receive the same cash consideration per ListCo Common Share payable to the holders of ListCo Common Shares in respect of the ListCo

Common Shares that such holder of ListCo Preference Shares is entitled to receive in respect of such holder’s ListCo Preference

Shares, including if such ListCo Preference Shares are deemed converted at the closing of such bona fide transaction.

“Real Property

Leases” means all leases, sub-leases, licenses or other agreements, in each case, pursuant to which any Group Company leases

or sub-leases any real property.

“Registration

Statement / Proxy Statement” means a registration statement on Form F-4 relating to the transactions contemplated by

this Agreement and the Ancillary Documents and containing a prospectus and proxy statement of CGC.

“Representatives”

means with respect to any Person, such Person’s Affiliates and its and such Affiliates’ respective directors, managers, officers,

employees, accountants, consultants, advisors, attorneys, agents and other representatives.

“Required CGC

Shareholder Approval” means the approval of each Required Transaction Proposal by the affirmative vote of the holders of

the requisite number of CGC Shares entitled to vote thereon, whether in person or by proxy at the CGC Shareholders Meeting (or any adjournment

thereof), in accordance with the Governing Documents of CGC and applicable Law.

“Required Governing

Document Proposals” means the Governing Document Proposals solely to the extent related to the amendments to the Governing

Documents of CGC.

“Required Transaction

Proposals” means, collectively, the Business Combination Proposal, the CGC Merger Proposal, the Nasdaq Proposal, and the

Required Governing Document Proposals.

“Rollover Option”

has the meaning set forth in Section 2.4(a).

“RPSP

of Public Sector Partners and on Amendments and Supplements to Some Act, as amended.

“Sanctioned Countries”

has the meaning set forth in Section 4.17(a).

“Sanctions and

Export Control Laws” means any applicable Law related to (a) import and export controls, including the U.S. Export

Administration Regulations, (b) economic sanctions, including those administered by the Office of Foreign Assets Control of the U.S.

Department of the Treasury, the U.S. Department of State, the European Union, any European Union Member State, the United Nations, and

His Majesty’s Treasury of the United Kingdom or (c) anti-boycott measures.

“Sarbanes-Oxley

Act” means the Sarbanes-Oxley Act of 2002.

“Schedules”

means, collectively, the Company Disclosure Schedules and the CGC Disclosure Schedules.

“SEC”

means the U.S. Securities and Exchange Commission.

“Securities Act”

means the U.S. Securities Act of 1933.

“Securities Laws”

means Federal Securities Laws and other applicable foreign and domestic securities or similar Laws.

“Shareholder

Support Agreements” has the meaning set forth in the recitals to this Agreement.

“Signing Filing”

has the meaning set forth in Section 5.4(b).

“Signing Press

Release” has the meaning set forth in Section 5.4(b).

“Slovak Social

Insurance Agency” (Slovak: Sociálna poisťovňa) means the state-run institution responsible for

the pension and social security.

“Software”

shall mean any and all (a) computer programs, including any and all software implementations of algorithms, models and methodologies,

whether in source code or object code; (b) databases and compilations, including any and all data and collections of data, whether

machine readable or otherwise; (c) descriptions, flowcharts and other work product used to design, plan, organize and develop any

of the foregoing, screens, user interfaces, report formats, firmware, development tools, templates, menus, buttons and icons; and (d) all

documentation, including user manuals and other training documentation, related to any of the foregoing.

“Specified Breach

Break Fee” has the meaning set forth in Section 7.2(c).

“Sponsor”

has the meaning set forth in the recitals to this Agreement.

“Sponsor Loans”

means any loan made to CGC by any of the Sponsor, an affiliate of the Sponsor, or any of CGC’s or the Sponsor’s management

team, as evidenced by one or more promissory notes, for the purpose of financing CGC.

“Sponsor

Support Agreement” has the meaning set forth in the recitals to this Agreement.

“Subsidiary”

means, with respect to any Person, any corporation, limited liability company, partnership or other legal entity of which (a) if

a corporation, a majority of the total voting power of Equity Securities entitled (without regard to the occurrence of any contingency)

to vote in the election of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by such

Person or one or more of the other Subsidiaries of such Person or a combination thereof, or (b) if a limited liability company, partnership,

association or other business entity (other than a corporation), a majority of the partnership or other similar ownership interests thereof

is at the time owned or controlled, directly or indirectly, by such Person or one or more Subsidiaries of such Person or a combination

thereof and for this purpose, a Person or Persons own a majority ownership interest in such a business entity (other than a corporation)

if such Person or Persons shall be allocated a majority of such business entity’s gains or losses or shall be a, or control any,

managing director or general partner of such business entity (other than a corporation). The term “Subsidiary”

shall include all Subsidiaries of such Subsidiary.

“Tax”

means any federal, state, local or non-United States income, gross receipts, franchise, estimated, alternative minimum, sales, use, transfer,

value added, excise, stamp, customs, duties, ad valorem, real property, personal property (tangible and intangible), capital stock, social

security, unemployment, payroll, wage, employment, severance, occupation, registration, environmental, communication, mortgage, profits,

license, lease, service, goods and services, withholding, premium, turnover, windfall profits or other taxes of any kind whatever, whether

computed on a separate or combined, unitary or consolidated basis or in any other manner, together with any interest, deficiencies, penalties,

additions to tax, or additional amounts imposed by any Governmental Entity with respect thereto, whether disputed or not, and including

any secondary Liability for any of the aforementioned.

“Tax Authority”

means any Governmental Entity responsible for the collection or administration of Taxes or Tax Returns.

“Tax Return”

means returns, information returns, statements, declarations, claims for refund, schedules, attachments and reports relating to Taxes

required to be filed with any Governmental Entity.

“Termination Date”

has the meaning set forth in Section 7.1(d).

“Transaction Litigation”

has the meaning set forth in Section 5.2(c).

“Transaction Proposals”

has the meaning set forth in Section 5.8.

“Transaction

Share Consideration” means an aggregate number of ListCo Common Shares equal to the sum of (a) the Upfront Consideration

Shares plus (b) the Earn-Out Shares.

“Trust Account”

has the meaning set forth in Section 8.18.

“Trust Account

Released Claims” has the meaning set forth in Section 8.18.

“Trust Agreement”

has the meaning set forth in Section 4.8.

“Trustee”

has the meaning set forth in Section 4.8.

“Undertaking Company

Percentage” means the quotient of (a) the sum of (i) the number of Undertaking Company Shares outstanding as of

immediately prior to the Closing (including Company Shares to be issued upon conversion of the Company Convertible Notes held by Undertaking

Company Shareholders) and (ii) the number of Company Shares underlying Company Options held by Undertaking Company Shareholders that

are outstanding as of immediately prior to the Closing (calculated using the treasury stock method) and (b) the Fully-Diluted Shares.

“Undertaking Company

Shareholders” has the meaning set forth in the recitals to this Agreement.

“Undertaking Company

Shares” has the meaning set forth in the recitals to this Agreement.

“Unpaid CGC Expenses”

means the CGC Expenses that are unpaid as of immediately prior to the Closing.

“Unpaid Company

Expenses” means the Company Expenses that are unpaid as of immediately prior to the Closing.

“Unvested Company

Option” means each Company Option outstanding as of immediately prior to the Exchange Effective Time that is not a Vested

Company Option.

“Upfront

Consideration Shares” means a number of ListCo Common Shares equal to the product of (a) the quotient of (i) the

Upfront Consideration Value and (ii) $10.20 and (b) Undertaking Company Percentage.

“Upfront Consideration

Value” means $575,000,000.

“Vested Company

Option” means each Company Option outstanding as of immediately prior to the Exchange Effective Time that is vested as of

immediately prior to the Exchange Effective Time or will vest as a result of the consummation of the Exchange.

“Willful Breach”

means a material breach of this Agreement by a Party that is a consequence of an act undertaken or a failure to act by the breaching Party

with the knowledge that the taking of such act or such failure to act would, or would reasonably be expected to, constitute or result

in a breach of this Agreement.

Article 2

MERGER AND EXCHANGE

Section 2.1           Closing

Transactions. On the terms and subject to the conditions set forth in this Agreement, the following transactions shall occur in the

order set forth in this Section 2.1:

(a)            Exchange.

(i)            At

the Closing, prior to giving effect to the CGC Merger (the “Exchange Effective Time”), pursuant to the Company

Shareholder Undertaking, and in accordance with the provisions of Section 2:204b of the Dutch Civil Code (Burgerlijk Wetboek),

each Undertaking Company Shareholder as of immediately prior to the Closing, shall sell, contribute or cancel, as applicable, each Undertaking

Company Share to, or for the benefit, of ListCo, and receive a number of ListCo Common Shares equal to the Exchange Ratio by, among other

things, entering into with ListCo (A) a Norwegian Share Transfer Deed in a form and substance reasonably satisfactory to CGC, pursuant

to which each Undertaking Company Shareholder shall sell or contribute, assign and transfer to ListCo the Undertaking Company Shares owned

by such Undertaking Company Shareholder, (B) a Dutch Deed of Issue, under which each Undertaking Company Share issued and outstanding

as of immediately prior to the Closing shall be exchanged for a number of ListCo Common Shares equal to the Exchange Ratio or (C) an

alternative agreement or deed that is reasonably acceptable to the Company and CGC which provides for an alternative mechanism which results

in the issuance to such Undertaking Company Shareholder of same number of ListCo Common Shares and the cancellation of such Undertaking

Company Shareholder’s ownership of the same number of Undertaking Company Shares (the transactions contemplated by this Section 2.1(a)(i),

the “Exchange”).

(ii)            Notwithstanding

any other provision of this Agreement to the contrary, if there are any Company Shares that are owned by Company as treasury shares or

any Company Shares owned by any direct or indirect Subsidiary of the Company immediately prior to the Exchange, immediately after the

Exchange, the Company shall take all action necessary to repurchase or cancel any Company Shares held by the Company or any direct or

indirect Subsidiary of the Company, for no consideration.

(iii)           At

the Closing, immediately after giving effect to the Exchange, a notarial deed of change of legal form shall be executed by a Dutch notary

associated with Dentons in Amsterdam, the Netherlands, and ListCo shall (i) change its legal form from a private company with limited

liability (besloten vennootschap met beperkte aansprakelijkheid) to a public limited liability company (naamloze vennootschap)

and (ii) amend and restate its articles of association pursuant to a notarial deed in a form to be agreed upon by CGC and the Company.

(iv)          The

directors and officers of ListCo as of the consummation of the Exchange shall be designated in accordance with Section 5.16.

(v)           If,

between the date of this Agreement and the Closing, the outstanding CGC Shares shall have been changed into a different number of shares

or a different class, by reason of any dividend, subdivision, reclassification, recapitalization, split, combination or exchange of shares,

or any similar event shall have occurred, then any number, value (including dollar value) or amount contained herein which is based upon

the number of CGC Shares will be appropriately adjusted to provide to the holders of Undertaking Company Shares the same economic effect

as contemplated by this Agreement; provided, however, that this Section 2.1(a)(iv) shall not be construed to permit

any Parties to take any action with respect to their respective securities that is prohibited by the terms and conditions of this Agreement.

(b)            PIPE.

At the Closing, ListCo and the PIPE Investors shall consummate the PIPE Financing pursuant and subject to the PIPE Subscription Agreements.

Merger.

(i)            On

the Closing Date, upon the terms and subject to the conditions of this Agreement, CGC shall execute and cause to be filed with the Registrar

of Companies of the Cayman Islands a plan of merger in a form mutually acceptable to the Company (the “Plan of Merger”)

and such other documents as may be required in accordance with the applicable provisions of the Cayman Act or by any other applicable

Laws to make the CGC Merger effective. The CGC Merger shall become effective at the time when the Plan of Merger is registered by the

Registrar of Companies of the Cayman Islands or at such later time permitted by the Cayman Act as may be specified in the Plan of Merger

(the “CGC Merger Effective Time”).

(ii)           At

and after the CGC Merger Effective Time, the CGC Merger shall have the effects set forth in this Agreement, the Plan of Merger and the

applicable provisions of the Cayman Act. Without limiting the generality of the foregoing, and subject thereto, at the CGC Merger Effective

Time, all the mortgages, charges, security interests, property, rights, privileges, agreements, contracts, powers and franchises, Liabilities

and duties of Merger Sub and CGC shall vest in and become the mortgages, charges, security interests, property, rights, privileges, agreements,

contracts, powers and franchises, Liabilities and duties of the CGC as the surviving company (the “CGC Merger Surviving Company”),

which shall include the assumption by CGC of any and all agreements, covenants, duties and obligations of the CGC and Merger Sub, and

CGC shall thereafter exist as a wholly-owned Subsidiary of ListCo and the separate corporate existence of Merger Sub shall cease to exist.

(iii)           Each

CGC Share issued and outstanding immediately prior to the CGC Merger Effective Time shall be exchanged for one (1) newly issued ListCo

Common Share, without interest. As of the CGC Merger Effective Time, the CGC Shareholders shall cease to have any other rights in and

to such CGC Shares, except as expressly provided herein.

(iv)          Notwithstanding

any other provision of this Agreement to the contrary, if there are any CGC Shares that are owned by CGC as treasury shares or any CGC

Shares owned by any direct or indirect Subsidiary of CGC immediately prior to the CGC Merger Effective Time, such CGC Shares shall automatically

be cancelled and shall cease to exist without any conversion thereof or payment or other consideration therefor pursuant to the Plan of

Merger.

(v)           All

shares of Merger Sub issued and outstanding immediately prior to the CGC Merger Effective Time shall automatically be converted into one

validly issued, fully paid and non-assessable ordinary share of CGC, which ordinary share shall constitute the only issued and outstanding

share in the capital of CGC pursuant to the Plan of Merger.

(vi)          If,

between the date of this Agreement and the Closing, the outstanding Company Shares shall have been changed into a different number of

shares or a different class, by reason of any dividend, subdivision, reclassification, recapitalization, split, combination or exchange

of shares, or any similar event shall have occurred, then any number, value (including dollar value) or amount contained herein which

is based upon the number of Company Shares will be appropriately adjusted to provide to the holders of CGC Shares the same economic effect

as contemplated by this Agreement; provided, however, that this Section 2.1(c)(vi) shall not be construed to permit

any Parties to take any action with respect to their respective securities that is prohibited by the terms and conditions of this Agreement.

(vii)            At

the CGC Merger Effective Time, the parties shall cause the Governing Documents of CGC, as in effect immediately prior to the CGC Merger

Effective Time, to be amended and restated in a form mutually agreed by CGC and the Company and, as so amended and restated, shall be

the memorandum and articles of association of the CGC Merger Surviving Corporation, until thereafter amended in accordance with the terms

thereof and the Cayman Act.

(viii)        At

the CGC Merger Effective Time, the directors and officers of the Company immediately prior to the CGC Merger Effective Time shall, unless

otherwise determined by the Company, be the initial directors and officers of the CGC Merger Surviving Company, each to hold office in

accordance with the Governing Documents of the CGC Merger Surviving Company until such director’s or officer’s successor

is duly elected or appointed and qualified, or until the earlier of their death, resignation or removal.

Section 2.2           Closing

of the Transactions Contemplated by this Agreement. The closing of the transactions contemplated by this Agreement (the “Closing”)

shall take place electronically by exchange of the closing deliverables by the means provided in Section 8.11 as promptly

as reasonably practicable, but in no event later than the second (2nd) Business Day, following the satisfaction (or, to the extent permitted

by applicable Law, waiver) of the conditions set forth in Article 6 (other than those conditions that by their nature are

to be satisfied at the Closing, but subject to satisfaction or waiver of such conditions) (the date upon which the Closing actually occurs

is referred to herein as “Closing Date”) or at such other place, date and/or time as CGC and the Company may

agree in writing.

Section 2.3           Allocation

Schedule. At least five (5) Business Days prior to the Closing Date, the Company shall deliver to CGC an allocation schedule

(the “Allocation Schedule”) setting forth (i) the number of Undertaking Company Shares held by each Undertaking

Company Shareholder (including the number of Undertaking Company Shares subject to the conversion of the Company Convertible Notes pursuant

to Section 2.4(b)), (ii) the number of Company Shares subject to each Company Option held by each holder thereof, as

well as whether each such Company Option will be a Vested Company Option or an Unvested Company Option as of immediately prior to the

Exchange Effective Time, and, in each case, the exercise price thereof, (iii) the number of ListCo Common Shares that will be subject

to each Rollover Option and the exercise price thereof at the completion of the Exchange, (iv) the Transaction Share Consideration,

the Fully-Diluted Shares and the Exchange Ratio, and (v) a certification, duly executed by an authorized officer of the Company,

that (a) the information and calculations delivered pursuant to clauses (i), (ii), (iii) and (iv) is, and will be as of

immediately prior to the Exchange Effective Time, true and correct in all respects and in accordance with the last sentence of this Section 2.3

and (b) the Company has performed, or otherwise complied with, as applicable, its covenants and agreements set forth in Section 2.4(b).

The Company will review any comments to the Allocation Schedule provided by CGC or any of its Representatives and consider in good faith

and incorporate any reasonable comments proposed by CGC or any of its Representatives. Notwithstanding the foregoing or anything to the

contrary herein, (A) the aggregate number of ListCo Common Shares that each Undertaking Company Shareholder will have a right to

receive pursuant to Section 2.1(a) will be rounded down to the nearest whole share, (B) in no event shall the aggregate

number of ListCo Common Shares set forth on the Allocation Schedule that are allocated in respect of the Equity Securities of the Company

exceed the Transaction Share Consideration, (C) in no event shall the Allocation Schedule (or the calculations or determinations

therein) breach, as applicable, any applicable Law, the Governing Documents of the Company, the Company Equity Plan or any other Contract

to which the Company is a party or bound (taking into account, for the avoidance of doubt, any actions taken by the Company pursuant

to Section 2.4(b)) and (D) CGC and the Exchange Agent will be entitled to rely upon the Allocation Schedule for purposes

of allocating the Transaction Share Consideration to the Undertaking Company Shareholders under this Agreement or under the Exchange

Agent Agreement, as applicable.

Section 2.4            Treatment

of Company Equity Awards, Company Convertible Notes.

(a)           At

the Exchange Effective Time, and without any action of any Party or any other Person (but subject to, in the case of the Company, Section 2.4(b)),

each Company Option (whether a Vested Company Option or an Unvested Company Option) shall cease to represent the right to purchase Company

Shares and shall be canceled in exchange for options to purchase ListCo Common Shares under a new incentive equity plan to be agreed among

the Parties (each, a “Rollover Option”) in an amount equal to the product (rounded down to the nearest whole

number) of (x) the number of Company Shares subject to such Company Option immediately prior to the Exchange Effective Time, multiplied

by (y) the Exchange Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to the quotient of (i) the

exercise price per share of such Company Option immediately prior to the Exchange Effective Time, and (ii) the Exchange Ratio. Each

Rollover Option shall be subject to the same terms and conditions (including applicable vesting, expiration and forfeiture provisions)

that applied to the corresponding Company Option immediately prior to the Exchange Effective Time, except for (i) as provided above

in this Section 2.4(a), (ii) (A) 9.09% of the ListCo Common Shares underlying each Rollover Option shall be unvested

and shall not vest unless and until Earn-Out 1 Target has been achieved, (B) 22.73% % of the ListCo Common Shares underlying each

Rollover Option shall be unvested and shall not vest unless and until Earn-Out 2 Target has been achieved, and (C) 22.73% % of the

ListCo Common Shares underlying each Rollover Option shall be unvested and shall not vest unless and until Earn-Out 3 Target has been

achieved, (iii) terms (A) rendered inoperative by reason of the transactions contemplated by this Agreement (including any anti-dilution

or other similar provisions that adjust the number of underlying shares that could become exercisable subject to the options) or (B) to

the extent they conflict with the new incentive equity plan, and (iv) such other immaterial administrative or ministerial changes

as the ListCo Board (or the compensation committee of the ListCo Board) may determine in good faith are appropriate to effectuate the

administration of the Rollover Options. Prior to the Closing, the Company shall take, or cause to be taken, all necessary or appropriate

actions under the Company Equity Plans and the underlying grant, award or similar agreement to give effect to the provisions of this Section 2.4.

(b)           Immediately

prior to the Exchange Effective Time, the Company Convertible Notes shall be converted into Undertaking Company Shares pursuant to their

terms (the “Company Convertible Notes Conversion”) and each such Company Convertible Note shall no longer be

issued or outstanding and shall instead automatically be canceled, extinguished, retired and shall cease to exist, and each holder of

the Company Convertible Notes shall thereafter cease to have any rights with respect to such Company Convertible Notes, other than, for

the avoidance of doubt, with respect to the Undertaking Company Shares into which such Company Convertible Notes have been converted

and then as expressly provided herein. Prior to the Closing, the Company shall take, or cause to be taken, all necessary or appropriate

actions under the Company Convertible Notes to give effect to the provisions of this Section 2.4.

Section 2.5           Treatment

of CGC Securities. On the Closing Date:

(a)           Prior

to the CGC Merger Effective Time, each CGC Class B Share issued and outstanding immediately prior to the CGC Merger Effective Time

shall, in accordance with CGC’s Governing Documents, automatically convert into one (1) CGC Class A Share.

(b)           Prior

to the CGC Merger Effective Time, to the extent any CGC Units remain outstanding and unseparated, immediately prior to the CGC Merger

Effective Time, the CGC Class A Shares and the CGC Public Warrants comprising each such issued and outstanding CGC Unit immediately

prior to the CGC Merger Effective Time shall be automatically separated, and the holder of each CGC Unit shall be deemed to hold one (1) CGC

Class A Share and one-third (1/3) of one (1) CGC Public Warrant; and all CGC Units shall cease to be outstanding and shall automatically

be canceled and retired and shall cease to exist.

the CGC Merger Effective Time, each CGC Warrant that is outstanding immediately prior to the CGC Merger Effective Time shall, pursuant

to the Assignment and Assumption Agreement, cease to represent a right to acquire the CGC Shares and shall be converted in accordance

with the terms of such Assignment and Assumption Agreement, at the CGC Merger Effective Time, into a right to acquire the same number

of ListCo Common Shares on substantially the same terms as were in effect immediately prior to the CGC Merger Effective Time.

Section 2.6           Deliverables

(a)           As

promptly as reasonably practicable following the date of this Agreement, but in no event later than ten (10) Business Days prior

to the Closing Date, CGC shall appoint an exchange agent reasonably acceptable to the Company (the “Exchange Agent”)

(it being understood and agreed that Continental (or any of its Affiliates) shall be deemed to be acceptable to the Company) and ListCo

shall enter into an exchange agent agreement (the “Exchange Agent Agreement”) with the Exchange Agent for the

purpose of (x) exchanging certificates, if any, representing the Undertaking Company Shares and each Undertaking Company Share held

in book-entry form on the share transfer books of the Company immediately prior to the Exchange, which shall be exchanged for the portion

of the Transaction Share Consideration issuable in respect of such Undertaking Company Shares pursuant to Section 2.1(a) and

on the terms and subject to the other conditions set forth in this Agreement and (y) exchanging certificates, if any, representing

CGC Shares and each CGC Share held in book-entry form on the share transfer books of CGC immediately prior to the CGC Merger Effective

Time, which shall be converted into ListCo Common Shares pursuant to Section 2.1(c)(iii) and on the terms and subject

to the other conditions set forth in this Agreement. Notwithstanding the foregoing or anything to the contrary herein, in the event that

Continental is unable or unwilling to serve as the Exchange Agent, then CGC and the Company shall, as promptly as reasonably practicable

thereafter, but in no event later than the Closing Date, mutually agree upon an exchange agent (in either case, such agreement not to

be unreasonably withheld, conditioned or delayed), ListCo shall appoint and enter into an exchange agent agreement with such exchange

agent, who shall for all purposes under this Agreement constitute the Exchange Agent and each of CGC and the Company shall mutually agree

to any changes to the Exchange Agent Agreement in order to satisfy any requirements of such exchange agent (in either case, such agreement

not to be unreasonably withheld, conditioned or delayed). The Company and CGC shall reasonably cooperate with ListCo and the Exchange

Agent in connection with the appointment of the Exchange Agent, the entry into the Exchange Agent Agreement and the covenants and agreements

set forth in this Section 2.6 (including the provision of any information, or the entry into any agreements or documentation,

necessary or advisable in connection with any of the foregoing or otherwise required by the Exchange Agent Agreement for the Exchange

Agent to fulfill its duties as the Exchange Agent in connection with the transactions contemplated hereby).

(b)           At

the Exchange Effective Time, ListCo shall deposit, or cause to be deposited, with the Exchange Agent, for the benefit of the Undertaking

Company Shareholders and CGC Shareholders and for exchange in accordance with this Section 2.6 through the Exchange Agent,

evidence of ListCo Common Shares in book-entry form issuable pursuant to Section 2.1(a) and Section 2.1(c)(iii),

in exchange for the Undertaking Company Shares or CGC Shares, as applicable, outstanding immediately prior to the Exchange or the CGC

Merger Effective Time, respectively. All ListCo Common Shares in book-entry form issuable pursuant to Section 2.1(a) and

Section 2.1(c)(iii) deposited with the Exchange Agent shall be referred to in this Agreement as the “Exchange

Fund”.

Undertaking Company Shareholder or CGC Shareholder holding a certificate representing Undertaking Company Shares or CGC Shares, as applicable,

whose Undertaking Company Shares or CGC Shares, as applicable, have been converted into or exchanged for the right to receive ListCo Common

Shares pursuant to or Section 2.1(c)(iii) shall be entitled to receive the amount of ListCo Common Shares to which he,

she or it is entitled pursuant to Section 2.1(a) or Section 2.1(c)(iii) upon the surrender to the Exchange

Agent of such certificate (or affidavit of loss in lieu thereof). Each Undertaking Company Shareholder or CGC Shareholder holding Undertaking

Company Shares or CGC Shares, as applicable, in book-entry form whose Company Shares or CGC Shares have been converted into or exchange

for the right to receive ListCo Common Shares pursuant to Section 2.1(a) or Section 2.1(c)(iii) (including

each Undertaking Company Share issued in connection with or as a result of the conversions and rollovers pursuant to Section 2.4)

shall automatically be entitled to receive the amount of ListCo Common Shares to which he, she or it is entitled pursuant to Section 2.1(a) or

Section 2.1(c)(iii).

(d)           On

the Closing Date, the Exchange Agent shall cause the applicable amount of ListCo Common Shares to be issued to the Undertaking Company

Shareholders and CGC Shareholders in book-entry form; provided, however, that in the case of any Undertaking Company Shares or

CGC Shares represented by a certificate, the Exchange Agent shall not issue such consideration until the surrender of such certificate

(or affidavit of loss in lieu thereof) in accordance with Section 2.6(a).

(e)           If

any ListCo Common Shares are to be issued to a Person other than the Undertaking Company Shareholder or CGC Shareholder in whose name

the surrendered certificate or the transferred Company Share or CGC Share in book-entry form is registered, it shall be a condition to

the issuance of the applicable ListCo Common Shares that (i) either such certificate shall be properly endorsed or shall otherwise

be in proper form for transfer or such Company Share or CGC Share in book-entry form shall be properly transferred and (ii) the Person

requesting such consideration pay to the Exchange Agent any Transfer Taxes required as a result of such consideration being issued to

a Person other than the registered holder of such certificate, or Undertaking Company Share or CGC Share in book-entry form or establish

to the satisfaction of the Exchange Agent that such Transfer Taxes have been paid or are not payable.

(f)            No

interest will be paid or accrued on the ListCo Common Shares issuable pursuant to Section 2.1(a) or Section 2.1(c)(iii).

From and after the Exchange Effective Time, until surrendered or transferred, as applicable, in accordance with this Section 2.6,

each Undertaking Company Share and CGC Share (other than, for the avoidance of doubt, the Undertaking Company Shares or CGC Shares cancelled

and extinguished pursuant to Section 2.1(a)(i) or Section 2.1(c)(iv)) shall solely represent the right to

receive the number of ListCo Common Shares to which such Undertaking Company Share or CGC Share is entitled to receive pursuant to Section 2.1(a) or

Section 2.1(c)(iii).

(g)           At

the Exchange Effective Time, the share transfer books of the Company and CGC shall be closed and there shall be no transfers of Undertaking

Company Shares, CGC Shares or CGC Warrants that were outstanding immediately prior to the Exchange Effective Time or CGC Merger Effective

Time, as applicable.

(h)           Any

portion of the Exchange Fund that remains unclaimed by the Company Shareholders or CGC Shareholders twelve (12) months following the

Closing Date shall be delivered to ListCo or as otherwise instructed by ListCo, and any Undertaking Company Shareholder or CGC Shareholder

who has not exchanged his, her or its Undertaking Company Shares or CGC Shares for the applicable amount of ListCo Common Shares in accordance

with this Section 2.6 prior to that time shall thereafter look only to ListCo for the issuance of the applicable amount of

ListCo Common Shares, without any interest thereon. None of ListCo or the CGC Merger Surviving Company or any of their respective Affiliates

shall be liable to any Person in respect of any consideration delivered to a public official pursuant to any applicable abandoned property,

unclaimed property, escheat, or similar Law. Any ListCo Common Shares remaining unclaimed by the Undertaking Company Shareholder or CGC

Shareholders immediately prior to such time when the amounts would otherwise escheat to or become property of any Governmental Entity

shall become, to the extent permitted by applicable Law, the property of ListCo free and clear of any claims or interest of any Person

previously entitled thereto.

Section 2.7           Withholding.

CGC, ListCo, Merger Sub, the Group Companies and the Exchange Agent shall be entitled to deduct and withhold (or cause to be deducted

and withheld) from any consideration payable pursuant to this Agreement such amounts as are required to be deducted and withheld under

applicable Tax Law. To the extent that amounts are so withheld and timely remitted to the applicable Governmental Entity, such withheld

amounts shall be treated for all purposes of this Agreement as having been paid to the Person in respect of which such deduction and

withholding was made. The Parties shall cooperate in good faith to eliminate or reduce any such deduction or withholding (including through

the request and provision of any statements, forms or other documents to reduce or eliminate any such deduction or withholding).

Article 3

REPRESENTATIONS AND WARRANTIES RELATING TO THE GROUP COMPANIES

Subject to Section 8.8,

except as set forth in the Company Disclosure Schedules, the Company hereby represents and warrants to CGC, in each case, as of the date

of this Agreement and as of the Closing Date, as follows:

Section 3.1           Organization

and Qualification.

(a)           Each

Group Company is a corporation, limited liability company or other applicable business entity duly organized, incorporated or formed,

as applicable, validly existing and in good standing (or the equivalent thereof, if applicable, in each case, with respect to the jurisdictions

that recognize the concept of good standing or any equivalent thereof) under the Laws of its jurisdiction of organization, incorporation

or formation (as applicable) and in each jurisdiction in which the property and assets owned, leased or operated by it, or the nature

of the business conducted by it, makes such qualification or licensing necessary, except where the failure to be so duly qualified or

licensed and in good standing would not have a Company Material Adverse Effect. Section 3.1(a) of the Company Disclosure

Schedules sets forth the jurisdiction of organization, incorporation or formation (as applicable) for each Group Company. Each Group Company

has the requisite corporate, limited liability company or other applicable business entity power and authority to own, lease and operate

its properties and to carry on its businesses as presently conducted, except where the failure to have such power or authority would not

have a Company Material Adverse Effect.

(b)           True

and complete copies of the Governing Documents of the Group Companies has been made available to CGC, in each case, as amended and in

effect as of the date of this Agreement. The Governing Documents of the Group Companies are in full force and effect, and the Group Companies

are not in breach or violation of any provision set forth in its Governing Documents, as applicable.

Section 3.2           Capitalization

of the Group Companies.

(a)           Section 3.2(a) of

the Company Disclosure Schedules sets forth a true and complete statement as of the date of this Agreement of (i) the number and

class or series (as applicable) of all of the Equity Securities of the Company issued and outstanding, (ii) the identity of the Persons

that are the record and beneficial owners thereof, and (iii) with respect to each Company Equity Award, (A) the date of grant,

(B) any applicable exercise (or similar) price, (C) the expiration date, and (D) any applicable vesting schedule (including

acceleration provisions), and (iv) with respect to the Company Convertible Notes, (A) the original principal amount, (B) the

applicable interest rate, (C) the maturity date, and (D) the current outstanding balance. All of the Equity Securities of the

Company have been duly authorized and validly issued. All of the outstanding Company Shares are fully paid and non-assessable. The Equity

Securities of the Company (1) were not issued in violation of the Governing Documents of the Company or any other Contract to which

the Company is party or bound, (2) were not issued in violation of any preemptive rights, call option, right of first refusal or

first offer, subscription rights, transfer restrictions or similar rights of any Person and (3) have been offered, sold and issued

in all material respects in compliance with applicable Law, including Securities Laws. Except for the Company Options and Company Convertible

Notes set forth on Section 3.2(a) of the Company Disclosure Schedules or the Company Options either permitted by Section 5.1(b) or

issued, granted or entered into in accordance with Section 5.1(b), the Company has no outstanding (x) equity appreciation,

phantom equity or profit participation rights or (y) options, restricted share units, phantom shares, warrants, purchase rights,

subscription rights, conversion rights, exchange rights, calls, puts, rights of first refusal or first offer or other Contracts that could

require the Company to issue, sell or otherwise cause to become outstanding or to acquire, repurchase or redeem any Equity Securities

or securities convertible into or exchangeable for Equity Securities of the Company.

(b)           The

Equity Securities of the Company are free and clear of all Liens (other than transfer restrictions under applicable Securities Law). There

are no shareholder agreements, voting trusts, proxies or other Contracts to which the Company is a party with respect to the voting or

transfer of the Company’s Equity Securities.

the Company Disclosure Schedules sets forth a true and complete statement of (i) the number and class or series (as applicable) of

all of the Equity Securities of each Subsidiary of the Company issued and outstanding and (ii) the identity of the Persons that are

the record and beneficial owners thereof. There are no outstanding (A) equity appreciation, phantom equity or profit participation

rights or (B) options, restricted shares, restricted share units, phantom shares, warrants, purchase rights, subscription rights,

conversion rights, exchange rights, calls, puts, rights of first refusal or first offer or other Contracts that could require any Subsidiary

of the Company to issue, sell or otherwise cause to become outstanding or to acquire, repurchase or redeem any Equity Securities or securities

convertible into or exchangeable for Equity Securities of the Subsidiaries of the Company. There are no voting trusts, proxies or other

Contracts with respect to the voting or transfer of any Equity Securities of any Subsidiary of the Company. There are no outstanding bonds,

debentures, notes or other indebtedness of the Company having the right to vote (or convertible into, or exchangeable for, securities

having the right to vote) on any matter for which holders of Company Shares may vote.

(d)           Except

as set forth on Section 3.2(d) of the Company Disclosure Schedules, there are no voting trusts, proxies or other Contracts

with respect to the voting or transfer of the Company’s Equity Securities between the Company and any other Person.

(e)           Except

as set forth on Section 3.2(e) of the Company Disclosure Schedules, none of the Group Companies owns or holds (of record,

beneficially, legally or otherwise), directly or indirectly, any Equity Securities in any other Person or the right to acquire any such

Equity Security, and none of the Group Companies are a partner or member of any partnership, limited liability company or joint venture.

(f)           Section 3.2(f) of

the Company Disclosure Schedules sets forth a list of all Indebtedness of the Group Companies as of the date of this Agreement, including

the principal amount of such Indebtedness, the outstanding balance as of the date of this Agreement, and the debtor and the creditor thereof.

(g)           No

Group Company has provided any legally binding guarantee pursuant to which such Group Company is obligated to pay or discharge the liabilities

or obligations of any direct or indirect holder of Equity Securities of the Company or any other Person that is not a Group Company, except

as otherwise disclosed in Section 3.2(g) of the Company Disclosure Schedule.

(h)           Section 3.2(h) of

the Company Disclosure Schedules sets forth a list of all Change of Control Payments of the Group Companies.

(i)            Other

than the Company Convertible Notes, there are no debt instruments outstanding convertible into or otherwise entitling the holder thereof

to any of the Company’s Equity Securities.

(j)            (i) No

triggering event for the weighted-average anti-dilution right contained in Article 7.1(xiv) of each convertible loan agreement

entered into with Avanea Investment Holding a.s. (the “AIH Anti-Dilution Right”) has occurred prior to the date

of this Agreement; and (ii) to the knowledge of the Company, no facts, matters or circumstances exist as at the date of this Agreement

that would reasonably be expected to result in the occurrence of a triggering event for the AIH Anti-Dilution Right prior to or upon Closing.

(k)           The

Company has, prior to the execution of this Agreement, provided a copy of this Agreement to each of the Company Shareholders.

Section 3.3           Authority.

(a)           The

Company has the requisite corporate power and authority to execute and deliver this Agreement and each Ancillary Document to which it

is or will be a party, to perform its obligations hereunder and thereunder, and to consummate the transactions contemplated hereby and

thereby. The execution and delivery of this Agreement, the Ancillary Documents to which the Company is or will be a party, the performance

of the Company’s obligations hereby and thereby and the consummation of the transactions contemplated hereby and thereby have been

(or, in the case of any Ancillary Document entered into after the date of this Agreement, will be upon execution thereof) duly authorized

by all necessary corporate (or other similar) action on the part of the Company. This Agreement and each Ancillary Document to which the

Company is or is contemplated to be a party has been or will be, upon execution thereof, as applicable, duly and validly executed and

delivered by the Company and constitutes or will constitute, upon execution and delivery thereof, as applicable, a valid, legal and binding

agreement of the Company (assuming that this Agreement and the Ancillary Documents to which the Company is or will be a party are or will

be upon execution thereof, as applicable, duly authorized, executed and delivered by the other Persons party thereto), enforceable against

the Company in accordance with their respective terms (subject to applicable bankruptcy, insolvency, reorganization, moratorium or other

Laws affecting generally the enforcement of creditors’ rights and subject to general principles of equity). The Company Shareholder

Undertaking signed by the Company Undertaking Shareholders is the only undertaking of the holders of any class or series of shares of

the Company required to approve and adopt this Agreement, the Ancillary Documents to which the Company is or is contemplated to be a party,

the performance of the Company’s obligations hereunder and thereunder and the consummation of the transactions contemplated hereby

and thereby.

(b)           The

Company Board unanimously and duly adopted resolutions (a) determining that entry into this Agreement and the other Ancillary Documents

to which the Company is party, and the consummation of the transactions contemplated hereby and thereby, are advisable and fair to, and

in the best interest of, the Company and its shareholders, and (b) approving this Agreement, such other Ancillary Documents and the

consummation of the transactions contemplated hereby and thereby, including the Exchange, which resolutions have not been subsequently

withdrawn or modified in a manner adverse to CGC or Merger Sub. A copy of such duly approved resolutions is attached to Section 3.3(b) of

the Company Disclosure Schedules.

Section 3.4           Financial

Statements; Undisclosed Liabilities.

(a)           The

Company has made available to CGC a true and complete copy of the following financial statements, which are attached as Section 3.4(a) of

the Company Disclosure Schedules: the unaudited consolidated balance sheets of the Group Companies as of December 31, 2024 and December 31,

2025 and the related unaudited consolidated statements of operations and comprehensive loss and shareholders’ deficit of the Group

Companies for each of the periods ended on December 31, 2024 and December 31, 2025 (collectively, the “Financial

Statements”). Each of the Financial Statements (including the notes thereto) (A) was prepared in accordance with local

accounting standards applied on a consistent basis throughout the periods indicated (except as may be indicated in the notes thereto),

(B) fairly presents, in all material respects, the financial position and results of operations of the Group Companies as at the

date thereof and for the period indicated therein, except as otherwise specifically noted therein, and (C) are undergoing an audit

in accordance with IFRS and the standards of the PCAOB and are expected to contain an unqualified report of the Company’s auditors.

(b)           The

audited consolidated balance sheets of the Group Companies as of December 31, 2024 and December 31, 2025 and the related audited

consolidated statements of operations and comprehensive loss, shareholders’ deficit and cash flows of the Group Companies for each

of the periods ended on December 31, 2024 and December 31, 2025 (the “Closing Company Audited Financial Statements”),

when delivered following the date of this Agreement in accordance with Section 5.17, (i) will be prepared in accordance

with IFRS and the standards of the PCAOB and applied on a consistent basis throughout the periods indicated (except as may be specifically

indicated in the notes thereto), (ii) will fairly present, in all material respects, the financial position, results of operations

and cash flows of the Group Companies as at the date thereof and for the period indicated therein, except as otherwise specifically noted

therein and (iii) will comply in all material respects with the applicable accounting requirements and with the rules and regulations

of the SEC, the Exchange Act and the Securities Act in effect as of the respective dates thereof (including Regulation S-X or Regulation

S-K, as applicable).

(i) as set forth on the face of the Financial Statements, (ii) for Liabilities incurred in the ordinary course of business since

the date of the Financial Statements (none of which are Liabilities directly or indirectly related to a breach of Contract, breach of

warranty, tort, infringement, Proceeding or violation of, or non-compliance with, Law), (iii) for Liabilities incurred in connection

with the negotiation, preparation or execution of this Agreement or any Ancillary Documents, the performance of their respective covenants

or agreements in this Agreement or any Ancillary Document or the consummation of the transactions contemplated hereby or thereby and (iv) for

Liabilities that are not and would not reasonably be expected to be, individually or in the aggregate, material to the Group Companies,

taken as a whole, no Group Company has any Liabilities of the type required to be set forth on a balance sheet in accordance with IFRS.

(d)           The

Group Companies have established and maintain systems of internal accounting controls that are designed to provide, in all material respects,

reasonable assurance (i) that all transactions are executed in accordance with management’s authorization, (ii) that all

transactions are recorded as necessary to permit preparation of proper and accurate financial statements in accordance with IFRS and to

maintain accountability for the Group Companies’ assets, and (iii) regarding prevention or timely detection of the unauthorized

acquisition, use or disposition of the Group Company’s properties or assets. The Group Companies maintain and, for all periods covered

by the Financial Statements, have maintained books and records of the Group Companies in the ordinary course of business that are accurate

and complete and reflect the revenues, expenses, assets and liabilities of the Group Companies in all material respects.

Section 3.5           Consents

and Requisite Governmental Approvals; No Violations.

(a)           No

consent, approval or authorization of, or designation, declaration or filing with, any Governmental Entity is required on the part of

the Company with respect to the Company’s execution, delivery or performance of its obligations under this Agreement or the Ancillary

Documents to which the Company is or will be party or the consummation of the transactions contemplated hereby or thereby, except for

(i) the filing with the SEC of (A) the Registration Statement / Proxy Statement and the declaration of the effectiveness thereof

by the SEC and (B) such reports under Section 13(a) or 15(d) of the Exchange Act as may be required in connection

with this Agreement, the Ancillary Documents or the transactions contemplated hereby or thereby, or (ii) any other consents, approvals,

authorizations, designations, declarations, waivers or filings, the absence of which would not have a Company Material Adverse Effect.

(b)           None

of the execution or delivery by the Company of this Agreement or any Ancillary Documents to which it is or will be a party, the performance

by the Company of its obligations hereunder or thereunder, or the consummation of the transactions contemplated hereby or thereby will,

directly or indirectly (with or without due notice or lapse of time or both) (i) result in a violation or breach of any provision

of the Company’s Governing Documents, (ii) result in a violation or breach of, or constitute a default or give rise to any

right of termination, Consent, cancellation, amendment, modification, suspension, sanction, revocation or acceleration under, any of the

terms, conditions or provisions of (A) any Contract (including any Public Aid Financial Scheme) to which any Group Company is a party

or (B) any Material Permits, (iii) violate, or constitute a breach under, any Order or applicable Law to which any Group Company

or any of its properties or assets are subject or bound or (iv) result in the creation of any Lien upon any of the assets or properties

(other than any Permitted Liens) or Equity Securities of any Group Company, except, in the case of any of clauses (ii) through (iv) above,

as would not have a Company Material Adverse Effect.

Section 3.6           Permits.

The Company has all franchises, permits, licenses and any similar authority necessary for the conduct of its business, the lack of which

could reasonably be expected to have a Company Material Adverse Effect. The Company is not in default in any material respect under any

of such franchises, permits, licenses or other similar authority.

Section 3.7           Material

Contracts.

(a)           Section 3.7(a) of

the Company Disclosure Schedules sets forth a list of the following Contracts to which a Group Company is a party as of the date of this

Agreement, excluding any Employee Benefit Plan (each Contract required to be set forth on Section 3.7(a) of the Company

Disclosure Schedules, together with each of the Contracts entered into after the date of this Agreement that would be required to be

set forth on Section 3.7(a) of the Company Disclosure Schedules if entered into prior to the execution and delivery

of this Agreement, collectively, the “Material Contracts”):

(i)            any

Contract relating to Indebtedness for borrowed money of any Group Company or to the placing of a Lien (other than any Permitted Lien)

on any material assets or properties of any Group Company;

(ii)            any

Contract under which any Group Company is lessee of or holds or operates, in each case, any tangible property (other than real property),

owned by any other Person, except for any lease or agreement under which the aggregate annual rental payments do not exceed $500,000;

(iii)           any

Contract under which any Group Company is lessor of or permits any third party to hold or operate, in each case, any tangible property

(other than real property), owned or controlled by such Group Company, except for any lease or agreement under which the aggregate annual

rental payments do not exceed $500,000;

(iv)          any

(A) joint venture, profit-sharing, partnership, collaboration, co-promotion, commercialization or research or development Contract,

in each case, which requires, or would reasonably be expected to require (based on any occurrence, development, activity or event contemplated

by such Contract), aggregate payments to or from any Group Company in excess of $500,000 over the life of the Contract and (B) any

Contract with respect to material Company Licensed Intellectual Property (other than Off-the-Shelf Software);

(v)           any

Contract that (A) limits or purports to limit, in any material respect, the freedom of any Group Company to engage or compete in

any line of business or with any Person or in any area or that would so limit or purport to limit, in any material respect, the operations

of CGC or any of its Affiliates after the Closing, (B) contains any exclusivity, “most favored nation” or similar provisions,

obligations or restrictions or (C) contains any other provisions restricting or purporting to restrict the ability of any Group Company

to sell, manufacture, develop, commercialize, test or research products, directly or indirectly through third parties, or to solicit any

potential employee or customer, in each case, in any material respect or that would so limit or purports to limit in any material respect,

CGC or any of its Affiliates after the Closing;

(vi)          any

Contract requiring any future capital commitment or capital expenditure (or series of capital expenditures) by any Group Company in an

amount in excess of (A) $500,000 annually or (B) $1,000,000 over the life of the agreement;

(vii)         any

Contract requiring any Group Company to guarantee the Liabilities of any Person (other than the Company or a Subsidiary) or pursuant to

which any Person (other than the Company or a Subsidiary) has guaranteed the Liabilities of a Group Company, in each case in excess of

$500,000;

(viii)         any

Contract under which any Group Company has, directly or indirectly, made or agreed to make any loan, advance, or assignment of payment

to any Person or made any capital contribution to, or other investment in, any Person;

(ix)           any

Contract required to be disclosed on Section 3.19 of the Company Disclosure Schedules;

(x)            any

Contract with any Person (A) pursuant to which any Group Company (or CGC or any of its Affiliates after the Closing) may be required

to pay milestones, royalties or other contingent payments based on any research, testing, development, regulatory filings or approval,

sale, distribution, commercial manufacture or other similar occurrences, developments, activities or events or (B) under which any

Group Company grants to any Person any right of first refusal, right of first negotiation, option to purchase, option to license or any

other similar rights with respect to any Company Product or any Intellectual Property Rights;

(xi)           any

Contract governing the terms of the employment, engagement or services of any current director, manager, officer, employee, individual

independent contractor or other service provider of a Group Company whose annual base salary (or, in the case of an independent contractor,

annual base compensation) is in excess of $300,000;

(xii)          any

Contract for the disposition of any portion of the assets or business of any Group Company or for the acquisition by any Group Company

of the assets or business of any other Person (other than acquisitions or dispositions made in the ordinary course of business), or under

which any Group Company has any continuing obligation with respect to an “earn-out”, contingent purchase price or other contingent

or deferred payment obligation;

(xiii)         any

settlement, conciliation or similar Contract (A) the performance of which would be reasonably likely to involve any payments after

the date of this Agreement, (B) with a Governmental Entity or (C) that imposes or is reasonably likely to impose, at any time

in the future, any material, non-monetary obligations on any Group Company (or CGC or any of its Affiliates after the Closing); and

(xiv)         any

other Contract the performance of which requires either (A) annual payments to or from any Group Company in excess of $500,000 or

(B) aggregate payments to or from any Group Company in excess of $1,000,000 over the life of the agreement and, in each case, that

is not terminable by the applicable Group Company without penalty upon less than thirty (30) days’ prior written notice; and

(xv)          any

Public Financial Aid Scheme.

(b)           (i) Each

Material Contract is valid and binding on the applicable Group Company and, to the knowledge of the Company, the counterparties thereto,

and is in full force and effect and enforceable in accordance with its terms against such Group Company and, to the Company’s knowledge,

the counterparties thereto, (ii) the applicable Group Company and, to the knowledge of the Company, the counterparties thereto are

not in material breach of, or default under, any Material Contract and (iii) no event has occurred that (with or without due notice

or lapse of time or both) would result in a material breach of, or default under, any Material Contract by the applicable Group Company

or, to the Company’s knowledge, the counterparties thereto. The Company has made available to CGC true and complete copies of all

Material Contracts in effect as of the date hereof (other than purchase orders, invoices, and similar confirmatory or administrative documents

that are ancillary to the main contractual relationship between the parties to a particular Contract or group of Contracts and that, in

each case, do not contain any material executory or continuing terms, conditions, obligations or rights).

with respects to breaches or defaults that have been remedied by any Person or waived in writing by the applicable Governmental Entity,

the Group Companies (a) are and have been at all times in compliance with the terms and conditions of any Public Financial Aid Schemes;

and (b) were not notified by Public Financial Aid Scheme providers or other Governmental Entities that any Group Company is in breach

of the terms and conditions of any Public Financial Aid Scheme.

Section 3.8           Absence

of Changes. During the period beginning on January 1, 2026 and ending on the date of this Agreement, (a) no Company Material

Adverse Effect has occurred and (b) except as expressly contemplated by this Agreement, any Ancillary Document or in connection

with the transactions contemplated hereby and thereby, (i) the Company has conducted its business in the ordinary course in all

material respects and (ii) no Group Company has taken any action that would require the consent of CGC if taken during the period

from the date of this Agreement until the Closing pursuant to Section 5.1(b)(i) (making dividends and distributions),

Section 5.1(b)(iv)(A) (sell, license, dispose of material assets), Section 5.1(b)(viii) (increase compensation

and bonuses), Section 5.1(b)(xii) (liquidate, restructure, reorganize), Section 5.1(b)(xv) (make any

change of control payments) or Section 5.1(b)(xvi) (amend, terminate or modify any Material Contracts, waive any material

benefit or right under any Material Contract or enter into any Contract that would constitute a Material Contract).

Section 3.9           Litigation.

(a)            There

is no claim, action, suit, proceeding, arbitration, complaint, charge or investigation pending or to the Company’s knowledge, currently

threatened (i) against the Group Companies or any officer, director or Key Person; (ii) that questions the validity of this

Agreement and the Ancillary Documents or the right of the Company to enter into them, or to consummate the transactions contemplated

by the transactions contemplated by this Agreement; or (iii) that would reasonably be expected to have, either individually or in

the aggregate, a Company Material Adverse Effect. None of the Group Companies or, to the Company’s knowledge, any of their officers,

directors or Key Persons is a party or is named as subject to the provisions of any order, writ, injunction, judgment or decree of any

court or government agency or instrumentality (in the case of officers, directors or Key Persons such as would affect the Company). There

is no action, suit, proceeding or investigation by a Group Company pending or which a Group Company intends to initiate. The foregoing

includes, without limitation, actions, suits, proceedings or investigations pending or threatened in writing (or any basis therefor known

to the Company) involving the prior employment of any of the Group Company’s employees, their services provided in connection with

the Group Company’s business, any information or techniques allegedly proprietary to any of their former employers or their obligations

under any agreements with prior employers.

(b)            Except

as set forth on Section 3.9(b) of the Company Disclosure Schedules, (i) no written demand, notice of claim, rescission

notice or formal notification of breach has been delivered by NDF II to the Company, InoBat Auto j.s.a. or InoBat Volta II s.r.o.

under or in connection with the investment agreement dated 20 December 2023 between the Company, InoBat Auto j.s.a., InoBat

Volta II s.r.o. and NDF II (as amended, the “NDF II Investment Agreement”); (ii) to the knowledge of the

Company, no facts or circumstances exist as at the date of this Agreement that would, individually or in the aggregate, constitute or

reasonably be expected to give rise to a claim by NDF II for financial compensation or the accrual of any contractual penalty under the

NDF II Investment Agreement; and (iii) there is no pending or, to the knowledge of the Company, threatened claim, action, or arbitration

by NDF II against the Company, InoBat Auto j.s.a. or InoBat Volta II s.r.o. arising out of or in connection with the NDF II Investment

Agreement.

Section 3.10         Compliance

with Applicable Law.

(a)           During

the three (3) years prior to the Closing, the Company has complied in all material respects with all federal, state, local or foreign

statutes, rule or regulations applicable to it. The Company is not in violation or default (i) of any provisions of its Governing

Documents, (ii) of any instrument, judgment, order, writ or decree, (iii) under any note, indenture or mortgage, or (iv) under

any lease, agreement, contract or purchase order to which it is a party or by which it is bound. The execution, delivery and performance

of this Agreement and the Ancillary Documents and the consummation of the transactions contemplated by this Agreement and the Ancillary

Documents will not result in any such violation or be in conflict with or constitute, with or without the passage of time and giving

of notice, either (i) a default under any such provision, instrument, judgment, order, writ, decree, contract or agreement; or (ii) an

event which results in the creation of any lien, charge or encumbrance upon any assets of the Company or the suspension, revocation,

forfeiture, or nonrenewal of any material permit or license applicable to the Company.

(b)           Each

Group Company which is or has at any time been subject to an obligation to register in the RPSP Register:

(i)            has,

since the date on which the obligation to register first arose, been duly and validly registered in the RPSP Register in accordance with

Slovak Act No. 315/2016 Coll. and all applicable Slovak laws and regulations;

(ii)            has

at all times ensured that all information entered in, or required to be entered in, the RPSP Register in respect of it is and has been

complete, accurate, true, up to date and not misleading in any respect, including without limitation all information relating to its ultimate

beneficial owners (konečný užívateľ výhod) and authorised persons (oprávnená

osoba) within the meaning of Slovak Act No. 315/2016 Coll.;

(iii)           has

fulfilled, in full and in a timely manner, each and every obligation imposed upon it under Slovak Act No. 315/2016 Coll.;

(iv)          has

not, at any time, been struck off, suspended, or had its registration in the RPSP Register lapsed, cancelled, or rendered invalid for

any reason;

(v)           has

not, at any time, been in breach of any obligation under Slovak Act No. 315/2016 Coll. or subject to any fine, penalty, sanction,

administrative proceeding, investigation or enforcement action by any competent authority in connection with the RPSP Register or Slovak

Act No. 315/2016 Coll.; and

(vi)          has

not received any notice, claim, complaint, warning or correspondence from any competent authority, public body or counterparty alleging

or indicating any actual or potential breach of, or non-compliance with, Slovak Act No. 315/2016 Coll. or any obligation relating

to the RPSP Register.

limiting the generality of paragraph (b) above, each Group Company which is or has at any time been subject to an obligation to register

in the RPSP Register has, at all times, maintained its registration in the RPSP Register and fulfilled all of its obligations under Slovak

Act No. 315/2016 Coll. in a manner that:

(i)            satisfies

all conditions, requirements and eligibility criteria applicable to it under each Public Finance Aid Scheme to which it is or has been

a party or beneficiary;

(ii)            has

not given rise to, and does not give rise to, any right on the part of any public authority, awarding body or competent authority to (x) suspend,

withdraw, claw back, reclaim or reduce any benefit, grant, subsidy, payment or advantage received or receivable by such Group Company

under any Public Finance Aid Scheme; or (y) terminate, rescind or invalidate any contract, agreement or arrangement entered into

with such Group Company under or in connection with any Public Finance Aid Scheme;

(iii)           has

not resulted in, and does not result in, any forfeiture, disqualification, exclusion or debarment of such Group Company from participation

in any current or future Public Finance Aid Scheme; and

(iv)          has

not had, and does not have, any adverse impact or consequence on any Public Finance Aid Scheme, including on the validity, continuity,

enforceability or value of any benefit thereunder.

(d)           To

the knowledge of the Company, there are no facts, matters or circumstances which are reasonably likely to give rise to any breach of,

or non-compliance with, Slovak Act No. 315/2016 Coll. or any obligation relating to the RPSP Register by any Group Company in the

future, or which would adversely affect the registration or standing of any Group Company in the RPSP Register.

(e)           The

transactions contemplated by this Agreement comply with the investment aid conditions applicable with respect to the Contracts set forth

in Section 3.10(e) of the Company Disclosure Schedules.

(f)            The

relevant portion of Owned Real Property described in Section 3.10(f) of the Company Disclosure Schedules (such portion

of Owned Real Property, the “Volta II Real Property”) has been permanently removed from the agricultural land

fund, and no further action, decision, levy, permit or administrative procedure under applicable agricultural land legislation will be

required in order to enable the development and use of such land for the further development currently contemplated by the relevant Group

Company.

(g)            Except

with respects to breaches or defaults that have been remedied by any Person or waived in writing by the applicable Governmental Entity,

to the Company’s knowledge, GIB (a) is and has been at all times in compliance with the terms and conditions applicable with

respect to the Contract set forth in Section 3.10(g) of the Company Disclosure Schedules and (b) was not notified

by public financial aid scheme providers or other Governmental Entities that it is in breach of the terms and conditions of such Contract.

Section 3.11         Employee

Plans.

(a)            Section 3.11(a) of

the Company Disclosure Schedules sets forth a true and complete list of all material Employee Benefit Plans (including, for each such

Employee Benefit Plan, its jurisdiction). With respect to each material Employee Benefit Plan, the Group Companies have provided CGC with

true and complete copies of (ii) copies of the most recent summary plan description or equivalent employee communication materials,

(iii) copies of all material filings with the Slovak Social Insurance Agency (or equivalent) and any health insurance companies,

in each case, for the two (2) most recent plan years, and (iv) the most recent annual reports or actuarial valuations for any

supplementary pension or severance schemes.

(b)            No

Employee Benefit Plan has any unfunded or underfunded Liability. No Group Company has any material Liabilities to provide any retiree

or post-termination health or life insurance or other welfare-type benefits to any Person, except as required by applicable Law regarding

statutory severance or notice periods. No Group Company has any material Liabilities by reason of at any time being considered part of

a single controlled group or related employer under applicable Law.

Employee Benefit Plan is in compliance, in all material respects, in accordance with its terms and the requirements of all applicable

Laws. Each Employee Benefit Plan that is intended to be tax-favored under applicable Law has timely received all necessary registrations

or approvals, and no fact or event has occurred that could reasonably be expected to result in the loss of such status. None of the Group

Companies has incurred any material penalty or arrears regarding mandatory social security, health insurance, or supplementary pension

contributions.

(d)            As

of the date of this Agreement, there are no pending or, to the Company’s knowledge, threatened in writing claims or Proceedings

with respect to any Employee Benefit Plan (other than routine claims for benefits). All contributions, social insurance premiums, and

mandatory health insurance payments that are due have been timely made to the relevant Governmental Entities, except as is not and would

not reasonably be expected to be, individually or in the aggregate, material to the Group Companies, taken as a whole.

(e)            Except

as set forth on Section 3.11(e) of the Company Disclosure Schedules, the execution and delivery of this Agreement and

the consummation of the transactions contemplated by this Agreement will not materially (alone or in combination with any other event)

(i) result in any payment or benefit becoming due to or result in the forgiveness of any indebtedness of any current or former director,

manager, officer, employee, individual independent contractor or other service providers of any of the Group Companies, (ii) increase

the amount or value of any compensation or benefits payable to any current or former director, manager, officer, employee, individual

independent contractor or other service providers of any of the Group Companies or (iii) result in the acceleration of the time

of payment or vesting, or trigger any payment or funding of any compensation or benefits to any current or former director, manager,

officer, employee, individual independent contractor or other service providers of any of the Group Companies.

Section 3.12           Environmental

Matters.

(a)            The

Group Companies have made available to CGC copies of all environmental assessments, audits and reports and all other material environmental,

health and safety documents that are in any Group Company’s possession or control relating to the current or former operations,

properties or facilities of the Group Companies. Except as could not reasonably be expected to have a Company Material Adverse Effect

(a) the Company is and has been in compliance with all Environmental Laws; (b) there has been no release or threatened release

of any Hazardous Substance, on, upon, into or from any site currently or heretofore owned, leased or otherwise used by the Company; (c) there

have been no Hazardous Substances generated by the Company that have been disposed of or come to rest at any site that has been included

in any published list of hazardous or toxic waste sites published by any governmental authority in Slovakia; and (d) the Company

does not manufacture, handle, import, export, or transport any nanoengineered or nanoscale material; and (e) the Company does not

and has not imported any hazardous substances. The Company has made available to CGC true and complete copies of all material environmental

records, reports, notifications, certificates of need, permits, pending permit applications, correspondence, engineering studies and

environmental studies or assessments.

(b)            No

Group Company is an originator (pôvodca) of any environmental burden and is not, and has not been determined as the responsible

person (povinná osoba) for any environmental burden pursuant to the Act No. 409/2011 Coll. on Certain Measures in the

Area of Environmental Burden and on Amendments to Certain Acts, as amended, and no proceeding on determination of any Group Company as

the responsible person is pending, and no Group Company has carried out any activity that could result in such Group Company being determined

as the originator of, or designated as the responsible person for, any environmental burden.

Group Company has assumed, retained or agreed to bear any liability under any applicable environmental legislation pursuant to any agreement

with any third party, nor has it provided any environmental indemnity, guarantee, covenant to remediate, or similar undertaking to any

third party.

(d)            No

Group Company has received any written notice, order, instruction, decision or other administrative correspondence from any Governmental

Entity alleging or relating to (i) any actual or pending violation of any applicable environmental legislation, (ii) any environmental

burden affecting or potentially affecting any real property owned, leased or otherwise occupied by any Group Company (including any environmental

burden registered to any third party in respect of which any Group Company has been copied, addressed or otherwise made aware), or (iii) any

remediation, monitoring or other environmental obligation, and no Group Company is subject to any ongoing or, to the knowledge of the

Company, threatened environmental investigation, claim, proceeding, enforcement action, order, or remediation obligation.

Section 3.13           Intellectual

Property.

(a)            The

Group Companies (i) own or possess and (ii) in the case of the Group Companies’ business presently proposed to be conducted,

reasonably believes it can acquire on commercially reasonable terms, sufficient legal rights to all Company Intellectual Property without

any known conflict with, or infringement of, the rights of others, including prior employees or consultants. The Group Companies have

not received any communications alleging that the Group Companies have violated, or by conducting its business, would violate any of the

Intellectual Property Rights of any other Person. No product or service marketed or sold (or proposed to be marketed or sold) by the Group

Companies violates or will violate any license or infringes or will infringe any Intellectual Property Rights of any other party. Other

than with respect to commercially available software products under standard end-user object code license agreements, there are no outstanding

options, licenses, agreements, claims, encumbrances or shared ownership interests of any kind relating to the Company Intellectual Property,

nor are the Group Companies bound by or a party to any Intellectual Property Rights of any other Person. The Group Companies have obtained

and possess valid licenses to use all of the software programs present on the computers and other software-enabled electronic devices

that it owns or leases or that it has otherwise provided to its employees for their use in connection with the Group Companies’

business.

(b)            Each

employee has assigned to the Group Companies all Intellectual Property Rights he or she owns that are related to the Group Companies’

business as now conducted and as presently proposed to be conducted and each employee and consultant has assigned to the Group Companies

all intellectual property rights that he, she or it solely or jointly conceived, reduced to practice, developed or made during the period

of his, her or its employment or consulting relationship with the Group Companies that (i) relate, at the time of conception, reduction

to practice, development, or making of such intellectual property right, to the Group Companies’ business as then conducted or as

then proposed to be conducted, (ii) were developed on any amount of the Group Companies’ time or with the use of any of the

Group Companies’ equipment, supplies, facilities or information or (iii) resulted from the performance of services for the

Group Companies. It will not be necessary to use any inventions of any of its employees or consultants (or Persons it currently intends

to hire) made prior to their employment by the Group Companies, including prior employees or consultants.

the Company Disclosure Schedules lists all patents, patent applications, registered trademarks, trademark applications, service marks,

service mark applications, tradenames, registered copyrights, and licenses to and under any of the foregoing, in each case owned by the

Group Companies.

(d)            The

Group Companies have not embedded, used or distributed any open source, copyleft or community source code (including but not limited to

any libraries or code, software, technologies or other materials that are licensed or distributed under any General Public License, Lesser

General Public License or similar license arrangement or other distribution model described by the Open Source Initiative at www.opensource.org,

collectively “Open Source Software”) in connection with any of its products or services that are generally available

or in development in any manner that would materially restrict the ability of the Group Companies to protect their proprietary interests

in any such product or service or in any manner that requires, or purports to require (i) any Company Intellectual Property (other

than the Open Source Software itself) be disclosed or distributed in source code form or be licensed for the purpose of making derivative

works; (ii) any restriction on the consideration to be charged for the distribution of any Company Intellectual Property; (iii) the

creation of any obligation for the Group Companies with respect to Company Intellectual Property owned by the Group Companies, or the

grant to any third party of any rights or immunities under Company Intellectual Property owned by the Group Companies; or (iv) any

other limitation, restriction or condition on the right of the Group Companies with respect to their use or distribution of any Company

Intellectual Property.

(e)            Except

as set forth on Section 3.13(e) of the Company Disclosure Schedules, no government funding, facilities of a university,

college, other educational institution or research center, or funding from third parties was used in the development of any Company Intellectual

Property. No Person who was involved in, or who contributed to, the creation or development of any Company Intellectual Property, has

performed services for the government, university, college, or other educational institution or research center in a manner that would

affect the Group Companies’ rights in the Company Intellectual Property.

Section 3.14           Employee

Matters.

(a)            Section 3.14(a) of

the Company Disclosure Schedules, lists the full-time employees, part time employees, consultants and independent contractors employed

or engaged by the Group Companies as of the date hereof. Section 3.14(a) of the Company Disclosure Schedules also sets

forth a detailed description of all compensation, including salary, bonus, severance obligations and deferred compensation paid or payable

for each officer, employee, consultant and independent contractor of the Group Companies.

(b)            To

the Company’s knowledge, none of the Group Companies’ employees is obligated under any contract (including licenses, covenants

or commitments of any nature) or other agreement, or subject to any judgment, decree or order of any court or administrative agency, that

would materially interfere with such employee’s ability to promote the interest of the Group Companies or that would conflict with

the Group Companies’ business. Neither the execution or delivery of this Agreement and the Ancillary Documents, nor the carrying

on of the Group Companies’ business by the employees of the Group Companies, nor the conduct of the Group Companies’ business

as now conducted and as presently proposed to be conducted, will, to the Company’s knowledge, conflict with or result in a breach

of the terms, conditions, or provisions of, or constitute a default under, any contract, covenant or instrument under which any such employee

is now obligated.

Group Companies are not delinquent in payments to any of its employees, consultants, or independent contractors for any wages, salaries,

commissions, bonuses, or other direct compensation for any service performed for it to the date hereof or amounts required to be reimbursed

to such employees, consultants or independent contractors. The Group Companies have complied in all material respects with all applicable

state and federal equal employment opportunity laws and with other laws related to employment, including those related to wages, hours,

worker classification and collective bargaining. The Group Companies have withheld and paid to the appropriate governmental entity or

is holding for payment not yet due to such governmental entity all amounts required to be withheld from employees of the Group Companies

and is not liable for any arrears of wages, taxes, penalties or other sums for failure to comply with any of the foregoing.

(d)           To

the Company’s knowledge, no Key Persons intends to terminate employment with the Company or is otherwise likely to become unavailable

to continue as a Key Persons, nor does the Company have a present intention to terminate the employment of any of the foregoing. The

employment of each employee of the Company is terminable at the will of the Company. Except as set forth in Section 3.14(d) of

the Company Disclosure Schedules or as required by law, upon termination of the employment of any such employees, no severance or other

payments will become due. Except as set forth in Section 3.14(d) of the Company Disclosure Schedules, the Company has

no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination

of employment services.

(e)           The

Group Companies have not made any representations regarding equity incentives to any officer, employee, director or consultant that are

inconsistent with the share amounts and terms set forth in the minutes of meetings of the Board of Directors.

(f)            Each

former Key Persons whose employment was terminated by the Company has entered into an agreement with the Company providing for the full

release of any claims against the Company or any related party arising out of such employment.

(g)           The

Group Companies are not bound by or subject to (and none of its assets or properties is bound by or subject to) any written or oral,

express or implied, contract, commitment or arrangement with any labor union, and no labor union has requested or, to the knowledge of

the Company, has sought to represent any of the employees, representatives or agents of the Group Companies. There is no strike or other

labor dispute involving the Group Companies pending, or to the Company’s knowledge, threatened, which could have a Company Material

Adverse Effect, nor is the Company aware of any labor organization activity involving its employees.

(h)           To

the Company’s knowledge, none of the Key Persons, officers or directors of the Group Companies has been (i) subject to voluntary

or involuntary petition under applicable bankruptcy Laws or the appointment of a receiver, fiscal agent or similar officer by a court

for his business or property; (ii) convicted in a criminal proceeding or named as a subject of a pending criminal proceeding (excluding

traffic violations and other minor offenses); (iii) subject to any order, judgment or decree (not subsequently reversed, suspended,

or vacated) of any court of competent jurisdiction permanently or temporarily enjoining him from engaging, or otherwise imposing limits

or conditions on his engagement in any securities, investment advisory, banking, insurance, or other type of business or acting as an

officer or director of a public company; or (iv) found by a court of competent jurisdiction in a civil action or by the Securities

and Exchange Commission or the Commodity Futures Trading Commission to have violated any federal or state securities, commodities, or

unfair trade practices law, which such judgment or finding has not been subsequently reversed, suspended, or vacated.

Section 3.15         Insurance.

Section 3.15 of the Company Disclosure Schedules sets forth a list of all material policies of fire, liability, workers’

compensation, property, casualty and other forms of insurance owned or held by any Group Company as of the date of this Agreement. All

such policies are in full force and effect, all premiums due and payable thereon as of the date of this Agreement have been paid in full

as of the date of this Agreement, and true and complete copies of all such policies have been made available to CGC. As of the date of

this Agreement, no claim by any Group Company is pending under any such policies as to which coverage has been denied or disputed, or

rights reserved to do so, by the underwriters thereof, except as is not and would not reasonably be expected to be, individually or in

the aggregate, material to the Group Companies, taken as a whole.

Section 3.16         Tax

Matters.

(a)           Except

as set forth on Section 3.16(a) of the Company Disclosure Schedules, each Group Company has prepared and filed all income

and other material Tax Returns required to have been filed by it, all such Tax Returns are true and complete in all material respects

and prepared in compliance in all material respects with all applicable Laws and Orders, and each Group Company has paid all material

Taxes required to have been paid by it regardless of whether shown on a Tax Return.

(b)           Each

Group Company has timely withheld and paid to the appropriate Tax Authority all material amounts required to have been withheld and paid

in connection with amounts paid or owing to any employee, individual independent contractor, other service providers, equity interest

holder or other third party.

Group Company is currently the subject of a Tax audit or examination with respect to material Taxes. No Group Company has been informed

in writing of the commencement or anticipated commencement of any Tax audit or examination that has not been resolved or completed in

each case with respect to material Taxes.

(d)           No

Group Company has consented to extend or waive the time in which any material Tax may be assessed or collected by any Tax Authority,

other than any such extensions or waivers that are no longer in effect or that were extensions of time to file Tax Returns obtained in

the ordinary course of business.

(e)           No

“closing agreement” as described in Section 7121 of the Code (or any corresponding or similar provision of state, local

or non-U.S. income Tax Law), private letter rulings, technical advice memoranda or similar agreements or rulings have been entered into

or issued by any Tax Authority with respect to a Group Company which agreement or ruling would be effective after the Closing Date.

(f)            No

Group Company is or has been a party to any “listed transaction” as defined in Section 6707A of the Code and Treasury

Regulations Section 1.6011-4 (or any corresponding or similar provision of state, local or non-U.S. income Tax Law).

(g)           There

are no Liens for material Taxes on any assets of the Group Companies other than Permitted Liens.

(h)           During

the two (2)-year period ending on the date of this Agreement, no Group Company was a distributing corporation or a controlled corporation

in a transaction purported or intended to be governed by Section 355 of the Code.

(i)            No

Group Company (i) has been a member of an affiliated group filing a consolidated federal income Tax Return (other than a group the

common parent of which was a Group Company or any of its current Affiliates) or (ii) has any material Liability for the Taxes of

any Person (other than a Group Company or any of its current Affiliates) under Section 1.1502-6 of the Treasury Regulations (or

any similar provision of state, local or non-United States Law), as a transferee or successor or by Contract (other than any Contract

the principal purpose of which does not relate to Taxes).

(j)            No

written claims have ever been made by any Tax Authority in a jurisdiction where a Group Company does not file Tax Returns that such Group

Company is or may be subject to taxation by that jurisdiction, which claims have not been resolved or withdrawn.

(k)           No

Group Company is a party to any Tax allocation, Tax sharing or Tax indemnity or similar agreements (other than one that is included in

a Contract entered into in the ordinary course of business that is not primarily related to Taxes) and no Group Company is a party to

any joint venture, partnership or other arrangement that is treated as a partnership for U.S. federal income Tax purposes.

(l)            Each

Group Company is tax resident only in its jurisdiction of formation.

(m)          No

Group Company has a permanent establishment (within the meaning of an applicable Tax treaty) or otherwise has an office or fixed place

of business in a country other than the country in which it is organized.

(n)           No

Group Company has taken or agreed to take any action not contemplated by this Agreement and/or any Ancillary Document that could reasonably

be expected to prevent the CGC Merger and the Exchange from qualifying for the Intended Tax Treatment. To the knowledge of the Company,

no facts or circumstances exist, other than any facts or circumstances to the extent that such facts or circumstances exist or arise

as a result of or related to any act or omission occurring after the signing date of CGC or any of its respective Affiliates not contemplated

by this Agreement and/or any of the Ancillary Documents, that could reasonably be expected to prevent the CGC Merger and the Exchange

from qualifying for the Intended Tax Treatment.

Section 3.17         Brokers.

Except for fees (including the amounts due and payable assuming the Closing occurs) set forth on Section 3.17 of the Company

Disclosure Schedules (which fees shall be the sole responsibility of the Company, except as otherwise provided in Section 8.6),

no broker, finder, investment banker or other Person is entitled to any brokerage fee, finders’ fee or other commission in connection

with the transactions contemplated by this Agreement based upon arrangements made by or on behalf of the Company or any of its Affiliates

for which any of the Group Companies has any obligation.

Section 3.18         Real

and Personal Property.

(a)           Owned

Real Property. Section 3.18(a) of the Company Disclosure Schedules sets forth a true and complete list (including

street addresses) of all real property owned by any of the Group Companies (the “Owned Real Property”). There

are no legal, administrative or other decisions or preliminary injunctions issued or proceedings pending that could materially impact

any Group Company’s legal title to the Owned Real Property. Existing utility lines from the Owned Real Property up to the connection

points to the public utility network are owned by the respective Group Company and are located on the lands owned by the Group Companies

or on the lands to which the respective in-rem easement for the benefit of the Owned Real Property. Each Owned Real Property is

directly accessible by and directly connected to the network of public roads. No financial obligations or Tax arrears exist that could

result in creation of a mortgage or other third party right in relation to any of the Owned Real Property.

(b)           Leased

Real Property. Section 3.18(b) of the Company Disclosure Schedules sets forth a true and complete list (including

street addresses) of all real property leased by any of the Group Companies (the “Leased Real Property”) and

all Real Property Leases pursuant to which any Group Company is a tenant or landlord as of the date of this Agreement. True and complete

copies of all such Real Property Leases have been made available to CGC. Each Real Property Lease is in full force and effect and is

a valid, legal and binding obligation of the applicable Group Company party thereto, enforceable in accordance with its terms against

such Group Company and, to the Company’s knowledge, each other party thereto (subject to applicable bankruptcy, insolvency, reorganization,

moratorium or other Laws affecting generally the enforcement of creditors’ rights and subject to general principles of equity).

There is no material breach or default by any Group Company or, to the Company’s knowledge, any third party under any Real Property

Lease, and, to the Company’s knowledge, no event has occurred which (with or without notice or lapse of time or both) would constitute

a material breach or default under any Real Property Lease or would permit termination of, or a material modification or acceleration

thereof, by any counterparty to any Real Property Lease. The Group Companies’ possession and quiet enjoyment of the Leased Real

Property under any Real Property Lease has not been materially disturbed, and to the Company’s knowledge there are no material

disputes with respect to any Real Property Lease. Except as set forth in Section 3.18(b) of the Company Disclosure Schedules,

as of the date hereof, no Group Company has (i) subleased, licensed or otherwise granted any Person the right to use or occupy the

Leased Real Property or any portion thereof; or (ii) collaterally assigned or granted any other security interest in any Real Property

Lease or any interest therein.

Property. Each Group Company has good, marketable and indefeasible title to, or a valid leasehold interest in or license or right

to use, all of the material assets and properties of the Group Companies reflected in the Financial Statements or thereafter acquired

by the Group Companies, except for assets disposed of in the ordinary course of business.

(d)           Assets.

Immediately after the Exchange Effective Time, the assets (which, for the avoidance of doubt, shall include any assets held pursuant

to valid leasehold interest, license or other similar interests or right to use any assets) of the Group Companies will constitute all

of the assets necessary to conduct the Business immediately after the Closing in materially the same manner (for the Group Companies,

taken as a whole) as it is conducted on the date of this Agreement, except as would not have a Company Material Adverse Effect.

(e)           GIB

Real Property. Section 3.18(e) of the Company Disclosure Schedules sets forth a true and complete list (including

street addresses) of all real property owned by GIB EnergyX Slovakia s.r.o., an entity incorporated and existing under the laws

of the Slovak Republic in the form of limited liability company, with its registered office at Mlynské nivy 5, Bratislava 821

09, Slovak Republic, ID No.: 55 901 328 (“GIB”) (the “GIB Real Property”).

There are no legal, administrative or other decisions or preliminary injunctions issued or proceedings pending that could materially

impact GIB’s legal title to the GIB Real Property. Each GIB Real Property is directly accessible by and directly connected to the

network of public roads. No financial obligations or Tax arrears exist that could result in creation of a mortgage or other third party

right in relation to any of the GIB Real Property.

Section 3.19         Transactions

with Affiliates. Section 3.19 of the Company Disclosure Schedules sets forth all Contracts between (a) any Group

Company, on the one hand, and (b) any officer, director, employee, partner, member, manager, direct or indirect equityholder or

Affiliate of any Group Company (other than, for the avoidance of doubt, any other Group Company) or any family member of the foregoing

Persons, on the other hand (each Person identified in this clause (b), a “Company Related Party”), other than

(i) Contracts with respect to a Company Related Party’s employment with (including benefit plans and other ordinary course

compensation from) any of the Group Companies entered into in the ordinary course of business, (ii) Contracts with respect to a

Company Shareholder’s or a holder of Company Equity Awards’ status as a holder of Equity Securities of the Company and (iii) Contracts

entered into after the date of this Agreement that are either permitted pursuant to Section 5.1(b) or entered into in

accordance with Section 5.1(b). No Company Related Party (A) owns any interest in any material asset used in any Group

Company’s business, or (B) possesses, directly or indirectly, any material financial interest in, or is a director or executive

officer of, any Person which is a supplier, vendor, partner, customer, lessor or other material business relation of any Group Company,

(C) is a supplier, vendor, (D) owes any material amount to, or is owed any material amount by, any Group Company (other than

accrued compensation, employee benefits, employee or director expense reimbursement, in each case, in the ordinary course of business

or pursuant to any transaction entered into after the date of this Agreement that is either permitted pursuant to Section 5.1(b) or

entered into in accordance with Section 5.1(b)). All Contracts, arrangements, understandings, interests and other matters

that are required to be disclosed pursuant to this Section 3.19 are referred to herein as “Company Related Party

Transactions”.

Section 3.20         Data

Privacy and Security.

(a)           Each

Group Company has implemented written policies relating to the Processing of Personal Data as and to the extent required by applicable

Law (“Privacy and Data Security Policies”). In connection with its collection, storage, use and/or disclosure

of any information that constitutes “personal information,” “personal data” or “personally identifiable

information” as defined in applicable laws (collectively “Personal Information”) by or on behalf of the Group

Companies, the Group Companies are and have been in material compliance with (i) all applicable laws (including, without limitation,

laws relating to privacy, data security, telephone and text message communications, and marketing by email or other channels) in all

relevant jurisdictions, (ii) the Group Companies’ privacy policies and public statements written by the Group Companies regarding

their privacy or data security practices and (iii) the requirements of any contract codes of conduct or industry standards by which

the Group Companies are a party. The Group Companies maintain and have maintained reasonable physical, technical, and administrative

security measures and policies designed to protect all Personal Information owned, stored, used, maintained or controlled by or on behalf

of the Group Companies from and against unlawful, accidental or unauthorized access, destruction, loss, use, modification and/or disclosure.

The Group Companies are and have been in compliance in all material respects with all laws relating to data loss, theft and breach of

security notification obligations. To the Company’s knowledge, there has been no occurrence of (x) unlawful, accidental or

unauthorized destruction, loss, use, modification or disclosure of or access to Personal Information owned, stored, used, maintained

or controlled by or on behalf of the Group Companies such that privacy requirements require or required the Group Companies to notify

government authorities, affected individuals or other parties of such occurrence or (y) unauthorized access to or disclosure of

the Group Companies’ confidential information or trade secrets that reasonably would be expected to result in a Company Material

Adverse Effect.

(b)           In

connection with its collection, storage, transfer (including without limitation, any transfer across national borders) and/or use of

any Personal Information, the Group Companies are and have been, to the Company’s knowledge, in compliance with all applicable

laws in all relevant jurisdictions, the Group Companies’ privacy policies, and the requirements of any contract or codes of conduct

to which the Group Companies are a party. The Group Companies have commercially reasonable physical, technical, organizational and administrative

security measures and policies in place to protect all Personal Information collected by it or on its behalf from and against unauthorized

access, use and/or disclosure. The Group Companies are and have been in compliance in all material respects with all laws relating to

data loss, theft and breach of security notification obligations.

Section 3.21         Compliance

with International Trade & Anti-Corruption Laws.

(a)           The

Group Companies have conducted all export transactions in accordance with applicable provisions of United States, Norway, European Union

and Slovakia export control laws and regulations, including the Export Administration Regulations, the International Traffic in Arms

Regulations, the regulations administered by the Office of Foreign Assets Control of the U.S. Treasury Department, and the export control

laws and regulations of any other applicable jurisdiction. Without limiting the foregoing: (a) the Group Companies have obtained

all export licenses and other approvals, timely filed all required filings and has assigned the appropriate export classifications to

all products, in each case as required for its exports of products, software and technologies from Slovakia, Norway and the European

Union and any other applicable jurisdiction; (b) the Group Companies are in compliance with the terms of all applicable export licenses,

classifications, filing requirements or other approvals; (c) there are no pending or, to the knowledge of the Company, threatened

claims against the Group Companies with respect to such exports, classifications, required filings or other approvals; (d) there

are no pending investigations related to the Group Companies’ exports; and (e) there are no actions, conditions, or circumstances

pertaining to the Company’s export transactions that would reasonably be expected to give rise to any material future claims.

(b)           Neither

the Company nor any of its directors, officers, employees or agents have made or authorized any bribe, rebate, payoff, influence payment,

kickback or other unlawful payment of funds or received or retained any funds in violation of any law, rule or regulation. The Company

further represents that the it has maintained, and has caused each of its subsidiaries to maintain, systems of internal controls (including,

but not limited to, accounting systems, purchasing systems and billing systems) and written policies to ensure compliance with applicable

anti-bribery or anti-corruption law and to ensure that all books and records of the Group Companies accurately and fairly reflect, in

reasonable detail, all transactions and dispositions of funds and assets. None of the Group Companies, or, to the Company’s knowledge,

any of their officers, directors or employees are the subject of any allegation, voluntary disclosure, investigation, prosecution or

other enforcement action related to any applicable anti-corruption law.

Section 3.22         Information

Supplied. None of the information supplied or to be supplied by or on behalf of the Group Companies expressly for inclusion or incorporation

by reference prior to the Closing in the Registration Statement / Proxy Statement will, when the Registration Statement / Proxy Statement

is declared effective or when the Registration Statement / Proxy Statement is mailed to the CGC Shareholders or at the time of the CGC

Shareholders Meeting, and in the case of any amendment thereto, at the time of such amendment, contain any untrue statement of a material

fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light

of the circumstances under which they are made, not misleading.

Section 3.23         Investigation;

No Other Representations.

(a)           The

Company, on its own behalf and on behalf of its Representatives, acknowledges, represents, warrants and agrees that (i) it has conducted

its own independent review and analysis of, and, based thereon, has formed an independent judgment concerning, the business, assets,

condition, operations and prospects of, CGC and (ii) it has been furnished with or given access to such documents and information

about CGC and its business and operations as it and its Representatives have deemed necessary to enable it to make an informed decision

with respect to the execution, delivery and performance of this Agreement, the Ancillary Documents and the transactions contemplated

hereby and thereby.

(b)           In

entering into this Agreement and the Ancillary Documents to which it is or will be a party, the Company has relied solely on its own

investigation and analysis and the representations and warranties expressly set forth in Article 4 and in the Ancillary Documents

to which it is or will be a party and no other representations or warranties of CGC, any CGC Non-Party Affiliate or any other Person,

either express or implied, and the Company, on its own behalf and on behalf of its Representatives, acknowledges, represents, warrants

and agrees that, except for the representations and warranties expressly set forth in Article 4 and in the Ancillary Documents

to which it is or will be a party, none of CGC, any CGC Non-Party Affiliate or any other Person makes or has made any representation

or warranty, either express or implied, in connection with or related to this Agreement, the Ancillary Documents or the transactions

contemplated hereby or thereby.

Section 3.24         EXCLUSIVITY

OF REPRESENTATIONS AND WARRANTIES. NOTWITHSTANDING THE DELIVERY OR DISCLOSURE TO CGC OR ANY OF ITS REPRESENTATIVES OF ANY DOCUMENTATION

OR OTHER INFORMATION (INCLUDING ANY FINANCIAL PROJECTIONS OR OTHER SUPPLEMENTAL DATA), EXCEPT AS OTHERWISE EXPRESSLY SET FORTH IN THIS

ARTICLE 3 OR THE ANCILLARY DOCUMENTS, NEITHER THE COMPANY NOR ANY OTHER PERSON MAKES, AND THE COMPANY EXPRESSLY DISCLAIMS,

ANY REPRESENTATIONS OR WARRANTIES OF ANY KIND OR NATURE, EXPRESS OR IMPLIED, IN CONNECTION WITH THIS AGREEMENT, THE ANCILLARY DOCUMENTS

OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY, INCLUDING AS TO THE MATERIALS RELATING TO THE BUSINESS AND AFFAIRS OR

HOLDINGS OF THE GROUP COMPANIES THAT HAVE BEEN MADE AVAILABLE TO CGC OR ANY OF ITS REPRESENTATIVES OR IN ANY PRESENTATION OF THE BUSINESS

AND AFFAIRS OF THE GROUP COMPANIES BY THE MANAGEMENT OF THE COMPANY OR OTHERS IN CONNECTION WITH THE TRANSACTIONS CONTEMPLATED HEREBY

OR BY THE ANCILLARY DOCUMENTS, AND NO STATEMENT CONTAINED IN ANY OF SUCH MATERIALS OR MADE IN ANY SUCH PRESENTATION SHALL BE DEEMED A

REPRESENTATION OR WARRANTY HEREUNDER OR OTHERWISE OR DEEMED TO BE RELIED UPON BY CGC IN EXECUTING, DELIVERING AND PERFORMING THIS AGREEMENT,

THE ANCILLARY DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EXCEPT FOR THE REPRESENTATIONS AND WARRANTIES EXPRESSLY SET

FORTH IN THIS ARTICLE 3 OR THE ANCILLARY DOCUMENTS, IT IS UNDERSTOOD THAT ANY COST ESTIMATES, PROJECTIONS OR OTHER PREDICTIONS,

ANY DATA, ANY FINANCIAL INFORMATION OR ANY MEMORANDA OR OFFERING MATERIALS OR PRESENTATIONS, INCLUDING ANY OFFERING MEMORANDUM OR

SIMILAR MATERIALS MADE AVAILABLE BY OR ON BEHALF OF ANY GROUP COMPANY ARE NOT AND SHALL NOT BE DEEMED TO BE OR TO INCLUDE REPRESENTATIONS

OR WARRANTIES OF THE COMPANY OR ANY OTHER PERSON, AND ARE NOT AND SHALL NOT BE DEEMED TO BE RELIED UPON BY CGC IN EXECUTING, DELIVERING

OR PERFORMING THIS AGREEMENT, THE ANCILLARY DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.

Article 4

REPRESENTATIONS AND WARRANTIES RELATING TO CGC

Subject to Section 8.8,

except (a) as set forth on the CGC Disclosure Schedules, or (b) except as set forth in any CGC SEC Reports (excluding any disclosures

in any “risk factors” section that do not constitute statements of fact, disclosures in any forward-looking

statements disclaimers and other disclosures that are generally cautionary, predictive or forward-looking in nature), CGC hereby represents

and warrants to the Company, in each case, as of the date of this Agreement and as of the Closing Date, as follows:

Section 4.1           Organization

and Qualification. CGC is an exempted company, corporation, limited liability company or other applicable business entity duly organized,

incorporated or formed, as applicable, validly existing and in good standing (or the equivalent thereof, if applicable, in each case,

with respect to the jurisdictions that recognize the concept of good standing or any equivalent thereof) under the Laws of its jurisdiction

of organization, incorporation or formation (as applicable).

Section 4.2           Authority.

(a)            CGC

has the requisite exempted company, corporate, limited liability company or other similar power and authority to execute and deliver

this Agreement and each of the Ancillary Documents to which it is or will be a party and to consummate the transactions contemplated

hereby and thereby. Subject to the receipt of the CGC Shareholder Approval and the approvals and consents to be obtained by Merger Sub

pursuant to Section 5.9, the execution and delivery of this Agreement, the Ancillary Documents to which CGC is or will be

a party and the consummation of the transactions contemplated hereby and thereby have been (or, in the case of any Ancillary Document

entered into after the date of this Agreement, will be upon execution thereof) duly authorized by all necessary exempted company, corporate,

limited liability company or other similar action on the part of CGC. This Agreement has been and each Ancillary Document to which CGC

is or will be a party will be, upon execution thereof, duly and validly executed and delivered by CGC and constitutes or will constitute,

upon execution thereof, as applicable, a valid, legal and binding agreement of CGC (assuming this Agreement has been and the Ancillary

Documents to which CGC is or will be a party are or will be, upon execution thereof, as applicable, duly authorized, executed and delivered

by the other Persons party hereto or thereto, as applicable), enforceable against CGC in accordance with their terms (subject to applicable

bankruptcy, insolvency, reorganization, moratorium or other Laws affecting generally the enforcement of creditors’ rights and subject

to general principles of equity).

Section 4.3            Consents

and Requisite Governmental Approvals; No Violations.

(a)            No

consent, approval or authorization of, or designation, declaration or filing with, any Governmental Entity is required on the part of

CGC with respect to CGC’s execution, delivery or performance of its obligations under this Agreement or the Ancillary Documents

to which it is or will be party or the consummation of the transactions contemplated by hereby or thereby, except for (i) the filing

with the SEC of (A) the Registration Statement / Proxy Statement and the declaration of the effectiveness thereof by the SEC and

(B) such reports under Section 13(a) or 15(d) of the Exchange Act as may be required in connection with this Agreement,

the Ancillary Documents or the transactions contemplated hereby or thereby, (ii) such filings with and approvals of Nasdaq to permit

the CGC Shares to be issued in connection with the transactions contemplated by this Agreement and the other Ancillary Documents to be

listed on Nasdaq, (iii) the filing of the Plan of Merger, (iv) the approvals and consents to be obtained by Merger Sub pursuant

to Section 5.9, (v) the CGC Shareholder Approval or (vi) any other consents, approvals, authorizations, designations,

declarations, waivers or filings, the absence of which would not have an CGC Material Adverse Effect.

(b)            None

of execution or delivery by CGC of this Agreement or any Ancillary Document to which it is or will be a party, the performance by CGC

of its obligations hereunder or thereunder or the consummation by CGC of the transactions contemplated hereby or thereby will, directly

or indirectly (with or without due notice or lapse of time or both) (i) result in a violation or breach of any provision of the

Governing Documents of CGC, (ii) result in a violation or breach of, or constitute a default or give rise to any right of termination,

cancellation, amendment, modification, suspension, revocation or acceleration under, any of the terms, conditions or provisions of any

Contract to which CGC is a party, (iii) violate, or constitute a breach under, any Order or applicable Law to which CGC or any of

its properties or assets are subject or bound or (iv) result in the creation of any Lien upon any of the assets or properties (other

than any Permitted Liens) or Equity Securities of CGC, except in the case of any of clauses (ii) through (iv) above, as would

not have a CGC Material Adverse Effect.

Section 4.4            Brokers.

Except for fees (including the amounts due and payable assuming the Closing occurs) set forth on Section 4.4 of the CGC Disclosure

Schedules (which fees shall be the sole responsibility of the CGC, except as otherwise provided in Section 8.6), no broker,

finder, investment banker or other Person is entitled to any brokerage fee, finders’ fee or other commission in connection with

the transactions contemplated by this Agreement based upon arrangements made by or on behalf of CGC or any of its Affiliates for which

CGC has any obligation.

Section 4.5            Information

Supplied. None of the information supplied or to be supplied by or on behalf of CGC expressly for inclusion or incorporation by reference

prior to the Closing in the Registration Statement / Proxy Statement will, when the Registration Statement / Proxy Statement is declared

effective or when the Registration Statement / Proxy Statement is mailed to the CGC Shareholders or at the time of the CGC Shareholders

Meeting, and in the case of any amendment thereto, at the time of such amendment, contain any untrue statement of a material fact or

omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances

under which they are made, not misleading; provided, however, notwithstanding the foregoing provisions of this Section 4.5,

no representation or warranty is made by CGC with respect to information or statements made or incorporated by reference in the Registration

Statement / Proxy Statement that were not supplied by or on behalf of CGC for use therein.

Section 4.6            Capitalization

of CGC.

(a)            Section 4.6(a) of

the CGC Disclosure Schedules sets forth a true and complete statement of the number and class or series (as applicable) of the issued

and outstanding CGC Shares prior to the consummation of the CGC Merger. All outstanding Equity Securities of CGC (except to the extent

such concepts are not applicable under the applicable Law of CGC’s jurisdiction of organization, incorporation or formation, as

applicable, or other applicable Law) prior to the consummation of the CGC Merger have been duly authorized and validly issued and are

fully paid and non-assessable. Such Equity Securities (x) were not issued in violation of the Governing Documents of CGC, (y) are

not subject to any preemptive rights, call option, right of first refusal, subscription rights, transfer restrictions or similar rights

of any Person (other than transfer restrictions under applicable Securities Laws or under the Governing Documents of CGC) and were not

issued in violation of any preemptive rights, call option, right of first refusal, subscription rights, transfer restrictions or similar

rights of any Person and (z) have been offered, sold and issued in compliance with applicable Law, including Securities Laws, in

each case under clause (y) and (x), in all material respects. Except for the CGC Shares set forth on Section 4.6(a) of

the CGC Disclosure Schedules (taking into account, for the avoidance of doubt, any changes or adjustments to the CGC Shares as a result

of, or to give effect to, the CGC Merger), immediately prior to Closing and before giving effect to the PIPE Financing and the CGC Shareholder

Redemption, there shall be no other Equity Securities of CGC issued and outstanding.

(b)            Except

as expressly contemplated by this Agreement, the Ancillary Documents or the transactions contemplated hereby or thereby or as otherwise

either permitted pursuant to Section 5.12 or issued, granted or entered into, as applicable, in accordance with Section 5.12,

there are no outstanding (A) equity appreciation, phantom equity or profit participation rights or (B) options, restricted

shares, phantom shares, warrants, purchase rights, subscription rights, conversion rights, exchange rights, calls, puts, rights of first

refusal or first offer or other Contracts, in each case, that could require CGC to issue, sell or otherwise cause to become outstanding

or to acquire, repurchase or redeem any Equity Securities or securities convertible into or exchangeable for Equity Securities of CGC.

Equity Securities of Merger Sub outstanding as of the date of this Agreement (i) have been duly authorized and validly issued and

are fully paid and nonassessable and (ii) were issued in compliance in all material respects with applicable Law, and (iii) were

not issued in breach or violation of any preemptive rights or Contract to which Merger Sub is a party or bound. All of the outstanding

Equity Securities of Merger Sub are owned directly by CGC free and clear of all Liens (other than transfer restrictions under applicable

Securities Law or under the Governing Documents of Merger Sub). As of the date of this Agreement, CGC has no Subsidiaries other than

Merger Sub and does not own, directly or indirectly, any Equity Securities in any Person other than Merger Sub.

Section 4.7             SEC

Filings. CGC has timely filed or furnished all statements, forms, reports and documents required to be filed or furnished by it prior

to the date of this Agreement with the SEC pursuant to Federal Securities Laws since its initial public offering (collectively, and together

with any exhibits and schedules thereto and other information incorporated therein, and as they have been supplemented, modified or amended

since the time of filing, the “CGC SEC Reports”), and, as of the Closing, will have filed or furnished all

other statements, forms, reports and other documents required to be filed or furnished by it subsequent to the date of this Agreement

with the SEC pursuant to Federal Securities Laws through the Closing (collectively, and together with any exhibits and schedules thereto

and other information incorporated therein, and as they have been supplemented, modified or amended since the time of filing, but excluding

the Registration Statement / Proxy Statement, the “Additional CGC SEC Reports”). Each of the CGC SEC Reports,

as of their respective dates of filing, and as of the date of any amendment or filing that superseded the initial filing, complied and

each of the Additional CGC SEC Reports, as of their respective dates of filing, and as of the date of any amendment or filing that superseded

the initial filing, will comply, in all material respects with the applicable requirements of the Federal Securities Laws (including,

as applicable, the Sarbanes-Oxley Act and any rules and regulations promulgated thereunder) applicable to the CGC SEC Reports or

the Additional CGC SEC Reports (for purposes of the Additional CGC SEC Reports, assuming that the representation and warranty set forth

in Section 3.22 is true and correct in all respects with respect to all information supplied by or on behalf of Group Companies

expressly for inclusion or incorporation by reference therein). As of their respective dates of filing, the CGC SEC Reports did not contain

any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements

therein, in light of the circumstances under which they were made or will be made, as applicable, not misleading (for purposes of the

Additional CGC SEC Reports, assuming that the representation and warranty set forth in Section 3.22 is true and correct in

all respects with respect to all information supplied by or on behalf of Group Companies expressly for inclusion or incorporation by

reference therein). As of the date of this Agreement, there are no outstanding or unresolved comments in comment letters received from

the SEC with respect to the CGC SEC Reports.

Section 4.8             Trust

Account. As of the date of this Agreement, CGC has an amount in cash in the Trust Account equal to at least $37,750,814. The funds

held in the Trust Account are (a) invested in United States “government securities” within the meaning of Section 2(a)(16)

of the Investment Company Act, having a maturity of 180 days or less or in money market funds meeting certain conditions under Rule 2a-7

promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations or in cash, or (b) held

in an interest-bearing bank demand deposit account. These funds are held in trust pursuant to that certain Investment Management Trust

Agreement, dated as of May 10, 2022, as amended on October 7, 2024 (the “Trust Agreement”), between

CGC and Continental, as trustee (the “Trustee”). There are no separate agreements, side letters or other agreements

or understandings (whether written or unwritten, express or implied) that would cause the description of the Trust Agreement in the CGC

SEC Reports to be inaccurate in any material respect or, to CGC’s knowledge, that would entitle any Person to any portion of the

funds in the Trust Account (other than (i) in respect of deferred underwriting commissions or Taxes, (ii) the CGC Shareholders

who shall have elected to redeem their CGC Shares pursuant to the Governing Documents of CGC or (iii) if CGC fails to complete a

business combination within the allotted time period set forth in the Governing Documents of CGC (as amended)). Since November 3,

2025, CGC has not released any money from the Trust Account (other than interest income earned on the funds to pay Taxes). Upon the consummation

of the transactions contemplated hereby, the Trust Agreement shall terminate in accordance with its terms.

Section 4.9             Transactions

with Affiliates. Section 4.9 of the CGC Disclosure Schedules sets forth all Contracts between (a) CGC, on the one

hand, and (b) any officer, director, employee, partner, member, manager, direct or indirect equityholder or Affiliate of either

CGC or the Sponsor, on the other hand (each Person identified in this clause (b), an “CGC Related Party”),

other than (i) Contracts with respect to a CGC Related Party’s employment with, or the provision of services to, CGC entered

into in the ordinary course of business (including benefit plans, indemnification arrangements and other ordinary course compensation)

and (ii) Contracts entered into after the date of this Agreement that are either permitted pursuant to Section 5.10

or entered into in accordance with Section 5.10. Except as set forth on Section 4.9 of the CGC Disclosure Schedules

or as either permitted pursuant to Section 5.10 or entered into in accordance with Section 5.10, no CGC Related

Party (A) owns any interest in any material asset used in the business of CGC, (B) possesses, directly or indirectly, any material

financial interest in, or is a director or executive officer of, any Person which is a material client, supplier, customer, lessor or

lessee of CGC or (C) owes any material amount to, or is owed material any amount by, CGC. All Contracts, arrangements, understandings,

interests and other matters that are required to be disclosed pursuant to this Section 4.9 are referred to herein as “CGC

Related Party Transactions”.

Section 4.10          Litigation.

As of the date of this Agreement, there is (and since its organization, incorporation or formation, as applicable, there has been) no

Proceeding pending or, to CGC’s knowledge, threatened against or involving CGC that, if adversely decided or resolved, would be

material to CGC. As of the date of this Agreement, neither CGC nor any of its properties or assets is subject to any material Order.

As of the date of this Agreement, there are no material Proceedings by CGC pending against any other Person.

Section 4.11          Compliance

with Applicable Law. CGC is (and since its organization, incorporation or formation, as applicable, has been) in compliance with

all applicable Laws, except as would not have a CGC Material Adverse Effect.

Section 4.12          Business

Activities.

(a)            Since

its incorporation, CGC has not conducted any business activities other than activities (i) in connection with or incident or related

to its incorporation or continuing corporate (or similar) existence, (ii) directed toward the accomplishment of a business or similar

combination, including those incident or related to or incurred in connection with the negotiation, preparation or execution of this

Agreement or any Ancillary Documents, the performance of its covenants or agreements in this Agreement or any Ancillary Document or the

consummation of the transactions contemplated hereby or thereby or (iii) those that are administrative, ministerial or otherwise

immaterial in nature. Except as set forth in this Agreement or the Ancillary Documents, there is no Contract binding upon CGC or to which

CGC is a party which has or would reasonably be expected to have the effect of prohibiting or materially impairing any business practice

of it or its Subsidiaries, any acquisition of property by it or its Subsidiaries or the conduct of business by it or its Subsidiaries

(including, in each case, following the Closing).

(b)            Merger

Sub was organized solely for the purpose of entering into this Agreement, the Ancillary Documents and consummating the transactions contemplated

hereby and thereby and has not engaged in any activities or business, other than those incident or related to or incurred in connection

with its organization, incorporation or formation, as applicable, or continuing corporate (or similar) existence or the negotiation,

preparation or execution of this Agreement or any Ancillary Documents, the performance of its covenants or agreements in this Agreement

or any Ancillary Document or the consummation of the transactions contemplated hereby or thereby.

Section 4.13          Internal

Controls; Listing; Financial Statements.

(a)            Except

as is not required in reliance on exemptions from various reporting requirements by virtue of CGC’s status as an “emerging

growth company” within the meaning of the Securities Act, as modified by the JOBS Act, or “smaller reporting company”

within the meaning of the Exchange Act, since its initial public offering, (i) CGC has established and maintained a system of internal

controls over financial reporting (as defined in Rule 13a-15 and Rule 15d-15 under the Exchange Act) sufficient to provide

reasonable assurance regarding the reliability of CGC’s financial reporting and the preparation of CGC’s financial statements

for external purposes in accordance with GAAP and (ii) CGC has established and maintained disclosure controls and procedures (as

defined in Rule 13a-15 and Rule 15d-15 under the Exchange Act) designed to ensure that material information relating to CGC

is made known to CGC’s principal executive officer and principal financial officer by others within CGC.

(b)            CGC

has not taken any action prohibited by Section 402 of the Sarbanes-Oxley Act.

classes of securities representing issued and outstanding CGC Class A Shares are registered pursuant to Section 12(b) of

the Exchange Act.

(d)            The

CGC SEC Reports contain true and complete copies of the applicable CGC Financial Statements. The CGC Financial Statements (i) fairly

present in all material respects the financial position of CGC as at the respective dates thereof, and the results of its operations,

shareholders’ equity and cash flows for the respective periods then ended (subject, in the case of any unaudited interim financial

statements, to normal year end audit adjustments (none of which is expected to be material) and the absence of notes thereto), (ii) were

prepared in conformity with GAAP applied on a consistent basis during the periods indicated (except, in the case of any audited financial

statements, as may be indicated in the notes thereto and subject, in the case of any unaudited financial statements, to normal year-end

audit adjustments (none of which is expected to be material) and the absence of notes thereto), (iii) in the case of the audited

CGC Financial Statements, were audited in accordance with the standards of the PCAOB and (iv) comply in all material respects with

the applicable accounting requirements and with the rules and regulations of the SEC, the Exchange Act and the Securities Act in

effect as of the respective dates thereof (including Regulation S-X or Regulation S-K, as applicable).

(e)            CGC

has established and maintains systems of internal accounting controls that are designed to provide, in all material respects, reasonable

assurance that (i) all transactions are executed in accordance with management’s authorization and (ii) all transactions

are recorded as necessary to permit preparation of proper and accurate financial statements in accordance with GAAP and to maintain accountability

for CGC’s and its Subsidiaries’ assets. CGC maintains and, for all periods covered by the CGC Financial Statements, has maintained

books and records of CGC in the ordinary course of business that are accurate and complete and reflect the revenues, expenses, assets

and liabilities of CGC in all material respects.

(f)             Since

its incorporation, CGC has not received any written complaint, allegation, assertion or claim that there is (i) a “significant

deficiency” in the internal controls over financial reporting of CGC to CGC’s knowledge, (ii) a “material weakness”

in the internal controls over financial reporting of CGC to CGC’s knowledge or (iii) fraud, whether or not material, that

involves management or other employees of CGC who have a significant role in the internal controls over financial reporting of CGC.

Section 4.14          No

Undisclosed Liabilities. Except for the Liabilities (a) set forth in Section 4.14 of the CGC Disclosure Schedules,

(b) incurred in connection with the negotiation, preparation or execution of this Agreement or any Ancillary Documents, the performance

of its covenants or agreements in this Agreement or any Ancillary Document or the consummation of the transactions contemplated hereby

or thereby (it being understood and agreed that the expected third parties that are, as of the date hereof, entitled to fees, expenses

or other payments in connection with the matters described in this clause (b) shall be set forth on Section 4.14 of

the CGC Disclosure Schedules), (c) incurred in connection with or incident or related to CGC’s organization, incorporation

or formation, as applicable, or continuing corporate (or similar) existence, in each case, which are immaterial in nature, (d) that

are incurred in connection with activities that are administrative or ministerial, in each case, which are immaterial in nature, (e) that

are either permitted pursuant to Section 5.10(d) or incurred in accordance with Section 5.10(d) (for

the avoidance of doubt, in each case, with the written consent of the Company) or (f) set forth or disclosed in the CGC Financial

Statements included in the CGC SEC Reports, CGC does not have any Liabilities of the type required to be set forth on a balance sheet

in accordance with GAAP.

Section 4.15          Tax

Matters.

(a)            CGC

has prepared and filed all income and other material Tax Returns required to have been filed by it, all such Tax Returns are true and

complete in all material respects and prepared in compliance in all material respects with all applicable Laws and Orders, and CGC has

paid all material Taxes required to have been paid or deposited by it regardless of whether shown on a Tax Return.

(b)           CGC

has timely withheld and paid to the appropriate Tax Authority all material amounts required to have been withheld and paid in connection

with amounts paid or owing to any employee, individual independent contractor, other service providers, equity interest holder or other

third party.

is not currently the subject of a Tax audit or examination with respect to material taxes. CGC has not been informed in writing of the

commencement or anticipated commencement of any Tax audit or examination that has not been resolved or completed, in each case with respect

to material Taxes.

(d)            CGC

has not consented to extend or waive the time in which any material Tax may be assessed or collected by any Tax Authority, other than

any such extensions or waivers that are no longer in effect or that were extensions of time to file Tax Returns obtained in the ordinary

course of business, in each case with respect to material Taxes.

(e)             No

“closing agreement” as described in Section 7121 of the Code (or any corresponding or similar provision of state, local

or non-U.S. income Tax Law), private letter rulings, technical advice memoranda or similar agreements or rulings have been entered into

or issued by any Tax Authority with respect to CGC which agreement or ruling would be effective after the Closing Date.

(f)             CGC

is not and has not been a party to any “listed transaction” as defined in Section 6707A of the Code and Treasury Regulations

Section 1.6011-4 (or any corresponding or similar provision of state, local or non-U.S. income Tax Law).

(g)            CGC

is a tax resident only in its jurisdiction of organization, incorporation or formation, as applicable.

(h)            CGC

has not taken or agreed to take any action not contemplated by this Agreement and/or any Ancillary Documents that could reasonably be

expected to prevent the CGC Merger and the Exchange from qualifying for the Intended Tax Treatment. To the knowledge of CGC, no facts

or circumstances exist, other than any facts or circumstances to the extent that such facts or circumstances exist or arise as a result

of or related to any act or omission occurring after the signing date by a Group Company or a Company Shareholder or any of their respective

Affiliates in each case not contemplated by this Agreement and/or any of the Ancillary Documents, that could reasonably be expected to

prevent the CGC Merger and the Exchange from qualifying for the Intended Tax Treatment.

Section 4.16          Investigation;

No Other Representations.

(a)            CGC,

on its own behalf and on behalf of its Representatives, acknowledges, represents, warrants and agrees that (i) it has conducted

its own independent review and analysis of, and, based thereon, has formed an independent judgment concerning, the business, assets,

condition, operations and prospects, of the Group Companies and (ii) it has been furnished with or given access to such documents

and information about the Group Companies and their respective businesses and operations as it and its Representatives have deemed necessary

to enable it to make an informed decision with respect to the execution, delivery and performance of this Agreement, the Ancillary Documents

and the transactions contemplated hereby and thereby.

(b)            In

entering into this Agreement and the Ancillary Documents to which it is or will be a party, CGC has relied solely on its own investigation

and analysis and the representations and warranties expressly set forth in Article 3 and in the Ancillary Documents to which

it is or will be a party and no other representations or warranties of the Company, any Company Non-Party Affiliate, or any other Person,

either express or implied, and CGC, on its own behalf and on behalf of its Representatives, acknowledges, represents, warrants and agrees

that, except for the representations and warranties expressly set forth in Article 3 and in the Ancillary Documents to which

it is or will be a party, none of the Company, any Company Non-Party Affiliate, nor any other Person makes or has made any representation

or warranty, either express or implied, in connection with or related to this Agreement, the Ancillary Documents or the transactions

contemplated hereby or thereby.

Section 4.17          Compliance

with International Trade & Anti-Corruption Laws.

(a)            Since

April 24, 2019, neither CGC nor, to CGC’s knowledge, any of their Representatives, or any other Persons acting for or on behalf

of any of the foregoing, is or has been, (i) a Person named on any Sanctions and Export Control Laws-related list of designated

Persons maintained by a Governmental Entity; (ii) located, organized or ordinarily resident in a country or territory which is itself

the subject of or target of any Sanctions and Export Control Laws (at the time of this Agreement, Cuba, Iran, North Korea, and the

Crimea, the so-called Donetsk People’s Republic, and the so-called Luhansk People’s Republic regions of Ukraine, collectively,

“Sanctioned Country”); (iii) an entity owned, directly or indirectly, by one or more Persons described

in clause (i) or (ii); or (iv) otherwise engaging in dealings with or for the benefit of any Person described in clauses (i) -

(iii) or any Sanctioned Country in violation of Sanctions and Export Control Laws.

(b)            In

the past five (5) years, neither CGC nor, to CGC’s knowledge, any of their Representatives, or any other Persons (in each

case, while acting for or on behalf of any of the foregoing) has (i) made, offered, promised, paid or received any unlawful bribes,

kickbacks or other similar payments to or from any Person, (ii) made or paid any unlawful contributions, directly or indirectly,

to a domestic or foreign political party or candidate or (iii) otherwise made, offered, received, authorized, promised or paid any

improper payment under any Anti-Corruption Laws.

Section 4.18       EXCLUSIVITY

OF REPRESENTATIONS AND WARRANTIES. NOTWITHSTANDING THE DELIVERY OR DISCLOSURE TO THE COMPANY OR ANY OF ITS REPRESENTATIVES OF ANY

DOCUMENTATION OR OTHER INFORMATION (INCLUDING ANY FINANCIAL PROJECTIONS OR OTHER SUPPLEMENTAL DATA), EXCEPT AS OTHERWISE EXPRESSLY SET

FORTH IN THIS ARTICLE 4 AND THE ANCILLARY DOCUMENTS, NEITHER CGC NOR ANY OTHER PERSON MAKES, AND CGC EXPRESSLY DISCLAIMS,

ANY REPRESENTATIONS OR WARRANTIES OF ANY KIND OR NATURE, EXPRESS OR IMPLIED, IN CONNECTION WITH THIS AGREEMENT, THE ANCILLARY DOCUMENTS

OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY, INCLUDING AS TO THE MATERIALS RELATING TO THE BUSINESS AND AFFAIRS OR

HOLDINGS OF CGC THAT HAVE BEEN MADE AVAILABLE TO THE COMPANY OR ANY OF ITS REPRESENTATIVES OR IN ANY PRESENTATION OF THE BUSINESS AND

AFFAIRS OF CGC BY OR ON BEHALF OF THE MANAGEMENT OF CGC OR OTHERS IN CONNECTION WITH THE TRANSACTIONS CONTEMPLATED HEREBY OR BY THE ANCILLARY

DOCUMENTS, AND NO STATEMENT CONTAINED IN ANY OF SUCH MATERIALS OR MADE IN ANY SUCH PRESENTATION SHALL BE DEEMED A REPRESENTATION OR WARRANTY

HEREUNDER OR OTHERWISE OR DEEMED TO BE RELIED UPON BY THE COMPANY OR ANY OF ITS REPRESENTATIVES IN EXECUTING, DELIVERING AND PERFORMING

THIS AGREEMENT, THE ANCILLARY DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EXCEPT FOR THE REPRESENTATIONS AND WARRANTIES

EXPRESSLY SET FORTH IN THIS ARTICLE 4 OR THE ANCILLARY DOCUMENTS, IT IS UNDERSTOOD THAT ANY COST ESTIMATES, PROJECTIONS

OR OTHER PREDICTIONS, ANY DATA, ANY FINANCIAL INFORMATION OR ANY MEMORANDA OR OFFERING MATERIALS OR PRESENTATIONS, INCLUDING, BUT

NOT LIMITED TO, ANY OFFERING MEMORANDUM OR SIMILAR MATERIALS MADE AVAILABLE BY OR ON BEHALF OF CGC ARE NOT AND SHALL NOT BE DEEMED TO

BE OR TO INCLUDE REPRESENTATIONS OR WARRANTIES OF CGC NOR ANY OTHER PERSON, AND ARE NOT AND SHALL NOT BE DEEMED TO BE RELIED UPON BY

THE COMPANY OR ANY OF ITS REPRESENTATIVES IN EXECUTING, DELIVERING OR PERFORMING THIS AGREEMENT, THE ANCILLARY DOCUMENTS OR THE TRANSACTIONS

CONTEMPLATED HEREBY OR THEREBY.

Article 5

COVENANTS

Section 5.1            Conduct

of Business of the Company.

(a)            From

and after the date of this Agreement until the earlier of the Closing or the termination of this Agreement in accordance with its terms,

the Company shall, and the Company shall cause its Subsidiaries to, except as expressly contemplated by this Agreement or any Ancillary

Document, as required by applicable Law, as set forth on Section 5.1(a) of the Company Disclosure Schedules or as consented

to in writing by CGC (it being agreed that any request for a consent shall not be unreasonably withheld, conditioned or delayed), (i) operate

the business of the Group Companies in the ordinary course in all material respects and (ii) use commercially reasonable efforts

to maintain and preserve intact in all material respects the business organization, assets, properties and material business relations

of the Group Companies, taken as a whole.

(b)            Without

limiting the generality of the foregoing, from and after the date of this Agreement until the earlier of the Closing or the termination

of this Agreement in accordance with its terms, the Company shall, and the Company shall cause its Subsidiaries to, except as expressly

contemplated by this Agreement or any Ancillary Document, as required by applicable Law, as set forth on Section 5.1(b) of

the Company Disclosure Schedules or as consented to in writing by CGC (which consent shall not be unreasonably conditioned, withheld

or delayed, and provided, that CGC or the Company, respectively, shall be deemed to have consented in writing if it provides no response

within three (3) Business Days after the Company or CGC, respectively, has made a request for such consent in writing), not do any

of the following:

(i)             declare,

set aside, make or pay a dividend on, or make any other distribution or payment in respect of, any Equity Securities of any Group Company

or repurchase or redeem any outstanding Equity Securities of any Group Company, other than dividends or distributions, declared, set

aside or paid by any of the Company’s Subsidiaries to the Company or any Subsidiary that is, directly or indirectly, wholly owned

by the Company;

(ii)            (A) merge,

consolidate, combine or amalgamate any Group Company with any Person or (B) purchase or otherwise acquire (whether by merging or

consolidating with, purchasing any Equity Security in or a substantial portion of the assets of, or by any other manner) any corporation,

partnership, association or other business entity or organization or division thereof;

(iii)           adopt

any amendments, supplements, restatements or modifications to any Group Company’s Governing Documents;

(iv)           (A) sell,

assign, abandon, lease, exclusively license or otherwise dispose of any material assets or properties of the Group Companies, other than

inventory or obsolete equipment in the ordinary course of business, or (B) subject any material assets or properties of the Group

Companies to any Lien (other than any Permitted Liens);

(v)            transfer,

issue, sell, grant or otherwise directly or indirectly dispose of, or subject to a Lien, (A) any Equity Securities of any Group

Company or (B) any options, warrants, rights of conversion or other rights, agreements, arrangements or commitments obligating any

Group Company to issue, deliver or sell any Equity Securities of any Group Company, other than the issuance of Company Shares upon (i) the

exercise or conversion of any Company Options outstanding on the date of this Agreement in accordance with the terms of the Company Equity

Plan and the underlying grant, award or similar agreement, and (ii) the conversion of the Company Convertible Notes in accordance

with its terms (if applicable);

(vi)           incur,

create or assume any Indebtedness (other than (x) as set forth on Section 5.1(b)(vi) of the Company Disclosure

Schedule or (y) ordinary course trade payables), or guarantee any Liability of any Person;

(vii)          make

any loans, advances or capital contributions to, or guarantees for the benefit of, or any investments in, any Person, other than (A) intercompany

loans or capital contributions between the Company and any of its wholly owned Subsidiaries, and (B) the reimbursement of expenses

of employees or advancements in the ordinary course of business;

(viii)         except

(x) as required under the terms of any Employee Benefit Plan of any Group Company that is set forth on the Section 3.11(a) of

the Company Disclosure Schedules or (y) in the ordinary course of business consistent with past practice (it being understood and

agreed, for the avoidance of doubt, that in no event shall the exception in this clause (y) be deemed or construed as permitting

any Group Company to take any action that is not permitted by any other provision of this Section 5.1(b)), (A) materially

increase the compensation or benefits payable to any current or former director, manager, officer, employee, individual independent contractor

or other service provider of any Group Company, (B) take any action to accelerate any payment, right to payment, or benefit, or

the funding of any payment or benefit, right to payment or benefit, payable or to become payable to any current or former director, manager,

officer, employee, individual independent contractor or other service provider of any Group Company or (C) waive or release any

noncompetition, non-solicitation, no-hire, nondisclosure or other restrictive covenant obligation of any current or former director,

manager, officer, employee, individual independent contractor or other service provider of any Group Company;

(ix)            except

as required under the terms of any Employee Benefit Plan of any Group Company that is set forth on the Section 3.11(a) of

the Company Disclosure Schedules, amend or modify in any material respect, adopt, enter into or terminate any material Employee Benefit

Plan of any Group Company or any material benefit or compensation plan, policy, program or Contract that would be an Employee Benefit

Plan if in effect as of the date of this Agreement,

(x)             make,

change or revoke any material election concerning Taxes, enter into any material Tax closing agreement, settle any material Tax claim

or assessment, or consent to any extension or waiver of the limitation period applicable to or relating to any material Tax claim or

assessment, other than any such extension or waiver that is obtained in the ordinary course of business;

(xi)            enter

into any settlement, conciliation or similar Contract the performance of which would involve the payment by the Group Companies in excess

of $1,000,000, in the aggregate, or that imposes, or by its terms will impose at any point in the future, any material, non-monetary

obligations on any Group Company (or CGC or any of its Affiliates after the Closing);

(xii)           authorize,

recommend, propose or announce an intention to adopt, or otherwise effect, a plan of complete or partial liquidation, dissolution, restructuring,

recapitalization, reorganization or similar transaction (other than, for the avoidance of doubt, the transactions expressly contemplated

by this Agreement) involving any Group Company;

(xiii)          change

any Group Company’s methods of accounting in any material respect, other than changes that are made in accordance with PCAOB standards;

(xiv)         enter

into any Contract with any broker, finder, investment banker or other Person under which such Person is or will be entitled to any brokerage

fee, finders’ fee or other commission in connection with the transactions contemplated by this Agreement or any Ancillary Document;

(xv)           make

any Change of Control Payment that is not set forth on Section 3.11(a) of the Company Disclosure Schedules or make any

payment with respect to a Company Related Party Transaction that is not set forth on Section 5.1(b)(xv) of the Company

Disclosure Schedule;

(xvi)         (A) amend,

modify or terminate any Material Contract, (B) waive any material benefit or right under any Material Contract, or (C) enter

into any Contract that would constitute a Material Contract had such Contract been effective prior to the date of this Agreement; or

(xvii)        enter

into any Contract to take, or cause to be taken, any of the actions set forth in this Section 5.1.

Notwithstanding anything

in this Section 5.1 or this Agreement to the contrary, nothing set forth in this Agreement shall give CGC, directly or indirectly,

the right to control or direct the operations of the Group Companies prior to the Closing.

Section 5.2             Efforts

to Consummate; Litigation.

(a)            Subject

to the terms and conditions herein provided, each of the Parties shall use reasonable best efforts to take, or cause to be taken, all

actions and to do, or cause to be done, all things reasonably necessary or advisable to consummate and make effective as promptly as

reasonably practicable the transactions contemplated by this Agreement (including (i) the satisfaction, but not waiver, of the closing

conditions set forth in Article 6 and, in the case of any Ancillary Document to which such Party is contemplated to be a

party after the date of this Agreement, to execute and delivery such Ancillary Document when required pursuant to this Agreement and

(ii) using reasonable best efforts to consummate the PIPE Financing, on the terms and subject to the conditions set forth in the

Investor Subscription Agreements). Without limiting the generality of the foregoing, each of the Parties shall use reasonable best efforts

to obtain, file with or deliver to, as applicable, any Consents of any Governmental Entities or other Persons necessary, proper or advisable

to consummate the transactions contemplated by this Agreement or the Ancillary Documents. Each Party shall bear its out-of-pocket costs

and expenses in connection with the preparation of any such Consents. The Company agrees that, in the event that any Company Shareholder

indicates an objection to the transactions contemplated by this Agreement, it shall: (i) use commercially reasonable efforts to

obtain the support and consent of such Company Shareholder; (ii) provide notice to CGC of such objection and the stated reason or

circumstances for such objection; (iii) permit CGC to meet with such objecting Company Shareholder; and (iv) consider in good

faith adjustments or actions as may be suggested by CGC.

(b)            From

and after the date of this Agreement until the earlier of the Closing or termination of this Agreement in accordance with its terms,

CGC, on the one hand, and the Company, on the other hand, shall give counsel for the Company (in the case of CGC) or CGC (in the case

of the Company), a reasonable opportunity to review in advance, and consider in good faith the views of the other in connection with,

any proposed written communication to any Governmental Entity relating to the transactions contemplated by this Agreement or the Ancillary

Documents; provided that documents and information provided to the other Party pursuant to this paragraph (i) may be redacted

(A) to remove references to valuation of the Company, (B) to comply with contractual arrangements or (C) to preserve legal

privilege and/or (ii) may be designated as “outside counsel only,” in which case such documents and information shall

be provided only to outside counsel and consultants retained by such counsel. Each of the Parties agrees not to participate in any substantive

meeting or discussion, either in person or by telephone with any Governmental Entity in connection with the transactions contemplated

by this Agreement unless it consults with, in the case of CGC, the Company, or, in the case of the Company, CGC in advance and, to the

extent not prohibited by such Governmental Entity, gives, in the case of CGC, the Company, or, in the case of the Company, CGC, the opportunity

to attend and participate in such meeting or discussion.

and after the date of this Agreement until the earlier of the Closing or termination of this Agreement in accordance with its terms,

CGC, on the one hand, and the Company, on the other hand, shall each notify the other in writing promptly after learning of any shareholder

demands or other shareholder Proceedings (including derivative claims) relating to this Agreement, any Ancillary Document or any matters

relating thereto (collectively, the “Transaction Litigation”) commenced against, in the case of CGC, any of

CGC or any of its respective Representatives (in their capacity as a representative of CGC) or, in the case of the Company, any Group

Company or any of their respective Representatives (in their capacity as a representative of CGC). CGC and the Company shall each (i) keep

the other reasonably informed regarding any Transaction Litigation, (ii) give the other the opportunity to, at its own cost and

expense, participate in the defense, settlement and compromise of any such Transaction Litigation and reasonably cooperate with the other

in connection with the defense, settlement and compromise of any such Transaction Litigation, (iii) consider in good faith the other’s

advice with respect to any such Transaction Litigation and (iv) reasonably cooperate with each other. Notwithstanding the foregoing,

the Company shall, subject to and without limiting the covenants and agreements, and the rights of CGC, set forth in the immediately

preceding sentence, control the negotiation, defense and settlement of any such Transaction Litigation; provided however, that

in no event shall the Company, any other Group Company or any of their respective Representatives settle or compromise any Transaction

Litigation without the prior written consent of CGC (not to be unreasonably withheld, conditioned or delayed, provided that it shall

be deemed to be reasonable for CGC to withhold, condition or delay its consent if any such settlement or compromise (A) does not

provide for a legally binding, full, unconditional and irrevocable release of CGC and each Representative that is the subject of such

Transaction Litigation, (B) provides for (x) the payment of cash any portion of which is payable by CGC or any Representative

thereof or would otherwise constitute a Liability of CGC or (y) any non-monetary, injunctive, equitable or similar relief against

CGC or (C) contains an admission of wrongdoing or Liability by CGC or any of its Representatives). Without limiting the generality

of the foregoing, in no event shall CGC or any of its Representatives settle or compromise any Transaction Litigation without the Company’s

prior written consent.

Section 5.3            Confidentiality

and Access to Information.

(a)            The

Parties hereby acknowledge and agree that the information being provided in connection with this Agreement and the consummation of the

transactions contemplated hereby is subject to the terms of the Confidentiality Agreement, the terms of which are incorporated herein

by reference. Notwithstanding the foregoing or anything to the contrary in this Agreement, in the event that this Section 5.3(a) or

the Confidentiality Agreement conflicts with any other covenant or agreement contained herein or any Ancillary Document that contemplates

the disclosure, use or provision of information or otherwise, then such other covenant or agreement contained in this Agreement or such

Ancillary Document, as applicable, shall govern and control to the extent of such conflict.

(b)            From

and after the date of this Agreement until the earlier of the Closing Date or the termination of this Agreement in accordance with its

terms, upon reasonable advance written notice, the Company shall provide, or cause to be provided, to CGC and its respective Representatives

during normal business hours reasonable access to the directors, officers, books and records and properties of the Group Companies (in

a manner so as to not interfere with the normal business operations of the Group Companies) for the purpose of consummating the CGC Merger

and the Exchange. Notwithstanding the foregoing, none of the Group Companies shall be required to provide, or cause to be provided, to

CGC or its respective Representatives any information (i) if and to the extent doing so would (A) violate any Law to which

any Group Company is subject, (B) result in the disclosure of any trade secrets of third parties in breach of any Contract with

such third party, (C) violate any legally binding obligation of any Group Company with respect to confidentiality, non-disclosure

or privacy or (D) jeopardize protections afforded to any Group Company under the attorney-client privilege or the attorney work

product doctrine (provided that, in case of each of clauses (A) through (D), the Company shall, and shall cause the other Group

Companies to, use commercially reasonable efforts to (x) provide such access as can be provided (or otherwise convey such information

regarding the applicable matter as can be conveyed) without violating such privilege, doctrine, Contract, obligation or Law and (y) provide

such information in a manner without violating such privilege, doctrine, Contract, obligation or Law), or (ii) if any Group Company,

on the one hand, and CGC, any CGC Non-Party Affiliate or any of their respect Representatives on the other hand, are adverse parties

in a litigation or other Proceeding and such information is reasonably pertinent thereto; provided that the Company shall, in

the case of clause (i) or (ii), provide prompt written notice of the withholding of access or information on any such basis unless

such written notice is prohibited by applicable Law or Order.

and after the date of this Agreement until the earlier of the Closing Date or the termination of this Agreement in accordance with its

terms, upon reasonable advance written notice, CGC shall provide, or cause to be provided, to the Company and its Representatives during

normal business hours reasonable access to the directors, officers, books and records of CGC (in a manner so as to not interfere with

the normal business operations of CGC). Notwithstanding the foregoing, CGC shall not be required to provide, or cause to be provided

to, the Company or any of its Representatives any information (i) if and to the extent doing so would (A) violate any Law to

which CGC is subject, (B) result in the disclosure of any trade secrets of third parties in breach of any Contract with such third

party, (C) violate any legally binding obligation of CGC with respect to confidentiality, non-disclosure or privacy or (D) jeopardize

protections afforded to CGC under the attorney-client privilege or the attorney work product doctrine (provided that, in case of each

of clauses (A) through (D), CGC shall use reasonable best efforts to (x) provide such access as can be provided (or otherwise

convey such information regarding the applicable matter as can be conveyed) without violating such privilege, doctrine, Contract, obligation

or Law and (y) provide such information in a manner without violating such privilege, doctrine, Contract, obligation or Law), or

(ii) if CGC or the Sponsor or any of their respective Representatives, on the one hand, and any Group Company, any Company Non-Party

Affiliate or any of their respective Representatives, on the other hand, are adverse parties in a litigation or other Proceeding and

such information is reasonably pertinent thereto; provided that CGC shall, in the case of clause (i) or (ii), provide prompt

written notice of the withholding of access or information on any such basis unless such written notice is prohibited by applicable Law

or Order.

Section 5.4            Public

Announcements.

(a)            Subject

to Section 5.4(b), Section 5.7 and Section 5.8, none of the Parties or any of their respective Representatives

shall issue any press releases or make any public announcements with respect to this Agreement or the transactions contemplated hereby

without the prior written consent of, prior to the Closing, the Company and CGC or, after the Closing, CGC; provided, however,

that each Party, the Sponsor and their respective Representatives may make any such announcement or other communication (i) if such

press release, announcement or other communication is required by applicable Law, in which case (A) prior to the Closing, the disclosing

Person shall, to the extent permitted by applicable Law use reasonable best efforts to consult with the Company, if the disclosing Person

is CGC or the Sponsor, or CGC, if the disclosing party is the Company or any of its Representatives, and give the Company or CGC, as

applicable, the opportunity to review such announcement or communication and comment thereon and the disclosing Person shall consider

such comments in good faith, or (B) after the Closing, the disclosing Person and/or its Representatives, as applicable, shall, to

the extent permitted by applicable Law, use reasonable best efforts to consult with CGC and give CGC the opportunity to review such announcement

or communication and comment thereon and the disclosing Person shall consider such comments in good faith, (ii) to the extent such

press release, announcement or other communication contains only information previously disclosed in a public statement, press release

or other communication previously approved in accordance with this Section 5.4 and (iii) to Governmental Entities in

connection with any Consents required to be made under this Agreement, the Ancillary Documents or in connection with the transactions

contemplated hereby or thereby. Notwithstanding anything to the contrary in this Section 5.4 or otherwise in this Agreement,

the Parties agree that the CGC Shareholders and their respective Representatives may provide general information about the subject matter

of this Agreement and the transactions contemplated hereby to any direct or indirect current or prospective investor or in connection

with normal fundraising or related marketing or informational or reporting activities.

(b)            The

initial press release concerning this Agreement and the transactions contemplated hereby shall be a joint press release in the form agreed

by the Company and CGC prior to the execution of this Agreement and such initial press release (the “Signing Press Release”)

shall be released as promptly as reasonably practicable after the execution of this Agreement on the day thereof. Promptly after the

execution of this Agreement, CGC shall file a current report on Form 8-K (the “Signing Filing”) with the

Signing Press Release and a description of this Agreement as required by, and in compliance with, the Securities Laws, which the Company

shall have the opportunity to review and comment upon prior to filing and CGC shall consider such comments in good faith. The Company,

on the one hand, and CGC, on the other hand, shall mutually agree upon (such agreement not to be unreasonably withheld, conditioned or

delayed by either the Company or CGC, as applicable) a press release announcing the consummation of the transactions contemplated by

this Agreement (the “Closing Press Release”) prior to the Closing, and, on the Closing Date (or such other

date as may be mutually agreed to in writing by the Company and CGC prior to the Closing), the Parties shall cause the Closing Press

Release to be released. Promptly after the Closing (but in any event within four (4) Business Days after the Closing), CGC shall

file a current report on Form 8-K (the “Closing Filing”) with the Closing Press Release and a description

of the Closing as required by Securities Laws, which Closing Filing shall be mutually agreed upon by the Company and CGC prior to the

Closing (such agreement not to be unreasonably withheld, conditioned or delayed by either the Company or CGC, as applicable). In connection

with the preparation of each of the Signing Press Release, the Signing Filing, the Closing Press Release and the Closing Filing, each

Party shall, upon written request by any other Party, furnish such other Party with all information concerning itself, its directors,

officers and equity holders, and such other matters as may be reasonably necessary for such press release or filing.

Section 5.5            Tax

Matters.

(a)            Tax

Treatment.

(i)              The

Parties intend that, for U.S. federal (and applicable state or local) income tax purposes, (i) the Exchange and the CGC Merger,

taken together with the PIPE Financing and any third party financing, will constitute an integrated transaction that qualifies as a tax

free capital contribution pursuant to Section 351(a) of the Code, (ii) the Dutch Conversion will qualify as a “reorganization”

within the meaning of Section 368(a)(1)(F) of the Code, and (iii) this Agreement be, and hereby is, adopted as a “plan

of reorganization” pursuant to Section 368(a) of the Code and Treasury Regulations Section 1.368-2(g), and each

Party shall, and shall cause its respective Affiliates to, use reasonable best efforts to so qualify. The Parties shall file all Tax

Returns consistent with, and take no position inconsistent with (whether in audits, Tax Returns or otherwise), the treatment described

in this Section 5.5(a)(i) unless required to do so pursuant to a “determination” that is final within the meaning

of Section 1313(a) of the Code.

(ii)             If,

in connection with the preparation and filing of the Registration Statement / Proxy Statement, the SEC requests or requires that tax

opinions be prepared and submitted in such connection, CGC and the Company shall deliver to GT and Dentons, respectively, customary Tax

representation letters satisfactory to its counsel, dated and executed as of the date the Registration Statement / Proxy Statement shall

have been declared effective by the SEC and such other date(s) as determined reasonably necessary by such counsel in connection

with the preparation and filing of the Registration Statement / Proxy Statement.

(b)            Tax

Matters Cooperation. Each of the Parties shall (and shall cause their respective Affiliates to) cooperate fully, as and to the extent

reasonably requested by another Party, in connection with the filing of relevant Tax Returns, and any audit or tax proceeding. Such cooperation

shall include the retention and (upon the other Party’s request) the provision (with the right to make copies) of records and information

reasonably relevant to any tax proceeding or audit, making employees available on a mutually convenient basis to provide additional information

and explanation of any material provided hereunder and making available to the CGC Shareholders information reasonably necessary to compute

any income of any such holder (or its direct or indirect owners) arising, if applicable, as a result of CGC’s status as a “passive

foreign investment company” within the meaning of Section 1297(a) of the Code or a “controlled foreign corporation”

within the meaning of Section 957(a) of the Code for any taxable period ending on or prior to the Closing, including timely

providing (A) a PFIC Annual Information Statement to enable such holders to make a “Qualifying Electing Fund” election

under Section 1295 of the Code for such taxable period, and (B) information to enable applicable holders to report their allocable

share of “subpart F” income under Section 951 of the Code for such taxable period.

Taxes. Any transfer, documentary, sales, use, stamp, registration, excise, recording, registration, value added and other such similar

Taxes (including any penalties and interest) that become payable in connection with or by reason of the execution of this Agreement and

the transactions set forth herein (collectively, “Transfer Taxes”) shall be borne and paid equally between

CGC and the Company.

Section 5.6             Exclusive

Dealing.

(a)            From

the date of this Agreement until the earlier of the Closing or the termination of this Agreement in accordance with its terms, the Company

shall not, and shall cause the other Group Companies and its and their respective Representatives not to, directly or indirectly: (i) solicit,

initiate, induce, encourage (including by means of furnishing or disclosing information), facilitate, discuss or negotiate, directly

or indirectly, any inquiry, proposal or offer (written or oral) that constitutes, or that could reasonably be expected to lead to, a

Company Acquisition Proposal; (ii) furnish or disclose any non-public information to any Person in connection with, or that could

reasonably be expected to lead to, a Company Acquisition Proposal; (iii) enter into any Contract or other arrangement or understanding

regarding a Company Acquisition Proposal; (iv) prepare or take any steps in connection with a public offering of any Equity Securities

of any Group Company (or any Affiliate or successor of any Group Company); or (v) otherwise cooperate in any way with, or assist

or participate in, or knowingly facilitate or encourage any effort or attempt by any Person to do or seek to do any of the foregoing.

The Company agrees to (A) notify CGC promptly upon receipt of any Company Acquisition Proposal by any Group Company, and to describe

the material terms and conditions of any such Company Acquisition Proposal in reasonable detail (including the identity of the Persons

making such Company Acquisition Proposal) and (B) keep CGC reasonably informed on a current basis of any modifications to such offer

or information.

(b)            From

the date of this Agreement until the earlier of the Closing or the termination of this Agreement in accordance with its terms, CGC shall

not, and shall cause its Representatives not to, directly or indirectly: (i) solicit, initiate, induce, encourage (including by

means of furnishing or disclosing information), facilitate, discuss or negotiate, directly or indirectly, any inquiry, proposal or offer

(written or oral) that constitutes, or that could reasonably be expected to lead to a CGC Acquisition Proposal; (ii) furnish or

disclose any non-public information to any Person in connection with, or that could reasonably be expected to lead to, a CGC Acquisition

Proposal; (iii) enter into any Contract or other arrangement or understanding regarding an CGC Acquisition Proposal; (iv) prepare

or take any steps in connection with an offering of any securities of CGC (or any Affiliate or successor of CGC); or (v) otherwise

cooperate in any way with, or assist or participate in, or knowingly facilitate or encourage any effort or attempt by any Person to do

or seek to do any of the foregoing. CGC agrees to (A) notify the Company promptly upon receipt of any CGC Acquisition Proposal by

CGC, and to describe the material terms and conditions of any such CGC Acquisition Proposal in reasonable detail (including the identity

of any person or entity making such CGC Acquisition Proposal) and (B) keep the Company reasonably informed on a current basis of

any modifications to such offer or information.

Section 5.7            Preparation

of Registration Statement / Proxy Statement. The Company and CGC shall promptly provide to the other Parties such information concerning

the Company, CGC and their respective shareholders as is either required by the federal securities laws or reasonably requested by CGC

or the Company for inclusion in the Registration Statement / Proxy Statement. As promptly as practicable after the receipt of all such

information, including the PCAOB Financials, CGC and the Company shall prepare and mutually agree upon (such agreement not to be unreasonably

withheld, conditioned or delayed by either CGC or the Company, as applicable), and ListCo shall file with the SEC, the Registration Statement

/ Proxy Statement (it being understood that the Registration Statement / Proxy Statement shall include a proxy statement / prospectus

of CGC which will be included therein and which will be used for the CGC Shareholders Meeting to adopt and approve the Transaction Proposals,

provide its applicable shareholders with the opportunity to elect to effect the CGC Shareholder Redemption, and other matters reasonably

related to the Transaction Proposals, all in accordance with and as required by CGC’s Governing Documents, applicable Law, and

any applicable rules and regulations of the SEC and Nasdaq). Each of CGC and the Company shall use its reasonable best efforts to

(a) cause the Registration Statement / Proxy Statement to comply in all material respects with the applicable rules and regulations

promulgated by the SEC (including, with respect to the Group Companies, the provision of financial statements of, and any other information

with respect to, the Group Companies for all periods, and in the form, required to be included in the Registration Statement / Proxy

Statement under Securities Laws (after giving effect to any waivers received) or in response to any comments from the SEC); (b) promptly

notify the others of, reasonably cooperate with each other with respect to, mutually agree upon (such agreement not to be unreasonably

withheld, conditioned or delayed by either of CGC or the Company, as applicable) and respond promptly to any comments of the SEC or its

staff; (c) have the Registration Statement / Proxy Statement declared effective under the Securities Act as promptly as reasonably

practicable after it is filed with the SEC; and (d) keep the Registration Statement / Proxy Statement effective through the Closing

in order to permit the consummation of the transactions contemplated by this Agreement. CGC, on the one hand, and the Company, on the

other hand, shall use reasonable best efforts to promptly furnish, or cause to be furnished, to the other all information concerning

such Party, its Non-Party Affiliates and their respective Representatives that may be required or reasonably requested in connection

with any action contemplated by this Section 5.7 or for inclusion in any other statement, filing, notice or application made

by or on behalf of CGC to the SEC or Nasdaq in connection with the transactions contemplated by this Agreement or the Ancillary Documents,

including using reasonable best efforts to deliver customary tax representation letters to counsel to enable counsel to deliver any tax

opinions requested or required by the SEC to be submitted in connection therewith as described in Section 5.5(a)(ii). If

any Party becomes aware of any information that should be disclosed in an amendment or supplement to the Registration Statement / Proxy

Statement, then (i) such Party shall promptly inform, in the case of CGC, the Company, or, in the case of the Company, CGC, thereof;

(ii) such Party shall prepare and mutually agree upon with, in the case of CGC, the Company, or, in the case of the Company, CGC

(in either case, such agreement not to be unreasonably withheld, conditioned or delayed), an amendment or supplement to the Registration

Statement / Proxy Statement; (iii) CGC shall file such mutually agreed upon amendment or supplement with the SEC; and (iv) the

Parties shall reasonably cooperate, if appropriate, in mailing such amendment or supplement to the CGC Shareholders. CGC shall as promptly

as reasonably practicable advise the Company of the time of effectiveness of the Registration Statement / Proxy Statement, the issuance

of any stop order relating thereto or the suspension of the qualification of CGC Shares for offering or sale in any jurisdiction, and

CGC and the Company shall each use its reasonable best efforts to have any such stop order or suspension lifted, reversed or otherwise

terminated. Each of the Parties shall use reasonable best efforts to ensure that none of the information related to him, her or it or

any of his, her or its Non-Party Affiliates or its or their respective Representatives, supplied by or on his, her or its behalf for

inclusion or incorporation by reference in the Registration Statement / Proxy Statement will, at the time the Registration Statement

/ Proxy Statement is initially filed with the SEC, at each time at which it is amended, or at the time it becomes effective under the

Securities Act contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary

to make the statements therein, in light of the circumstances under which they are made, not misleading.

Section 5.8            CGC

Shareholder Approval. As promptly as reasonably practicable following the time at which the Registration Statement / Proxy Statement

is declared effective under the Securities Act, CGC shall (a) duly give notice of and (b) use reasonable best efforts to duly

convene and hold a meeting of its shareholders (the “CGC Shareholders Meeting”) in accordance with the Governing

Documents of CGC, for the purposes of obtaining the CGC Shareholder Approval and, if applicable, any approvals related thereto and providing

its shareholders with the opportunity to elect to effect a CGC Shareholder Redemption. CGC shall, through unanimous approval of its board

of directors, recommend to its shareholders (the “CGC Board Recommendation”), (i) the adoption and approval

of this Agreement and the transactions contemplated hereby (including the CGC Merger) (the “Business Combination Proposal”);

(ii) the adoption and the approval of the CGC Merger (the “CGC Merger Proposal”); (iii) the adoption

and approval of the issuance of the ListCo Common Shares in connection with the transactions contemplated by this Agreement as required

by Nasdaq listing requirements (the “Nasdaq Proposal”); (iv) the adoption and approval of the amendments

to the Governing Documents of CGC contemplated by the CGC Certificate of Incorporation and the CGC Bylaws (the “Governing

Document Proposals”); (v) the adoption and approval of each other proposal that either the SEC or Nasdaq (or the respective

staff members thereof) indicates is necessary in its comments to the Registration Statement / Proxy Statement or in correspondence related

thereto; (vi) the adoption and approval of each other proposal reasonably agreed to by CGC and the Company as necessary or appropriate

in connection with the consummation of the transactions contemplated by this Agreement or the Ancillary Documents; and (vii) the

adoption and approval of a proposal for the adjournment of the CGC Shareholders Meeting, if necessary, to permit further solicitation

of proxies because there are not sufficient votes to approve and adopt any of the foregoing (such proposals in (i) through (vii) together,

the “Transaction Proposals”); provided that CGC may adjourn the CGC Shareholders Meeting (A) to

solicit additional proxies for the purpose of obtaining the CGC Shareholder Approval, (B) for the absence of a quorum, (C) to

allow reasonable additional time for the filing or mailing of any supplemental or amended disclosures that CGC has determined, based

on the advice of outside legal counsel, is reasonably likely to be required under applicable Law and for such supplemental or amended

disclosure to be disseminated and reviewed by the CGC Shareholders prior to the CGC Shareholders Meeting or (D) if the holders of

CGC Class A Shares have elected to redeem a number of CGC Class A Shares as of such time that would reasonably be expected

to result in the condition set forth in Section 6.3(d) not being satisfied; provided that, without the consent

of the Company, in no event shall CGC adjourn the CGC Shareholders Meeting for more than fifteen (15) Business Days later than the most

recently adjourned meeting or to a date that is beyond the Termination Date. The CGC recommendation contemplated by the preceding sentence

shall be included in the Registration Statement / Proxy Statement. Except as otherwise required by applicable Law, CGC covenants that

none of the CGC Board or CGC nor any committee of the CGC Board shall withdraw or modify, or propose publicly or by formal action of

the CGC Board, any committee of the CGC Board or CGC to withdraw or modify, in a manner adverse to the Company, the CGC Board Recommendation

or any other recommendation by the CGC Board or CGC of the proposals set forth in the Registration Statement / Proxy Statement.

Section 5.9            Joinder

Amendment; ListCo and Merger Sub Shareholder Approval.

(a)            The

Company shall use its reasonable best efforts to, as promptly as reasonably practicable following the date hereof, form ListCo and cause

ListCo to form Merger Sub. The Parties agree that, as promptly as reasonably practicable following the formation of ListCo and Merger

Sub, the Parties shall enter into an amendment to this Agreement (the “Joinder Amendment”) to include ListCo

and Merger Sub as parties hereto, in a form to be mutually agreed by the Parties.

(b)            As

promptly as reasonably practicable (and in any event within one Business Day) following the date of the Joinder Amendment, (a) the

Company, as the sole shareholder of ListCo, will approve and adopt this Agreement, the Ancillary Documents to which ListCo is or will

be a party and the transactions contemplated hereby and thereby and (b) ListCo, as the sole shareholder of Merger Sub, will approve

and adopt this Agreement, the Ancillary Documents to which Merger Sub is or will be a party and the transactions contemplated hereby

and thereby (including the CGC Merger).

Section 5.10          Conduct

of Business of CGC. From and after the date of this Agreement until the earlier of the Closing or the termination of this Agreement

in accordance with its terms, CGC shall not, except as expressly contemplated by this Agreement or any Ancillary Document (including,

for the avoidance of doubt, in connection with the CGC Merger and the Exchange or the PIPE Financing), as required by applicable Law,

as set forth on Section 5.10 of the CGC Disclosure Schedules or as consented to in writing by the Company (such consent not

to be unreasonably withheld, conditioned or delayed), do any of the following:

(a)            adopt

any amendments, supplements, restatements or modifications to the Trust Agreement or the Governing Documents of CGC;

(b)           declare,

set aside, make or pay a dividend on, or make any other distribution or payment in respect of, any Equity Securities of CGC, or repurchase,

redeem or otherwise acquire, or offer to repurchase, redeem or otherwise acquire, any outstanding Equity Securities of CGC, as applicable;

combine or reclassify any of its shares or other Equity Securities or issue any other security in respect of, in lieu of or in substitution

for its shares;

(d)           other

than working capital loans, incur, create or assume any Indebtedness or other Liability;

(e)            make

any loans or advances to, or capital contributions in, any other Person, other than to, or in, CGC;

(f)            issue

any Equity Securities or grant any additional options, warrants or share appreciation rights with respect to its Equity Securities;

(g)           enter

into, renew, modify or revise any CGC Related Party Transaction (or any Contract or agreement that if entered into prior to the execution

and delivery of this Agreement would be a CGC Related Party Transaction), other than, for the avoidance of doubt, any expiration or automatic

extension or renewal of any Contract pursuant to its terms or extension of any working capital loans;

(h)           engage

in activities or business, other than any activities or business (i) in connection with or incident or related to such Person’s

organization, incorporation or formation, as applicable, or continuing corporate (or similar) existence, (ii) contemplated by, or

incident or related to, this Agreement, any Ancillary Document, the performance of covenants or agreements hereunder or thereunder or

the consummation of the transactions contemplated hereby or thereby or (iii) those that are administrative or ministerial in nature;

(i)             make,

change or revoke any material election concerning Taxes, enter into any material Tax closing agreement, settle any material Tax claim

or assessment, or consent to any extension or waiver of the limitation period applicable to or relating to any material Tax claim or

assessment, other than any such extension or waiver that is obtained in the ordinary course of business;

(j)             authorize,

recommend, propose or announce an intention to adopt a plan of complete or partial liquidation or dissolution;

(k)            enter

into any Contract with any broker, finder, investment banker or other Person under which such Person is or will be entitled to any brokerage

fee, finders’ fee or other commission in connection with the transactions contemplated by this Agreement; or

(l)             enter

into any Contract to take, or cause to be taken, any of the actions set forth in this Section 5.10.

Notwithstanding anything in this Section 5.10

or this Agreement to the contrary, (i) nothing set forth in this Agreement shall give the Company, directly or indirectly, the right

to control or direct the operations of CGC and (ii) nothing set forth in this Agreement shall prohibit, or otherwise restrict the

ability of, CGC from using the funds held by CGC outside the Trust Account to pay any CGC Expenses or from otherwise distributing or

paying over any funds held by CGC outside the Trust Account to the Sponsor or any of its Affiliates, in each case, prior to the Closing.

Section 5.11          Nasdaq

Listing. CGC and the Company shall use their respective reasonable best efforts and shall cooperate in good faith to cause: (a) ListCo’s

initial listing application with Nasdaq in connection with the transactions contemplated by this Agreement to have been approved: (b) ListCo

to satisfy all applicable initial and continuing listing requirements of Nasdaq, including sufficient round lot holders, unrestricted

publicly-held ListCo Common Shares and public float (including those expected to be held by historic stakeholders of the Company); and

(c) the ListCo Common Shares issuable in accordance with this Agreement, including the CGC Merger and the Exchange, to be approved

for listing on Nasdaq, subject to official notice of issuance, in each case, as promptly as reasonably practicable after the date of

this Agreement, and in any event prior to the CGC Merger Effective Time.

Section 5.12          Trust

Account. Upon satisfaction or, to the extent permitted by applicable Law, waiver of the conditions set forth in Article 6

and provision of notice thereof to the Trustee, (a) at the Closing, CGC shall (i) cause the documents, certificates and notices

required to be delivered to the Trustee pursuant to the Trust Agreement to be so delivered, and (ii) make all appropriate arrangements

to cause the Trustee to (A) pay as and when due all amounts, if any, payable to the Public Shareholders of CGC pursuant to the CGC

Shareholder Redemption and (B) immediately thereafter, pay all remaining amounts then available in the Trust Account to CGC in accordance

with the Trust Agreement, and (b) thereafter, the Trust Account shall terminate, except as otherwise provided therein.

Section 5.13          Company

Shareholder Undertaking.

(a)            From

and after the date hereof, the Company shall use its reasonable best efforts to obtain an executed Company Shareholder Undertaking from

each Company Shareholder as soon as practicable after the formation of ListCo, but in no event later than August 31, 2026.

(b)            The

Company may not amend, modify or waive any provisions of a Shareholder Support Agreement or Company Shareholder Undertaking without the

prior written consent of CGC.

Section 5.14          PIPE

Financing. CGC, ListCo (after it is added to the Investor Subscription Agreements) and the Company shall each use its reasonable

best efforts to (a) take, or to cause to be taken, all actions required, necessary or that it otherwise deems to be proper or advisable

to consummate the transactions contemplated by the Investor Subscription Agreements on or prior to the Closing on the terms described

therein, and (b) satisfy on a timely basis all conditions and covenants applicable to CGC, ListCo and the Company in such agreements

and otherwise comply with its obligations thereunder and to enforce the rights of CGC, ListCo and the Company under the Investor Subscription

Agreements to cause the applicable investors to pay to (or as directed by) ListCo the applicable purchase price in accordance with the

terms of the applicable agreements. As promptly as practicable after any of CGC, ListCo or the Company acquires knowledge thereof, such

Party shall give the other Parties written notice: (i) of any breach or default (or the occurrence of any event or circumstance

that, with or without notice, lapse of time or both, is likely to give rise to any breach or default) by any party to any Investor Subscription

Agreement known to such Party; (ii) of the receipt of any written notice or other written communication from any party to any Investor

Subscription Agreement with respect to any actual, potential or claimed expiration, lapse, withdrawal, breach, default, termination or

repudiation by any party to any such agreement or any provisions of any such agreement; or (iii) if any Party does not expect to

receive all or any portion of the PIPE Financing on the terms, in the manner, or from the sources contemplated by such agreements. CGC

may, in its reasonable discretion, amend or modify the terms of any Investor Subscription Agreement or take such other actions as is

useful or necessary to maintain the economic benefit to CGC, ListCo and the Company of such agreements.

Section 5.15          Indemnification;

Directors’ and Officers’ Insurance.

(a)            Each

Party agrees that (i) all rights to indemnification or exculpation now existing in favor of the directors and officers of each Party,

as provided in the applicable Party’s Governing Documents or otherwise in effect as of immediately prior to the Exchange Effective

Time or the CGC Merger Effective Time, as applicable, in either case, solely with respect to any matters occurring on or prior to the

CGC Merger Effective Time shall survive the transactions contemplated by this Agreement and shall continue in full force and effect from

and after the CGC Merger Effective Time for a period of six (6) years and (ii) ListCo will perform and discharge, or cause

to be performed and discharged, all obligations to provide such indemnity and exculpation during such six (6)-year period. To the maximum

extent permitted by applicable Law, during such six (6)-year period, ListCo shall advance, or caused to be advanced, expenses in connection

with such indemnification as provided in the applicable Party’s Governing Documents or other applicable agreements as in effect

immediately prior to the CGC Merger Effective Time. The indemnification and liability limitation or exculpation provisions of the Parties’

Governing Documents shall not, during such six (6)-year period, be amended, repealed or otherwise modified after the CGC Merger Effective

Time in any manner that would materially and adversely affect the rights thereunder of individuals who, as of immediately prior to the

CGC Merger Effective Time, or at any time prior to such time, were directors or officers of any Party (the “D&O Persons”)

entitled to be so indemnified, have their liability limited or be exculpated with respect to any matters occurring on or prior to the

Exchange Effective Time or the CGC Merger Effective Time, as applicable and relating to the fact that such D&O Person was a director

or officer of CGC on or prior to the Exchange Effective Time or the CGC Merger Effective Time, as applicable, unless such amendment,

repeal or other modification is required by applicable Law.

(b)            ListCo

shall not have any obligation under this Section 5.14 to any D&O Person when and if a court of competent jurisdiction

shall ultimately determine (and such determination shall have become final and non-appealable) that the indemnification of such D&O

Person in the manner contemplated hereby is prohibited by applicable Law.

a period of six (6) years following the Exchange Effective Time or the CGC Merger Effective Time, as applicable, ListCo shall maintain,

without any lapses in coverage, “tail” policy or policies providing directors’ and officers’ liability

insurance for the benefit of those Persons who are covered by any comparable insurance policies of the Parties in effect as of the date

of this Agreement with respect to matters occurring on or prior to the CGC Merger Effective Time. Such insurance policies shall provide

coverage on terms (with respect to coverage and amount) that are substantially the same as (and no less favorable in the aggregate to

the Persons covered thereby than) the coverage provided under each Party’s directors’ and officers’ liability insurance

policies in effect as of the date of this Agreement; provided that ListCo shall not be obligated to pay annual premiums in excess

of three hundred percent (300%) of the most recent annual premium paid by CGC and the Company prior to the date of this Agreement and,

in such event, ListCo shall purchase the maximum coverage available for three hundred percent (300%) of the most recent annual premium

paid by CGC and the Company prior to the date of this Agreement.

(d)            If

ListCo or any of its successors or assigns (i) shall merge or consolidate with or merge into any other corporation or entity and

shall not be the surviving or continuing corporation or entity of such consolidation or merger or (ii) shall transfer all or substantially

all of their respective properties and assets as an entity in one or a series of related transactions to any Person, then in each such

case, proper provisions shall be made so that the successors or assigns of ListCo shall assume all of the obligations set forth in this

Section 5.14.

(e)            The

D&O Persons entitled to the indemnification, expense reimbursement, liability limitation, exculpation and insurance set forth in

this Section 5.14 are intended to be third-party beneficiaries of this Section 5.14. This Section 5.14

shall survive the consummation of the transactions contemplated by this Agreement and shall be binding on all successors and assigns

of ListCo.

Section 5.16          Post-Closing

Directors and Officers.

(a)            CGC

and the Company shall take all such action within its power as may be necessary or appropriate such that effective immediately after

the CGC Merger Effective Time, (i) the ListCo Board shall initially consist of seven (7) directors; (ii) the members of

the ListCo Board are the individuals determined in accordance with Section 5.16(b); (iii) the members of the compensation

committee, audit committee and nominating committee of the ListCo Board are the individuals determined in accordance with Section 5.16(c);

and (iv) the officers of ListCo (the “Officers”) are the individuals determined in accordance with Section 5.16(d).

(b)            The

individuals identified on Section 5.16(b) of the Company Disclosure Schedules, who shall include the Company’s

Chief Executive Officer, the Company’s Chairman of the Board, and one additional individual designated by a majority of the Company

Shareholders, shall be directors on the ListCo Board immediately after the CGC Merger Effective Time (each, an “Initial Company

Designee”). Prior to the mailing of the Registration Statement / Proxy Statement to the CGC Shareholders, the Company may

in its sole discretion designate four (4) additional individuals to serve as a director on the ListCo Board immediately after the

CGC Merger Effective Time, each of whom must qualify as an “independent director” under Nasdaq listing regulations (the “Other

Company Designee”, and together with the Initial Company Designees, collectively, the “Company Designees”);

provided that, if an individual is not designated to serve as the Other Company Designee prior to the mailing of the Registration

Statement / Proxy Statement to the CGC Shareholders, such unfilled director position shall be left vacant and shall be filled following

the CGC Merger Effective Time in accordance with the Governing Documents of ListCo. Prior to the mailing of the Registration Statement

/ Proxy Statement to the CGC Shareholders, the Company may in its sole discretion replace any Company Designee with any qualifying individual

by notice to CGC.

to the mailing of the Registration Statement / Proxy Statement to the CGC Shareholders, (i) the board of directors of the Company

may designate independent directors to serve as a member of the compensation committee, the audit committee or the nominating committee

of the ListCo Board immediately after the CGC Merger Effective Time, subject to CGC’s consent (not to be unreasonably withheld,

conditioned or delayed) based on the qualifications of the independent directors, subject to applicable listing rules of Nasdaq

and applicable Law, and (ii) the Company shall, subject to clause (i), designate each other director that will serve on the compensation

committee, the audit committee and the nominating committee of the ListCo Board immediately after the CGC Merger Effective Time, based

on the qualifications of each director, subject to applicable listing rules of Nasdaq and applicable Law.

(d)            The

individuals identified on Section 5.16(d) of the Company Disclosure Schedules shall be the Officers immediately after

the CGC Merger Effective Time, with each such individual holding the title set forth opposite his or her name. In the event that such

individuals identified on Section 5.16(d) of the Company Disclosure Schedules is unwilling or unable (whether due to

death, disability, termination of service or otherwise) to serve as an Officer, then, prior to the mailing of the Registration Statement

/ Proxy Statement to the CGC Shareholders, the Company may in its sole discretion replace such individual with another individual to

serve as such Officer by amending Section 5.16(d) of the Company Disclosure Schedules to include such replacement individual

as such Officer.

(e)            Effective

immediately after the CGC Merger Effective Time, two (2) individuals designated by Sponsor shall be appointed as observers to the

ListCo Board (with no power to vote on any matter before the ListCo Board).

Section 5.17          PCAOB

Financials.

(a)            As

promptly as reasonably practicable, the Company shall deliver to CGC (i) the Closing Company Audited Financial Statements, and (ii) any

other audited or unaudited consolidated balance sheets and the related audited or unaudited consolidated statements of operations and

comprehensive loss, shareholders’ deficit and cash flows of the Group Companies as of and for a year-to-date period ended as of

the end of any other different fiscal quarter (and as of and for the same period from the previous fiscal year) or fiscal year (and as

of and for the prior fiscal quarter), as applicable that is required to be included in the Registration Statement / Proxy Statement (collectively,

the “PCAOB Financials”). All such financial statements, together with any audited or unaudited consolidated

balance sheet and the related audited or unaudited consolidated statements of operations and comprehensive loss, shareholders’

deficit and cash flows of the Group Companies as of and for a year-to-date period ended as of the end of a different fiscal quarter (and

as of and for the same period from the previous fiscal year) or fiscal year (and as of and for the prior fiscal quarter) that is required

to be included in the Registration Statement / Proxy Statement (A) will fairly present in all material respects the financial position

of the Group Companies as at the date thereof, and the results of its operations, shareholders’ equity and cash flows for the respective

periods then ended (subject, in the case of any unaudited interim financial statements, to normal year end audit adjustments (none of

which is expected to be material) and the absence of footnotes), (B) will be prepared in conformity with IFRS applied on a consistent

basis during the periods involved (except, in the case of any audited financial statements, as may be indicated in the notes thereto

and subject, in the case of any unaudited financial statements, to normal year-end audit adjustments (none of which is expected to be

material) and the absence of footnotes), (C) in the case of any audited financial statements, will be audited in accordance with

the standards of the PCAOB and contain an unqualified report of the Company’s auditor and (D) will comply in all material

respects with the applicable accounting requirements and with the rules and regulations of the SEC, the Exchange Act and the Securities

Act in effect as of the respective dates thereof (including Regulation S-X or Regulation S-K, as applicable).

(b)            The

Company shall use its reasonable best efforts (i) to assist, upon advance written notice, during normal business hours and in a

manner such as to not unreasonably interfere with the normal operation of any member of such Group Company, CGC in causing to be prepared

in a timely manner any other financial information or statements (including customary pro forma financial statements) that are required

to be included in the Registration Statement / Proxy Statement and any other filings to be made by CGC with the SEC in connection with

the transactions contemplated by this Agreement or any Ancillary Document and (ii) to obtain the consents of its auditors with respect

thereto as may be required by applicable Law or requested by the SEC.

Section 5.18          Equity

Incentive Plan; Key Person Employment Agreements.

(a)            Prior

to the effectiveness of the Registration Statement / Proxy Statement, the ListCo Board shall approve and adopt an equity incentive plan,

the form of which will be mutually agreed between CGC and the Company prior to the initial filing of the Registration Statement / Proxy

Statement, in the manner prescribed under applicable Laws, effective as of one day prior to the Closing Date, reserving an agreed upon

percentage of the issued and outstanding ListCo Common Shares on a fully-diluted basis, determined as of the effective date of such plan

for grant thereunder, which shall include (and not be in addition to) the ListCo Common Shares issuable upon the exercise or conversion

of the Company Options.

(b)            The

Company and/or ListCo shall enter into Key Person Employment Agreements with each of the Key Persons, to be effective at the Closing.

Section 5.19          Registration

Rights Agreement and Lock-up Agreement. The Company shall cause each of (a) the Registration Rights Agreement and (b) the

Lock-up Agreement to be duly executed by the Company Shareholders that are parties thereto.

Section 5.20          Assignment

and Assumption Agreement. At the CGC Merger Effective Time, ListCo and CGC shall enter into an assignment and assumption agreement

with respect to the CGC Warrant Agreement with Continental, in the form to be mutually agreed by SPAC and the Company (the “Assignment

and Assumption Agreement”).

Section 5.21          Company

Indebtedness. The Company shall, within ten (10) Business Days following the Closing, cause all Indebtedness of the Group Companies

as of the date of this Agreement (after giving effect to the conversion of the Company Convertible Notes pursuant to Section 2.4(b))

to be paid off and released.

Section 5.22          Agricultural

Land Fund. The Company agrees that if, following the date hereof, any portion the Volta II Real Property is included in the agricultural

land fund, the Company shall use its reasonable best efforts to cause such portion of the Volta II Real Property to be permanently removed

from the agricultural land fund, including as applicable through a new decision by the relevant Governmental Entity; provided,

however, that the failure of the Company to comply with this Section 5.22 shall not entitle CGC to terminate this

Agreement pursuant to Section 7.1(b).

Section 5.23          Ministry

of Economy Notification. The Company shall, in connection with the investment aid conditions applicable to the Contracts set forth

in Section 5.23 of the Company Disclosure Schedule:

(a)            on

or before August 31, 2026, deliver to the Ministry of Economy of the Slovak Republic a written explanation of the transactions contemplated

by this Agreement, including their likely impact on the shareholder structure of the Group Companies;

(b)            provide

to the Ministry of Economy of the Slovak Republic such information and cooperation as the Ministry of Economy of the Slovak Republic

may reasonably request in connection with the transactions contemplated by this Agreement;

CGC promptly informed of all correspondence and communications with the Ministry of Economy of the Slovak Republic relating to the transactions

contemplated by this Agreement; and

(d)            invite

CGC to participate in any explanatory meetings held with the Ministry of Economy of the Slovak Republic in connection with the transactions

contemplated by this Agreement.

Section 5.24          Lot

Size Support. In compliance with applicable laws and prior to the Closing, the Company shall use its commercially reasonable efforts

to support the distribution of Company Shares by certain of the Undertaking Company Shareholders to at least three hundred (300) indirect

equity owners of the Undertaking Company Shareholders in an aggregate amount that will result in each such owner holding, in connection

with the Closing, a lot size (all such lots to be the same size to the extent practicable) of approximately five hundred (500) ListCo

Common Shares.

Section 5.25          Waivers.

The Company shall use its commercially reasonable efforts to obtain written waivers from all current and former directors, officers and

other members of the corporate bodies of any Group Company, containing (i) a waiver of all claims against the relevant Group Company

arising from or in connection with their appointment and service; and (ii) confirmation that they have no claims of any nature against

the relevant company (in each case, other than with respect to customary remuneration and other payments accrued in the ordinary course

preceding the Closing Date).

Section 5.26          NDF

II Consent. The Company shall:

(a)            on

or before August 31, 2026, deliver to CGC: (i) the prior written consent of NDF II to the execution of this Agreement, which

constitutes a reserved matter requiring NDF II’s consent under Schedule D to the NDF II Investment Agreement; and (ii) written

confirmation by NDF II that, as at the date of such confirmation, except as set forth on Section 3.9(b) of the Company

Disclosure Schedules, NDF II has not raised, and does not currently have, any claim, demand or action against the Company, InoBat

Auto j.s.a. or InoBat Volta II s.r.o. under, or in connection with, the NDF II Investment Agreement, including under the representations

and warranties in Schedule B thereto; and

(b)            prior

to the Closing, deliver to CGC the prior written consent of NDF II to all further matters contemplated by this Agreement which constitute

reserved matters requiring NDF II’s prior written consent under Schedule D to the NDF II Investment Agreement and which are triggered

by the consummation of the transactions contemplated by this Agreement;

provided,

however, that the failure of the Company to deliver such consents and confirmation, as applicable, to CGC by August 31, 2026,

or prior to the Closing, as applicable, shall not entitle CGC to terminate this Agreement pursuant to Section 7.1(b).

Article 6

CONDITIONS TO CONSUMMATION OF THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT

Section 6.1            Conditions

to the Obligations of the Parties. The obligations of the Parties to consummate the transactions contemplated by this Agreement are

subject to the satisfaction or, if permitted by applicable Law, written waiver by the Party for whose benefit such condition exists of

the following conditions:

(a)            all

notifications, approvals, decisions, clearances or the like required under applicable antitrust or foreign direct investment Laws shall

have been obtained (or deemed, by applicable Law, to have been obtained) from each FDI Authority or other applicable Governmental Entity,

and any agreement between a Party with any Governmental Entity not to consummate transactions contemplated by this Agreement, shall have

expired or been terminated, as applicable;

(b)            no

Order or Law or other legal restraint or prohibition issued by any court of competent jurisdiction or other Governmental Entity enjoining,

prohibiting or preventing the consummation of the transactions contemplated by this Agreement (including the CGC Merger and the Exchange)

shall be in effect;

Registration Statement / Proxy Statement shall have become effective in accordance with the provisions of the Securities Act, no stop

order shall have been issued by the SEC and shall remain in effect with respect to the Registration Statement / Proxy Statement, and

no proceeding seeking such a stop order shall have been threatened or initiated by the SEC and remain pending;

(d)            the

Required CGC Shareholder Approval shall have been obtained;

(e)            CGC’s

initial listing application with Nasdaq in connection with the transactions contemplated by this Agreement shall have been approved and,

immediately following the CGC Merger Effective Time, ListCo shall satisfy any applicable initial and continuing listing requirements

of Nasdaq, and ListCo shall not have received any notice of non-compliance therewith that has not been cured or would not be cured at

or immediately following the CGC Merger Effective Time, and the ListCo Common Shares (after giving effect, for the avoidance of doubt,

to the CGC Merger and the Exchange and, including, for the avoidance of doubt, the ListCo Common Shares to be issued pursuant to the

CGC Merger and the Exchange) shall have been approved for listing on Nasdaq; and

(f)            the

Required Transaction Proposals shall have been approved.

Section 6.2            Other

Conditions to the Obligations of CGC. The obligations of CGC to consummate the transactions contemplated by this Agreement are subject

to the satisfaction or, if permitted by applicable Law, prior written waiver by CGC of the following further conditions:

(a)            (i) the

Company Fundamental Representations (other than the representations and warranties set forth in Section 3.2(a) and Section 3.8(a))

shall be true and correct (without giving effect to any limitation as to “materiality” or “Company Material Adverse

Effect” or any similar limitation set forth herein) in all material respects as of the Closing Date, as though made on and as of

the Closing Date (except to the extent that any such representation and warranty is made as of an earlier date, in which case such representation

and warranty shall be true and correct in all material respects as of such earlier date), (ii) the representations and warranties

set forth in Section 3.2(a) shall be true and correct in all respects (except for de minimis inaccuracies) as

of Closing Date, as though made on and as of the Closing Date (except to the extent that any such representation and warranty is made

as of an earlier date, in which case such representation and warranty shall be true and correct in all respects (except for de minimis

inaccuracies) as of such earlier date), (iii) the representations and warranties set forth in Section 3.8(a) shall

be true and correct in all respects as of the Closing Date, as though made on and as of the Closing Date (except to the extent that any

such representation and warranty is made as of an earlier date, in which case such representation and warranty shall be true and correct

in all respects as of such earlier date); provided, however, that this clause (iii) shall be deemed to be satisfied

if no Company Material Adverse Effect is continuing, and (iv) the representations and warranties of the of the Company set forth

in Article 3 (other than the Company Fundamental Representations and the representations and warranties of the Company set

forth in Section 3.16(n)) shall be true and correct (without giving effect to any limitation as to “materiality”

or “Company Material Adverse Effect” or any similar limitation set forth herein) in all respects as of the Closing Date,

as though made on and as of the Closing Date (except to the extent that any such representation and warranty is made as of an earlier

date, in which case such representation and warranty shall be true and correct in all respects as of such earlier date), except where

the failure of such representations and warranties to be true and correct, taken as a whole, does not cause a Company Material Adverse

Effect;

(b)            the

Company shall have performed and complied in all material respects with the covenants and agreements required to be performed or complied

with by the Company under this Agreement at or prior to the Closing;

the date of this Agreement, no Company Material Adverse Effect shall have occurred that is continuing;

(d)            on

or before August 31, 2026, the Company Shareholder Undertaking shall have been executed by Company Shareholders holding at least

ninety percent (90%) of the Company Shares outstanding immediately prior to the delivery of such Company Shareholder Undertaking, and

the same shall not have been or be revoked, modified, amended, waived or terminated;

(e)            at

or prior to the Closing, the Company shall have delivered, or caused to be delivered, to CGC the following documents:

(i)             a

certificate duly executed by an authorized officer of the Company, dated as of the Closing Date, to the effect that the conditions specified

in Section 6.2(a), Section 6.2(b) and Section 6.2(c) are satisfied, in a form and substance

reasonably satisfactory to CGC; and

(ii)            counterparts

to the Earn-Out Agreements, duly executed by each of the Undertaking Company Shareholders;

(iii)           counterparts

to each of (a) the Registration Rights Agreement and (b) the Lock-up Agreement, duly executed by the Undertaking Company Shareholders;

(iv)           counterparts

to the Orderly Disposition Agreements, duly executed by each of the ODA Holder;

(v)            with

respect to each Share Subscription Right Agreement under the Company Equity Plan pursuant to which the holder’s entitlement is

expressed as a percentage of the Company’s registered capital (each, a “Percentage-Based SSRA”), a written

amendment to such Percentage-Based SSRA, duly executed by the Company and the relevant holder, documenting such holder’s entitlement

as a fixed number of Company Shares calculated by reference to the Fully-Diluted Shares as of immediately prior to the Exchange Effective

Time;

(vi)           written

confirmation from each holder of a Share Subscription Right Agreement under the Company Equity Plan who holds unexercised rights thereunder

as of immediately prior to the Exchange Effective Time, confirming its agreement that such unexercised rights shall, at the Exchange

Effective Time, be cancelled and exchanged for a Rollover Option on the terms set forth in Section 2.4(a) of this Agreement;

and

(vii)           with

respect to the share subscription right agreement (the “Gotion ESOP Agreement”) to be entered into between

the Company and Shanghai Xuanyl Oufei New Energy Development Co., Ltd. (“Gotion Shanghai”), the following

documents: (A) copy of the Gotion ESOP Agreement, duly executed by the Company and Gotion Shanghai, together with evidence that:

(i) the aggregate number of Company Shares issuable to all grantees thereunder does not exceed five percent (5%) of the Fully-Diluted

Shares as of immediately prior to the Exchange Effective Time; (ii) the Gotion ESOP Agreement does not confer on Gotion Shanghai

or any grantee thereunder any anti-dilution protection or adjustment right in connection with the transactions contemplated by this Agreement

or otherwise; and (iii) the rights of grantees under the Gotion ESOP Agreement are in all respects no more favorable than the rights

of participants under the Company’s existing Share Subscription Right Agreements forming part of the Company Equity Plan; and (B) a

written confirmation from each grantee under the Gotion ESOP Agreement who holds unexercised rights thereunder as of immediately prior

to the Exchange Effective Time, in form and substance reasonably satisfactory to CGC, confirming its agreement that such unexercised

rights shall, at the Exchange Effective Time, be cancelled and exchanged for a Rollover Option on the terms set forth in Section 2.4(a) of

this Agreement.

Section 6.3            Other

Conditions to the Obligations of the Company. The obligations of the Company to consummate the transactions contemplated by this

Agreement are subject to the satisfaction or, if permitted by applicable Law, written waiver by the Company of the following further

conditions:

(a)            (i) the

CGC Fundamental Representations (other than the representations and warranties set forth in Section 4.6(a)) shall be true

and correct in all material respects as of the Closing Date, as though made on and as of the Closing Date (except to the extent that

any such representation and warranty is made as of an earlier date, in which case such representation and warranty shall be true and

correct in all material respects as of such earlier date), (ii) the representations and warranties set forth in Section 4.6(a) shall

be true and correct in all respects (except for de minimis inaccuracies) as of the Closing Date, as though made on and as of the

Closing Date (except to the extent that any such representation and warranty is made as of an earlier date, in which case such representation

and warranty shall be true and correct in all respects (except for de minimis inaccuracies) as of such earlier date), (iii) the

representations and warranties of CGC (other than the CGC Fundamental Representations) contained in Article 4 of this Agreement

shall be true and correct (without giving effect to any limitation as to “materiality” or “CGC Material Adverse Effect”

or any similar limitation set forth herein) in all respects as of the Closing Date, as though made on and as of the Closing Date (except

to the extent that any such representation and warranty is made as of an earlier date, in which case such representation and warranty

shall be true and correct as of such earlier date), except where the failure of such representations and warranties to be true and correct,

taken as a whole, does not cause a CGC Material Adverse Effect;

(b)           CGC

shall have performed and complied in all material respects with the covenants and agreements required to be performed or complied with

by them under this Agreement at or prior to the Closing;

the date of this Agreement, no CGC Material Adverse Effect shall have occurred that is continuing;

(d)           the

ListCo Board shall consist of the number of directors, and be comprised of the individuals, determined pursuant to Section 5.16;

(e)           the

PIPE Investors shall have funded the PIPE Financing Amount pursuant to the Investor Subscription Agreements;

(f)            at

or prior to the Closing, CGC shall have delivered, or caused to be delivered, to the Company the following documents:

(i)             a

certificate duly executed by an authorized officer of CGC, dated as of the Closing Date, to the effect that the conditions specified

in Section 6.3(a), Section 6.3(b) and Section 6.3(c) are satisfied, in a form and substance

reasonably satisfactory to the Company; and

(ii)             a

counterpart to each of (a) the Registration Rights Agreement and (b) the Lock-up Agreement, duly executed by the Sponsor.

Section 6.4             Frustration

of Closing Conditions. The Company may not rely on the failure of any condition set forth in this Article 6 to be satisfied

if such failure was proximately caused by the Company’s failure to use reasonable best efforts to cause the Closing to occur, as

required by Section 5.2. CGC may not rely on the failure of any condition set forth in this Article 6 to be satisfied

if such failure was proximately caused by CGC’s failure to use reasonable best efforts to cause the Closing to occur, as required

by Section 5.2.

Article 7

TERMINATION

Section 7.1            Termination.

This Agreement may be terminated, and the transactions contemplated by this Agreement may be abandoned at any time prior to the Closing,

solely:

(a)            by

mutual written consent of CGC and the Company;

(b)            by

CGC, if any of the representations or warranties set forth in Article 3 shall not be true and correct or if the Company has

failed to perform or has otherwise breached any of its covenants or agreements set forth in this Agreement (including an obligation to

consummate the Closing) such that the condition to Closing set forth in either Section 6.2(a) or Section 6.2(b) would

not be satisfied (assuming the Closing occurred as of such date) and the breach or breaches causing such representations or warranties

not to be true and correct, or the failures to perform any covenant or agreement, as applicable, is (or are) not cured or cannot be cured

within the earlier of (i) thirty (30) days after written notice thereof is delivered to the Company by CGC, and (ii) the Termination

Date; provided, however, that CGC is not then in breach of this Agreement so as to prevent the conditions to Closing set forth

in either Section 6.3(a) or Section 6.3(b) from being satisfied (assuming the Closing occurred as of

such date);

the Company, if any of the representations or warranties set forth in Article 4 shall not be true and correct or if CGC has

failed to perform any of its covenants or agreements set forth in this Agreement (including an obligation to consummate the Closing)

such that the condition to Closing set forth in either Section 6.3(a) or Section 6.3(b) could not be

satisfied (assuming the Closing occurred as of such date) and the breach or breaches causing such representations or warranties not to

be true and correct, or the failures to perform any covenant or agreement, as applicable, is (or are) not cured or cannot be cured within

the earlier of (i) thirty (30) days after written notice thereof is delivered to CGC by the Company and (ii) the Termination

Date; provided, however, the Company is not then in breach of this Agreement so as to prevent the condition to Closing set forth

in Section 6.2(a) or Section 6.2(b) from being satisfied (assuming the Closing occurred as of such

date);

(d)            by

either CGC or the Company, if the transactions contemplated by this Agreement shall not have been consummated on or prior to December 31,

2026 (the “Termination Date”); provided that (i) the right to terminate this Agreement pursuant

to this Section 7.1(d) shall not be available to CGC if CGC’s breach of any of its covenants or obligations under

this Agreement, or any Ancillary Documents to which it is a party, shall have proximately caused the failure to consummate the transactions

contemplated by this Agreement on or before the Termination Date, and (ii) the right to terminate this Agreement pursuant to this

Section 7.1(d) shall not be available to the Company if the Company’s breach of any of its covenants or obligations

under this Agreement, or any Ancillary Documents to which it is a party, shall have proximately caused the failure to consummate the

transactions contemplated by this Agreement on or before the Termination Date;

(e)            by

either CGC or the Company, if any Governmental Entity shall have issued an Order or taken any other action permanently enjoining, restraining

or otherwise prohibiting the transactions contemplated by this Agreement (including the CGC Merger and the Exchange) and such Order or

other action shall have become final and nonappealable;

(f)             by

either CGC or the Company if the CGC Shareholders Meeting has been held (including any adjournment thereof), has concluded, CGC’s

shareholders have duly voted and the Required CGC Shareholder Approval was not obtained;

(g)            by

CGC, if the Company has not delivered, or caused to be delivered, to CGC, the Company Shareholder Undertaking executed by Company Shareholders

holding at least ninety percent (90%) of the Company Shares outstanding immediately prior to the delivery of such Company Shareholder

Undertaking, on or prior to August 31, 2026; or

(h)            by

CGC, if (i) the Company shall have failed to comply with the obligations set forth on Section 5.26 and (ii) NDF

II or any of its Affiliates or Representatives shall have (x) objected to the transactions contemplated by this Agreement or (y) imposed,

or notified the Company or any Group Company in writing of its intention to impose, any penalty on the Company or any Group Company under

the NDF II Investment Agreement arising from or in connection with the entry into this Agreement or any transactions contemplated hereby.

Section 7.2            Effect

of Termination.

(a)            In

the event of the termination of this Agreement pursuant to Section 7.1, (i) this entire Agreement shall forthwith become

void (and there shall be no Liability or obligation on the part of the Parties and their respective Non-Party Affiliates) with the exception

of Section 5.3(a), this Section 7.2, Article 8 and Article 1 (to the extent related to

the foregoing), each of which shall survive such termination and remain valid and binding obligations of the Parties and (ii) the

Confidentiality Agreements, which shall survive such termination and remain valid and binding obligations of the parties thereto in accordance

with their respective terms. Notwithstanding the foregoing or anything to the contrary herein, the termination of this Agreement pursuant

to Section 7.1 shall not affect (x) any Liability on the part of any Party for any Willful Breach of any covenant or

agreement set forth in this Agreement prior to such termination or Fraud or (y) any Person’s Liability under any Investor

Subscription Agreement, any Confidentiality Agreement, any Shareholder Support Agreement or the Sponsor Support Agreement to which he,

she or it is a party to the extent arising from a claim against such Person by another Person party to such agreement on the terms and

subject to the conditions thereunder.

(b)            If

(i) this Agreement is terminated by CGC pursuant to Section 7.1(b), and (ii) the Company shall, within the period

beginning on the date hereof and ending twelve months after such termination, enter into a definitive agreement for a Competing Transaction,

then the Company shall, within three (3) Business Days after the consummation of such definitive agreement, pay CGC and the Sponsor

an aggregate of $10,000,000 in cash (the “Alternative Transaction Break Fee”), on the basis that it is to compensate

CGC and its affiliates, including the Sponsor, for the costs and expenses incurred by them, including (A) fees for legal, financial

and other professional advice in planning and implementing the transactions contemplated hereby (excluding success fees), (B) opportunity

costs incurred in engaging in such transactions or in not engaging in other alternative acquisitions or strategic initiatives, (C) costs

of management and directors’ time in planning such transactions, and (D) out of pocket expenses incurred by CGC and its employees,

advisers, affiliates, and agents in planning such transactions and effecting any extension, and the Parties agree that the costs actually

incurred by CGC will be of such a nature that they cannot all be accurately ascertained and that the Alternative Transaction Break Fee

is equal to or less than a genuine and reasonable pre-estimate of those costs. For the avoidance of doubt, CGC’s exercise of its

right to terminate this Agreement pursuant to Section 7.1(b) and receive payment of the Alternative Transaction Break

Fee pursuant to this Section 7.2(b) shall not preclude or limit CGC’s right to terminate this Agreement pursuant

to Section 7.1(h) and receive payment of the Specified Breach Break Fee pursuant to Section 7.2(c).

this Agreement is terminated by CGC pursuant to Section 7.1(h), then the Company shall, within three (3) Business Days

after such termination, pay CGC and the Sponsor an aggregate of $500,000 (the “Specified Breach Break Fee”)

in cash, on the basis that it is to compensate CGC and its affiliates, including the Sponsor, for the costs and expenses incurred by

them, including (A) fees for legal, financial and other professional advice in planning and implementing the transactions contemplated

hereby (excluding success fees), (B) opportunity costs incurred in engaging in such transactions or in not engaging in other alternative

acquisitions or strategic initiatives, (C) costs of management and directors’ time in planning such transactions, and (D) out

of pocket expenses incurred by CGC and its employees, advisers, affiliates, and agents in planning such transactions and effecting any

extension, and the Parties agree that the costs actually incurred by CGC will be of such a nature that they cannot all be accurately

ascertained and that the Specified Breach Break Fee is equal to or less than a genuine and reasonable pre-estimate of those costs. For

the avoidance of doubt, CGC’s exercise of its right to terminate this Agreement pursuant to Section 7.1(h) and

receive payment of the Specified Breach Break Fee pursuant to this Section 7.2(c) shall not preclude or limit CGC’s

right to terminate this Agreement pursuant to Section 7.1(b) and receive payment of the Alternative Transaction Break

Fee pursuant to Section 7.2(b).

(d)            If

(i) this Agreement is terminated by the Company pursuant to Section 7.1(c) and (ii) CGC shall, within the

period beginning on the date hereof and ending twelve months after such termination, enter into a definitive agreement with respect to

a CGC Acquisition Proposal, then CGC shall, within three (3) Business Days after the consummation of such definitive agreement,

pay the Company the Alternative Transaction Break Fee, on the basis that it is to compensate the Company for the costs and expenses incurred

by it, including (A) fees for legal, financial and other professional advice in planning and implementing the transactions contemplated

hereby (excluding success fees), (B) opportunity costs incurred in engaging in such transactions or in not engaging in other alternative

acquisitions or strategic initiatives, (C) costs of management and directors’ time in planning such transactions, and (D) out

of pocket expenses incurred by the Company and its employees, advisers, affiliates, and agents in planning such transaction, and the

Parties agree that the costs actually incurred by the Company will be of such a nature that they cannot all be accurately ascertained

and that the Alternative Transaction Break Fee is equal to or less than a genuine and reasonable pre-estimate of those costs.

Article 8

MISCELLANEOUS

Section 8.1            Non-Survival.

All of the representations and warranties set forth in this Agreement, shall terminate at the CGC Merger Effective Time, such that no

claim for breach of any such representation, warranty, agreement or covenant, detrimental reliance or other right or remedy (whether

in contract, in tort, at law, in equity or otherwise) may be brought with respect thereto after the CGC Merger Effective Time against

any Party, any Company Non-Party Affiliate or any CGC Non-Party Affiliate, except in the case of Fraud. Each covenant and agreement contained

herein that, by its terms, expressly contemplates performance after the CGC Merger Effective Time shall so survive the CGC Merger Effective

Time in accordance with its terms, and each covenant and agreement contained in any Ancillary Document that, by its terms, expressly

contemplates performance after the CGC Merger Effective Time shall so survive the CGC Merger Effective Time in accordance with its terms

and any other provision in any Ancillary Document that expressly survives the CGC Merger Effective Time shall so survive the CGC Merger

Effective Time in accordance with the terms of such Ancillary Document.

Section 8.2            Entire

Agreement; Assignment. This Agreement (together with the Ancillary Documents and the Confidentiality Agreement) constitutes the entire

agreement among the Parties with respect to the subject matter hereof and supersedes all other prior agreements and understandings, both

written and oral, among the Parties with respect to the subject matter hereof. This Agreement may not be assigned by any Party (whether

by operation of law or otherwise) without the prior written consent of the other Party.

Section 8.3            Amendment.

This Agreement may be amended or modified only by a written agreement executed and delivered by CGC and the Company. This Agreement may

not be modified or amended except as provided in the immediately preceding sentence and any purported amendment by any Party or Parties

effected in a manner which does not comply with this Section 8.3 shall be void, ab initio.

Section 8.4            Notices.

All notices, requests, claims, demands and other communications hereunder shall be in writing and shall be given (and shall be deemed

to have been duly given) by delivery in person, by e-mail (having obtained electronic delivery confirmation thereof (i.e., an electronic

record of the sender that the e-mail was sent to the intended recipient thereof without an “error” or similar message that

such e-mail was not received by such intended recipient)), or by registered or certified mail (postage prepaid, return receipt requested)

(upon receipt thereof) to the other Parties as follows:

(a)           If

to CGC, or the Sponsor, to:

505 Fifth Avenue, Suite 1500

New York, NY 10017

Attention: Peter Yu

E-mail: @@@

with a copy (which shall not constitute notice) to:

Greenberg Traurig, LLP

One Vanderbilt Avenue

New York, New York 10017

Attention: Adam Namoury; Thomas Martin

E-mail: @@@

(b)            If

to the Company, to:

InoBat

Voderady 429

919 42 Voderady

Slovak Republic

Attention: CEO, Marian

Bocek

Email: @@@

with a copy (which shall not constitute notice) to:

Dentons US LLP

1221 Avenue of the

Americas

New York, New York

10020

Attention: Ilan Katz;

Brian Lee; Grant Levine

Email: @@@

or to such other address as the Party to whom

notice is given may have previously furnished to the others in writing in the manner set forth above.

Section 8.5            Governing

Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York, without giving effect

to any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdiction) that would

cause the application of the law of any jurisdiction other than the State of New York.

Section 8.6            Fees

and Expenses. Except as otherwise set forth in this Agreement, all fees and expenses incurred in connection with this Agreement,

the Ancillary Documents and the transactions contemplated hereby and thereby, including the fees and disbursements of counsel, financial

advisors and accountants, shall be paid by the Party incurring such fees or expenses; provided that for the avoidance of doubt,

(i) all filing fees required by the SEC in connection with the Registration Statement / Proxy Statement and all filing fees required

by Nasdaq in connection with the initial listing application shall be borne and paid fifty percent (50%) by CGC and fifty percent (50%)

by the Company, (ii) if this Agreement is terminated in accordance with its terms, the Company shall pay, or cause to be paid, all

Unpaid Company Expenses and CGC shall pay, or cause to be paid, all Unpaid CGC Expenses and (iii) if the Closing occurs, then ListCo

shall pay, or cause to be paid, all Unpaid Company Expenses and all Unpaid CGC Expenses.

Section 8.7            Construction;

Interpretation. The term “this Agreement” means this Business Combination Agreement together with the Schedules and Exhibits

hereto, as the same may from time to time be amended, modified, supplemented or restated in accordance with the terms hereof. The headings

set forth in this Agreement are inserted for convenience only and shall not affect in any way the meaning or interpretation of this Agreement.

No Party, nor its respective counsel, shall be deemed the drafter of this Agreement for purposes of construing the provisions hereof,

and all provisions of this Agreement shall be construed according to their fair meaning and not strictly for or against any Party. Unless

otherwise indicated to the contrary herein by the context or use thereof: (a) the words, “herein,” “hereto,”

“hereof” and words of similar import refer to this Agreement as a whole, including the Schedules and Exhibits, and not to

any particular section, subsection, paragraph, subparagraph or clause set forth in this Agreement; (b) masculine gender shall also

include the feminine and neutral genders, and vice versa; (c) words importing the singular shall also include the plural, and vice

versa; (d) the words “include,” “includes” or “including” shall be deemed to be followed by

the words “without limitation”; (e) references to “$” or “dollar” or “US$” shall

be references to United States dollars; (f) the word “or” is disjunctive but not necessarily exclusive; (g) the

words “writing”, “written” and comparable terms refer to printing, typing and other means of reproducing words

(including electronic media) in a visible form; (h) the word “day” means calendar day unless Business Day is expressly

specified; (i) references from or through any date mean from and including or through and including such date, respectively, (j) the

word “extent” in the phrase “to the extent” means the degree to which a subject or other thing extends, and such

phrase shall not mean simply “if”; (k) all references to Articles, Sections, Exhibits or Schedules are to Articles,

Sections, Exhibits and Schedules of this Agreement; (l) the words “made available” (regardless of whether capitalized

or not) shall mean, when used with reference to documents or other materials required to be provided or made available to CGC, any documents

or other materials posted to the electronic data room located at Datasite under the project name “InoBat” as of 10:00p.m.,

Eastern Time, at least one (1) Business Day prior to the date of this Agreement; (m) all references to any Law will be to such

Law as amended, supplemented or otherwise modified or re-enacted from time to time; and (n) all references to any Contract are to

that Contract as amended or modified from time to time in accordance with the terms thereof (subject to any restrictions on amendments

or modifications set forth in this Agreement). If any action under this Agreement is required to be done or taken on a day that is not

a Business Day, then such action shall be required to be done or taken not on such day but on the first succeeding Business Day thereafter.

Section 8.8            Exhibits

and Schedules. All Exhibits and Schedules, or documents expressly incorporated into this Agreement, are hereby incorporated into

this Agreement and are hereby made a part hereof as if set out in full in this Agreement. The Schedules shall be arranged in sections

and subsections corresponding to the numbered and lettered Sections and subsections set forth in this Agreement. Any item disclosed in

the Company Disclosure Schedules or in the CGC Disclosure Schedules corresponding to any Section or subsection of Article 3

(in the case of the Company Disclosure Schedules) or Article 4 (in the case of the CGC Disclosure Schedules), respectively,

shall be deemed to have been disclosed with respect to every other section and subsection of Article 3 (in the case of the

Company Disclosure Schedules) or Article 4 (in the case of the CGC Disclosure Schedules), respectively, where the relevance

of such disclosure to such other Section or subsection is reasonably apparent on the face of the disclosure. The information and

disclosures set forth in the Schedules that correspond to the section or subsections of Article 3 or Article 4

may not be limited to matters required to be disclosed in the Schedules, and any such additional information or disclosure is for informational

purposes only and does not necessarily include other matters of a similar nature.

Section 8.9            Parties

in Interest. This Agreement shall be binding upon and inure solely to the benefit of each Party and its successors and permitted

assigns and, except as provided in Section 5.14, nothing in this Agreement, express or implied, is intended to or shall confer

upon any other Person any rights, benefits or remedies of any nature whatsoever under or by reason of this Agreement. Each of the Non-Party

Affiliates shall be an express third-party beneficiary of Section 8.13.

Section 8.10          Severability.

Whenever possible, each provision of this Agreement will be interpreted in such a manner as to be effective and valid under applicable

Law, but if any term or other provision of this Agreement is held to be invalid, illegal or unenforceable under applicable Law, all other

provisions of this Agreement shall remain in full force and effect so long as the economic or legal substance of the transactions contemplated

hereby is not affected in any manner materially adverse to any Party. Upon such determination that any term or other provision of this

Agreement is invalid, illegal or unenforceable under applicable Law, the Parties shall negotiate in good faith to modify this Agreement

so as to effect the original intent of the Parties as closely as possible in an acceptable manner in order that the transactions contemplated

hereby are consummated as originally contemplated to the greatest extent possible.

Section 8.11          Counterparts;

Electronic Signatures. This Agreement and each Ancillary Document (including any of the closing deliverables contemplated hereby)

may be executed in one or more counterparts, each of which shall be deemed to be an original, but all of which shall constitute one and

the same agreement. Delivery of an executed counterpart of a signature page to this Agreement or any Ancillary Document (including

any of the closing deliverables contemplated hereby) by e-mail, or scanned pages shall be effective as delivery of a manually executed

counterpart to this Agreement or any such Ancillary Document.

Section 8.12          Knowledge

of Company; Knowledge of CGC. For all purposes of this Agreement, the phrase “to the Company’s knowledge”, “to

the knowledge of the Company” and “known by the Company” and any derivations thereof shall mean as of the applicable

date, the actual knowledge of the individuals set forth on Section 8.12 of the Company Disclosure Schedules, assuming reasonable

due inquiry and investigation of his or her direct reports. For all purposes of this Agreement, the phrase “to CGC’s knowledge”,

“to the knowledge of CGC” and “known by CGC” and any derivations thereof shall mean as of the applicable date,

the actual knowledge of the individuals set forth on Section 8.12 of the CGC Disclosure Schedules, assuming reasonable due

inquiry and investigation of his or her direct reports. For the avoidance of doubt, none of the individuals set forth on Section 8.12

of the Company Disclosure Schedules or Section 8.12 of the CGC Disclosure Schedules shall have any personal Liability or

obligations regarding such knowledge.

Section 8.13          No

Recourse. Except for claims pursuant to any Ancillary Document by any party(ies) thereto against any Company Non-Party Affiliate

or any CGC Non-Party Affiliate (each, a “Non-Party Affiliate”), and then solely with respect to claims against

the Non-Party Affiliates that are party to the applicable Ancillary Document, each Party agrees on behalf of itself and on behalf of

the Company Non-Party Affiliates, in the case of the Company, and the CGC Non-Party Affiliates, in the case of CGC, that (a) this

Agreement may only be enforced against, and any action for breach of this Agreement may only be made against, the Parties, and no claims

of any nature whatsoever arising under or relating to this Agreement, the negotiation hereof or its subject matter, or the transactions

contemplated hereby shall be asserted against any Non-Party Affiliate, and (b) none of the Non-Party Affiliates shall have any Liability

arising out of or relating to this Agreement, the negotiation hereof or its subject matter, or the transactions contemplated hereby,

including with respect to any claim (whether in tort, contract or otherwise) for breach of this Agreement or in respect of any written

or oral representations made or alleged to be made in connection herewith, as expressly provided herein, or for any actual or alleged

inaccuracies, misstatements or omissions with respect to any information or materials of any kind furnished by the Company, CGC or any

Non-Party Affiliate concerning any Group Company, CGC, this Agreement or the transactions contemplated hereby.

Section 8.14          Extension;

Waiver. The Company may (a) extend the time for the performance of any of the obligations or other acts of CGC set forth herein,

(b) waive any inaccuracies in the representations and warranties of CGC set forth herein or (c) waive compliance by CGC with

any of the agreements or conditions set forth herein. CGC may (i) extend the time for the performance of any of the obligations

or other acts of the Company set forth herein, (ii) waive any inaccuracies in the representations and warranties of the Company

set forth herein or (iii) waive compliance by the Company with any of the agreements or conditions set forth herein. Any agreement

on the part of any such Party to any such extension or waiver shall be valid only if set forth in a written instrument signed on behalf

of such Party. Any waiver of any term or condition shall not be construed as a waiver of any subsequent breach or a subsequent waiver

of the same term or condition, or a waiver of any other term or condition of this Agreement. The failure of any Party to assert any of

its rights hereunder shall not constitute a waiver of such rights.

Section 8.15          Waiver

of Jury Trial. THE PARTIES EACH HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO TRIAL BY JURY OF ANY PROCEEDING,

CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION (I) ARISING UNDER THIS AGREEMENT OR UNDER ANY ANCILLARY DOCUMENT OR (II) IN ANY WAY

CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES IN RESPECT OF THIS AGREEMENT OR ANY ANCILLARY DOCUMENT OR ANY

OF THE TRANSACTIONS RELATED HERETO OR THERETO OR ANY FINANCING IN CONNECTION WITH THE TRANSACTIONS CONTEMPLATED HEREBY OR ANY OF THE

TRANSACTIONS CONTEMPLATED THEREBY, IN EACH CASE, WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER IN CONTRACT, TORT, EQUITY,

OR OTHERWISE. THE PARTIES EACH HEREBY AGREES AND CONSENTS THAT ANY SUCH PROCEEDING, CLAIM, DEMAND, ACTION OR CAUSE OF ACTION SHALL BE

DECIDED BY COURT TRIAL WITHOUT A JURY AND THAT THE PARTIES MAY FILE AN ORIGINAL COUNTERPART OF A COPY OF THIS AGREEMENT WITH

ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY. EACH PARTY CERTIFIES

AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT

SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (B) EACH SUCH PARTY UNDERSTANDS

AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (C) EACH SUCH PARTY MAKES THIS WAIVER VOLUNTARILY AND (D) EACH SUCH PARTY

HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 8.15.

Section 8.16          Submission

to Jurisdiction. Each of the Parties irrevocably and unconditionally submits to the exclusive jurisdiction of any New York State

court or Federal court of the United States of America sitting in New York City in the Borough of Manhattan for the purposes of any Proceeding,

claim, demand, action or cause of action (a) arising under this Agreement or under any Ancillary Document or (b) in any way

connected with or related or incidental to the dealings of the Parties in respect of this Agreement or any Ancillary Document or any

of the transactions contemplated hereby or any of the transactions contemplated thereby, and irrevocably and unconditionally waives any

objection to the laying of venue of any such Proceeding in any such court, and further irrevocably and unconditionally waives and agrees

not to plead or claim in any such court that any such Proceeding has been brought in an inconvenient forum. Each Party hereby irrevocably

and unconditionally waives, and agrees not to assert, by way of motion or as a defense, counterclaim or otherwise, in any Proceeding

claim, demand, action or cause of action against such Party (i) arising under this Agreement or under any Ancillary Document or

(ii) in any way connected with or related or incidental to the dealings of the Parties in respect of this Agreement or any Ancillary

Document or any of the transactions contemplated hereby or any of the transactions contemplated thereby, (A) any claim that such

Party is not personally subject to the jurisdiction of the courts as described in this Section 8.16 for any reason, (B) that

such Party or such Party’s property is exempt or immune from the jurisdiction of any such court or from any legal process commenced

in such courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution

of judgment or otherwise) and (C) that (x) the Proceeding, claim, demand, action or cause of action in any such court is brought

against such Party in an inconvenient forum, (y) the venue of such Proceeding, claim, demand, action or cause of action against

such Party is improper or (z) this Agreement, or the subject matter hereof, may not be enforced against such Party in or by such

courts. Each Party agrees that service of any process, summons, notice or document by registered mail to such party’s respective

address set forth in Section 8.4 shall be effective service of process for any such Proceeding, claim, demand, action or

cause of action.

Section 8.17          Remedies.

Except as otherwise expressly provided herein, any and all remedies provided herein will be deemed cumulative with and not exclusive

of any other remedy conferred hereby, or by law or equity upon such Party, and the exercise by a Party of any one remedy will not preclude

the exercise of any other remedy. The Parties agree that irreparable damage for which monetary damages, even if available, would not

be an adequate remedy, would occur in the event that the Parties do not perform their respective obligations under the provisions of

this Agreement (including failing to take such actions as are required of them hereunder to consummate the transactions contemplated

by this Agreement) in accordance with their specific terms or otherwise breach such provisions. It is accordingly agreed that the Parties

shall be entitled to an injunction or injunctions, specific performance and other equitable relief to prevent breaches of this Agreement

and to enforce specifically the terms and provisions of this Agreement, in each case, without posting a bond or undertaking and without

proof of damages and this being in addition to any other remedy to which they are entitled at law or in equity. Each of the Parties agrees

that it will not oppose the granting of an injunction, specific performance and other equitable relief when expressly available pursuant

to the terms of this Agreement on the basis that the other parties have an adequate remedy at law or an award of specific performance

is not an appropriate remedy for any reason at law or equity.

Section 8.18          Trust

Account Waiver. Reference is made to the final prospectus of CGC, filed with the SEC (File No. 333-261866) on May 5, 2022

(the “Prospectus”). The Company acknowledges and agrees and understands that CGC has established a trust account

(the “Trust Account”) containing the proceeds of its initial public offering (the “IPO”)

and from certain private placements occurring simultaneously with the IPO (including interest accrued from time to time thereon) for

the benefit of CGC’s public shareholders (including overallotment shares acquired by CGC’s underwriters, the “Public

Shareholders”), and CGC may disburse monies from the Trust Account only in the express circumstances described in the Prospectus.

For and in consideration of CGC entering into this Agreement, and for other good and valuable consideration, the receipt and sufficiency

of which is hereby acknowledged, the Company hereby agrees on behalf of itself and its Representatives that, notwithstanding the foregoing

or anything to the contrary in this Agreement, none of the Company nor any of their respective Representatives does now or shall at any

time hereafter have any right, title, interest or claim of any kind in or to any monies in the Trust Account or distributions therefrom,

or make any claim against the Trust Account (including any distributions therefrom), regardless of whether such claim arises as a result

of, in connection with or relating in any way to, this Agreement or any proposed or actual business relationship between CGC or any of

its Representatives, on the one hand, and, the Company or any of its respective Representatives, on the other hand, or any other matter,

and regardless of whether such claim arises based on contract, tort, equity or any other theory of legal liability (any and all such

claims are collectively referred to hereafter as the “Trust Account Released Claims”). The Company (on its

own behalf and on behalf of its Representatives) hereby irrevocably waives any Trust Account Released Claims that it or any of its Representatives

may have against the Trust Account (including any distributions therefrom) now or in the future as a result of, or arising out of, any

negotiations, or Contracts with CGC or its Representatives and will not seek recourse against the Trust Account (including any distributions

therefrom) for any reason whatsoever (including for an alleged breach of any agreement with CGC or its Affiliates).

Section 8.19          Legal

Representation; Privilege.

(a)            The

Parties agree that, notwithstanding the fact that Greenberg Traurig, LLP (“GT”) may have, prior to Closing,

jointly represented CGC, Merger Sub, and/or the Sponsor in connection with this Agreement, the Ancillary Documents and the transactions

contemplated hereby and thereby, and has also represented CGC and/or its Affiliates in connection with matters other than the transaction

that is the subject of this Agreement, GT will be permitted in the future, after Closing, to represent the Sponsor or its Affiliates

in connection with matters in which such Persons are adverse to CGC or any of its Affiliates, including any disputes arising out of,

or related to, this Agreement. The Company, hereby agrees, in advance, to waive (and to cause their Affiliates to waive) any actual or

potential conflict of interest that may hereafter arise in connection with GT’s future representation of one or more of the Sponsor

or its respective Affiliates in which the interests of such Person are adverse to the interests of CGC, the Company or any of its respective

Affiliates, including any matters that arise out of this Agreement or that are substantially related to this Agreement or to any prior

representation by GT of CGC, Merger Sub, any Sponsor, or any of their respective Affiliates. The Parties acknowledge and agree that,

for the purposes of the attorney-client privilege, the Sponsor shall be deemed the client of GT with respect to the negotiation, execution

and performance of this Agreement and the Ancillary Documents. All such communications shall remain privileged after the Closing and

the privilege and the expectation of client confidence relating thereto shall belong solely to the Sponsor shall be controlled by the

Sponsor and shall not pass to or be claimed by CGC or the CGC Merger Surviving Company; provided, further, that nothing contained

herein shall be deemed to be a waiver by CGC or any of its Affiliates (including, after the CGC Merger Effective Time, the CGC Merger

Surviving Company and its Affiliates) of any applicable privileges or protections that can or may be asserted to prevent disclosure of

any such communications to any third party.

(b)            The

Parties agree that, notwithstanding the fact that Dentons US LLP (“Dentons”) may have, prior to Closing, jointly

represented the Company in connection with this Agreement, the Ancillary Documents and the transactions contemplated hereby and thereby,

and has also represented the Company and/or its Affiliates in connection with matters other than the transaction that is the subject

of this Agreement, Dentons will be permitted in the future, after Closing, to represent the Company or its Affiliates in connection with

matters in which such Persons are adverse to CGC or any of its Affiliates, including any disputes arising out of, or related to, this

Agreement. CGC, Merger Sub, and/or the Sponsor, who are or have the right to be represented by independent counsel in connection with

the transactions contemplated by this Agreement, hereby agree, in advance, to waive (and to cause their Affiliates to waive) any actual

or potential conflict of interest that may hereafter arise in connection with Dentons future representation of one or more of the Company

or its respective Affiliates in which the interests of such Person are adverse to the interests of CGC, Merger Sub, and/or the Sponsor

or any of their respective Affiliates, including any matters that arise out of this Agreement or that are substantially related to this

Agreement or to any prior representation by Dentons of the Company or any of its respective Affiliates. The Parties acknowledge and agree

that, for the purposes of the attorney-client privilege, the Company shall be deemed the client of Dentons with respect to the negotiation,

execution and performance of this Agreement and the Ancillary Documents. All such communications shall remain privileged after the Closing

and the privilege and the expectation of client confidence relating thereto shall belong solely to the Company shall be controlled by

the Company and shall not pass to or be claimed by CGC or the CGC Merger Surviving Company; provided, further, that nothing contained

herein shall be deemed to be a waiver by CGC or any of its Affiliates (including, after the CGC Merger Effective Time, the CGC Merger

Surviving Company and its Affiliates) of any applicable privileges or protections that can or may be asserted to prevent disclosure of

any such communications to any third party.

* * * * *

WITNESS WHEREOF, each of the Parties has caused this Business Combination Agreement to be duly executed on its behalf as of

the date first above written.

Cartesian

Growth Corporation II

By:

/s/ Peter Yu

Name:

Peter Yu

Title:

Chief Executive Officer

INOBAT AS

By:

/s/ Marian Bocek

Name:

Marian Bocek

Title:

CEO and Member of the Board

By:

/s/ Dr Andy Palmer

Name:

Dr Andy Palmer

Title:

Chairman of the Board

Annex A

Key Supporting Company Shareholders

Avanea Investment Holding a.s.

InoBat j.s.a.

Avanea InoBat Auto DealCo

Avanea InoBat Series C DealCo

Annex B

Key Persons

Marián Boček

Victoria Vernarecová

Henrich Hajdin

Schedule I

Terms of Lock-Up and Orderly Disposition Agreement

1. Notwithstanding the following provisions,

any sale of ListCo Shares will be subject to a trading policy to be established by the ListCo

Board in consultation with counsel and consistent with US law and regulations. Enforcement

of such trading policy will be the responsibility of ListCo’s Chief Financial Officer

and the relevant committee of the ListCo Board.

2. 10% of the Upfront Consideration Shares

will not be subject to a lock-up.

3. 40% of the Upfront Consideration Shares

held, as of immediately following the Closing, by each of (a) Avanea Investment Holding

a.s., (b) Avanea InoBat Auto DealCo, (c) Avanea InoBat Series C DealCo, and

(d) the employees of the Group Companies with respect to the ListCo Shares held by them

as a result of the exchange of Company Shares issued under the Company ESOP (after giving

effect to the exercise of Company Options thereunder) (such ListCo Shares, collectively,

the “ODA Shares”, and collectively with the ListCo Shares described

in paragraph (2) above, the “IML Shares”; and the holders

of ODA Shares, collectively, the “ODA Holders”) shall not be subject

to a lock-up but shall be subject to an Orderly Disposition Agreement, pursuant to which:

(i) ODA Holders will agree to comply with

Section 5.24 (Lot Size Support) of this Agreement to cause 500 ListCo

Shares to be, prior to the Closing, distributed to each of 300 indirect equity owners of

Company Shares (i.e., 500 x 300 shares);

(ii) ODA Holders will agree to (i) not

sell, on a daily basis, ODA Shares representing more than 30% of the 20-day average daily

volume of ListCo Shares, and (ii) not sell ODA Shares at a price per share less

than $10.20; and

(iii) any ODA Shares not sold by the ODA

Holders within 12 months following the Closing will not be subject to transfer restrictions

under the Orderly Disposition Agreement following the date that is 12 months of the Closing.

4. All Upfront Consideration Shares other

than IML Shares (collectively, the “Non-IML Shares”) shall be subject

to a lock-up as of the Closing, subject to release as follows:

(i) 12 months after Closing (or earlier

if the 20-day VWAP exceeds $14.00 per ListCo Share), 33.3% of the Non-IML Shares will no

longer be subject to a lock-up;

(ii) 15 months after Closing (or earlier

if the 20-day VWAP exceeds $16.00 per ListCo Share), 33.3% of the Non-IML Shares will no

longer be subject to a lock-up; and

(iii) 18 months after Closing (or earlier

if the 20-day VWAP exceeds $18.00 per ListCo Share), 33.3% of the Non-IML Shares will no

longer be subject to a lock-up.

5. Earn-Out 1 Shares and Earn-Out 2 Shares

will be subject to a lock-up, subject to release as follows:

(i) 6 months after the date of issuance

of such Earn-Out Shares (or earlier if the 20-day VWAP exceeds $14.00 per ListCo Share following

the issuance of such Earn-Out Shares), 33.3% of such Earn-Out Shares will no longer be subject

to a lock-up;

(ii) 9 months after the date of issuance

of such Earn-Out Shares (or earlier if the 20-day VWAP exceeds $16.00 per ListCo Share following

the issuance of such Earn-Out Shares), 33.3% of such Earn-Out Shares will no longer be subject

to a lock-up; and

(iii) 12 months after the date of issuance

of such Earn-Out Shares (or earlier if the 20-day VWAP exceeds $18.00 per ListCo Share following

the issuance of such Earn-Out Shares), 33.3% of such Earn-Out Shares will no longer be subject

to a lock-up.

6. Earn-Out 3 Shares will not be subject

to a lock-up.

As used in this

Schedule I, the following terms have the respective meanings set forth below: “Company ESOP”

has the meaning set forth in the Company Disclosure Schedules; “Trading Day” shall mean any day on which shares

of ListCo Shares are tradeable on Nasdaq (or the principal securities exchange or securities market on which shares of ListCo Shares

are then traded); and “VWAP” means, for each Trading Day, the daily volume-weighted average price for shares

of ListCo Shares on Nasdaq (or the principal securities exchange or securities market on which shares of ListCo Shares are then traded)

during the period beginning at 9:30:01 a.m., New York time and ending at 4:00:00 p.m., New York time, as reported by Bloomberg through

its “VAP” function.

EX-10.1 — EXHIBIT 10.1

EX-10.1

Filename: tm2621302d1_ex10-1.htm · Sequence: 3

Exhibit 10.1

EXECUTION

VERSION

SPONSOR SUPPORT AGREEMENT

This SPONSOR SUPPORT AGREEMENT

is made and entered into as of July 24, 2026 (this “Agreement”), by and between CGC II Sponsor LLC, a Cayman Islands

limited liability company (“Sponsor”) and InoBat AS, a private limited company (aksjeselskap) organized under

the laws of Norway (the “Company”).

WHEREAS, Cartesian Growth Corporation

II, an exempted company incorporated under the Laws of the Cayman Islands (“CGC”) and the Company propose to enter

into, contemporaneously herewith, that certain Business Combination Agreement, dated as of the date hereof (the “BCA”;

terms used but not defined in this Agreement shall have the meanings ascribed to them in the BCA);

WHEREAS, as of the date hereof,

Sponsor owns beneficially and of record 5,649,999 CGC Class A Shares and one (1) CGC Class B Share (collectively, the “Sponsor

Shares”); and

WHEREAS, as of the date hereof,

Sponsor owns beneficially and of record 6,600,000 CGC Warrants (the “CGC Private Warrants”).

NOW, THEREFORE, in consideration

of the foregoing and of the mutual covenants and agreements contained herein, the receipt and sufficiency of which is hereby acknowledged,

and intending to be legally bound, the parties hereto hereby agree as follows:

1. Voting Obligations.

Until the earlier of (a) the Closing or (b) termination of the BCA in accordance with its terms, Sponsor agrees that, at the

CGC Shareholders Meeting and in connection with any written consent of the CGC Shareholders, Sponsor shall (A) appear at each such

meeting or otherwise cause all of its Sponsor Shares to be counted as present thereat for purposes of calculating a quorum and (B) vote

(or duly and promptly execute and deliver an action by written consent), or cause to be voted at such meeting (or cause such consent to

be duly and promptly executed and delivered with respect to), all of the Sponsor Shares (i) in favor of the approval and adoption

of the BCA, the transactions contemplated by the BCA, and any other proposal submitted by the CGC Board for approval by the CGC Shareholders

in connection with the transactions contemplated by the BCA, (ii) in favor of any other matter reasonably necessary to the consummation

of the transactions contemplated by the BCA and considered and voted upon by the CGC Shareholders, (iii) against any action, agreement

or transaction or proposal that would (A) reasonably be expected to result in a breach of any covenant, representation or warranty

or any other obligation or agreement of CGC under the BCA or Ancillary Documents, (B) reasonably be expected to result in the failure

of the transactions contemplated by the BCA to be consummated, or (C) change the business, management, or CGC Board except as contemplated

by the BCA and the Ancillary Documents, and (iv) against any merger agreement, merger, consolidation, combination, sale of substantial

assets, reorganization, recapitalization, dissolution, liquidation or winding up of or by CGC (other than the BCA and the transactions

contemplated by the BCA).

2. Sponsor Accommodation.

At the Closing, Sponsor shall (a) forfeit and surrender to CGC all of its CGC Private Warrants (comprising 6,600,000 CGC Private

Warrants), (b) transfer (which transfer may be effected by way of forfeiture and new issuance) to the Institutional PIPE Investor

(as defined in the BCA) or its designee 800,000 CGC Class A Shares, (c) cancel obligations under the Sponsor Loans (as defined

in the BCA) of $1,800,000, and (d) exchange obligations of $9,200,000 under the Sponsor Loans into 90,196 ListCo Series B Preference

Shares and 901,961 ListCo Warrants.

3. Board Observers.

At the Closing, Sponsor shall have the right to appoint two (2) non-voting observers to the Board of ListCo and, for the avoidance

of doubt, no affiliate of Sponsor shall be a director on the Board of ListCo.

4. Waiver of Redemption

Rights. Sponsor agrees not to (a) demand that CGC redeem the Sponsor Shares in connection with the transactions contemplated

by the BCA or (b) otherwise participate in any such redemption by tendering or submitting any of the Sponsor Shares for redemption.

5. Waiver of Anti-Dilution

Rights. Sponsor hereby agrees to waive the provisions of Section 17.2 set forth in the Governing Document of CGC relating to

the adjustment of the Initial Conversion Ratio (as defined in the Governing Document of CGC) in connection with the transactions contemplated

by the BCA and agrees not to exercise, assert or perfect, any rights to adjustment or other anti-dilution protections with respect to

the rate at which CGC Class B Shares held by such Sponsor convert into CGC Class A Shares, whether resulting from the transactions

contemplated by the BCA or otherwise, so that the CGC Class B Share held by Sponsor issued and outstanding as of the Closing shall

convert into one CGC Class A Share pursuant to, and in accordance with, the Governing Document of CGC.

6. Transfer of

Shares and CGC Private Warrants. Sponsor acknowledges and agrees that the Sponsor Shares and CGC Private Warrants are subject to the

transfer restrictions under that certain Letter Agreement, dated May 5, 2022, between Sponsor and CGC (the “Letter Agreement”).

Sponsor hereby agrees that the Company is an express third party beneficiary of the Letter Agreement with rights to enforce the provisions

thereof against the Sponsor.

7. Representations

and Warranties. Sponsor represents and warrants to the Company as follows:

(a)            Organization.

Sponsor is duly organized, validly existing and in good standing under the Laws of the jurisdiction in which it is incorporated, formed,

organized or constituted, and the execution, delivery and performance of this Agreement and the consummation of the transactions contemplated

hereby are within the Sponsor’s corporate, limited liability company or organizational powers and have been duly authorized by all

necessary corporate, limited liability company or organizational actions on the part of the Sponsor.

(b)           No

Conflicts. The execution, delivery and performance by Sponsor of this Agreement and the consummation by Sponsor of the transactions

contemplated hereby do not and will not (i) conflict with or violate any United States or non-United States Law applicable to Sponsor,

(ii) require any consent, approval or authorization of, declaration, filing or registration with, or notice to, any person or entity,

(iii) result in the creation of any encumbrance on any Sponsor Shares or CGC Private Warrants (other than under this Agreement, the

BCA and the agreements contemplated by the BCA, including the other Ancillary Documents), or (iv) conflict with or result in a breach

of or constitute a default under any provision of Sponsor’s governing documents.

As of the date of this Agreement, Sponsor owns exclusively and has good, valid and marketable title to the Sponsor Shares and the CGC

Private Warrants free and clear of any Lien, proxy, option, right of first refusal, agreement, voting restriction, limitation on disposition,

charge, adverse claim of ownership or use or other encumbrance of any kind, other than pursuant to (i) this Agreement, (ii) applicable

securities Laws, and (iii) the Governing Document of CGC, and as of the date of this Agreement, Sponsor has the sole power (as currently

in effect) to vote and right, power and authority to sell, transfer and deliver the Sponsor Shares and the CGC Private Warrants, as applicable,

and Sponsor does not own, directly or indirectly, any other Sponsor Shares.

(d)           Due

Authorization. Sponsor has the power, authority and capacity to execute, deliver and perform this Agreement and this Agreement has

been duly authorized, executed and delivered by Sponsor and, assuming due authorization, execution and delivery by the other parties to

this Agreement, this Agreement constitutes a legally valid and binding obligation of the Sponsor, enforceable against the Sponsor in accordance

with the terms hereof (except as enforceability may be limited by bankruptcy Laws, other similar Laws affecting creditors’ rights

and general principles of equity affecting the availability of specific performance and other equitable remedies).

(e)           Litigation.

There is no Proceeding pending against the Sponsor, or to the knowledge of the Sponsor threatened against Sponsor, before (or, in the

case of threatened actions, that would be before) any arbitrator or any Governmental Entity, which in any manner challenges or seeks to

prevent, enjoin or materially delay the performance by Sponsor of its obligations under this Agreement, the BCA or the transactions contemplated

thereby.

(f)            Acknowledgment.

Sponsor understands and acknowledges that the Company is entering into the BCA in reliance upon its execution and delivery of this Agreement.

8. Termination.

The obligations of the parties under this Agreement shall automatically terminate upon the earlier of (i) the Effective Time and

(ii) the termination of the BCA in accordance with its terms. Upon termination or expiration of this Agreement, no party shall have

any further obligations or liabilities under this Agreement. Notwithstanding any termination of this Agreement, no such termination or

expiration shall relieve any party hereto from liability for fraud or willful breach of this Agreement occurring prior to its termination.

9. Miscellaneous.

(a)           All

notices, requests, claims, demands and other communications hereunder shall be in writing and shall be given (and shall be deemed to have

been duly given upon receipt) by delivery in person, by e-mail or by registered or certified mail (postage prepaid, return receipt requested)

to the respective parties at the following addresses or e-mail addresses (or at such other address or e-mail address for a party as shall

be specified in a notice given in accordance with this Section 9(a)):

If to CGC prior to or on the Closing Date, or to Sponsor,

to:

505 Fifth Avenue, Suite 1500

New York, NY 10017

Attention: Peter Yu

E-mail: @@@

with a copy (which shall not constitute notice) to:

Greenberg Traurig, LLP

One Vanderbilt Avenue

New York, New York 10017

Attention: Adam Namoury; Thomas Martin

E-mail: @@@

If to the Company:

InoBat AS

Voderady 429

919 42 Voderady

Slovak Republic

Attention: CEO, Marian Bocek

E-mail: @@@

with a copy (which shall not constitute notice) to:

Dentons US LLP

1221 Avenue of the Americas

New York, New York 10020

Attention: Ilan Katz; Brian Lee; Grant Levine

Email: @@@

(b)           If

any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of Law, or public policy,

all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal

substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party hereto. Upon such determination

that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith

to modify this Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable manner in

order that the transactions contemplated hereby be consummated as originally contemplated to the fullest extent possible.

words “hereof”, “herein”, and “hereunder” and words of similar import, when used in this Agreement,

shall refer to this Agreement as a whole and not to any particular provision of this Agreement; (ii) the words “date hereof,”

when used in this Agreement, shall refer to the date set forth in the Preamble; (iii) the terms defined in the singular have a comparable

meaning when used in the plural, and vice versa; (iv) the terms defined in the present tense have a comparable meaning when used

in the past tense, and vice versa; (v) any references herein to a specific Section or Article shall refer, respectively,

to Sections or Articles of this Agreement; (vi) references herein to any gender (including the neuter gender) includes each other

gender; (vii) the word “or” shall not be exclusive; (viii) the headings herein are for convenience of reference

only, do not constitute part of this Agreement and shall not be deemed to limit or otherwise affect any of the provisions hereof, and

(ix) the parties hereto have participated jointly in the negotiation and drafting of this Agreement and, in the event that an ambiguity

or question of intent or interpretation arises, this Agreement shall be construed as jointly drafted by the parties hereto and no presumption

or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provision of this Agreement.

(d)           Sponsor

agrees while this Agreement is in effect, not to take or agree or commit to take any action that would make any representation and warranty

of Sponsor contained in this Agreement inaccurate or has the effect of preventing or disabling Sponsor from performing its obligations

under this Agreement.

(e)           This

Agreement is intended to create, and creates, a contractual relationship and is not intended to create, and does not create, any agency,

partnership, joint venture or any like relationship between the parties hereto.

(f)            This

Agreement, the BCA and Ancillary Documents constitute the entire agreement among the parties hereto with respect to the subject matter

hereof and supersedes all prior agreements and undertakings, both written and oral, among the parties hereto, or any of them, with respect

to the subject matter hereof. This Agreement shall not be assigned (whether pursuant to a merger, by operation of Law or otherwise) by

any party hereto without the prior express written consent of the other parties hereto.

(g)           This

Agreement shall be binding upon and inure solely to the benefit of each party hereto, and nothing in this Agreement, express or implied,

is intended to or shall confer upon any other person any right, benefit or remedy of any nature whatsoever under or by reason of this

Agreement.

(h)           The

parties hereto agree that irreparable damage would occur if any provision of this Agreement were not performed in accordance with the

terms hereof, and, accordingly, that the parties hereto shall, to the fullest extent permitted by Law, be entitled to an injunction or

injunctions to prevent breaches of this Agreement or to enforce specifically the performance of the terms and provisions hereof in any

New York State court or Federal court of the United States of America sitting in New York City in the Borough of Manhattan without proof

of actual damages or otherwise, in addition to any other remedy to which they are entitled at law or in equity. To the fullest extent

permitted by applicable Law, each of the parties hereto hereby further waives (i) any defense in any Proceeding for specific performance

that a remedy at law would be adequate and (ii) any requirement under any Law to post security or a bond as a prerequisite to obtaining

equitable relief.

(i)            This

Agreement shall be governed by, and construed in accordance with, the Laws of the State of New York applicable to contracts executed in

and to be performed in that State. Any Proceeding arising out of or relating to this Agreement or the transactions contemplated hereby

shall, to the fullest extent permitted by applicable Law, be heard and determined exclusively in any New York State court or Federal court

of the United States of America sitting in New York City in the Borough of Manhattan. To the fullest extent permitted by applicable Law,

the parties hereto hereby (i) irrevocably submit to the exclusive jurisdiction of the aforesaid courts for themselves and with respect

to their respective properties for the purpose of any Proceeding arising out of or relating to this Agreement or the transactions contemplated

hereby brought by any party, and (ii) agree not to commence any such Proceeding except in the courts described above in New York,

other than any Proceeding in any court of competent jurisdiction to enforce any judgment, decree or award rendered by any such court in

New York as described herein. To the fullest extent permitted by applicable Law, each of the parties hereto further agrees that notice

as provided herein shall constitute sufficient service of process and the parties hereto further waive any argument that such service

is insufficient. To the fullest extent permitted by applicable Law, each of the parties hereto hereby irrevocably and unconditionally

waives, and agrees not to assert, by way of motion or as a defense, counterclaim or otherwise, in any Proceeding arising out of or relating

to this Agreement or the transactions contemplated hereby, (A) any claim that it is not personally subject to the jurisdiction of

the courts in New York as described herein for any reason, (B) that it or its property is exempt or immune from jurisdiction of any

such court or from any legal process commenced in such courts (whether through service of notice, attachment prior to judgment, attachment

in aid of execution of judgment, execution of judgment or otherwise), and (C) that (x) the Proceeding in any such court is brought

in an inconvenient forum, (y) the venue of such Proceeding is improper, or (z) this Agreement or the transactions contemplated

hereby, or the subject matter hereof, may not be enforced in or by such courts.

(j)            This

Agreement may be executed and delivered (including by facsimile or portable document format (PDF) transmission) in one or more counterparts,

and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to be an original but all of

which taken together shall constitute one and the same agreement.

(k)           Without

further consideration, each party hereto shall execute and deliver or cause to be executed and delivered such additional documents and

instruments and take all such further action as may be reasonably necessary or desirable to consummate the transactions contemplated by

this Agreement.

(l)            This

Agreement shall not be effective or binding upon any party hereto until after such time as the BCA is executed and delivered by CGC and

the Company.

(m)          Each

of the parties hereto hereby waives to the fullest extent permitted by applicable Law any right it may have to a trial by jury with respect

to any Proceeding directly or indirectly arising out of or relating to this Agreement or the transactions contemplated hereby. Each of

the parties hereto (i) certifies that no representative, agent or attorney of any other party has represented, expressly or otherwise,

that such other party would not, in the event of any Proceeding, seek to enforce that foregoing waiver and (ii) acknowledges that

it and the other parties hereto have been induced to enter into this Agreement and the transactions contemplated hereby, as applicable,

by, among other things, the mutual waivers and certifications in this Section 9(m).

[Signature pages follow]

IN WITNESS WHEREOF, the parties

have executed this Agreement as of the date first written above.

CGC II SPONSOR LLC

By:

/s/ Peter Yu

Name: Peter Yu

Title: President

INOBAT AS

By:

/s/ Marian Bocek

Name: Marian Bocek

Title: CEO and Member of the Board

By:

/s/. Dr Andy Palmer

Name: Dr Andy Palmer

Title: Chairman of the Board

[Signature

page to Sponsor Support Agreement]

EX-10.2 — EXHIBIT 10.2

EX-10.2

Filename: tm2621302d1_ex10-2.htm · Sequence: 4

Exhibit 10.2

EXECUTION VERSION

SHAREHOLDER SUPPORT AGREEMENT

This SHAREHOLDER SUPPORT

AGREEMENT is made and entered into as of July 24, 2026 (this “Agreement”), by and among Cartesian Growth Corporation

II, an exempted company incorporated under the Laws of the Cayman Islands (“CGC”), InoBat AS, a private limited

company (aksjeselskap) organized under the laws of Norway and registered with registration number 927 439 948 in the Norwegian

signature pages of this Agreement (each a “Shareholder” and, collectively, the “Shareholders”).

WHEREAS, CGC and the Company

propose to enter into, contemporaneously herewith, that certain Business Combination Agreement, dated as of the date hereof (the “BCA”;

terms used but not defined in this Agreement shall have the meanings ascribed to them in the BCA); and

WHEREAS, as of the date hereof,

each Shareholder owns of record the Company Shares as set forth opposite such Shareholder’s name on Exhibit A hereto

(all such Company Shares and any Company Shares of which ownership of record or the power to vote is hereafter acquired by the Shareholders

prior to the termination of this Agreement being referred to herein as the “Shares”).

NOW, THEREFORE, in consideration

of the foregoing and of the mutual covenants and agreements contained herein, and intending to be legally bound hereby, the parties hereto

hereby agree as follows:

1.             Agreement

to Vote.

(a)           Subject

to the earlier termination of this Agreement in accordance with Section 10, each Shareholder, severally and not jointly,

hereby agrees to vote at any meeting of the shareholders of the Company, and in any action by written consent of the shareholders of

the Company (which written consent shall be delivered promptly, and in any event within twenty-four (24) hours after the Company requests

such delivery), all of such Shareholder’s Shares held by such Shareholder at such time (i) in favor of the approval and adoption

of the BCA and approval of the transactions contemplated by the BCA (“Transactions”) and (ii) against any action,

agreement or transaction or proposal that would result in a breach of any covenant, representation or warranty or any other obligation

or agreement of the Company under the BCA or that would reasonably be expected to result in the failure of the transactions contemplated

by the BCA from being consummated.

(b)           Each

Shareholder, severally and not jointly, hereby agrees that it shall not enter into any commitment, agreement, understanding, or similar

arrangement to vote or give voting instructions or express consent or dissent in writing in any manner inconsistent with the foregoing.

Shareholder, severally and not jointly, hereby agrees to take any and all actions, and to execute and deliver any and all documents and

agreements, deemed reasonably necessary or reasonably requested by CGC or the Company in order to implement the Transactions on a timely

basis and as contemplated by the BCA.

(d)           Without

limiting any other rights or remedies of CGC or the Company, each Shareholder, severally and not jointly, hereby irrevocably appoints

each of CGC and the Company or any individual designated by each of them (acting jointly) as such Shareholder’s agent, attorney-in-fact

and proxy (with full power of substitution and resubstituting), for and in the name, place and stead of such Shareholder, to attend on

behalf of such Shareholder the general meeting or any meeting of the shareholders of the Company with respect to the matters described

in Sections 1(a)-(c), to include such Shareholder’s Shares in any computation for purposes of establishing a quorum at any

such meeting of the shareholders of the Company, to vote (or cause to be voted) such Shareholder’s Shares or consent (or withhold

consent) with respect to any of the matters described in Sections 1(a)-(c) in connection with any meeting of the shareholders

of the Company or any action by written consent or written resolutions, as applicable, by the shareholders of the Company, in each case,

in the event that (i) such Shareholder fails to perform or otherwise comply with the covenants, agreements or obligations set forth

in Sections 1(a)-(c) and continues to fail to perform or otherwise comply with the covenants, agreements or obligations set

forth in Sections 1(a)-(c) for two Business Days following written notice from the Company and CGC of such failure to perform

or comply, or (ii) such Shareholder challenges, directly or indirectly, the validity or enforceability of its covenants, agreements

or obligations under Sections 1(a)-(c), or the voting proxy it executes. For the avoidance of doubt, this does not prevent such

Shareholder from withdrawing or otherwise challenging the voting proxy if this Agreement has terminated in accordance with its terms.

(e)           The

proxy granted by the Shareholders pursuant to Section 1(d) is coupled with an interest sufficient in law to support

an irrevocable proxy and is granted in consideration for CGC and the Company entering into the BCA and agreeing to consummate the transactions

contemplated thereby. The proxy granted by each Shareholder pursuant to Section 1(d) is also a durable proxy and shall

survive the bankruptcy, dissolution, death, incapacity or other inability to act by such Shareholder and, upon such Shareholder’s

execution of this Agreement, shall revoke any and all prior proxies granted by such Shareholder with respect to the Shares. The vote

or consent of the proxyholder with respect to the matters described in Sections 1(a)-(c) shall control in the event of any

conflict between such vote or consent by the proxyholder of such Shareholder’s Shares and a vote or consent by such Shareholder

of its Shares (or any other Person with the power to vote or provide consent with respect to such Shares) with respect to the matters

described in Sections 1(a)-(c). The proxyholder may not exercise the proxy granted pursuant to Section 1(d) on

any matter except for those matters described in Sections 1(a)-(c). For the avoidance of doubt, the proxy granted by each Shareholder

pursuant to Section 1(d) shall terminate automatically with no further action required if the BCA (or any provision

thereof) or any Ancillary Documents (or any provision thereof) is entered into, amended, supplemented, modified or waived in any manner

adverse to such Shareholder without the prior written consent of such Shareholder, such consent not to be unreasonably withheld or delayed.

2.             Transfer

of Shares. Each Shareholder, severally and not jointly, agrees that it shall not, directly or indirectly, (a) sell, assign,

transfer (including by operation of law), allow the imposition of a lien, pledge, dispose of or otherwise encumber any of the Shares

or otherwise agree to do any of the foregoing, (b) deposit any Shares into a voting trust or enter into a voting agreement or arrangement

or grant any proxy or power of attorney with respect thereto that is inconsistent with this Agreement, or (c) enter into any contract,

option or other arrangement or undertaking with respect to the direct or indirect acquisition or sale, assignment, transfer (including

by operation of law) or other disposition of any Shares.

3.             No

Solicitation; Waiver of Appraisal Rights.

(a)           Each

of the Shareholders, severally and not jointly, agrees to be bound by and subject to Section 5.6 (Exclusive Dealing)

of the BCA to the same extent as such provisions apply to the Company as if such Shareholder was a party thereto.

(b)           Each

Shareholder hereby agrees not to assert, exercise or perfect, directly or indirectly, and irrevocably and unconditionally waives, any

appraisal rights with respect to the Exchange and the other transactions contemplated by the BCA, and any rights to dissent with respect

to the Exchange and the other transactions contemplated by the BCA or to oppose any reorganization or amendment designed to facilitate

drag along rights or otherwise facilitate the BCA.

4.             Termination

of Agreements. Each Shareholder, by this Agreement, with respect to its Shares, severally and not jointly, hereby agrees to terminate,

subject to the occurrence of, and effective immediately prior to, the Exchange Effective Time (as defined in the BCA), (a) each

investment agreement between the Company and such Shareholder, (b) each share subscription agreement between the Company and such

Shareholder (such agreements, including any amendment, side letter, conversion deed or deed of assignment and assumption relating thereto,

together, the “Shareholder Agreements”), and (c) if applicable to such Shareholder, any rights under any other

letter agreement providing for redemption rights, put rights, purchase rights, information rights, rights to consult with and advise

management, inspection rights, preemptive rights, rights to appoint or nominate voting members of the Company Board, Company Board observer

rights, rights to nominate or appoint key management or executive personnel of the Company or any of its Subsidiaries, rights to receive

information delivered to the Company Board, anti-dilution rights (including any weighted-average or other adjustment mechanism), equity

exchange rights (including any right to exchange, convert or reclassify shares or other equity interests in the Company into any class

of preferred shares), reserved matters or veto rights over specified actions by the Company or its Subsidiaries or other similar rights

not generally available to shareholders of the Company (the “Terminating Rights”) between such Shareholder and the

Company, in each case irrespective of whether any such rights were expressed or intended to survive the termination or expiration of

the applicable agreement, but excluding, for the avoidance of doubt, any rights such Shareholder may have that relate to any commercial

or employment agreements or arrangements between such Shareholder and the Company or any subsidiary, which shall survive in accordance

with their terms.

5.             Further

Assurances; Lot Size Support.

(a)           Each

Shareholder shall take, or cause to be taken, all such further actions and do, or cause to be done, all things, including, but not limited

to, execution of all such proper agreements, deeds, assignments, assurances and other instruments, reasonably necessary (including under

applicable Laws) to effect the actions required to consummate the Transactions and the other transactions contemplated by this Agreement

and the BCA, in each case, on the terms and subject to the conditions set forth therein and herein, as applicable. Without limiting the

foregoing, each Shareholder agrees to execute a Company Shareholder Undertaking as promptly as practicable following the Company’s

or CGC’s request to do so.

(b)           Without

limiting the generality of the foregoing, in compliance with applicable laws, prior to the Closing, each Shareholder shall support the

distribution of Company Shares to as many of its indirect equity owners as is reasonably practicable, in an aggregate amount intended

to result in at least three hundred (300) round lot holders of the Company and each such owner holding, in connection with the Closing,

a lot size (all such lots to be the same size to the extent practicable) of approximately five hundred (500) ListCo Common Shares.

6.             No

Challenges; Release.

as of the Closing, each Shareholder generally and irrevocably releases and discharges the Company and CGC and their respective successors,

directors and officers from any and all claims, liabilities and obligations, known or unknown, arising prior to the Closing; provided,

however, that nothing in this Section 6 shall release any rights of such Shareholder (i) under this Agreement, the BCA

or any Ancillary Document, (ii) to indemnification or advancement of expenses under the Company’s Governing Documents, (iii) arising

out of fraud or willful misconduct, or (iv) any accrued and unpaid amounts owing to such Shareholder under any commercial or employment

agreement or arrangement with the Company or any of its Subsidiaries (including any accrued compensation or expense reimbursement).

(d)           Each

Shareholder agrees not to, and shall direct its representatives and agents not to, bring, commence, institute, maintain, voluntarily

aid, join in, facilitate, assist or encourage, and agrees to take all actions necessary to, and to direct his or her representatives

and agents to, opt out of any class in any class action with respect to, any claim, derivative or otherwise, against CGC or the Company

or any of their respective successors or directors, (i) challenging the validity of, or seeking to enjoin the operation of, any

provision of this Agreement or the BCA or (ii) alleging a breach of any fiduciary duty of any person (or that such person may be

alleged to have, including to the Company or any other Shareholder) in connection with the evaluation, negotiation or entry into the

BCA or this Agreement. Notwithstanding the foregoing, nothing herein shall be deemed to prohibit such Shareholder from enforcing such

Shareholder’s rights under this Agreement.

7.             Consent

to Disclosure. Each Shareholder hereby consents to the publication and disclosure in the Registration Statement / Proxy Statement

(and, as and to the extent otherwise required by applicable securities Laws or the SEC or any other securities authorities, any other

documents or communications provided by CGC or the Company to any Governmental Entity or to securityholders of CGC) of such Shareholder’s

identity and the nature of such Shareholder’s commitments, arrangements and understandings under and relating to this Agreement

and, if deemed appropriate by CGC or the Company, a copy of this Agreement. Each Shareholder will promptly provide any information reasonably

requested by CGC or the Company for any regulatory application or filing made or approval sought in connection with the Transactions

(including filings with the SEC), subject to confidentiality obligations that may be applicable to information furnished to the Company

or the Company’s Subsidiaries by third parties that may be in the Company’s or the Company’s Subsidiaries’ possession

from time to time, and except for any information that is subject to attorney-client privilege (provided, that, to the extent

reasonably possible, the parties shall cooperate in good faith to permit disclosure of such information in a manner that preserves such

privilege or compliance with such confidentiality obligation), to the extent permitted by applicable Law.

8.             Public

Announcements. No Shareholder will make any public announcement or issue any public communication regarding this Agreement, the BCA,

the transactions contemplated hereby or thereby or any matter related to the foregoing, without the prior written consent of CGC and

the Company, except: (a) if such announcement or other communication is required by applicable Laws or the rules of any stock

exchange, in which case the disclosing Shareholder shall, to the extent permitted by applicable Laws, first allow CGC and the Company

to review such announcement or communication and have the opportunity to comment thereon, and such disclosing Shareholder shall consider

such comments in good faith; (b) to the extent such announcements or other communications contain only information previously disclosed

in a public statement, press release or other communication previously approved in accordance with this Section 8; and (c) announcements

and communications to Governmental Entities in connection with registrations, declarations and filings required to be made as a result

of the BCA.

9.             Representations

and Warranties. Each Shareholder, severally and not jointly, represents and warrants to CGC and the Company as follows:

(a)           The

execution, delivery and performance by such Shareholder of this Agreement and the consummation by such Shareholder of the transactions

contemplated hereby do not and will not (i) conflict with or violate any United States or non-United States statute, Law, ordinance,

regulation, rule, code, executive order, injunction, judgment, decree or other order applicable to such Shareholder, (ii) require

any consent, approval or authorization of, declaration, filing or registration with, or notice to, any person or entity, (iii) result

in the creation of any encumbrance on any Shares (other than under this Agreement, the BCA and the agreements contemplated by the BCA)

or (iv) if such Shareholder is not a natural person, conflict with or result in a breach of or constitute a default under any provision

of such Shareholder’s governing documents.

(b)           As

of the date of this Agreement, such Shareholder owns beneficially and exclusively of record and has good and valid title to the Shares

set forth opposite such Shareholder’s name on Exhibit A free and clear of any security interest, Lien, claim, pledge,

proxy, option, right of first refusal, agreement, voting restriction, limitation on disposition, charge, adverse claim of ownership or

use or other encumbrance of any kind, other than pursuant to (i) this Agreement, (ii) applicable securities laws, (iii) the

Company’s Governing Documents and (iv) the Shareholder Agreements, and as of the date of this Agreement, such Shareholder

has the sole power (as currently in effect) to vote and right, power and authority to sell, transfer and deliver such Shares, and such

Shareholder does not own, directly or indirectly, any other Shares.

Shareholder has the power, authority and capacity to execute, deliver and perform this Agreement and this Agreement has been duly authorized,

executed and delivered by such Shareholder.

(d)           As

of the date of this Agreement, there is no Proceeding pending against such Shareholder or, to the knowledge of such Shareholder, threatened

against such Shareholder that, in any manner, questions the beneficial or record ownership of the Shares or the validity of this Agreement,

or challenges or seeks to prevent, enjoin or materially delay the performance by such Shareholder of its obligations under this Agreement.

(e)           Such

Shareholder is a sophisticated shareholder and has adequate information concerning the business and financial condition of CGC and the

Company to make an informed decision regarding this Agreement and the Transactions and has independently made its own analysis and decision

to enter into this Agreement. Such Shareholder acknowledges that CGC and the Company have not made and do not make any representation

or warranty, whether express or implied, of any kind or character except as expressly set forth in this Agreement and the BCA.

(f)            Other

than as provided in the BCA, such Shareholder has not made, nor has any third party made on behalf of such Shareholder, any arrangement

for any broker’s, finder’s, financial advisor’s or other similar fee or commission for which CGC, the Company or any

of their subsidiaries is or could be liable in connection with the BCA or this Agreement or any of the respective transactions contemplated

hereby or thereby.

10.           Termination.

This Agreement and the obligations of the Shareholders under this Agreement shall automatically terminate upon the earliest of (a) the

Closing, (b) the termination of the BCA in accordance with its terms, (c) the mutual agreement of the parties hereto, and (d) the

Termination Date (as defined in the BCA), if the Closing has not occurred on or prior to such date. Upon termination of this Agreement,

no party shall have any further obligations or liabilities under this Agreement; provided, that, nothing in this Section 10

shall relieve any party of liability for any breach of this Agreement occurring prior to termination. The representations and warranties

contained in this Agreement and in any certificate or other writing delivered pursuant hereto shall not survive the Closing or the termination

of this Agreement.

11.           Miscellaneous.

(a)           Except

as otherwise provided herein, all costs and expenses incurred in connection with this Agreement and the transactions contemplated hereby

shall be paid by the party incurring such costs and expenses, whether or not the transactions contemplated hereby are consummated.

(b)           All

notices, requests, claims, demands and other communications hereunder shall be in writing and shall be given (and shall be deemed to

have been duly given upon receipt) by delivery in person, by e-mail or by registered or certified mail (postage prepaid, return receipt

requested) to the respective parties at the following addresses or e-mail addresses (or at such other address or e-mail address for a

party as shall be specified in a notice given in accordance with this Section 11(b)):

If to CGC, to:

Cartesian Growth Corporation II

505 Fifth Avenue, Suite 1500

New York, NY 10017

Attention: Peter Yu

E-mail: @@@@

with a copy to:

Greenberg Traurig, LLP

One Vanderbilt Avenue

New York, New York 10017

Attention: Adam Namoury; Thomas

Martin

E-mail: @@@@

if to the Company:

InoBat AS

Voderady 429

919 42 Voderady

Slovak Republic

Attention: CEO, Marian Bocek

E-mail: @@@@

with a copy to:

Dentons US LLP

1221 Avenue of the Americas

New York, New York 10020

Attention: Ilan Katz; Brian

Lee; Grant Levine

Email: @@@@

If to a Shareholder, to the address or

e-mail address set forth for such Shareholder on the signature page hereof.

any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of Law, or public policy,

all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal

substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party hereto. Upon such determination

that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith

to modify this Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable manner in

order that the transactions contemplated hereby be consummated as originally contemplated to the fullest extent possible.

(d)           This

Agreement, the BCA and Ancillary Documents constitute the entire agreement among the parties hereto with respect to the subject matter

hereof and supersedes all prior agreements and undertakings, both written and oral, among the parties hereto, or any of them, with respect

to the subject matter hereof. This Agreement shall not be assigned (whether pursuant to a merger, by operation of law or otherwise) by

any party hereto without the prior express written consent of the other parties hereto.

(e)           This

Agreement shall be binding upon and inure solely to the benefit of each party hereto (and CGC’s permitted assigns), and nothing

in this Agreement, express or implied, is intended to or shall confer upon any other person any right, benefit or remedy of any nature

whatsoever under or by reason of this Agreement. No Shareholder shall be liable for the breach by any other Shareholder of this Agreement.

(f)            This

Agreement may not be amended, modified or supplemented in any manner, whether by course of conduct or otherwise, except by an instrument

in writing signed by each of the parties hereto.

(g)           The

parties hereto agree that irreparable damage would occur in the event any provision of this Agreement was not performed in accordance

with the terms hereof and that the parties hereto shall be entitled, to the fullest extent permitted by Law, to specific performance

of the terms hereof, in addition to any other remedy at law or in equity.

(h)           This

Agreement shall be governed by, and construed in accordance with, the Laws of the State of New York applicable to contracts executed

in and to be performed in that State. Any Proceeding arising out of or relating to this Agreement or the transactions contemplated hereby

shall, to the fullest extent permitted by applicable Law, be heard and determined exclusively in any New York State court or Federal

court of the United States of America sitting in New York City in the Borough of Manhattan. To the fullest extent permitted by applicable

Law, the parties hereto hereby (i) irrevocably submit to the exclusive jurisdiction of the aforesaid courts for themselves and with

respect to their respective properties for the purpose of any Proceeding arising out of or relating to this Agreement or the transactions

contemplated hereby brought by any party and (ii) agree not to commence any such Proceeding except in the courts described above

in New York, other than any Proceeding in any court of competent jurisdiction to enforce any judgment, decree or award rendered by any

such court in New York as described herein. To the fullest extent permitted by applicable Law, each of the parties hereto further agrees

that notice as provided herein shall constitute sufficient service of process and the parties hereto further waive any argument that

such service is insufficient. To the fullest extent permitted by applicable Law, each of the parties hereto hereby irrevocably and unconditionally

waives, and agrees not to assert, by way of motion or as a defense, counterclaim or otherwise, in any Proceeding arising out of or relating

to this Agreement or the transactions contemplated hereby, (A) any claim that it is not personally subject to the jurisdiction of

the courts in New York as described herein for any reason, (B) that it or its property is exempt or immune from jurisdiction of

any such court or from any legal process commenced in such courts (whether through service of notice, attachment prior to judgment, attachment

in aid of execution of judgment, execution of judgment or otherwise), and (C) that (x) the Proceeding in any such court is

brought in an inconvenient forum, (y) the venue of such Proceeding is improper, or (z) this Agreement or the transactions contemplated

hereby, or the subject matter hereof, may not be enforced in or by such courts.

(i)            This

Agreement may be executed and delivered (including by facsimile or portable document format (.PDF) transmission) in one or more counterparts,

and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to be an original but all of

which taken together shall constitute one and the same agreement.

(j)            At

the request of CGC, in the case of any Shareholder, or at the request of the Shareholders, in the case of CGC, and without further consideration,

each party shall execute and deliver or cause to be executed and delivered such additional documents and instruments and take such further

action as may be reasonably necessary to consummate the transactions contemplated by this Agreement.

(k)           This

Agreement shall not be effective or binding upon any Shareholder until after such time as the BCA is executed and delivered by CGC and

the Company.

(l)            Each

of the parties hereto hereby waives to the fullest extent permitted by applicable Law any right it may have to a trial by jury with respect

to any Proceeding directly or indirectly arising out of or relating to this Agreement or the transactions contemplated hereby. Each of

the parties hereto (i) certifies that no representative, agent or attorney of any other party has represented, expressly or otherwise,

that such other party would not, in the event of any Proceeding, seek to enforce the foregoing waiver and (ii) acknowledges that

it and the other parties hereto have been induced to enter into this Agreement and the transactions contemplated hereby, as applicable,

by, among other things, the mutual waivers and certifications in this Section 11(l).

[SIGNATURE PAGES FOLLOW]

IN WITNESS WHEREOF, the parties

have executed this Agreement as of the date first written above.

CARTESIAN GROWTH CORPORATION II

By:

/s/ Peter Yu

Name: Peter Yu

Title: Chief Executive Officer

INOBAT AS

By:

/s/ Marian Bocek

Name: Marian Bocek

Title: CEO and Member of the Board

By:

/s/ Dr Andy Palmer

Name: Dr Andy Palmer

Title: Chairman of the Board

[Signature page to Shareholder Support

Agreement]

IN WITNESS WHEREOF, the parties

have executed this Agreement as of the date first written above.

SHAREHOLDER:

INOBAT J.S.A.

By:

/s/ Marian Bocek

Name: Marian Bocek

Title: Chairman of the board

By:

/s/ Adam Jasek

Name: Adam Jasek

Title: Member of the board

Address and e-mail address for purposes of Section 11(b):

Name:

Address:

E-mail:

[Signature page to Shareholder Support

Agreement]

IN WITNESS WHEREOF, the parties

have executed this Agreement as of the date first written above.

SHAREHOLDER:

AVANEA INVESTMENT HOLDING A.S.

By:

/s/ Adam Jasek

Name: Adam Jasek

Title: Chairman of the board

Address and e-mail address for purposes of Section 11(b):

Name:

Address:

E-mail:

[Signature page to Shareholder Support

Agreement]

IN WITNESS WHEREOF, the parties

have executed this Agreement as of the date first written above.

SHAREHOLDER:

AVANEA INOBAT AUTO DEALCO

By:

/s/ Marian Bocek

Name: Marian Bocek

Title: Chairman of the board

By:

/s/ Alexander Polsky

Name: Alexander Polsky

Title: Member of the board

Address and e-mail address for purposes of Section 11(b):

Name:

Address:

E-mail:

[Signature page to Shareholder Support

Agreement]

IN WITNESS WHEREOF, the parties have executed

this Agreement as of the date first written above.

SHAREHOLDER:

AVANEA INOBAT SERIES C DEALCO

By:

/s/ Marian Bocek

Name: Marian Bocek

Title: Chairman of the board

By:

/s/ Alexander Polsky

Name: Alexander Polsky

Title: Member of the board

Address and e-mail address for purposes of Section 11(b):

Name:

Address:

E-mail:

[Signature page to Shareholder Support

Agreement]

EXHIBIT A

LIST OF SHAREHOLDERS

Name of Shareholder

Number of Company Shares Owned

InoBat j.s.a.

50,000,000

Avanea Investment Holding a.s.

39,433,483

Avanea InoBat Auto DealCo

3,734,440

Avanea InoBat Series C DealCo

321,791

EX-10.3 — EXHIBIT 10.3

EX-10.3

Filename: tm2621302d1_ex10-3.htm · Sequence: 5

Exhibit 10.3

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this “Agreement”)

is dated as of July 24, 2026, by and among Cartesian Growth Corporation II, a Cayman Islands exempted company (“CGC”), InoBat

AS, a private limited company (aksjeselskap) organized under the Laws of Norway (the “Target”), CGC II Sponsor

LLC, a Cayman Islands limited liability company and sponsor of the Company (the “Sponsor”) and the purchaser identified

on the signature pages hereto (including its successors and assigns, the “Purchaser”).

WHEREAS, promptly after the date of this

Agreement, the Target will form InoBat B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid)

to be incorporated and existing under the laws of the Netherlands (the “Company”), and the Company will become a party

to this Agreement;

WHEREAS, the Target, CGC, and InoBat Cayman

Merger Sub, a Cayman Islands exempted company and a wholly-owned subsidiary of the Target (“Merger Sub”), entered into

a Business Combination Agreement, dated as of July 24, 2026 (as it may be amended, modified, supplemented or otherwise modified from

time to time in accordance with its terms, the “Business Combination Agreement,” and the transactions contemplated

by the Business Combination Agreement, the “Business Combination”), pursuant to which, among other things,

(a) the

Target will form the Company;

(b) the

Company will convert into a naamloze vennootschap organized under the laws of the Netherlands;

shareholders of the Target holding at least 90% of the Target Equity Securities (as defined below) will contribute such Target Equity

Securities to the Company, in exchange for a number of Common Shares equal to the Exchange Ratio (as defined in the Business Combination

Agreement in effect as of the date hereof) (the “Exchange”);

(d) certain

shareholders of the Target will enter into an Undertaking (as defined in the Business Combination Agreement) and effect the Exchange (as

defined in the Business Combination Agreement); and

(e) Merger

Sub shall merge with and into CGC (the “CGC Merger”), with CGC surviving the Merger as a direct wholly-owned subsidiary

of the Company, as a result of which, CGC will become a direct, wholly owned subsidiary of the Company;

WHEREAS, in connection with the Business

Combination, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities

Act (as defined below), the Company desires to issue and sell to the Purchaser, and the Purchaser desires to purchase from the Company,

securities of the Company as more fully described in this Agreement.

NOW, THEREFORE, IN CONSIDERATION of

the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are

hereby acknowledged, the Company, the Target and the Purchaser agree as follows:

ARTICLE 1

DEFINITIONS

1.1 Definitions. In addition to

the terms defined elsewhere in this Agreement: (a) capitalized terms that are not otherwise defined herein have the meanings given

to such terms in the Articles (as defined herein), and (b) the following terms have the meanings set forth in this Section 1.1:

“Action” means any

action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the applicable party, threatened

against or affecting the applicable party or any of its properties before or by any court, arbitrator, governmental or administrative

agency or regulatory authority (federal, state, county, local or foreign).

“Affiliate” means

any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with

a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

“Articles” means

the Amended and Restated Articles of Association of the Company, to be effective as of the Closing, in the form of Exhibit A

attached hereto.

“Beneficial Ownership Letter

Agreement” means the Beneficial Ownership Letter Agreement in the form of Annex A-2 attached hereto.

“Board of Directors”

means the board of directors of the Company.

“Business Combination”

shall have the meaning ascribed to such term in the recitals.

“Business Combination Agreement”

shall have the meaning ascribed to such term in the recitals.

“Business Day” means

any day other than Saturday, Sunday or other day on which commercial banks in The City of New York, United States; Amsterdam, the Netherlands;

or Bratislava, Slovakia are authorized or required by law to remain closed; provided, however, for clarification,

commercial banks shall not be deemed to be authorized or required by law to remain closed due to “stay at home,” “shelter-in-place,”

“non-essential employee” or any other similar orders or restrictions or the closure of any physical branch locations at the

direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial

banks in The City of New York are generally are open for use by customers on such day.

“CGC Material Adverse Effect”

means any change, event, effect or occurrence that, individually or in the aggregate with any other change, event, effect or occurrence,

has had or would reasonably be expected to have a material adverse effect on the ability of CGC to consummate the CGC Merger in accordance

with the terms of the Business Combination Agreement or consummate the transactions contemplated hereby in accordance with the terms of

this Agreement; provided, however, that none of the following shall be taken into account in determining whether a CGC Material

Adverse Effect has occurred or is reasonably likely to occur: any adverse change, event, effect or occurrence arising after the date of

the Business Combination Agreement from or related to (i) general business or economic conditions in or affecting Europe, or changes

therein, or the global economy generally, (ii) any national or international political or social conditions in Europe or any other

country, including the engagement by Europe or any other country in hostilities, whether or not pursuant to the declaration of a national

emergency or war, or the occurrence in any place of any military or terrorist attack, sabotage or cyberterrorism, (iii) changes in

conditions of the financial, banking, capital or securities markets generally in Europe or any other country or region in the world, or

changes therein, including changes in interest rates in Europe or any other country and changes in exchange rates for the currencies of

any countries, (iv) changes in any applicable Laws, (v) any change, event, effect or occurrence that is generally applicable

to the industries or markets in which CGC operates, or (vi) the execution or public announcement of the Business Combination Agreement

or the pendency or consummation of the transactions contemplated by the Business Combination Agreement, including the impact thereof on

the relationships, contractual or otherwise, of CGC with investors, contractors, lenders, suppliers, vendors, partners, licensors, licensees,

payors or other third parties related thereto.

“Class A Ordinary Shares”

means the Class A ordinary shares of CGC, par value $0.0001 per share.

“Closing” means

the closing of the purchase and sale of the Securities pursuant to Section 2.1.

“Closing Date” means

the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and all

conditions precedent to (i) the Purchaser’s obligations to pay the Subscription Amount and (ii) the Company’s obligations

to deliver the Securities, in each case, have been satisfied or waived.

“Code” means the

U.S. Internal Revenue Code of 1986, as amended, and any successor statute thereto, as amended.

“Commission” means

the United States Securities and Exchange Commission.

“Common Shares”

means the Common Shares of the Company, par value EUR 0.01 per share, and any other class of securities into which such securities may

hereafter be reclassified or changed.

“Common Share Equivalents”

means any securities that would entitle the holder thereof to acquire at any time a share of capital stock, including, without limitation,

any debt, preferred stock, rights, options or other instrument that is at any time convertible into or exchangeable for, or otherwise

entitles the holder thereof to receive, shares of capital stock.

“Company Party”

means the Company and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally

equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls the

Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers,

shareholders, agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such

titles notwithstanding a lack of such title or any other title) of such controlling persons.

“Consent” means

any consent, approval, waiver, authorization or Permit of, or notice to or declaration or filing with any Governmental Authority or any

other Person.

“Contingent Obligation”

means, as to any Person, any direct or indirect liability, contingent or otherwise, of that Person with respect to any Indebtedness, lease,

dividend or other obligation of another Person if the primary purpose or intent of the Person incurring such liability, or the primary

effect thereof, is to provide assurance to the obligee of such liability that such liability will be paid or discharged, or that any agreements

relating thereto will be complied with, or that the holders of such liability will be protected (in whole or in part) against loss with

respect thereto.

“Contracts” means

all legally binding contracts, contracts, agreements, binding arrangements, bonds, notes, indentures, mortgages, debt instruments, purchase

order, licenses (and all other contracts, agreements or binding arrangements concerning Intellectual Property), franchises, leases and

other instruments or obligations of any kind, written or oral (including any amendments and other modifications thereto).

“Conversion Shares”

means the Common Shares issued or issuable upon conversion of the Preference Shares purchased pursuant to this Agreement in accordance

with the terms of the Articles.

“COVID-19” means

SARS-CoV-2 or COVID-19, and any evolutions or mutations thereof or related or associated epidemics, pandemic or disease outbreaks.

“Disqualification Event”

shall have the meaning ascribed to such term in Section 3.1(i).

“Effective Date”

means the first date on which (a) the initial Registration Statement has been declared effective by the Commission registering the

resale of all of the Underlying Shares or (b) all of the Underlying Shares have been sold pursuant to Rule 144 or may be sold

pursuant to Rule 144 (but with no volume or other restrictions or limitations including as

to manner or timing of sale or current public information requirements).

“Environmental Laws”

means any federal, state, local, municipal, foreign, international, or multinational law, regulation, or other applicable requirement,

policy, guidance or treaty relating to (a) releases or threatened release of Hazardous Substance; (b) pollution or protection

of employee health or safety, public health or the environment; or (c) the manufacture, handling, transport, use, treatment, storage,

or disposal of Hazardous Substances.

“Exchange Act” means

the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

“Governmental Authority”

means any federal, state, local, foreign government or other governmental, quasi-governmental, regulatory or administrative authority,

body, instrumentality, department, board, bureau or agency or any court, tribunal, administrative hearing body, arbitration panel, commission,

or other similar dispute-resolving panel or body (private or public).

“Government Contract”

means any Contract, grant, basic ordering agreement, letter contract, or order between a Target Company, on the one hand, and (i) any

Governmental Authority, (ii) another Person under such other Person’s prime contract with a Governmental Authority, or (iii) any

higher tier subcontractor of a Governmental Authority in its capacity as a subcontractor, on the other hand, for which the period of performance

has not expired or terminated, or final payment has not been received, or which remain open to audit as of the date of this Agreement.

Unless otherwise indicated, a task, purchase or delivery order under a Government Contract will not constitute a separate Government Contract,

for purposes of this definition, but will be part of the Government Contract under which it was issued.

“Hazardous Substance”

means any pollutant, contaminant or toxic or hazardous material, substance or waste or petroleum, or any fraction thereof.

“IFRS” means the

International Financial Reporting Standards as issued by the International Accounting Standards Board.

“Indebtedness” of

any Person means, without duplication (A) all indebtedness for borrowed money, (B) all obligations issued, undertaken or assumed

as the deferred purchase price of property or services (including, without limitation, “capital leases” in accordance with

IFRS) (other than trade payables entered into in the ordinary course of business consistent with past practice), (C) all reimbursement

or payment obligations with respect to letters of credit, surety bonds and other similar instruments, (D) all obligations evidenced

by notes, bonds, debentures or similar instruments, including obligations so evidenced incurred in connection with the acquisition of

property, assets or businesses, (E) all indebtedness created or arising under any conditional sale or other title retention agreement,

or incurred as financing, in either case with respect to any property or assets acquired with the proceeds of such indebtedness (even

though the rights and remedies of the seller or bank under such agreement in the event of default are limited to repossession or sale

of such property), (F) all monetary obligations under any leasing or similar arrangement which, in connection with IFRS, consistently

applied for the periods covered thereby, is classified as a capital lease, (G) all indebtedness referred to in clauses (A) through

(F) above secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured

by) any Lien upon or in any property or assets (including accounts and contract rights) owned by any Person, even though the Person which

owns such assets or property has not assumed or become liable for the payment of such indebtedness, and (H) all Contingent Obligations

in respect of indebtedness or obligations of others of the kinds referred to in clauses (A) through (G) above.

“Intellectual Property”

means any and all intellectual or proprietary property and all rights, title, and interest therein or thereto arising anywhere in the

world, including: (i) all United States and foreign patents and patent applications, patent disclosures and inventions, (whether

patentable or unpatentable and whether or not reduced to practice), including any continuations, divisions, continuations in part, renewals,

divisionals, extensions, reissues or foreign counterparts of any of the foregoing; (ii) all United States, international and foreign

trade names, trade dress, trademarks, service marks, logos or internet domain name registrations, social media usernames, handles, and

similar identifiers, including all goodwill associated therewith, together with all registrations and applications relating thereto (“Trademarks”);

(iii) all United States, international, and foreign copyrights (whether registered or unregistered), original works of authorship

(including Software and all rights therein), copyrightable works, together with all registrations and applications relating thereto (“Copyright”);

(iv) all proprietary databases and data; (v) all industrial designs and any registrations and applications therefor throughout

the world; (vi) Trade Secrets, (vii) Software and data, databases, compilations, and any other electronic data files, including

any and all collections of data, whether machine readable or otherwise; (viii) rights to sue or recover and retain damages and costs

and attorneys’ fees for the past, present or future infringement, dilution, misappropriation, or other violation of any of the foregoing

anywhere in the world; (ix) any and all other intellectual or industrial property rights protectable by applicable law in any jurisdiction;

and (x) all issuances, renewals, registrations and applications of or for any of the foregoing.

“Law” means any

federal, state, local, municipal, foreign or other law, statute, legislation, principle of common law, ordinance, code, edict, decree,

proclamation, treaty, convention, rule, regulation, directive, requirement, writ, injunction, settlement, Order or Consent that is or

has been issued, enacted, adopted, passed, approved, promulgated, made, implemented or otherwise put into effect by or under the authority

of any Governmental Authority.

“Lead Purchaser”

means Alyeska Master Fund, L.P.

“Legal Proceeding”

means any notice of noncompliance or violation, or any claim, demand, charge, action, suit, litigation, audit, settlement, complaint,

stipulation, assessment or arbitration, or any request (including any request for information), inquiry, hearing, proceeding or investigation,

by or before any Governmental Authority.

“Liabilities” means

any and all liabilities, Indebtedness, Legal Proceedings or obligations of any nature (whether absolute, accrued, contingent or otherwise,

whether known or unknown, whether direct or indirect, whether matured or unmatured, whether due or to become due and whether or not required

to be recorded or reflected on a balance sheet under IFRS or other applicable accounting standards).

“Lien” means any

mortgage, pledge, security interest, attachment, right of first refusal, option, proxy, voting trust, encumbrance, lien or charge of any

kind (including any conditional sale or other title retention agreement or lease in the nature thereof), restriction (whether on voting,

sale, transfer, disposition or otherwise), any subordination arrangement in favor of another Person, or any filing or agreement to file

a financing statement as debtor under the Uniform Commercial Code or any similar Law.

“Liens” means a

lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.

“Losses” means losses,

liabilities, obligations, claims, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable

attorneys’ fees and costs of investigation.

“Off-the-Shelf Software”

means any Software that is made generally and widely available to the public on a commercial basis and is licensed to any of the Target

Companies on a non-exclusive basis under standard terms and conditions for a one-time license fee of less than $100,000 per license or

an ongoing licensee fee of less than $50,000 per year.

“Order” means any

order, decree, ruling, judgment, injunction, writ, determination, binding decision, verdict, judicial award or other action that is or

has been made, entered, rendered, or otherwise put into effect by or under the authority of any Governmental Authority.

“Organizational Documents”

means, with respect to any Person that is an entity, its certificate of incorporation or formation, bylaws, operating agreement, memorandum

and articles of association or similar organizational documents, in each case, as amended.

“Other SPAs” means

this Agreement together with the other securities purchase agreements, dated as of the date hereof for the Purchaser and the investors

named in such other agreements to purchase 12.0% Series A Cumulative Convertible Preference Shares or Series B Convertible Preference

Shares.

“PCAOB” means the

Public Company Accounting Oversight Board.

“Permits” means

all federal, state, local or foreign or other third-party permits, grants, easements, consents, approvals, authorizations, exemptions,

licenses, franchises, concessions, ratifications, permissions, clearances, confirmations, endorsements, waivers, certifications, designations,

ratings, registrations, qualifications or orders of any Governmental Authority or any other Person.

“Permitted Liens”

means (a) Liens for Taxes or assessments and similar governmental charges or levies, which either are (i) not yet due and payable

or (ii) being contested in good faith and by appropriate proceedings, and adequate reserves have been established with respect thereto

in accordance with IFRS, (b) other Liens imposed by operation of Law arising in the ordinary course of business for amounts which

are not due and payable and as would not in the aggregate materially adversely affect the value of, or materially adversely interfere

with the use of, the property subject thereto, (c) Liens incurred or deposits made in the ordinary course of business in connection

with social security, (d) Liens on goods in transit incurred pursuant to documentary letters of credit, in each case arising in the

ordinary course of business, (e) Liens arising under any Transaction Document or (f) non-exclusive licenses of owned Intellectual

Property granted in the ordinary course of business.

“Person” means an

individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint

stock company, government (or an agency or subdivision thereof) or other entity of any kind.

“Preference Shares”

means the [12.0% Series A Cumulative Convertible Preference Shares]1 [Series B

Convertible Preference Shares]2 of the Company having the rights, preferences and privileges

set forth in the Articles, in the form of Exhibit A hereto.

“Proceeding” means

an action, claim, suit, investigation or proceeding, whether commenced or threatened.

“Prohibited Financing Arrangement”

means any agreement, arrangement, commitment or transaction (whether entered into directly or indirectly through the Sponsor, any Affiliate

or any other Person) that constitutes, or that has the economic effect of, any forward purchase agreement, forward sale agreement, equity

forward, contingent capital or contingent forward arrangement, non-redemption agreement or non-redemption incentive arrangement, redemption

recapture, redemption reversal or redemption backstop facility or any other similar agreement, arrangement or transaction, in each case

that (i) provides for, or has the effect of, the payment or transfer of cash or other consideration to CGC, the Company or any of

their respective Subsidiaries (including any amount released or to be released from the trust account established by CGC) prior to, or

calculated by reference to, the sale, resale, redemption or non-redemption of any equity securities of CGC or the Company; (ii) is

entered into for the purpose of, or that has the effect of, reducing, reversing, offsetting, funding or discouraging the exercise of redemption

rights by holders of ordinary shares of CGC or the Company; or (iii) obligates CGC, the Company or any of their respective Subsidiaries

to purchase, repurchase, redeem or make any payment or share issuance in respect of any equity securities determined by reference to a

future price, reset price, volume-weighted average price or valuation or measurement period; provided that “Prohibited Financing

Arrangement” shall not include (A) this Agreement, the other Transaction Agreements and the transactions expressly contemplated

hereby and thereby or (B) the issuance and sale of Securities pursuant to this Agreement and the Other SPAs.

“Purchaser Party”

means the Purchaser and the Purchaser’s directors, officers, shareholders, members, partners, employees and agents (and any other

Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title),

each Person who controls the Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange

Act), and the directors, officers, shareholders, agents, members, partners or employees (and any other Persons with a functionally equivalent

role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons.

“Real Property Leases”

means all leases, sub-leases, licenses or other agreements, in each case, pursuant to which any Target Company leases or sub-leases any

real property.

“Redemption” shall

have the meaning ascribed to such term in the Business Combination Agreement.

“Registration Rights Agreement”

means the Amended and Restated Registration Rights Agreement among the Company, the Purchaser and the other parties thereto, in the form

of Exhibit B attached hereto.

1 For anchor investor.

2 For other investors.

“Registration Statement”

means a registration statement meeting the requirements set forth in the Registration Rights Agreement and covering the resale of the

Underlying Shares by the Purchaser as provided for in the Registration Rights Agreement.

“Required Minimum”

means, as of any date, the maximum aggregate number of Common Shares then issued or potentially issuable in the future pursuant to the

Transaction Documents, including any Underlying Shares issuable upon exercise in full of all Warrants (assuming for this purpose, an exercise

price equal to the Floor Price) and conversion in full of all Preference Shares (assuming for this purpose, a conversion price equal to

the Floor Price and taking into account PIK Dividends for a period of at least three years following the Closing Date), ignoring any conversion

or exercise limits set forth therein.

“Rule 144”

means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such rule may be amended or interpreted from

time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect

as such rule.

“Rule 424”

means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such rule may be amended or interpreted from

time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect

as such rule.

“SEC” means the

United States Securities and Exchange Commission.

“SEC Reports” shall

have the meaning ascribed to such term in Section 3.1(m).

“Securities” means

the Preference Shares, the Warrants and the Underlying Shares.

“Securities Act”

means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

“Short Sales” shall

include, without limitation, all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act and all

types of direct and indirect stock pledges (other than pledges in the ordinary course of business as part of prime brokerage arrangements),

forward sale contracts, options, puts, calls, swaps and similar arrangements (including on a total return basis), and sales and other

transactions through non-U.S. broker dealers or foreign regulated brokers.

“Software” means

any and all (i) computer software, firmware and computer programs and applications, including all source code, object code, middleware,

utilities, computer programs, application programming interfaces, algorithms, plugins, libraries, subroutines, tools, drivers, microcode,

scripts, batch files, instruction sets and macros, models, and methodologies, in each case of the foregoing whether in source code, executable

or object code form, documentation related thereto including user manuals, related to any of the foregoing and all software modules, tools

and databases; and (ii) deep learning, machine learning, and other artificial intelligence technologies (collectively, “AI/ML”).

“Stated Value” means

$120.00 per Preference Share.

“Stock Exchange”

means either The Nasdaq Stock Market LLC or the New York Stock Exchange (or any successors to any of the foregoing).

“Subscription Amount”

shall mean the aggregate amount to be paid for the Preference Shares and the Warrants purchased hereunder pursuant to the terms of this

Agreement as set forth across from the Purchaser’s name on Schedule A hereto in U.S. dollars and in immediately available funds.

“Subsidiary” means,

with respect to any Person, any corporation, partnership, association or other business entity of which (i) if a corporation, a majority

of the total voting power of shares of stock entitled (without regard to the occurrence of any contingency) to vote in the election of

directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more of the

other Subsidiaries of that Person or a combination thereof, or (ii) if a partnership, association or other business entity, a majority

of the partnership or other similar ownership interests thereof is at the time owned or controlled, directly or indirectly, by any Person

or one or more Subsidiaries of that Person or a combination thereof. For purposes hereof, a Person or Persons will be deemed to have a

majority ownership interest in a partnership, association or other business entity if such Person or Persons will be allocated a majority

of partnership, association or other business entity gains or losses or will be or control the managing director, managing member, general

partner or other managing Person of such partnership, association or other business entity. A Subsidiary of a Person will also include

any variable interest entity which is consolidated with such Person under applicable accounting rules.

“Target Benefit Plans”

means any and all deferred compensation, executive compensation, incentive compensation, equity purchase or other equity-based compensation

plan, employment or consulting, severance or termination pay, holiday, vacation or other bonus plan or practice, hospitalization or other

medical, life or other insurance, supplemental unemployment benefits, profit sharing, pension, or retirement plan, program, agreement,

commitment or arrangement, and each other Target Benefit Plan, program, agreement or arrangement, including each “Target Benefit

Plan” as such term is defined under Section 3(3) of ERISA, maintained or contributed to or required to be contributed

to by the Target or any Subsidiary of the Target for the benefit of any current or former employee or other individual service provider

of the Target or any Subsidiary of the Company, or with respect to which the Target or any Subsidiary of the Target has any Liability,

whether direct or indirect, whether actual or contingent, whether formal or informal, and whether legally binding or not (other than a

multiemployer plan within the meaning of Section 3(37) of ERISA or any plan or program that is sponsored solely by a Governmental

Authority and to which the Target or any Subsidiary of the Target is required to contribute pursuant to applicable Law).

“Target Companies”

means the Target and its Subsidiaries, including the Company and Merger Sub.

“Target Licensed Intellectual

Property” means Intellectual Property owned by any Person (other than a Target Company) that is licensed to any Target Company.

“Target Material Adverse Effect”

means any change, event, effect or occurrence that, individually or in the aggregate with any other change, event, effect or occurrence,

has had or would reasonably be expected to have a material adverse effect on (a) the business, results of operations or financial

condition of the Target Companies, taken as a whole, or (b) the ability of the Target to consummate the Exchange in accordance with

the terms of this Agreement or consummate the transactions contemplated hereby in accordance with the terms of this Agreement; provided,

however, that, in the case of clause (a), none of the following shall be taken into account in determining whether a Target Material Adverse

Effect has occurred or is reasonably likely to occur: any adverse change, event, effect or occurrence arising after the date of this Agreement

from or related to (i) general business or economic conditions in or affecting Europe, or changes therein, or the global economy

generally, (ii) any national or international political or social conditions in Europe or any other country, including the engagement

by Europe or any other country in hostilities, whether or not pursuant to the declaration of a national emergency or war, or the occurrence

in any place of any military or terrorist attack, sabotage or cyberterrorism, (iii) changes in conditions of the financial, banking,

capital or securities markets generally in Europe or any other country or region in the world, or changes therein, including changes in

interest rates in Europe or any other country and changes in exchange rates for the currencies of any countries, (iv) changes in

any applicable Laws or the interpretation or enforcement thereof by any Governmental Authority, (v) any change, event, effect or

occurrence that is generally applicable to the industries or markets in which any Target Company operates, (vi) the execution or

public announcement of this Agreement or the pendency or consummation of the transactions contemplated by this Agreement, including the

impact thereof on the relationships, contractual or otherwise, of any Target Company with employees, customers, investors, contractors,

lenders, suppliers, vendors, partners, licensors, licensees, payors or other third parties related thereto (provided that the exception

in this clause (vi) shall not apply to the representations and warranties set forth in Section 3.3(d)(ii) to the

extent that its purpose is to address the consequences resulting from the public announcement or pendency or consummation of the transactions

contemplated by this Agreement), (vii) any failure by any Target Company to meet, or changes to, any internal or published budgets,

projections, forecasts, estimates or predictions (although the underlying facts and circumstances resulting in such failure may be taken

into account to the extent not otherwise excluded from this definition pursuant to clauses (i) through (vi) or (viii)), or (viii) any

hurricane, tornado, flood, earthquake, tsunami, natural disaster, mudslides, wild fires, epidemics, pandemics or quarantines, acts of

God or other natural disasters or comparable events in Europe or any other country or region in the world, or any escalation of the foregoing,

(ix) any actions taken or omitted to be taken by any Target Companies at the written request or with the written consent of CGC,

(x) any changes in IFRS or other applicable accounting standards or the interpretation thereof, (xi) any loss of employees,

customers, suppliers, distributors, licensors, licensees or other business partners to the extent resulting from the public announcement

or pendency of the transactions contemplated by this Agreement, or (xii) any litigation arising from or relating to this Agreement

or the transactions contemplated hereby; provided, however, that any change, event, effect or occurrence resulting from a matter described

in any of the foregoing clauses (i) through (v) or (viii) through (xii) may be taken into account in determining whether

a Target Material Adverse Effect has occurred or is reasonably likely to occur to the extent such change, event, effect or occurrence

has had or would reasonably be expected to have a disproportionate adverse effect on the Target Companies, taken as a whole, relative

to other participants operating in the industries or markets in which the Target Companies operate.

“Target Options”

means, as of any determination time, each option to purchase Target Shares that is outstanding and unexercised, whether granted under

a Target Benefit Plan or otherwise.

“Target Party” means

each Target Company and each of their respective directors, officers, shareholders, members, partners, employees and agents (and any other

Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title),

each Person who controls any Target Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange

Act), and the directors, officers, shareholders, agents, members, partners or employees (and any other Persons with a functionally equivalent

role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons.

“Target Shares”

means the shares, par value NOK 0.01 per share, of the Target.

“Taxes” means all

direct or indirect federal, state, local, foreign and other net income, gross income, gross receipts, sales, use, value-added, ad valorem,

transfer, franchise, profits, license, lease, service, service use, withholding, payroll, employment, social security and related contributions

due in relation to the payment of compensation to employees, excise, severance, stamp, occupation, premium, property, windfall profits,

alternative minimum, estimated, customs, duties or other taxes, fees, assessments or charges in the nature of a tax, together with any

interest and any penalties, additions to tax or additional amounts with respect thereto imposed by a Governmental Authority.

“Tax Authority”

means any Governmental Authority responsible for the collection or administration of Taxes or Tax Returns.

“Tax Return” means

any return, form, declaration, election, disclosure, report, claim for refund, information return or other documents (including any related

or supporting schedules, statements or information) filed or required to be filed in connection with the determination, assessment or

collection of any Taxes or the administration of any Laws or administrative requirements relating to any Taxes.

“Trade Secrets”

means any trade secrets, confidential business information, concepts, ideas, designs, research or development information, processes,

procedures, techniques, technical information, specifications, operating and maintenance manuals, engineering drawings, methods, know-how,

data, mask works, discoveries, inventions, modifications, extensions, improvements, and other proprietary rights (whether or not patentable

or subject to Copyright, Trademark, or trade secret protection).

“Trading Day” means

a day on which the principal Trading Market is open for trading.

“Trading Market”

means any of the following markets or exchanges on which the Common Shares is listed or quoted for trading on the date in question: the

NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or

any successors to any of the foregoing).

“Transaction Documents”

means this Agreement, the Articles, the Warrants, the Registration Rights Agreement, and all exhibits and schedules thereto.

“Transactions” means

each of the transactions contemplated by this Agreement and the other Transaction Documents.

“Transfer Agent”

means Continental Stock Transfer & Trust Company, the current transfer agent of the Company, and any successor transfer agent

of the Company.

“Underlying Shares”

means the Conversion Shares and the Warrant Shares.

“Warrants” means,

collectively, the Common Share purchase warrants of the Company delivered to the Purchaser at the Closing in accordance with Section 2.2(a) hereof,

which Warrants shall be exercisable immediately and have a term of exercise equal to 5 years, in the form of Exhibit C

attached hereto.

“Warrant Shares”

means the Common Shares issuable upon exercise of the Warrants.

ARTICLE 2

PURCHASE AND SALE

2.1 Closing. On the Closing Date,

upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and the Purchaser agrees to purchase, a number

of Preference Shares equal to the Subscription Amount set forth opposite the Purchaser’s name on Schedule A hereto divided by $102.00,

and Warrants as determined pursuant to Section 2.2(a). Not later than 10:00 am Eastern Time on the date two business days

prior to the date on which the Closing will occur (and the conditions thereto will be satisfied) (the “Closing Date”),

the Company shall provide written notice on signed Company letterhead (which may be via email) to the Purchaser (the “Closing

Notice”) that (i) all closing conditions pursuant to the Business Combination Agreement (as determined by the parties to

the Business Combination Agreement) or waived in writing by the Person(s) with the authority to make such waiver (other than those

conditions which, by their nature, are to be satisfied at the closing of the Business Combination pursuant to the Business Combination

Agreement including to the extent that any such condition precedent is, or is dependent upon, the consummation of the transactions contemplated

hereby) and (ii) this Agreement (as determined by the parties to this Agreement) or waived in writing by the Person(s) with

the authority to make such waiver (other than those conditions which, by their nature, are to be satisfied at the Closing pursuant to

this Agreement including to the extent that any such condition precedent is, or is dependent upon, the consummation of the Business Combination),

have been met and that such date is the Closing Date, which Closing Notice shall contain the Flow of Funds Letter (as defined below) with

the Company’s wire instructions for the Company’s operating account.2.2 Deliveries.

(a) On or prior to the

Closing Date, the Company shall deliver or cause to be delivered to the Purchaser the following:

(i) the Beneficial

Ownership Letter Agreement duly executed by the Company;

(ii) a certificate

evidencing (or reasonable evidence of issuance by book entry, as applicable, of) a number of Preference Shares with an aggregate Stated

Value as set forth opposite the Purchaser’s name on Schedule A hereto, registered in the name of the Purchaser and evidence

of the filing and acceptance of the Articles from the Dutch Trade Register;

(iii) a Warrant

registered in the name of the Purchaser to purchase up to a number of Common Shares equal to [100%]3

[75%]4 of the total number of Common Shares into which the Purchaser’s Preference

Shares are convertible on the date of Closing, with an exercise price equal to $12.00, subject to adjustment as set forth therein; and

(iv) the

Registration Rights Agreement duly executed by the Company.

(b) On or prior to the

Closing Date, the Purchaser shall deliver or cause to be delivered to the Company, the following:

(i) the Beneficial

Ownership Letter Agreement duly executed by the Purchaser;

(ii) the

Registration Rights Agreement duly executed by the Purchaser;

(iii) the

Purchaser’s counter-signature to the Warrant described in Section 2.2(a)(ii); and

(iv) the

Purchaser’s Subscription Amount.

3 For anchor investor.

4 For other investors.

2.3 Closing Conditions.

(a) The Closing shall

be subject to the satisfaction, or valid waiver in writing by each of the parties hereto, of the conditions that, on the Closing Date:

(i) all conditions

precedent to the closing of the Business Combination set forth in Article VII of the Business Combination Agreement shall have been

satisfied (as determined by the parties to the Business Combination Agreement) or waived in writing by the Person(s) with the authority

to make such waiver (other than those conditions which, by their nature, are to be satisfied at the closing of the Business Combination

pursuant to the Business Combination Agreement including to the extent that any such condition precedent is, or is dependent upon, the

consummation of the transactions contemplated hereby), and the closing of the Business Combination shall be scheduled to occur concurrently

with the Closing; and

(ii) no governmental

authority shall have enacted, issued, promulgated, enforced or entered any judgment, order, law, rule or regulation which is then

in effect and has the effect of making the consummation of the transactions contemplated hereby illegal or otherwise restraining or prohibiting

consummation of the transactions contemplated hereby.

(b) The obligation of

the Company to consummate the Closing shall be subject to the satisfaction or valid waiver in writing by the Company of the additional

conditions that, on the Closing Date:

(i) except

as otherwise provided under Section 2.3(b)(ii), all representations and warranties of the Purchaser contained in this Agreement

shall be true and correct in all material respects (other than representations and warranties that are qualified as to materiality or

material adverse effect, which representations and warranties shall be true and correct in all respects) at and as of the Closing Date

(except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation

and warranty shall be true and correct in all material respects (other than representations and warranties that are qualified as to materiality

or material adverse effect, which representations and warranties shall be true and correct in all respects) as of such earlier date),

and consummation of the Closing shall constitute a reaffirmation by the Purchaser of each of the representations, warranties and agreements

of the Purchaser contained in this Agreement as of the Closing Date, but without giving effect to consummation of the Business Combination,

or as of such earlier date, as applicable;

(ii) the

representations and warranties of the Purchaser contained in Section 3.2(q) of this Agreement shall be true and correct

at all times on or prior to the Closing Date, and consummation of the Closing shall constitute a reaffirmation by the Purchaser of such

representations and warranties;

(iii) the

Purchaser shall have performed, satisfied and complied with in all material respects all covenants, agreements and conditions required

by this Agreement to be performed, satisfied or complied with by it at or prior to the Closing; and

(iv) the

delivery by the Purchaser of the items set forth in Section 2.2(b) of this Agreement.

the Purchaser to consummate the Closing shall be subject to the satisfaction or valid waiver in writing by the Purchaser of the additional

conditions that, on the Closing Date:

(i) all representations

and warranties of the Company, the Target, and CGC contained in this Agreement shall be true and correct in all material respects (other

than representations and warranties that are qualified as to materiality, CGC Material Adverse Effect or Target Material Adverse Effect,

as applicable, which representations and warranties shall be true and correct in all respects) at and as of the Closing Date (except to

the extent that any such representation or warranty expressly speaks as of an earlier date, in which case such representation and warranty

shall be true and correct in all material respects (other than representations and warranties that are qualified as to materiality, CGC

Material Adverse Effect or Target Material Adverse Effect, as applicable, which representations and warranties shall be true and correct

in all respects) as of such earlier date), and consummation of the Closing shall constitute a reaffirmation by the Company, the Target

and CGC of each of their respective representations, warranties and agreements contained in this Agreement as of the Closing Date, but

without giving effect to the consummation of the Business Combination, or as of such earlier date, as applicable;

(ii) the

Company shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required by

this Agreement to be performed, satisfied or complied with by it at or prior to the Closing;

(iii) the

delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;

(iv) no CGC

Material Adverse Effect or Target Material Adverse Effect shall have occurred;

(v) the transactions

contemplated by the Other SPAs shall be consummated concurrently with the Closing;

(vi) the

Company shall have been duly formed and joined to this Agreement as contemplated hereby;

(vii) all

conditions to the listing of the Common Shares on the Stock Exchange shall have been satisfied and the listing of the Common Shares shall

have occurred prior to or be scheduled to occur concurrently with the Closing; and

(viii) the

delivery by the Sponsor of the Sponsor Accommodation Shares as set forth in Section 4.14 of this Agreement.

ARTICLE 3

REPRESENTATIONS AND WARRANTIES

3.1 Representations and Warranties of the

Company. Upon its joinder to this Agreement, the Company will represent and warrant to the Purchaser, as of the date of such joinder

to this Agreement and as of the Closing Date (or, if such representations and warranties are made with respect to a specified date, as

of such date):

(a) The Company (i) is

validly existing and in good standing under the laws of the jurisdiction of incorporation, (ii) has the requisite power and authority

to own, lease and operate its properties, to carry on its business as it is now being conducted and to enter into and perform its obligations

under this Agreement and the other Transaction Documents, and (iii) is duly licensed or qualified to conduct its business and, if

applicable, is in good standing under the laws of each jurisdiction (other than its jurisdiction of incorporation) in which the conduct

of its business or the ownership of its properties or assets requires such license or qualification, except, with respect to the foregoing

clause (iii), where the failure to be in good standing would not reasonably be expected to have a Target Material Adverse Effect.

(b) As of the Closing

Date, the Securities will be duly authorized and, when issued, paid for and delivered in accordance with the applicable Transaction Documents,

will be validly issued, fully paid and non-assessable, free and clear of all liens or other restrictions (other than those arising under

the Transaction Documents, the Organizational Documents of the Company or applicable securities laws), and will not have been issued in

violation of any preemptive or similar rights created under the Company’s Organizational Documents (as adopted on the Closing Date)

or the laws of its jurisdiction of incorporation.

the other Transaction Documents has been duly authorized, validly executed and delivered by the Company, and assuming the due authorization,

execution and delivery of the same by the Target and the Purchaser of this Agreement and the other Transaction Documents to which they

are a party and the due authorization, execution and delivery of the same by all other parties to any Transaction Document, this Agreement

and the other Transaction Documents shall constitute the valid and legally binding obligation of the Company, enforceable against the

Company in accordance with its terms, except to the extent that enforceability thereof may be limited by applicable bankruptcy, insolvency,

reorganization and moratorium laws and other laws of general application affecting the enforcement of creditors’ rights generally

or by any applicable statute of limitation or by any valid defense of set-off or counterclaim, and the fact that equitable remedies or

relief (including the remedy of specific performance) are subject to the discretion of the court from which such relief may be sought

(collectively, the “Enforceability Exceptions”).

(d) Assuming the accuracy

of the representations and warranties of the Purchaser set forth in Section 3.2 of this Agreement, the execution and delivery

of this Agreement and the other Transaction Documents, the issuance and sale of the Securities hereunder, the compliance by the Company

with all of the provisions hereof and thereof and the consummation of the transactions contemplated herein and therein will not conflict

with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation

or imposition of any lien, charge or encumbrance upon any of the property or assets of the Company pursuant to the terms of (i) any

indenture, mortgage, deed of trust, loan agreement, lease, license or other agreement or instrument to which the Company is a party or

by which the Company is bound or to which any of the property or assets of the Company is subject, (ii) the Organizational Documents

of the Company, or (iii) any statute or any judgment, order, rule or regulation of any court or governmental agency or body,

domestic or foreign, having jurisdiction over the Company or any of its properties that, in the case of clauses (i) and (iii),

would reasonably be expected to have a Target Material Adverse Effect.

(e) Assuming the accuracy

of the representations and warranties of the Purchaser set forth in Section 3.2 of this Agreement, the Company is not required

to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other

federal, state, local or other governmental authority, self-regulatory organization or other person in connection with the execution,

delivery and performance of this Agreement or the other Transaction Documents (including, without limitation, the issuance of the Securities),

other than (i) filings required by applicable state securities laws, (ii) the filing of the Registration Statement pursuant

to the Registration Rights Agreement, (iii) filings required by the Commission, (iv) filings required by the Stock Exchange,

including with respect to obtaining shareholder approval, (v) filings and approvals required to consummate the Business Combination

as provided under the Business Combination Agreement, (vi) the filing of notification under the Hart-Scott-Rodino Antitrust Improvements

Act of 1976, if applicable, and (vii) those filings, the failure of which to obtain would not have a Target Material Adverse Effect.

(f) Except for such

matters as have not had and would not have a Target Material Adverse Effect, there is no (i) Action, Proceeding or arbitration before

a governmental authority or arbitrator pending, or, to the knowledge of the Company, threatened in writing against the Company or (ii) judgment,

decree, injunction, ruling or order of any governmental authority or arbitrator outstanding against the Company.

(g) Assuming the accuracy

of the Purchaser’s representations and warranties set forth in Section 3.2 of this Agreement, no registration under

the Securities Act or any state securities (or Blue Sky) laws is required for the offer and sale of the Securities by the Company to the

Purchaser.

(h) Neither the Company

nor any person acting on its behalf has engaged in any form of general solicitation or general advertising (within the meaning of Regulation

D) in connection with any offer or sale of the Securities. The Securities are not being offered in a manner involving a public offering

under, or in a distribution in violation of, the Securities Act or any state securities laws. Neither the Company nor any person acting

on the Company’s behalf has, directly or indirectly, at any time within the past six (6) months, made any offer or sale of

any security or solicitation of any offer to buy any security under circumstances that would cause the offering of the Securities pursuant

to this Agreement to be integrated with prior offerings by the Company for purposes of the Securities Act or any applicable shareholder

approval provisions. Neither the Company nor any person acting on the Company’s behalf has offered or sold any securities, or has

taken any other action, which would reasonably be expected to subject the offer, issuance or sale of the Securities, as contemplated hereby,

to the registration provisions of the Securities Act.

(i) No “bad actor”

disqualifying event described in Rule 506(d)(1)(i)-(viii) of the Securities Act (a “Disqualification Event”)

is applicable to the Company, except for a Disqualification Event as to which Rule 506(d)(2)(ii–iv) or (d)(3) is applicable.

(j) Except as would

not reasonably be expected to be material to the Company, the Company is in all material respects in compliance with applicable provisions

of the Sarbanes-Oxley Act of 2002, as amended, and the rules and regulations thereunder.

(k) As of the Closing

Date, the Common Shares will be eligible for clearing through The Depository Trust Company (“DTC”), through its Deposit/Withdrawal

At Custodian (DWAC) system, and the Company is eligible and participating in the Direct Registration System (DRS) of DTC with respect

to the Common Shares. The Company’s Transfer Agent is a participant in DTC’s Fast Automated Securities Transfer Program.

(l) It is the intent

of the Company that it be deemed a “successor issuer” of CGC in accordance with Rule 12g-3 under the Exchange Act of

1934, as amended (the “Exchange Act”), solely for purposes of the Exchange Act, and in accordance with Rule 414 under

the Securities Act, solely for purposes of the Securities Act, and, as of the Closing Date, the Company represents and warrants as set

forth in Section 3.4(l).

(m) As of the Closing

Date, the Company has (i) converted into a naamloze vennootschap incorporated under the laws of the Netherlands, (ii) adopted

the Articles in the form of Exhibit A, and (iii) has authorized the maximum amount of share capital permissible

under Dutch law.

(n) As of the Closing

Date, the Company has issued, pursuant to this Agreement and the Other SPAs, (i) 490,196 12.0% Series A Cumulative Convertible

Preference Shares, each having a par value of twelve eurocents (EUR 0.12); (ii) 269,608 Series B Convertible Preference

Shares, each having a par value of twelve eurocents (EUR 0.12), and (iii) 7,598,039 Warrants.

(o) Following the Business

Combination and immediately after the issuance of the Common Shares pursuant to this Agreement, the Common Shares are expected to be registered

under the Exchange Act and listed for trading on the Stock Exchange.

(p) To the knowledge

of the Company, the Company is not, and immediately after receipt of payment for the Securities and consummation of the Business Combination,

will not be, an “investment company” within the meaning of the Investment Company Act of 1940, as amended.

(q) Neither the Company

nor, to the knowledge of the Company, any agent or other person acting on behalf of the Company has (i) directly or indirectly, used

any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity,

(ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties

or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company (or made by any person acting

on its behalf of which the Company is aware) which is in violation of law or (iv) violated in any material respect any provision

of the Foreign Corrupt Practices Act of 1977, as amended.

(r) The Company’s

accounting firm is Ernst & Young (EY). To the knowledge and belief of the Company, such accounting firm is a registered public

accounting firm as required by the Exchange Act.

(s) There are no disagreements

of any kind presently existing, or reasonably anticipated by the Company to arise, between the Company and the accountants and lawyers

formerly or presently employed by the Company and the Company is current with respect to any fees owed to its accountants and lawyers

which could affect the Company’s ability to perform any of its obligations under any of the Transaction Documents.

(t) The Company acknowledges

and agrees that the Purchaser is acting solely in the capacity of an arm’s length purchaser with respect to the Transaction Documents

and the transactions contemplated thereby. The Company further acknowledges that the Purchaser is not acting as a financial advisor or

fiduciary of the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby

and any advice given by the Purchaser or any of its representatives or agents in connection with the Transaction Documents and the transactions

contemplated thereby is merely incidental to the Purchaser’s purchase of the Securities. The Company further represents to the Purchaser

that the Company’s decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent

evaluation of the transactions contemplated hereby by the Company and its representatives.

(u) The Company has

not, and to its knowledge no one acting on its behalf has, taken, directly or indirectly, any action designed to cause or to result in

the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities.

[(v) The Company has

not entered into, and will not enter into, any other agreement or any definitive transaction document, side letter, undertaking letter,

or other similar agreement or instrument with the Purchaser or any other purchaser of Securities in connection with the transactions contemplated

hereby or by the Other SPAs with terms and conditions that are more favorable than the terms and conditions provided to the Purchaser

under this Agreement.]5

(w) Except

as provided in this Section 3.1, none of the Company nor any of its Affiliates, nor any of their respective directors, managers,

officers, employees, equityholders, partners, members or representatives has made, or is making, any representation or warranty whatsoever

to any other party hereto or any other Person and no such party shall be liable in respect of the accuracy or completeness of any information

provided to any other party hereto or any other Person.

3.2 Representations and Warranties of the

Purchaser. The Purchaser hereby represents and warrants as of the date of this Agreement and as of the Closing Date (or, if such

representations and warranties are made with respect to a specified date, as of such date):

(a) The Purchaser is

either an individual or an entity duly incorporated or formed, validly existing and in good standing under the laws of its jurisdiction

of formation or incorporation with the requisite power and authority to enter into and perform its obligations under the Transaction Documents.

5 For anchor investor

(b) Each Transaction

Document to which it is a party has been duly authorized, executed and delivered by the Purchaser, and assuming the due authorization,

execution and delivery of the same by the Company, each Transaction Document to which the Purchaser is a party shall constitute the valid

and legally binding obligation of the Purchaser, enforceable against the Purchaser in accordance with its terms, subject to the Enforceability

Exceptions.

and performance of the Transaction Documents, including the purchase of the Securities hereunder, the compliance by the Purchaser with

all of the provisions of the Transaction Documents and the consummation of the transactions contemplated herein will not conflict with

or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition

of any lien, charge or encumbrance upon any of the property or assets of the Purchaser pursuant to the terms of (i) any indenture,

mortgage, deed of trust, loan agreement, lease, license or other agreement or instrument to which the Purchaser is a party or by which

the Purchaser is bound or to which any of the property or assets of the Purchaser is subject; (ii) the Organizational Documents of

the Purchaser; or (iii) any statute or any judgment, order, rule or regulation of any court or governmental agency or body,

domestic or foreign, having jurisdiction over the Purchaser or any of its properties that in the case of clauses (i) and (iii), would

reasonably be expected to have a material adverse effect on the Purchaser’s ability to consummate the transactions contemplated

by the Transaction Documents, including the purchase of the Securities.

(d) At the time the

Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which it exercises any Warrants or

converts any Preference Shares, it will be, an “accredited investor” (within the meaning of Rule 501(a) under the

Securities Act), satisfying the applicable requirements set forth on Annex A-1 hereto, (ii) acquiring the Securities only

for its own account and not for the account of others, or if the Purchaser is subscribing for the Securities as a fiduciary or agent for

one or more investor accounts, each owner of such account is an “accredited investor” (within the meaning of Rule 501(a) under

the Securities Act) and the Purchaser has full investment discretion with respect to each such account, and the full power and authority

to make the acknowledgements, representations and agreements herein on behalf of each owner of each such account, and (iii) not acquiring

the Securities with a view to, or for offer or sale in connection with, any distribution thereof in violation of the Securities Act (and

has provided the Company with the requested information on Annex A-1 following the signature page hereto).

(e) The Purchaser acknowledges

and agrees that the Securities are being offered in a transaction not involving any public offering within the meaning of the Securities

Act and that the Securities have not been registered under the Securities Act or the securities laws of any state in the United States

or other jurisdiction and that the Company is not required to register the Securities except as set forth in the Registration Rights Agreement.

The Purchaser acknowledges and agrees that the Securities may not be offered, resold, transferred, pledged or otherwise disposed of by

the Purchaser absent an effective registration statement under the Securities Act, except (i) to the Company or a Subsidiary thereof,

(ii) pursuant to an applicable exemption from the registration requirements of the Securities Act (including without limitation a

private resale pursuant to so called “Section 4(a)1½”), or (iii) an ordinary course pledge such as a broker

lien over account property generally, and, in each of clauses (i)-(iii), in accordance with any applicable securities laws of the states

and other jurisdictions of the United States, and that any certificates or account entries representing the Securities shall contain a

restrictive legend to such effect. The Purchaser acknowledges and agrees that the Securities will be subject to these securities law transfer

restrictions, and as a result of these transfer restrictions, the Purchaser may not be able to readily offer, resell, transfer, pledge

or otherwise dispose of the Securities and may be required to bear the financial risk of an investment in the Securities for an indefinite

period of time. The Purchaser acknowledges and agrees that the Securities will not be immediately eligible for offer, resale, transfer,

pledge or disposition pursuant to Rule 144 promulgated under the Securities Act until at least one year following the filing of certain

required information with the Commission after the Closing Date. The Purchaser acknowledges and agrees that it has been advised to consult

legal counsel prior to making any offer, resale, pledge or transfer of any of the Securities.

(f) The Purchaser understands

and agrees that it is purchasing the Securities directly from the Company. The Purchaser further acknowledges that there have not been,

and the Purchaser hereby agrees that it is not relying on, any representations, warranties, covenants or agreements made to the Purchaser

by the Company, the Target, the Sponsor, any of their respective Affiliates or any control persons, officers, directors, employees, partners,

agents or representatives, any other party to the Business Combination or any other person or entity, expressly or by implication, other

than those representations, warranties, covenants and agreements of the Company and the Target set forth in this Agreement. The Purchaser

agrees that none of (i) any other Purchaser (including the controlling persons, members, officers, directors, partners, agents, or

employees of any such other Purchaser), (ii) the Sponsor, its Affiliates (other than the Company), or any of its or its’ Affiliates

respective control persons, officers, directors or employees or (iii) any other party to the Business Combination Agreement, including

any such party’s representatives, Affiliates or any of its or their control persons, officers, directors or employees, that is not

a party hereto, shall be liable to the Purchaser pursuant to this Agreement for any action heretofore or hereafter taken or omitted to

be taken by any of them in connection with the purchase of the Securities.

(g) In making its decision

to purchase the Securities, the Purchaser has relied solely upon independent investigation made by the Purchaser of the Company’s

and the Target’s representations in Sections 3.1 and 3.3, respectively, of this Agreement. The Purchaser acknowledges

and agrees that the Purchaser has received such information as the Purchaser deems necessary in order to make an investment decision with

respect to the Securities, including with respect to the Company, the Target Companies and the Business Combination, and made its own

assessment and is satisfied concerning the relevant financial, tax and other economic considerations relevant to the Purchaser’s

investment in the Securities. Without limiting the generality of the foregoing, the Purchaser acknowledges that it has reviewed the Company’s

filings with the Commission. The Purchaser represents and agrees that the Purchaser and the Purchaser’s professional advisor(s),

if any, have had the full opportunity to ask such questions, receive such answers and obtain such information as the Purchaser and the

Purchaser’s professional advisor(s), if any, have deemed necessary to make an investment decision with respect to the Securities.

The Purchaser acknowledges that certain information provided by the Company and the Target was based on projections, and such projections

were prepared based on assumptions and estimates that are inherently uncertain and are subject to a wide variety of significant business,

economic and competitive risks and uncertainties that could cause actual results to differ materially from those contained in the projections.

The Purchaser further acknowledges that the information provided to the Purchaser was preliminary and subject to change, including in

the registration statement and the proxy statement and/or prospectus that the Company intends to file with the Commission in connection

with the Business Combination (which will include substantial additional information about the Company, the Target Companies and the Business

Combination and will update and supersede the information previously provided to the Purchaser). The Purchaser acknowledges and agrees

that none of the Sponsor or any of its Affiliates or any of such Person’s or its Affiliate’s control persons, officers, directors,

employees or other representatives, legal counsel, financial advisors, accountants or agents (collectively, “Representatives”)

has provided the Purchaser with any information, recommendation or advice with respect to the Securities nor is such information, recommendation

or advice necessary or desired. None of the Sponsor or any of its respective Affiliates or Representatives has made or makes any representation

as to the Company or the Target Companies or the quality or value of the Securities. In addition, the Company, the Target, the Sponsor

and their respective Affiliates or Representatives may have acquired non-public information with respect to the Company or the Target

Companies which the Purchaser agrees need not be provided to it. In connection with the issuance of the Securities to the Purchaser, none

of the Company, the Target, the Sponsor or any of their respective Affiliates or Representatives has acted as a financial advisor or fiduciary

to the Purchaser.

(h) The Purchaser became

aware of this offering of the Securities solely by means of direct contact between the Purchaser and the Company or its Affiliates, by

means of direct contact between the Purchaser and the Target or its Affiliates, and Securities were offered to the Purchaser solely by

direct contact between the Purchaser and the Company or its Affiliates. The Purchaser did not become aware of this offering of the Securities,

nor were the Securities offered to the Purchaser, by any other means. The Purchaser acknowledges that the Company represents and warrants

that the Securities (i) were not offered by any form of general solicitation or general advertising (within the meaning of Regulation

D of the Securities Act) and (ii) are not being offered in a manner involving a public offering under, or in a distribution in violation

of, the Securities Act, or any state securities laws.

(i) The Purchaser acknowledges

that it is aware that there are substantial risks incident to the purchase and ownership of the Securities, including those set forth

in the SEC Reports. The Purchaser has such knowledge and experience in financial and business matters as to be capable of evaluating the

merits and risks of an investment in the Securities, and the Purchaser has had an opportunity to seek, and has sought, such accounting,

legal, business and tax advice as the Purchaser has considered necessary to make an informed investment decision. The Purchaser (i) is

an institutional account as defined in FINRA Rule 4512(c), (ii) is a sophisticated investor, experienced in investing in private

equity transactions and capable of evaluating investment risks independently, both in general and with regard to all transactions and

investment strategies involving a security or securities, and (iii) has exercised independent judgment in evaluating its participation

in the purchase of the Securities. The Purchaser understands and acknowledges that the purchase and sale of the Securities hereunder meets

(i) the exemptions from filing under FINRA Rule 5123(b)(1)(A) and (ii) the institutional customer exemption under

FINRA Rule 2111(b).

(j) The Purchaser has

adequately analyzed and fully considered the risks of an investment in the Securities and determined that the Securities are a suitable

investment for the Purchaser and that the Purchaser is able at this time and in the foreseeable future to bear the economic risk of a

total loss of the Purchaser’s investment in the Company. The Purchaser acknowledges specifically that a possibility of total loss

exists.

(k) The Purchaser understands

and agrees that no federal or state agency has passed upon or endorsed the merits of the offering of the Securities or made any findings

or determination as to the fairness of this investment.

(l) The Purchaser is

not (i) a person or entity named on the List of Specially Designated Nationals and Blocked Persons (“SDN List”)

administered by the U.S. Treasury Department’s Office of Foreign Assets Control (“OFAC”) or in any Executive

Order issued by the President of the United States and administered by OFAC (“OFAC List”), or a person or entity prohibited

by any OFAC sanctions program, (ii) a Designated National as defined in the Cuban Assets Control Regulations, 31 C.F.R. Part 515,

or (iii) a non-U.S. shell bank or providing banking services indirectly to a non-U.S. shell bank. The Purchaser agrees to provide

law enforcement agencies, if requested thereby, such records as required by applicable law, provided that the Purchaser is permitted to

do so under applicable law. If the Purchaser is a financial institution subject to the Bank Secrecy Act (31 U.S.C. Section 5311 et

seq.), as amended by the USA PATRIOT Act of 2001, and its implementing regulations (collectively, the “BSA/PATRIOT Act”),

the Purchaser maintains policies and procedures reasonably designed to comply with applicable obligations under the BSA/PATRIOT Act. To

the extent required, the Purchaser maintains policies and procedures reasonably designed for the screening of its investors against the

OFAC sanctions programs, including the OFAC List. To the extent required, the Purchaser maintains policies and procedures reasonably designed

to ensure that the funds held by the Purchaser and used to purchase the Securities were legally derived.

(m) No foreign person

(as defined in 31 C.F.R. Part 800.224) in which the national or subnational governments of a single foreign state have a substantial

interest (as defined in 31 C.F.R. Part 800.244) will acquire a substantial interest in the Company as a result of the purchase and

sale of Securities hereunder such that a declaration to the Committee on Foreign Investment in the United States would be mandatory under

31 C.F.R. Part 800.401, and no foreign person will have control (as defined in 31 C.F.R. Part 800.208) over the Company from

and after the Closing as a result of the purchase and sale of Securities hereunder.

(n) The Purchaser will

have sufficient funds to pay the Subscription Amount pursuant to Section 2.2(b)(iv) of this Agreement and

any expenses incurred by the Purchaser in connection with the transactions contemplated by or in connection with the Transaction Documents;

(ii) has the resources and capabilities (financial or otherwise) to perform its obligations under the Transaction Documents; and

(iii) has not incurred any obligation, commitment, restriction or liability of any kind, absolute or contingent, present or future,

which would impair or adversely affect its ability to perform its obligations under the Transaction Documents.

(o) The Purchaser acknowledges

that it is not relying upon, and has not relied upon, any statement, representation or warranty made by any person, firm or corporation

(including, without limitation, the Company, the Target, the Sponsor or any of their respective Affiliates or any of their respective

or their respective Affiliates’ control persons, officers, directors, employees, agents or representatives), other than the representations

and warranties of the Company and the Target contained in Sections 3.1 and 3.3, respectively, of this Agreement, in making

its investment or decision to invest in the Company. The Purchaser agrees that none of (i) any other Purchaser or any other Person

participating in any other private placement of Common Shares (including the controlling persons, officers, directors, partners, agents

or employees of any such other Person), (ii) the Company, its Affiliates or any of its or their respective Affiliates’ control

persons, officers, directors, partners, agents, employees or representatives, nor (iii) the Sponsor, its Affiliates or any of its

or their respective Affiliates’ control persons, officers, directors, partners, agents, employees or representatives shall be liable

to the Purchaser or any other Purchaser pursuant to the Transaction Documents or any other agreement related to a private placement of

Securities for any action heretofore or hereafter taken or omitted to be taken by any of them in connection with the purchase of the Securities

hereunder or thereunder.

(p) No broker or finder

is entitled to any brokerage or finder’s fee or commission to be paid by the Purchaser solely in connection with the sale of the

Securities to the Purchaser.

(q) At all times on

or prior to the Closing Date, the Purchaser has no binding commitment to dispose of, or otherwise transfer (directly or indirectly), any

of the Securities.

(r) The Purchaser hereby

agrees that neither it, nor any person or entity acting on its behalf or pursuant to any understanding with the Purchaser, shall, directly

or indirectly, engage in any hedging activities or execute any Short Sales with respect to the securities of the Company from the date

hereof until the Closing or the earlier termination of this Agreement in accordance with its terms.

(s) Except as expressly

disclosed in a Schedule 13D or Schedule 13G (or amendments thereto) filed by the Purchaser with the Commission with respect to the beneficial

ownership of the Company’s outstanding securities prior to the date hereof, the Purchaser is not currently (and at all times through

Closing will refrain from being or becoming) a member of a “group” (within the meaning of Section 13(d)(3) or Section 14(d)(2) of

the Exchange Act, or any successor provision), including any group acting for the purpose of acquiring, holding or disposing of equity

securities of the Company (within the meaning of Rule 13d-5(b)(1) under the Exchange Act).

(t) The Purchaser acknowledges

that (i) the Company, the Target Companies, the Sponsor and any of their respective Affiliates, control persons, officers, directors,

employees, agents or representatives may later come into possession of, information regarding the Company and the Target Companies that

is not known to the Purchaser and that may be material to a decision to purchase the Securities, (ii) the Purchaser has determined

to purchase the Securities notwithstanding its lack of knowledge of such information, and (iii) none of the Company, the Target Companies,

the Sponsor or any of their respective Affiliates, control persons, officers, directors, employees, agents or representatives shall have

liability to the Purchaser, and the Purchaser hereby, to the extent permitted by law, waives and releases any claims it may have against

the Company, the Target Companies, the Sponsor and their respective Affiliates, control persons, officers, directors, employees, agents

or representatives, with respect to the nondisclosure of such information.

(u) The Purchaser acknowledges

its obligations under applicable securities laws with respect to the treatment of non-public information relating to the Company.

(v) Except

as provided in this Section 3.2, none of the Purchaser nor any of its Affiliates, nor any of their respective directors,

managers, officers, employees, equityholders, partners, members or representatives has made, or is making, any representation or warranty

whatsoever to any other party hereto or any other Person and no such party shall be liable in respect of the accuracy or completeness

of any information provided to any other party hereto or any other Person.

3.3 Representations and Warranties of the

Target. Except as set forth in the disclosure letter dated as of the date of this Agreement delivered by the Target to the Purchaser

(the “Target Disclosure Letter”) prior to or in connection with the execution and delivery of this Agreement, the Target

hereby represents and warrants to the Purchaser, as of the date hereof and as of the Closing Date, as follows:

(a) Organization

and Qualification.

(i)             Each

Target Company is a corporation, limited liability company or other applicable business entity duly organized, incorporated or formed,

as applicable, validly existing and in good standing (or the equivalent thereof, if applicable, in each case, with respect to the jurisdictions

that recognize the concept of good standing or any equivalent thereof) under the Laws of its jurisdiction of organization, incorporation

or formation (as applicable) and in each jurisdiction in which the property and assets owned, leased or operated by it, or the nature

of the business conducted by it, makes such qualification or licensing necessary, except where the failure to be so duly qualified or

licensed and in good standing would not have a Target Material Adverse Effect. Section 3.3(a)(i) of the Target Disclosure

Letter sets forth the jurisdiction of organization, incorporation or formation (as applicable) for each Target Company. Each Target Company

has the requisite corporate, limited liability company or other applicable business entity power and authority to own, lease and operate

its properties and to carry on its businesses as presently conducted, except where the failure to have such power or authority would

not have a Target Material Adverse Effect.

(ii)            True

and complete copies of the Organizational Documents of the Target Companies have been made available to the Purchaser, in each case, as

amended and in effect as of the date of this Agreement. The Organizational Documents of the Target Companies are in full force and effect,

and the Target Companies are not in breach or violation of any provision set forth in their respective Organizational Documents.

(b) Capitalization

of the Target Companies.

(i)             Section 3.3(b)(i) of

the Target Disclosure Letter sets forth a true and complete statement as of the date of this Agreement of (A) the number and class

or series (as applicable) of all of the equity securities of the Target (“Target Equity Securities”) issued and outstanding,

(B) the identity of the Persons that are the record and beneficial owners thereof, and (C) with respect to each equity award

set forth on set forth on Section 3.3(b)(i) of the Target Disclosure Letter (each, a “Target Equity Award”),

(1) the date of grant, (2) any applicable exercise (or similar) price, (3) the expiration date, and (4) any applicable

vesting schedule (including acceleration provisions), and (D) with respect to the convertible notes set forth on Section 3.3(b)(i) of

the Target Disclosure Letter (the “Target Convertible Notes”), (1) the original principal amount, (2) the

applicable interest rate, (3) the maturity date, and (4) the current outstanding balance. All of the Target Equity Securities

have been duly authorized and validly issued. All of the outstanding Target Shares are fully paid and non-assessable. The Target Equity

Securities (1) were not issued in violation of the Organizational Documents of the Target or any other Contract to which the Target

is party or bound, (2) were not issued in violation of any preemptive rights, call option, right of first refusal or first offer,

subscription rights, transfer restrictions or similar rights of any Person and (3) have been offered, sold and issued in all material

respects in compliance with applicable Law, including Securities Laws. Except for the Target Options and Target Convertible Notes set

forth on 3.3(b)(i) of the Target Disclosure Letter or the Target Options either permitted by Section 5.1(b) of

the Business Combination Agreement or issued, granted or entered into in accordance with Section 5.1(b) of the Business

Combination Agreement, the Target has no outstanding (x) equity appreciation, phantom equity or profit participation rights or (y) options,

restricted share units, phantom shares, warrants, purchase rights, subscription rights, conversion rights, exchange rights, calls, puts,

rights of first refusal or first offer or other Contracts that could require the Target to issue, sell or otherwise cause to become outstanding

or to acquire, repurchase or redeem any Target Equity Securities or securities convertible into or exchangeable for Target Equity Securities.

(ii)            The

Target Equity Securities are free and clear of all Liens (other than transfer restrictions under applicable securities Laws). There are

no shareholder agreements, voting trusts, proxies or other Contracts to which the Target is a party with respect to the voting or transfer

of the Target’s Equity Securities.

(iii)            Section 3.3(b)(iii) of

the Target Disclosure Letter sets forth a true and complete statement of (A) the number and class or series (as applicable) of all

of the equity securities of each Subsidiary of the Target issued and outstanding and (B) the identity of the Persons that are the

record and beneficial owners thereof. There are no outstanding (1) equity appreciation, phantom equity or profit participation rights

or (2) options, restricted shares, restricted share units, phantom shares, warrants, purchase rights, subscription rights, conversion

rights, exchange rights, calls, puts, rights of first refusal or first offer or other Contracts that could require any Subsidiary of the

Target to issue, sell or otherwise cause to become outstanding or to acquire, repurchase or redeem any Equity Securities or securities

convertible into or exchangeable for equity securities of the Subsidiaries of the Target. There are no voting trusts, proxies or other

Contracts with respect to the voting or transfer of any equity securities of any Subsidiary of the Target. There are no outstanding bonds,

debentures, notes or other indebtedness of the Target having the right to vote (or convertible into, or exchangeable for, securities having

the right to vote) on any matter for which holders of Target Shares may vote.

(iv)           Except

as set forth on Section 3.2(b)(iv) of the Target Disclosure Letter, there are no voting trusts, proxies or other Contracts

with respect to the voting or transfer of the Target’s Equity Securities between the Target and any other Person.

(v)            Except

as set forth on Section 3.2(b)(v) of the Target Disclosure Letter, none of the Target Companies owns or holds (of record,

beneficially, legally or otherwise), directly or indirectly, any equity in any other Person or the right to acquire any such equity security,

and none of the Target Companies are a partner or member of any partnership, limited liability company or joint venture.

(vi)          No

Target Company has provided any legally binding guarantee pursuant to which such Target Company is obligated to pay or discharge the liabilities

or obligations of any direct or indirect holder of equity securities of Target or any other Person that is not a Target Company, except

as otherwise disclosed in Section 3.3(b)(vi) of the Target Disclosure Letter.

(vii)          Section 3.3(b)(vii) of

the Target Disclosure Letter sets forth a list of all Indebtedness of the Target Companies as of the date of this Agreement, including

the principal amount of such Indebtedness, the outstanding balance as of the date of this Agreement, and the debtor and the creditor thereof.

(viii)         Section 3.3(b)(viii) of

the Target Disclosure Letter sets forth a list of all Change of Control Payments (as defined in the Business Combination Agreement in

effect as of the date hereof) of the Target Companies.

(ix)             Other

than the Target Convertible Notes, there are no debt instruments outstanding convertible into or otherwise entitling the holder thereof

to any of the Target’s Equity Securities.

(x)            (i) No

triggering event for the weighted-average anti-dilution right contained in Article 7.1(xiv) of each convertible loan agreement

entered into with Avanea Investment Holding a.s. (the “AIH Anti-Dilution Right”) has occurred prior to the date of

this Agreement; and (ii) to the knowledge of the Target, no facts, matters or circumstances exist as at the date of this Agreement

that would reasonably be expected to result in the occurrence of a triggering event for the AIH Anti-Dilution Right prior to or upon Closing.

(xi)             The

Target has, prior to the execution of this Agreement, provided a copy of this Agreement to each of the equityholders of Target.

(i)             The

Target has the requisite corporate power and authority to execute and deliver this Agreement and each Transaction Document to which it

is or will be a party, to perform its obligations hereunder and thereunder, and to consummate the transactions contemplated hereby and

thereby. The execution and delivery of this Agreement, the Transaction Documents to which the Target is or will be a party, the performance

of the Target’s obligations hereby and thereby and the consummation of the transactions contemplated hereby and thereby have been

(or, in the case of any Transaction Document entered into after the date of this Agreement, will be upon execution thereof) duly authorized

by all necessary corporate (or other similar) action on the part of the Target. This Agreement and each Transaction Document to which

the Target is or is contemplated to be a party has been or will be, upon execution thereof, as applicable, duly and validly executed and

delivered by the Target and constitutes or will constitute, upon execution and delivery thereof, as applicable, a valid, legal and binding

agreement of the Target (assuming that this Agreement and the Transaction Documents to which the Target is or will be a party are or will

be upon execution thereof, as applicable, duly authorized, executed and delivered by the other Persons party thereto), enforceable against

the Target in accordance with their respective terms (subject to applicable bankruptcy, insolvency, reorganization, moratorium or other

Laws affecting generally the enforcement of creditors’ rights and subject to general principles of equity). Execution of the Undertaking

signed by the equityholders of the Target party thereto is the only action of the holders of any class or series of shares of the Target

required to approve and adopt this Agreement, the Transaction Documents to which the Target is or is contemplated to be a party, the performance

of the Target’s obligations hereunder and thereunder and the consummation of the transactions contemplated hereby and thereby.

(ii)            The

board of directors of the Target unanimously and duly adopted resolutions (A) determining that entry into this Agreement and the

other Transaction Documents to which the Target is party, and the consummation of the transactions contemplated hereby and thereby, are

advisable and fair to, and in the best interest of, the Target and its shareholders, and (B) approving this Agreement, such other

Transaction Documents and the consummation of the transactions contemplated hereby and thereby, including the Exchange, which resolutions

have not been subsequently withdrawn or modified in a manner adverse to CGC..

(d)             Financial

Statements; Undisclosed Liabilities.

(i)             Each

of the unaudited consolidated balance sheets of the Target Companies as of December 31, 2024 and December 31, 2025 and the related

unaudited consolidated statements of operations and comprehensive loss and shareholders’ deficit of the Target Companies for each

of the periods ended on December 31, 2024 and December 31, 2025 (including the notes thereto) (A) was prepared in accordance

with local accounting standards applied on a consistent basis throughout the periods indicated (except as may be indicated in the notes

thereto), (B) fairly presents, in all material respects, the financial position and results of operations of the Target Companies

as at the date thereof and for the period indicated therein, except as otherwise specifically noted therein, and (C) are undergoing

an audit in accordance with IFRS and the standards of the PCAOB and are expected to contain an unqualified report of the Company’s

auditors.

(ii)            Each

of the audited consolidated balance sheets of the Target Companies as of December 31, 2024 and December 31, 2025 and the related

audited consolidated statements of operations and comprehensive loss, shareholders’ deficit and cash flows of the Target Companies

for each of the periods ended on December 31, 2024 and December 31, 2025, when delivered to CGC following the date of this Agreement

in accordance with Section 5.17 of the Business Combination Agreement, (A) will be prepared in accordance with IFRS and

the standards of the PCAOB and applied on a consistent basis throughout the periods indicated (except as may be specifically indicated

in the notes thereto), (B) will fairly present, in all material respects, the financial position, results of operations and cash

flows of the Target Companies as at the date thereof and for the period indicated therein, except as otherwise specifically noted therein

and (C) will comply in all material respects with the applicable accounting requirements and with the rules and regulations

of the SEC, the Exchange Act and the Securities Act in effect as of the respective dates thereof (including Regulation S-X or Regulation

S-K, as applicable).

(ii)           Except

(A) for Liabilities incurred in the ordinary course of business since December 31, 2025 (none of which are Liabilities directly

or indirectly related to a breach of Contract, breach of warranty, tort, infringement, Proceeding or violation of, or non-compliance with,

Law), (B) for Liabilities incurred in connection with the negotiation, preparation or execution of this Agreement or any Transaction

Documents, the performance of their respective covenants or agreements in this Agreement or any Transaction Document or the consummation

of the transactions contemplated hereby or thereby and (C) for Liabilities that are not and would not reasonably be expected to be,

individually or in the aggregate, material to the Target Companies, taken as a whole, no Target Company has any Liabilities of the type

required to be set forth on a balance sheet in accordance with IFRS.

(d)           The

Target Companies have established and maintain systems of internal accounting controls that are designed to provide, in all material respects,

reasonable assurance (i) that all transactions are executed in accordance with management’s authorization, (ii) that all

transactions are recorded as necessary to permit preparation of proper and accurate financial statements in accordance with IFRS and to

maintain accountability for the Target Companies’ assets, and (iii) regarding prevention or timely detection of the unauthorized

acquisition, use or disposition of the Target Company’s properties or assets. The Target Companies maintain books and records of

the Target Companies in the ordinary course of business that are accurate and complete and reflect the revenues, expenses, assets and

liabilities of the Target Companies in all material respects.

(e)             Consents

and Requisite Governmental Approvals; No Violations.

(i)             No

consent, approval or authorization of, or designation, declaration or filing with, any Governmental Authority is required on the part

of the Target with respect to the Target’s execution, delivery or performance of its obligations under this Agreement or the Transaction

Documents to which the Target is or will be party or the consummation of the transactions contemplated hereby or thereby, except for (A) the

filing with the SEC of (1) the registration statement of the Company / proxy statement of CGC in connection with the Business Combination

and the declaration of the effectiveness thereof by the SEC and (2) such reports under Section 13(a) or 15(d) of the

Exchange Act as may be required in connection with this Agreement, the Transaction Documents or the transactions contemplated hereby or

thereby, or (B) any other consents, approvals, authorizations, designations, declarations, waivers or filings, the absence of which

would not have a Target Material Adverse Effect.

(ii)            None

of the execution or delivery by the Target of this Agreement or any Transaction Documents to which it is or will be a party, the performance

by the Target of its obligations hereunder or thereunder, or the consummation of the transactions contemplated hereby or thereby will,

directly or indirectly (with or without due notice or lapse of time or both) (A) result in a violation or breach of any provision

of the Target’s Organizational Documents, (B) result in a violation or breach of, or constitute a default or give rise to

any right of termination, Consent, cancellation, amendment, modification, suspension, sanction, revocation or acceleration under, any

of the terms, conditions or provisions of (1) any Contract (including any Public Aid Financial Scheme) to which any Target Company

is a party or (2) any Material Permits, (C) violate, or constitute a breach under, any Order or applicable Law to which any

Target Company or any of its properties or assets are subject or bound or (D) result in the creation of any Lien upon any of the

assets or properties (other than any Permitted Liens) or equity securities of any Target Company, except, in the case of any of clauses

(B) through (D) above, as would not have a Target Material Adverse Effect.

(f)             Permits.

The Target has all franchises, permits, licenses and any similar authority necessary for the conduct of its business, the lack of which

would reasonably be expected to have a Target Material Adverse Effect (each, a “Material Permit”). The Target is not

in default in any material respect under any of such franchises, permits, licenses or other similar authority.

(g)             Material

Contracts.

(i)             Section 3.3(g) of

the Target Disclosure Letter sets forth a list of the following Contracts to which a Target Company is a party as of the date of this

Agreement, excluding any Target Benefit Plan (each Contract required to be set forth on Section 3.3(g) of the Target

Disclosure Letter, together with each of the Contracts entered into after the date of this Agreement that would be required to be set

forth on Section 3.3(g) of the Target Disclosure Letter if entered into prior to the execution and delivery of this

Agreement, collectively, the “Material Contracts”):

(A)             any

Contract relating to Indebtedness for borrowed money of any Target Company or to the placing of a Lien (other than any Permitted Lien)

on any material assets or properties of any Target Company;

(B)             any

Contract under which any Target Company is lessee of or holds or operates, in each case, any tangible property (other than real property),

owned by any other Person, except for any lease or agreement under which the aggregate annual rental payments do not exceed $500,000;

Contract under which any Target Company is lessor of or permits any third party to hold or operate, in each case, any tangible property

(other than real property), owned or controlled by such Target Company, except for any lease or agreement under which the aggregate annual

rental payments do not exceed $500,000;

(D)             any

(1) joint venture, profit-sharing, partnership, collaboration, co-promotion, commercialization or research or development Contract,

in each case, which requires, or would reasonably be expected to require (based on any occurrence, development, activity or event contemplated

by such Contract), aggregate payments to or from any Target Company in excess of $500,000 over the life of the Contract and (2) any

Contract with respect to material Target Licensed Intellectual Property (other than Off-the-Shelf Software);

(E)             any

Contract that (1) limits or purports to limit, in any material respect, the freedom of any Target Company to engage or compete in

any line of business or with any Person or in any area or that would so limit or purport to limit, in any material respect, the operations

of CGC or any of its Affiliates after the Closing, (2) contains any exclusivity, “most favored nation” or similar provisions,

obligations or restrictions or (3) contains any other provisions restricting or purporting to restrict the ability of any Target

Company to sell, manufacture, develop, commercialize, test or research products, directly or indirectly through third parties, or to solicit

any potential employee or customer, in each case, in any material respect or that would so limit or purports to limit in any material

respect, CGC or any of its Affiliates after the Closing;

(F)             any

Contract requiring any future capital commitment or capital expenditure (or series of capital expenditures) by any Target Company in an

amount in excess of (A) $500,000 annually or (B) $1,000,000 over the life of the agreement;

(G)             any

Contract requiring any Target Company to guarantee the Liabilities of any Person (other than the Target or a Subsidiary) or pursuant to

which any Person (other than the Target or a Subsidiary) has guaranteed the Liabilities of a Target Company, in each case in excess of

$500,000;

(H)             any

Contract under which any Target Company has, directly or indirectly, made or agreed to make any loan, advance, or assignment of payment

to any Person or made any capital contribution to, or other investment in, any Person;

(I)             any

Contract required to be disclosed on Section 3.3(s) of the Target Disclosure Letter;

(J)             any

Contract with any Person (1) pursuant to which any Target Company (or CGC or any of its Affiliates after the Closing) may be required

to pay milestones, royalties or other contingent payments based on any research, testing, development, regulatory filings or approval,

sale, distribution, commercial manufacture or other similar occurrences, developments, activities or events or (2) under which any

Target Company grants to any Person any right of first refusal, right of first negotiation, option to purchase, option to license or any

other similar rights with respect to any Target Product or any Intellectual Property;

(K)             any

Contract governing the terms of the employment, engagement or services of any current director, manager, officer, employee, individual

independent contractor or other service provider of a Target Company whose annual base salary (or, in the case of an independent contractor,

annual base compensation) is in excess of $300,000;

(L)             any

Contract for the disposition of any portion of the assets or business of any Target Company or for the acquisition by any Target Company

of the assets or business of any other Person (other than acquisitions or dispositions made in the ordinary course of business), or under

which any Target Company has any continuing obligation with respect to an “earn-out”, contingent purchase price or other contingent

or deferred payment obligation;

(M)             any

settlement, conciliation or similar Contract (1) the performance of which would be reasonably likely to involve any payments after

the date of this Agreement, (2) with a Governmental Authority or (3) that imposes or is reasonably likely to impose, at any

time in the future, any material, non-monetary obligations on any Target Company (or CGC or any of its Affiliates after the Closing);

and

(N)             any

other Contract the performance of which requires either (1) annual payments to or from any Target Company in excess of $500,000 or

(2) aggregate payments to or from any Target Company in excess of $1,000,000 over the life of the agreement and, in each case, that

is not terminable by the applicable Target Company without penalty upon less than thirty (30) days’ prior written notice; and

(O)             any

Public Financial Aid Scheme.

(ii)            (A) Each

Material Contract is valid and binding on the applicable Target Company and, to the knowledge of the Target, the counterparties thereto,

and is in full force and effect and enforceable in accordance with its terms against such Target Company and, to the Target’s knowledge,

the counterparties thereto, (B) the applicable Target Company and, to the knowledge of the Target, the counterparties thereto are

not in material breach of, or default under, any Material Contract and (C) no event has occurred that (with or without due notice

or lapse of time or both) would result in a material breach of, or default under, any Material Contract by the applicable Target Company

or, to the Target’s knowledge, the counterparties thereto.

(iii)           Except

with respects to breaches or defaults that have been remedied by any Person or waived in writing by the applicable Governmental Authority,

the Target Companies (A) are and have been at all times in compliance with the terms and conditions of any Public Financial Aid Schemes;

and (B) were not notified by Public Financial Aid Scheme providers or other Governmental Authorities that any Target Company is in

breach of the terms and conditions of any Public Financial Aid Scheme.

(h)             Absence

of Changes. During the period beginning on January 1, 2026 and ending on the date of this Agreement, (a) no Target

Material Adverse Effect has occurred and (b) except as expressly contemplated by this Agreement, any Transaction Document or in

connection with the transactions contemplated hereby and thereby, the Target has conducted its business in the ordinary course in all

material respects.

(i)             Litigation.

(i)             There

is no claim, action, suit, proceeding, arbitration, complaint, charge or investigation pending or to the Target’s knowledge, currently

threatened (A) against the Target Companies or any officer, director or person set forth on Section 3.3(i)(i) of

the Target Disclosure Letter (each, a “Key Person”); (B) that questions the validity of this Agreement and the

Transaction Documents or the right of the Target to enter into them, or to consummate the transactions contemplated by the transactions

contemplated by this Agreement; or (C) that would reasonably be expected to have, either individually or in the aggregate, a Target

Material Adverse Effect. None of the Target Companies or, to the Target’s knowledge, any of their officers, directors or Key Persons

is a party or is named as subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency

or instrumentality (in the case of officers, directors or Key Persons such as would affect the Target). There is no action, suit, proceeding

or investigation by a Target Company pending or which a Target Company intends to initiate. The foregoing includes, without limitation,

actions, suits, proceedings or investigations pending or threatened in writing (or any basis therefor known to the Target) involving

the prior employment of any of the Target Company’s employees, their services provided in connection with the Target Company’s

business, any information or techniques allegedly proprietary to any of their former employers or their obligations under any agreements

with prior employers.

(ii)            Except

as set forth in Section 3.3(i)(ii) of the Target Disclosure Letter, (i) no written demand, notice of claim, recission

notice or formal notification of breach has been delivered by NDF II to the Target, InoBat Auto j.s.a. or InoBat Volta II s.r.o.

under or in connection with the investment agreement dated 20 December 2023 between the Target, InoBat Auto j.s.a., InoBat

Volta II s.r.o. and NDF II (as amended, the “NDF II Investment Agreement”); (ii) to the knowledge of the

Target, no facts or circumstances exist as at the date of this Agreement that would, individually or in the aggregate, constitute or

reasonably be expected to give rise to a claim by NDF II for financial compensation or the accrual of any contractual penalty under the

NDF II Investment Agreement; and (iii) there is no pending or, to the knowledge of the Target, threatened claim, action, or arbitration

by NDF II against the Target, InoBat Auto j.s.a. or InoBat Volta II s.r.o. arising out of or in connection with the NDF II Investment

Agreement.

(j)             Compliance

with Applicable Law.

(i)             During

the three (3) years prior to the Closing, the Target has complied in all material respects with all federal, state, local or foreign

statutes, rule or regulations applicable to it. The Target is not in violation or default (A) of any provisions of its Organizational

Documents, (B) of any instrument, judgment, order, writ or decree, (C) under any note, indenture or mortgage, or (D) under

any lease, agreement, contract or purchase order to which it is a party or by which it is bound. The execution, delivery and performance

of this Agreement and the Transaction Documents and the consummation of the transactions contemplated by this Agreement and the Transaction

Documents will not result in any such violation or be in conflict with or constitute, with or without the passage of time and giving

of notice, either (A) a default under any such provision, instrument, judgment, order, writ, decree, contract or agreement; or (B) an

event which results in the creation of any lien, charge or encumbrance upon any assets of the Target or the suspension, revocation, forfeiture,

or nonrenewal of any material permit or license applicable to the Target.

(ii)            Each

Target Company which is or has at any time been subject to an obligation to register in the RPSP Register:

(A)             has,

since the date on which the obligation to register first arose, been duly and validly registered in the RPSP Register in accordance with

Slovak Act No. 315/2016 Coll. and all applicable Slovak laws and regulations;

(B)             has

at all times ensured that all information entered in, or required to be entered in, the RPSP Register in respect of it is and has been

complete, accurate, true, up to date and not misleading in any respect, including without limitation all information relating to its

ultimate beneficial owners (konečný užívateľ výhod) and authorised persons (oprávnená

osoba) within the meaning of Slovak Act No. 315/2016 Coll.;

fulfilled, in full and in a timely manner, each and every obligation imposed upon it under Slovak Act No. 315/2016 Coll.;

(D)             has

not, at any time, been struck off, suspended, or had its registration in the RPSP Register lapsed, cancelled, or rendered invalid for

any reason;

(E)             has

not, at any time, been in breach of any obligation under Slovak Act No. 315/2016 Coll. or subject to any fine, penalty, sanction,

administrative proceeding, investigation or enforcement action by any competent authority in connection with the RPSP Register or Slovak

Act No. 315/2016 Coll.; and

(F)             has

not received any notice, claim, complaint, warning or correspondence from any competent authority, public body or counterparty alleging

or indicating any actual or potential breach of, or non-compliance with, Slovak Act No. 315/2016 Coll. or any obligation relating

to the RPSP Register.

(iii)             Without

limiting the generality of paragraph (b) above, each Target Company which is or has at any time been subject to an obligation to

register in the RPSP Register has, at all times, maintained its registration in the RPSP Register and fulfilled all of its obligations

under Slovak Act No. 315/2016 Coll. in a manner that:

(A)             satisfies

all conditions, requirements and eligibility criteria applicable to it under each Public Finance Aid Scheme to which it is or has been

a party or beneficiary;

(B)             has

not given rise to, and does not give rise to, any right on the part of any public authority, awarding body or competent authority to (x) suspend,

withdraw, claw back, reclaim or reduce any benefit, grant, subsidy, payment or advantage received or receivable by such Target Company

under any Public Finance Aid Scheme; or (y) terminate, rescind or invalidate any contract, agreement or arrangement entered into

with such Target Company under or in connection with any Public Finance Aid Scheme;

not resulted in, and does not result in, any forfeiture, disqualification, exclusion or debarment of such Target Company from participation

in any current or future Public Finance Aid Scheme; and

(D)             has

not had, and does not have, any adverse impact or consequence on any Public Finance Aid Scheme, including on the validity, continuity,

enforceability or value of any benefit thereunder.

(iv)           To

the knowledge of the Target, there are no facts, matters or circumstances which are reasonably likely to give rise to any breach of, or

non-compliance with, Slovak Act No. 315/2016 Coll. or any obligation relating to the RPSP Register by any Target Company in the future,

or which would adversely affect the registration or standing of any Target Company in the RPSP Register.

(v)           The transactions contemplated

by this Agreement comply with the investment aid conditions applicable with respect to the Contracts set forth in Section 3.3(j)(v) of

the Target Disclosure Letter.

(vi)          The relevant portion

of Owned Real Property described in Section 3.3(i)(vi) of the Target Disclosure Letter (such portion of Owned Real Property,

the “Volta II Real Property”) has been permanently removed from the agricultural land fund, and no further action,

decision, levy, permit or administrative procedure under applicable agricultural land legislation will be required in order to enable

the development and use of such land for the further development currently contemplated by the relevant Target Company.

(vii)         Except with respects

to breaches or defaults that have been remedied by any Person or waived in writing by the applicable Governmental Entity, to the Target’s

knowledge, GIB (A) is and has been at all times in compliance with the terms and conditions applicable with respect to the Contract

set forth in Section 3.3(j)(vii) of the Target Disclosure Letter and (B) was not notified by public financial aid

scheme providers or other Governmental Entities that it is in breach of the terms and conditions of such Contract.

(k)             Employee

Plans.

(i)             Section 3.3(k)(i) of

the Target Disclosure Letter sets forth a true and complete list of all material Target Benefit Plans (including, for each such Target

Benefit Plan, its jurisdiction).. Any equity awards that are outstanding under or authorized to be made pursuant to Target Benefit Plans

relate solely to the Target’s ordinary shares and will not result in the issuance of preference shares of the Company.

(ii)            No

Target Benefit Plan has any unfunded or underfunded Liability. No Target Company has any material Liabilities to provide any retiree or

post-termination health or life insurance or other welfare-type benefits to any Person, except as required by applicable Law regarding

statutory severance or notice periods. No Target Company has any material Liabilities by reason of at any time being considered part of

a single controlled group or related employer under applicable Law.

(iii)           Each

Target Benefit Plan is in compliance, in all material respects, in accordance with its terms and the requirements of all applicable Laws.

Each Target Benefit Plan that is intended to be tax-favored under applicable Law has timely received all necessary registrations or approvals,

and no fact or event has occurred that would reasonably be expected to result in the loss of such status. None of the Target Companies

has incurred any material penalty or arrears regarding mandatory social security, health insurance, or supplementary pension contributions.

(iv)           As

of the date of this Agreement, there are no pending or, to the Target’s knowledge, threatened in writing claims or Proceedings with

respect to any Target Benefit Plan (other than routine claims for benefits). All contributions, social insurance premiums, and mandatory

health insurance payments that are due have been timely made to the relevant Governmental Authority, except as is not and would not reasonably

be expected to be, individually or in the aggregate, material to the Target Companies, taken as a whole.

(v)             Except

as set forth on Section 3.3(k)(v) of the Target Disclosure Letter execution and delivery of this Agreement and the consummation

of the transactions contemplated by this Agreement will not materially (alone or in combination with any other event) (i) result

in any payment or benefit becoming due to or result in the forgiveness of any indebtedness of any current or former director, manager,

officer, employee, individual independent contractor or other service providers of any of the Target Companies, (ii) increase the

amount or value of any compensation or benefits payable to any current or former director, manager, officer, employee, individual independent

contractor or other service providers of any of the Target Companies or (iii) result in the acceleration of the time of payment

or vesting, or trigger any payment or funding of any compensation or benefits to any current or former director, manager, officer, employee,

individual independent contractor or other service providers of any of the Target Companies.

(l)             Environmental

Matters.

(i)             Except

as could not reasonably be expected to have a Target Material Adverse Effect (a) the Target is and has been in compliance with all

Environmental Laws; (b) there has been no release or threatened release of any Hazardous Substance, on, upon, into or from any site

currently or heretofore owned, leased or otherwise used by the Target; (c) there have been no Hazardous Substances generated by

the Target that have been disposed of or come to rest at any site that has been included in any published list of hazardous or toxic

waste sites published by any governmental authority in Slovakia; and (d) the Target does not manufacture, handle, import, export,

or transport any nanoengineered or nanoscale material; and (e) the Target does not and has not imported any hazardous substances.

(ii)            No

Target Company is an originator (pôvodca) of any environmental burden and is not, and has not been determined as the responsible

person (povinná osoba) for any environmental burden pursuant to the Act No. 409/2011 Coll. on Certain Measures in the

Area of Environmental Burden and on Amendments to Certain Acts, as amended, and no proceeding on determination of any Target Company as

the responsible person is pending, and no Target Company has carried out any activity that could result in such Target Company being determined

as the originator of, or designated as the responsible person for, any environmental burden.

(iii)           No

Target Company has assumed, retained or agreed to bear any liability under any applicable environmental legislation pursuant to any agreement

with any third party, nor has it provided any environmental indemnity, guarantee, covenant to remediate, or similar undertaking to any

third party.

(iv)          No

Target Company has received any written notice, order, instruction, decision or other administrative correspondence from any Governmental

Authority alleging or relating to (A) any actual or pending violation of any applicable environmental legislation, (B) any environmental

burden affecting or potentially affecting any real property owned, leased or otherwise occupied by any Target Company (including any environmental

burden registered to any third party in respect of which any Target Company has been copied, addressed or otherwise made aware), or (C) any

remediation, monitoring or other environmental obligation, and no Target Company is subject to any ongoing or, to the knowledge of the

Target, threatened environmental investigation, claim, proceeding, enforcement action, order, or remediation obligation.

(m)             Intellectual

Property.

(i)             The

Target Companies (A) own or possess and (B) in the case of the Target Companies’ business presently proposed to be conducted,

reasonably believes it can acquire on commercially reasonable terms, sufficient legal rights to all Target Intellectual Property without

any known conflict with, or infringement of, the rights of others, including prior employees or consultants. The Target Companies have

not received any communications alleging that the Target Companies have violated, or by conducting its business, would violate any of

the Intellectual Property of any other Person. No product or service marketed or sold (or proposed to be marketed or sold) by the Target

Companies violates or will violate any license or infringes or will infringe any Intellectual Property of any other party. Other than

with respect to commercially available software products under standard end-user object code license agreements, there are no outstanding

options, licenses, agreements, claims, encumbrances or shared ownership interests of any kind relating to the Target Intellectual Property,

nor are the Target Companies bound by or a party to any Intellectual Property of any other Person. The Target Companies have obtained

and possess valid licenses to use all of the software programs present on the computers and other software-enabled electronic devices

that it owns or leases or that it has otherwise provided to its employees for their use in connection with the Target Companies’

business.

(ii)            Each

employee has assigned to the Target Companies all Intellectual Property he or she owns that are related to the Target Companies’

business as now conducted and as presently proposed to be conducted and each employee and consultant has assigned to the Target Companies

all intellectual property rights that he, she or it solely or jointly conceived, reduced to practice, developed or made during the period

of his, her or its employment or consulting relationship with the Target Companies that (A) relate, at the time of conception, reduction

to practice, development, or making of such intellectual property right, to the Target Companies’ business as then conducted or

as then proposed to be conducted, (B) were developed on any amount of the Target Companies’ time or with the use of any of

the Target Companies’ equipment, supplies, facilities or information or (C) resulted from the performance of services for the

Target Companies. It will not be necessary to use any inventions of any of its employees or consultants (or Persons it currently intends

to hire) made prior to their employment by the Target Companies, including prior employees or consultants.

(iii)           Section 3.3(m)(iii) of

the Target Disclosure Letter lists all patents, patent applications, registered trademarks, trademark applications, service marks, service

mark applications, tradenames, registered copyrights, and licenses to and under any of the foregoing, in each case owned by the Target

Companies.

(iv)          The

Target Companies have not embedded, used or distributed any open source, copyleft or community source code (including but not limited

to any libraries or code, software, technologies or other materials that are licensed or distributed under any General Public License,

Lesser General Public License or similar license arrangement or other distribution model described by the Open Source Initiative at www.opensource.org,

collectively “Open Source Software”) in connection with any of its products or services that are generally available

or in development in any manner that would materially restrict the ability of the Target Companies to protect their proprietary interests

in any such product or service or in any manner that requires, or purports to require (i) any Target Intellectual Property (other

than the Open Source Software itself) be disclosed or distributed in source code form or be licensed for the purpose of making derivative

works; (ii) any restriction on the consideration to be charged for the distribution of any Target Intellectual Property; (iii) the

creation of any obligation for the Target Companies with respect to Target Intellectual Property owned by the Target Companies, or the

grant to any third party of any rights or immunities under Target Intellectual Property owned by the Target Companies; or (iv) any

other limitation, restriction or condition on the right of the Target Companies with respect to their use or distribution of any Target

Intellectual Property.

(v)             Except

as set forth in Section 3.3(m)(v) of the Target Disclosure Letter No government funding, facilities of a university,

college, other educational institution or research center, or funding from third parties was used in the development of any Target Intellectual

Property. No Person who was involved in, or who contributed to, the creation or development of any Target Intellectual Property, has performed

services for the government, university, college, or other educational institution or research center in a manner that would affect the

Target Companies’ rights in the Target Intellectual Property.

(n)             Employee

Matters.

(i)             Section 3.3(n)(i) of

the Target Disclosure Letter, lists the full-time employees, part time employees, consultants and independent contractors employed or

engaged by the Target Companies as of the date hereof. Section 3.3(n)(i) of the Target Disclosure Letter also sets forth

a detailed description of all compensation, including salary, bonus, severance obligations and deferred compensation paid or payable for

each officer, employee, consultant and independent contractor of the Target Companies.

(ii)            To

the Target’s knowledge, none of the Target Companies’ employees is obligated under any contract (including licenses, covenants

or commitments of any nature) or other agreement, or subject to any judgment, decree or order of any court or administrative agency, that

would materially interfere with such employee’s ability to promote the interest of the Target Companies or that would conflict with

the Target Companies’ business. Neither the execution or delivery of this Agreement and the Transaction Documents, nor the carrying

on of the Target Companies’ business by the employees of the Target Companies, nor the conduct of the Target Companies’ business

as now conducted and as presently proposed to be conducted, will, to the Target’s knowledge, conflict with or result in a breach

of the terms, conditions, or provisions of, or constitute a default under, any contract, covenant or instrument under which any such employee

is now obligated.

(iii)           The

Target Companies are not delinquent in payments to any of its employees, consultants, or independent contractors for any wages, salaries,

commissions, bonuses, or other direct compensation for any service performed for it to the date hereof or amounts required to be reimbursed

to such employees, consultants or independent contractors. The Target Companies have complied in all material respects with all applicable

state and federal equal employment opportunity laws and with other laws related to employment, including those related to wages, hours,

worker classification and collective bargaining. The Target Companies have withheld and paid to the appropriate Governmental Authority

or is holding for payment not yet due to such Governmental Authority all amounts required to be withheld from employees of the Target

Companies and is not liable for any arrears of wages, taxes, penalties or other sums for failure to comply with any of the foregoing.

(iv)           To

the Target’s knowledge, no Key Persons intends to terminate employment with the Target or is otherwise likely to become unavailable

to continue as a Key Persons, nor does the Target have a present intention to terminate the employment of any of the foregoing. The employment

of each employee of the Target is terminable at the will of the Target. Except as set forth in Section 3.3(n)(iv) of

the Target Disclosure Letter r or as required by law, upon termination of the employment of any such employees, no severance or other

payments will become due. Except as set forth in Section 3.3(n)(iv) of the Target Disclosure Letter, the Target has no

policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of

employment services.

(v)           The

Target Companies have not made any representations regarding equity incentives to any officer, employee, director or consultant that are

inconsistent with the share amounts and terms set forth in the minutes of meetings of the Board of Directors.

(vi)          Each

former Key Persons whose employment was terminated by the Target has entered into an agreement with the Target providing for the full

release of any claims against the Target or any related party arising out of such employment.

(vii)         The

Target Companies are not bound by or subject to (and none of its assets or properties is bound by or subject to) any written or oral,

express or implied, contract, commitment or arrangement with any labor union, and no labor union has requested or, to the knowledge of

the Target, has sought to represent any of the employees, representatives or agents of the Target Companies. There is no strike or other

labor dispute involving the Target Companies pending, or to the Target’s knowledge, threatened, which could have a Target Material

Adverse Effect, nor is the Target aware of any labor organization activity involving its employees.

(viii)         To

the Target’s knowledge, none of the Key Persons, officers or directors of the Target Companies has been (A) subject to voluntary

or involuntary petition under applicable bankruptcy Laws or the appointment of a receiver, fiscal agent or similar officer by a court

for his business or property; (B) convicted in a criminal proceeding or named as a subject of a pending criminal proceeding (excluding

traffic violations and other minor offenses); (C) subject to any order, judgment or decree (not subsequently reversed, suspended,

or vacated) of any court of competent jurisdiction permanently or temporarily enjoining him from engaging, or otherwise imposing limits

or conditions on his engagement in any securities, investment advisory, banking, insurance, or other type of business or acting as an

officer or director of a public company; or (D) found by a court of competent jurisdiction in a civil action or by the Securities

and Exchange Commission or the Commodity Futures Trading Commission to have violated any federal or state securities, commodities, or

unfair trade practices law, which such judgment or finding has not been subsequently reversed, suspended, or vacated.

(o)             Insurance.

Section 3.3(o) of the Target Disclosure Letter sets forth a list of all material policies of fire, liability, workers’

compensation, property, casualty and other forms of insurance owned or held by any Target Company as of the date of this Agreement. All

such policies are in full force and effect, all premiums due and payable thereon as of the date of this Agreement have been paid in full

as of the date of this Agreement. As of the date of this Agreement, no claim by any Target Company is pending under any such policies

as to which coverage has been denied or disputed, or rights reserved to do so, by the underwriters thereof, except as is not and would

not reasonably be expected to be, individually or in the aggregate, material to the Target Companies, taken as a whole.

(p)             Tax

Matters.

(i)             Except

as set forth in Section 3.3(p) of the Target Disclosure Letter, each Target Company has prepared and filed all income

and other material Tax Returns required to have been filed by it, all such Tax Returns are true and complete in all material respects

and prepared in compliance in all material respects with all applicable Laws and Orders, and each Target Company has paid all material

Taxes required to have been paid by it regardless of whether shown on a Tax Return.

(ii)            Each

Target Company has timely withheld and paid to the appropriate Tax Authority all material amounts required to have been withheld and paid

in connection with amounts paid or owing to any employee, individual independent contractor, other service providers, equity interest

holder or other third party.

(iii)           No

Target Company is currently the subject of a Tax audit or examination with respect to material Taxes. No Target Company has been informed

in writing of the commencement or anticipated commencement of any Tax audit or examination that has not been resolved or completed in

each case with respect to material Taxes.

(iv)          No

Target Company has consented to extend or waive the time in which any material Tax may be assessed or collected by any Tax Authority,

other than any such extensions or waivers that are no longer in effect or that were extensions of time to file Tax Returns obtained in

the ordinary course of business.

(v)           No

“closing agreement” as described in Section 7121 of the Code (or any corresponding or similar provision of state, local

or non-U.S. income Tax Law), private letter rulings, technical advice memoranda or similar agreements or rulings have been entered into

or issued by any Tax Authority with respect to a Target Company which agreement or ruling would be effective after the Closing Date.

(vi)          No

Target Company is or has been a party to any “listed transaction” as defined in Section 6707A of the Code and Treasury

Regulations Section 1.6011-4 (or any corresponding or similar provision of state, local or non-U.S. income Tax Law).

(vii)          There

are no Liens for material Taxes on any assets of the Target Companies other than Permitted Liens.

(viii)        During

the two (2)-year period ending on the date of this Agreement, no Target Company was a distributing corporation or a controlled corporation

in a transaction purported or intended to be governed by Section 355 of the Code.

(ix)           No

Target Company (A) has been a member of an affiliated group filing a consolidated federal income Tax Return (other than a group the

common parent of which was a Target Company or any of its current Affiliates) or (B) has any material Liability for the Taxes of

any Person (other than a Target Company or any of its current Affiliates) under Section 1.1502-6 of the Treasury Regulations (or

any similar provision of state, local or non-United States Law), as a transferee or successor or by Contract (other than any Contract

the principal purpose of which does not relate to Taxes).

(x)             No

written claims have ever been made by any Tax Authority in a jurisdiction where a Target Company does not file Tax Returns that such Target

Company is or may be subject to taxation by that jurisdiction, which claims have not been resolved or withdrawn.

(xi)           No

Target Company is a party to any Tax allocation, Tax sharing or Tax indemnity or similar agreements (other than one that is included in

a Contract entered into in the ordinary course of business that is not primarily related to Taxes) and no Target Company is a party to

any joint venture, partnership or other arrangement that is treated as a partnership for U.S. federal income Tax purposes.

(xii)          Each

Target Company is tax resident only in its jurisdiction of formation.

(xiii)         No

Target Company has a permanent establishment (within the meaning of an applicable Tax treaty) or otherwise has an office or fixed place

of business in a country other than the country in which it is organized.

(xiv)         No

Target Company has taken or agreed to take any action not contemplated by this Agreement and/or any Transaction Document that would reasonably

be expected to prevent the CGC Merger and the Exchange from qualifying for the Intended Tax Treatment. To the knowledge of the Target,

no facts or circumstances exist, other than any facts or circumstances to the extent that such facts or circumstances exist or arise

as a result of or related to any act or omission occurring after the date hereof not contemplated by this Agreement and/or any of the

Transaction Documents, that would reasonably be expected to prevent the CGC Merger and the Exchange from qualifying for the Intended

Tax Treatment.

(q)             Brokers.

Except for fees (including the amounts due and payable assuming the Closing occurs) set forth on Section 3.3(q) of the

Target Disclosure Letter (which fees shall be the sole responsibility of the Target, except as otherwise provided in Section 8.6

of the Business Combination Agreement), no broker, finder, investment banker or other Person is entitled to any brokerage fee, finders’

fee or other commission in connection with the transactions contemplated by the Business Combination Agreement based upon arrangements

made by or on behalf of the Target or any of its Affiliates for which any of the Target Companies has any obligation.

(r)             Real

and Personal Property.

(i)             Owned

Real Property. Section 3.3(r)(i) of the Target Disclosure Letter sets forth a true and complete list (including

street addresses) of all real property owned by any of the Target Companies (the “Owned Real Property”). There are

no legal, administrative or other decisions or preliminary injunctions issued or proceedings pending that could materially impact any

Target Company’s legal title to the Owned Real Property. Existing utility lines from the Owned Real Property up to the connection

points to the public utility network are owned by the respective Target Company and are located on the lands owned by the Target Companies

or on the lands to which the respective in-rem easement for the benefit of the Owned Real Property. Each Owned Real Property is

directly accessible by and directly connected to the network of public roads. No financial obligations or Tax arrears exist that could

result in creation of a mortgage or other third party right in relation to any of the Owned Real Property.

(ii)            Leased

Real Property. Section 3.3(r)(ii) of the Target Disclosure Letter sets forth a true and complete list (including

street addresses) of all real property leased by any of the Target Companies (the “Leased Real Property”) and all Real

Property Leases pursuant to which any Target Company is a tenant or landlord as of the date of this Agreement. Each Real Property Lease

is in full force and effect and is a valid, legal and binding obligation of the applicable Target Company party thereto, enforceable in

accordance with its terms against such Target Company and, to the Target’s knowledge, each other party thereto (subject to applicable

bankruptcy, insolvency, reorganization, moratorium or other Laws affecting generally the enforcement of creditors’ rights and subject

to general principles of equity). There is no material breach or default by any Target Company or, to the Target’s knowledge, any

third party under any Real Property Lease, and, to the Target’s knowledge, no event has occurred which (with or without notice or

lapse of time or both) would constitute a material breach or default under any Real Property Lease or would permit termination of, or

a material modification or acceleration thereof, by any counterparty to any Real Property Lease. The Target Companies’ possession

and quiet enjoyment of the Leased Real Property under any Real Property Lease has not been materially disturbed, and to the Target’s

knowledge there are no material disputes with respect to any Real Property Lease. Except as set forth in Section 3.3(r)(ii) of

the Target Disclosure Letter, as of the date hereof, no Target Company has (i) subleased, licensed or otherwise granted any Person

the right to use or occupy the Leased Real Property or any portion thereof; or (ii) collaterally assigned or granted any other security

interest in any Real Property Lease or any interest therein.

(iii)           Personal

Property. Each Target Company has good, marketable and indefeasible title to, or a valid leasehold interest in or license or right

to use, all of the material assets and properties of the Target Companies, except for assets disposed of in the ordinary course of business.

(iv)           Assets.

Immediately after the Exchange Effective Time, the assets (which, for the avoidance of doubt, shall include any assets held pursuant to

valid leasehold interest, license or other similar interests or right to use any assets) of the Target Companies will constitute all of

the assets necessary to conduct the Business immediately after the Closing in materially the same manner (for the Target Companies, taken

as a whole) as it is conducted on the date of this Agreement, except as would not have a Target Material Adverse Effect.

(v)            GIB

Real Property. Section 3.3(r)(v) of the Target Disclosure Letter sets forth a true and complete list (including

street addresses) of all real property owned by GIB EnergyX Slovakia s.r.o., an entity incorporated and existing under the laws

of the Slovak Republic in the form of limited liability company, with its registered office at Mlynské nivy 5, Bratislava 821

09, Slovak Republic, ID No.: 55 901 328 (“GIB”) (the “GIB Real Property”).

There are no legal, administrative or other decisions or preliminary injunctions issued or proceedings pending that could materially

impact GIB’s legal title to the GIB Real Property. Each GIB Real Property is directly accessible by and directly connected to the

network of public roads. No financial obligations or Tax arrears exist that could result in creation of a mortgage or other third party

right in relation to any of the GIB Real Property.

(s)             Transactions

with Affiliates. Section 3.3(s) of the Target Disclosure Letter sets forth all Contracts between (i) any

Target Company, on the one hand, and (ii) any officer, director, employee, partner, member, manager, direct or indirect equityholder

or Affiliate of any Target Company (other than, for the avoidance of doubt, any other Target Company) or any family member of the foregoing

Persons, on the other hand (each Person identified in this clause (ii), a “Target Related Party”), other than (A) Contracts

with respect to a Target Related Party’s employment with (including benefit plans and other ordinary course compensation from)

any of the Target Companies entered into in the ordinary course of business, (B) Contracts with respect to a Company Shareholder’s

or a holder of Company Equity Awards’ status as a holder of Target Equity Securities and (C) Contracts entered into after

the date of this Agreement that are either permitted pursuant to Section 5.1(b) of the Business Combination Agreement

or entered into in accordance with Section 5.1(b) of the Business Combination Agreement. No Target Related Party (1) owns

any interest in any material asset used in any Target Company’s business, or (2) possesses, directly or indirectly, any material

financial interest in, or is a director or executive officer of, any Person which is a supplier, vendor, partner, customer, lessor or

other material business relation of any Target Company, (3) is a supplier, vendor, (4) owes any material amount to, or is owed

any material amount by, any Target Company (other than accrued compensation, employee benefits, employee or director expense reimbursement,

in each case, in the ordinary course of business or pursuant to any transaction entered into after the date of this Agreement that is

either permitted pursuant to Section 5.1(b) of the Business Combination Agreement or entered into in accordance with

Section 5.1(b) of the Business Combination Agreement). All Contracts, arrangements, understandings, interests and other

matters that are required to be disclosed pursuant to this Section 3.3(s) are referred to herein as “Target

Related Party Transactions”.

(t)             Data

Privacy and Security.

(i)             Each

Target Company has implemented written policies relating to the Processing of Personal Data as and to the extent required by applicable

Law (“Privacy and Data Security Policies”). In connection with its collection, storage, use and/or disclosure of any

information that constitutes “personal information,” “personal data” or “personally identifiable information”

as defined in applicable laws (collectively “Personal Information”) by or on behalf of the Target Companies, the Target

Companies are and have been in material compliance with (A) all applicable laws (including, without limitation, laws relating to

privacy, data security, telephone and text message communications, and marketing by email or other channels) in all relevant jurisdictions,

(B) the Target Companies’ privacy policies and public statements written by the Target Companies regarding their privacy or

data security practices and (C) the requirements of any contract codes of conduct or industry standards by which the Target Companies

are a party. The Target Companies maintain and have maintained reasonable physical, technical, and administrative security measures and

policies designed to protect all Personal Information owned, stored, used, maintained or controlled by or on behalf of the Target Companies

from and against unlawful, accidental or unauthorized access, destruction, loss, use, modification and/or disclosure. The Target Companies

are and have been in compliance in all material respects with all laws relating to data loss, theft and breach of security notification

obligations. To the Target’s knowledge, there has been no occurrence of (x) unlawful, accidental or unauthorized destruction,

loss, use, modification or disclosure of or access to Personal Information owned, stored, used, maintained or controlled by or on behalf

of the Target Companies such that privacy requirements require or required the Target Companies to notify government authorities, affected

individuals or other parties of such occurrence or (y) unauthorized access to or disclosure of the Target Companies’ confidential

information or trade secrets that reasonably would be expected to result in a Target Material Adverse Effect.

(ii)            In

connection with its collection, storage, transfer (including without limitation, any transfer across national borders) and/or use of any

Personal Information, the Target Companies are and have been, to the Target’s knowledge, in compliance with all applicable laws

in all relevant jurisdictions, the Target Companies’ privacy policies, and the requirements of any contract or codes of conduct

to which the Target Companies are a party. The Target Companies have commercially reasonable physical, technical, organizational and administrative

security measures and policies in place to protect all Personal Information collected by it or on its behalf from and against unauthorized

access, use and/or disclosure. The Target Companies are and have been in compliance in all material respects with all laws relating to

data loss, theft and breach of security notification obligations.

(u)             Compliance

with International Trade & Anti-Corruption Laws.

(i)             The

Target Companies have conducted all export transactions in accordance with applicable provisions of United States, Norway, European Union

and Slovakia export control laws and regulations, including the Export Administration Regulations, the International Traffic in Arms Regulations,

the regulations administered by the Office of Foreign Assets Control of the U.S. Treasury Department, and the export control laws and

regulations of any other applicable jurisdiction. Without limiting the foregoing: (A) the Target Companies have obtained all export

licenses and other approvals, timely filed all required filings and has assigned the appropriate export classifications to all products,

in each case as required for its exports of products, software and technologies from Slovakia, Norway and the European Union and any other

applicable jurisdiction; (B) the Target Companies are in compliance with the terms of all applicable export licenses, classifications,

filing requirements or other approvals; (C) there are no pending or, to the knowledge of the Target, threatened claims against the

Target Companies with respect to such exports, classifications, required filings or other approvals; (D) there are no pending investigations

related to the Target Companies’ exports; and (E) there are no actions, conditions, or circumstances pertaining to the Target’s

export transactions that would reasonably be expected to give rise to any material future claims.

(ii)            Neither

the Target nor any of its directors, officers, employees or agents have made or authorized any bribe, rebate, payoff, influence payment,

kickback or other unlawful payment of funds or received or retained any funds in violation of any law, rule or regulation. The Target

further represents that the it has maintained, and has caused each of its subsidiaries to maintain, systems of internal controls (including,

but not limited to, accounting systems, purchasing systems and billing systems) and written policies to ensure compliance with applicable

anti-bribery or anti-corruption law and to ensure that all books and records of the Target Companies accurately and fairly reflect, in

reasonable detail, all transactions and dispositions of funds and assets. None of the Target Companies, or, to the Target’s knowledge,

any of their officers, directors or employees are the subject of any allegation, voluntary disclosure, investigation, prosecution or other

enforcement action related to any applicable anti-corruption law.

[(v)            The

Target has not entered into, and will not enter into, any other agreement or any definitive transaction document, side letter, undertaking

letter, or other similar agreement or instrument with the Purchaser or any other purchaser of Securities in connection with the transactions

contemplated hereby or by the Other SPAs with terms and conditions that are more favorable than the terms and conditions provided to

the Purchaser under this Agreement.]6

(w)             No

Additional Representations or Warranties. Except as provided in this Section 3.3, none of the Target Companies nor

any of their respective Affiliates, nor any of their respective directors, managers, officers, employees, equityholders, partners, members

or representatives has made, or is making, any representation or warranty whatsoever to any other party hereto or any other Person and

no such party shall be liable in respect of the accuracy or completeness of any information provided to any other party hereto or any

other Person.

3.4 Representations and Warranties of CGC.

Except as set forth in any SEC Reports filed by CGC or other documents submitted or furnished to the SEC by CGC on or prior to the date

hereof, or on or prior to the Closing Date, as applicable, and provided that no representation or warranty by CGC shall apply to any statement

or information in the SEC Reports that relates to changes to historical accounting policies of CGC in connection with any order, directive,

guideline, comment or recommendation from the Commission or CGC’s auditor or accountant that is applicable to CGC (collectively,

the “SEC Guidance”), nor shall any correction, amendment, revision or restatement of CGC’s financial statements

due wholly or in part to SEC Guidance or any other accounting matters, nor any other effects that relate to or arise out of, or are in

connection with or in response to, any of the foregoing or any changes in accounting or disclosure related thereto, be deemed to be a

breach of any representation or warranty by CGC, CGC represents and warrants to the Purchaser, as of the date of this Agreement and as

of the Closing Date (or, if such representations and warranties are made with respect to a specified date, as of such date):

(a) CGC (i) is

validly existing and in good standing under the laws of the jurisdiction of incorporation, (ii) has the requisite power and authority

to own, lease and operate its properties, to carry on its business as it is now being conducted and to enter into and perform its obligations

under this Agreement and the other Transaction Documents, and (iii) is duly licensed or qualified to conduct its business and, if

applicable, is in good standing under the laws of each jurisdiction (other than its jurisdiction of incorporation) in which the conduct

of its business or the ownership of its properties or assets requires such license or qualification, except, with respect to the foregoing

clause (iii), where the failure to be in good standing would not reasonably be expected to have a CGC Material Adverse Effect.

(b) As of the Closing

Date, the Securities will be duly authorized and, when issued, paid for and delivered in accordance with the applicable Transaction Documents,

will be validly issued, fully paid and non-assessable, free and clear of all liens or other restrictions (other than those arising under

the Transaction Documents, the Organizational Documents of CGC or applicable securities laws), and will not have been issued in violation

of any preemptive or similar rights created under CGC’s Organizational Documents (as adopted on the Closing Date) or the laws of

its jurisdiction of incorporation.

6 For anchor investor

the other Transaction Documents has been duly authorized, validly executed and delivered by CGC, and assuming the due authorization, execution

and delivery of the same by the Target and the Purchaser of this Agreement and the other Transaction Documents to which they are a party

and the due authorization, execution and delivery of the same by all other parties to any Transaction Document, this Agreement and the

other Transaction Documents shall constitute the valid and legally binding obligation of CGC, enforceable against CGC in accordance with

its terms, except to the extent that enforceability thereof may be limited by applicable bankruptcy, insolvency, reorganization and moratorium

laws and other laws of general application affecting the enforcement of creditors’ rights generally or by any applicable statute

of limitation or by any valid defense of set-off or counterclaim, and the fact that equitable remedies or relief (including the remedy

of specific performance) are subject to the discretion of the court from which such relief may be sought (collectively, the “Enforceability

Exceptions”).

(d) Assuming the accuracy

of the representations and warranties of the Purchaser set forth in Section 3.2 of this Agreement, the execution and delivery

of this Agreement and the other Transaction Documents, the issuance and sale of the Securities hereunder, the compliance by CGC with all

of the provisions hereof and thereof and the consummation of the transactions contemplated herein and therein will not conflict with or

result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition

of any lien, charge or encumbrance upon any of the property or assets of CGC pursuant to the terms of (i) any indenture, mortgage,

deed of trust, loan agreement, lease, license or other agreement or instrument to which CGC is a party or by which CGC is bound or to

which any of the property or assets of CGC is subject, (ii) the Organizational Documents of CGC, or (iii) any statute or any

judgment, order, rule or regulation of any court or governmental agency or body, domestic or foreign, having jurisdiction over CGC

or any of its properties that, in the case of clauses (i) and (iii), would reasonably be expected to have a CGC Material

Adverse Effect.

(e) Assuming the accuracy

of the representations and warranties of the Purchaser set forth in Section 3.2 of this Agreement, CGC is not required to

obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other

federal, state, local or other governmental authority, self-regulatory organization or other person in connection with the execution,

delivery and performance of this Agreement or the other Transaction Documents (including, without limitation, the issuance of the Securities),

other than (i) filings required by applicable state securities laws, (ii) the filing of the Registration Statement pursuant

to the Registration Rights Agreement, (iii) filings required by the Commission, (iv) filings required by the Stock Exchange,

including with respect to obtaining shareholder approval, (v) filings and approvals required to consummate the Business Combination

as provided under the Business Combination Agreement, (vi) the filing of notification under the Hart-Scott-Rodino Antitrust Improvements

Act of 1976, if applicable, and (vii) those filings, the failure of which to obtain would not have a CGC Material Adverse Effect.

(f) Except for such

matters as have not had and would not have a CGC Material Adverse Effect, there is no (i) Action, Proceeding or arbitration before

a governmental authority or arbitrator pending, or, to the knowledge of CGC, threatened in writing against CGC or (ii) judgment,

decree, injunction, ruling or order of any governmental authority or arbitrator outstanding against CGC.

(g) Assuming the accuracy

of the Purchaser’s representations and warranties set forth in Section 3.2 of this Agreement, no registration under

the Securities Act or any state securities (or Blue Sky) laws is required for the offer and sale of the Securities by CGC to the Purchaser.

(h) Neither CGC nor

any person acting on its behalf has engaged in any form of general solicitation or general advertising (within the meaning of Regulation

D) in connection with any offer or sale of the Securities. The Securities are not being offered in a manner involving a public offering

under, or in a distribution in violation of, the Securities Act or any state securities laws. Neither CGC nor any person acting on CGC’s

behalf has, directly or indirectly, at any time within the past six (6) months, made any offer or sale of any security or solicitation

of any offer to buy any security under circumstances that would cause the offering of the Securities pursuant to this Agreement to be

integrated with prior offerings by CGC for purposes of the Securities Act or any applicable shareholder approval provisions. Neither CGC

nor any person acting on CGC’s behalf has offered or sold any securities, or has taken any other action, which would reasonably

be expected to subject the offer, issuance or sale of the Securities, as contemplated hereby, to the registration provisions of the Securities

Act.

(i) No “bad actor”

disqualifying event described in Rule 506(d)(1)(i)-(viii) of the Securities Act (a “Disqualification Event”)

is applicable to CGC, except for a Disqualification Event as to which Rule 506(d)(2)(ii–iv) or (d)(3) is applicable.

(j) Except as would

not reasonably be expected to be material to CGC, CGC is in all material respects in compliance with applicable provisions of the Sarbanes-Oxley

Act of 2002, as amended, and the rules and regulations thereunder.

(k) As of the Closing

Date, the Common Shares will be eligible for clearing through DTC, through its Deposit/Withdrawal At Custodian (DWAC) system, and CGC

is eligible and participating in the Direct Registration System (DRS) of DTC with respect to the Common Shares. CGC’s Transfer Agent

is a participant in DTC’s Fast Automated Securities Transfer Program.

(l) As of their respective

filing dates, or, if amended, as of the date of such amendment, which shall be deemed to supersede such original filing, all reports required

to be filed by CGC with the Commission (the “SEC Reports”) complied in all material respects with the applicable requirements

of the Securities Act and the Exchange Act, and the rules and regulations of the Commission promulgated thereunder, and none of the

SEC Reports, when filed, or, if amended, as of the date of such amendment, which shall be deemed to supersede such original filing, contained

any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make

the statements therein, in the light of the circumstances under which they were made, not misleading. As of the date hereof, there are

no material outstanding or unresolved comments in comment letters received by CGC from the staff of the Division of Corporation Finance

of the Commission with respect to any of the SEC Reports. The financial statements of CGC included in the SEC Reports comply in all material

respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect

at the time of filing, or, if amended, as of the date of such amendment, which shall be deemed to supersede such original filing, and

fairly present in all material respects the financial position of CGC as of and for the dates thereof and the results of operations and

cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, year-end audit adjustments. Notwithstanding

the foregoing, this representation and warranty shall not apply to any statement or information in the SEC Reports that relates or arises

from the topics referenced in SEC Guidance, and any restatement, revision or other modification to the SEC Reports (including any financial

statements contained therein) relating to or arising from SEC Guidance shall not be deemed material noncompliance for purposes of this

Agreement or the other Transaction Documents.

(m) As of the date hereof,

the authorized share capital of CGC is $22,100 divided into 200,000,000 Class A Ordinary Shares, 20,000,000 Class B ordinary

shares, par value $0.0001 per share (the “Class B Ordinary Shares” and, together with the Class A Ordinary

Shares, the “Ordinary Shares”) and 1,000,000 preference shares of a par value of $0.0001 (the “CGC Preference

Shares”). As of the date hereof and prior to giving effect to the Closing and the Business Combination: (i) 8,826,092 Class A

Ordinary Shares, two Class B Ordinary Shares and no CGC Preference Shares were issued and outstanding; and (ii) 7,666,666 public

warrants, each exercisable to purchase one Class A Ordinary Share at $11.50 per share (the “IPO Public Warrants”),

and 8,900,000 private placement warrants, each exercisable to purchase one Class A Ordinary Share at $11.50 per share (together the

“IPO Private Placement Warrants” and, together with the IPO Public Warrants, the “Outstanding IPO Warrants”),

were issued and outstanding. No Outstanding IPO Warrants are exercisable on or prior to the closing of the Business Combination. All (A) issued

and outstanding Ordinary Shares have been duly authorized and validly issued, are fully paid and non-assessable and are not subject to

preemptive rights; and (B) Outstanding IPO Warrants have been duly authorized and validly issued, are fully paid and are not subject

to preemptive rights. As of the date hereof, except as set forth above and pursuant to the Business Combination Agreement, there are no

outstanding options, warrants or other rights to subscribe for, purchase or acquire from CGC any Ordinary Shares or other equity interests

in CGC (collectively, “CGC Equity Interests”) or securities convertible into or exchangeable or exercisable for CGC

Equity Interests. Except as set forth in the Business Combination Agreement, as of the date hereof, CGC has no subsidiaries and does not

own, directly or indirectly, interests or investments (whether equity or debt) in any person, whether incorporated or unincorporated.

There are no shareholder agreements, voting trusts or other agreements or understandings to which CGC is a party or by which it is bound

relating to the voting of any CGC Equity Interests, other than (A) as set forth in the SEC Reports and (B) as contemplated by

the Business Combination Agreement. Except as described in the SEC Reports, there are no securities or instruments issued by or to which

CGC is a party containing anti-dilution or similar provisions that will be triggered by the issuance of the Purchased Securities.

(n) The issued and outstanding

Class A Ordinary Shares are registered pursuant to Section 12(g) of the Exchange Act, and are listed for trading on the

Pink Open Market under the symbol “RENEF.” Except as set forth in the SEC Reports or as contemplated by the Business Combination

Agreement: (i) there is no suit, Action, Proceeding or investigation pending or, to the knowledge of CGC, threatened against CGC

by the Commission with respect to any intention by such entity to deregister the Class A Ordinary Shares and (ii) CGC has taken

no action that is designed to terminate the registration of the Class A Ordinary Shares under the Exchange Act. Following the Business

Combination, the Common Shares are expected to be registered under the Exchange Act and listed for trading on the Stock Exchange.

(o) To the knowledge

of CGC, CGC is not, and immediately after receipt of payment for the Securities and consummation of the Business Combination, will not

be, an “investment company” within the meaning of the Investment Company Act of 1940, as amended.

(p) Neither CGC nor,

to the knowledge of CGC, any agent or other person acting on behalf of CGC has (i) directly or indirectly, used any funds for unlawful

contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful

payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate

funds, (iii) failed to disclose fully any contribution made by CGC (or made by any person acting on its behalf of which CGC is aware)

which is in violation of law or (iv) violated in any material respect any provision of the Foreign Corrupt Practices Act of 1977,

as amended.

(q) CGC’s accounting

firm is CBIZ CPAs P.C. To the knowledge and belief of CGC, such accounting firm is a registered public accounting firm as required by

the Exchange Act.

(r) There are no disagreements

of any kind presently existing, or reasonably anticipated by CGC to arise, between CGC and the accountants and lawyers formerly or presently

employed by CGC and CGC is current with respect to any fees owed to its accountants and lawyers which could affect CGC’s ability

to perform any of its obligations under any of the Transaction Documents.

(s) CGC acknowledges

and agrees that the Purchaser is acting solely in the capacity of an arm’s length purchaser with respect to the Transaction Documents

and the transactions contemplated thereby. CGC further acknowledges that the Purchaser is not acting as a financial advisor or fiduciary

of CGC (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice

given by the Purchaser or any of its representatives or agents in connection with the Transaction Documents and the transactions contemplated

thereby is merely incidental to the Purchaser’s purchase of the Securities. CGC further represents to the Purchaser that CGC’s

decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions

contemplated hereby by CGC and its representatives.

(t) CGC has not, and

to its knowledge no one acting on its behalf has, taken, directly or indirectly, any action designed to cause or to result in the stabilization

or manipulation of the price of any security of CGC to facilitate the sale or resale of any of the Securities.

[(u) CGC

has not entered into, and will not enter into, any other agreement or any definitive transaction document, side letter, undertaking letter,

or other similar agreement or instrument with the Purchaser or any other purchaser of Securities in connection with the transactions

contemplated hereby or by the Other SPAs with terms and conditions that are more favorable than the terms and conditions provided to

the Purchaser under this Agreement.]7

(v)             Except

as provided in this Section 3.4, none of CGC nor any of its Affiliates, nor any of their respective directors, managers, officers,

employees, equityholders, partners, members or representatives has made, or is making, any representation or warranty whatsoever to any

other party hereto or any other Person and no such party shall be liable in respect of the accuracy or completeness of any information

provided to any other party hereto or any other Person.

7 For anchor investor

ARTICLE 4

OTHER AGREEMENTS OF THE PARTIES

4.1 Transfer Restrictions.

(a) The Securities may

only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities other than pursuant

to an effective registration statement or Rule 144, to the Company or to an Affiliate of the Purchaser or in connection with a pledge

as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion of

counsel selected by the transferor (in-house counsel to suffice), the form and substance of which opinion shall be reasonably satisfactory

to the Company, to the effect that such transfer does not require registration of such transferred Securities under the Securities Act.

As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and, if permitted pursuant

to the terms thereof, the Registration Rights Agreement and shall have the rights and obligations of the Purchaser under this Agreement

and the Registration Rights Agreement, if a party thereto.

(b) The Purchaser agrees

to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities in the following form:

NEITHER THIS SECURITY NOR THE SECURITIES

INTO WHICH THIS SECURITY IS CONVERTIBLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF

ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),

AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT

TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE

WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON CONVERSION OF THIS SECURITY MAY BE PLEDGED

IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED

INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.

The Company acknowledges and agrees that the Purchaser

may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant a security interest in

some or all of the Securities to a financial institution that is an “accredited investor” as defined in Rule 501(a) under

the Securities Act and who agrees to be bound by the provisions of this Agreement and, if required under the terms of such arrangement,

the Purchaser may transfer pledged or secured Securities to the pledgees or secured parties; provided, however, that, as a prerequisite

to any such pledge other than a pledge pursuant to a bona fide margin agreement with a registered broker dealer, the Purchaser shall (x) provide

notice to the Company of such pledge or transfer at least five (5) Business Days prior thereto and (y) cause to be delivered

to the Company customary legal opinions of legal counsel of the pledgee, secured party and pledgor as shall be reasonably requested by

the Company in connection therewith. Thereafter, at the Purchaser’s expense, the Company will execute and deliver such reasonable

documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities,

including, if the Securities are subject to registration pursuant to the Registration Rights Agreement, the preparation and filing of

any required prospectus supplement under Rule 424(b) under the Securities Act or other applicable provision of the Securities

Act to appropriately amend the list of selling securityholders thereunder.

reasonable evidence of issuance by book entry, as applicable) evidencing the Underlying Shares shall not contain any legend (including

the legend set forth in Section 4.1(b) hereof): (i) while a registration statement (including the Registration Statement)

covering the resale of such security is effective under the Securities Act, (ii) following any sale of such Underlying Shares pursuant

to Rule 144 or (iii) as otherwise provided in the Articles. The Company shall use commercially reasonable efforts to cause its

counsel to issue a legal opinion to the Transfer Agent or the Purchaser promptly after the Effective Date if required by the Transfer

Agent to effect the removal of the legend hereunder or if requested by the Purchaser, respectively, in each case, if the proposed sale

is to be made pursuant to an effective registration statement or subject to an exemption from registration under the federal securities

laws. If all or any Preference Shares are converted or any portion of a Warrant is exercised at a time when there is an effective registration

statement to cover the resale of the Underlying Shares, or if such Underlying Shares may be sold under Rule 144 and the Company is

then in compliance with the current public information required under Rule 144(c)(1) (or Rule 144(i)(2), if applicable),

or if the Underlying Shares may be sold under Rule 144 without the requirement for the Company to be in compliance with the current

public information required under required under Rule 144(c)(1) (or Rule 144(i)(2), if applicable) as to such Underlying

Shares and without volume or manner-of-sale restrictions or if such legend is not otherwise required under applicable requirements of

the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission) or as provided in the

Articles or Warrants, then such Underlying Shares shall be issued free of all legends. The Company agrees that following the Effective

Date or at such time as such legend is no longer required under this Section 4.1(c), it will, no later than the number of

Trading Days comprising the Standard Settlement Period (as defined below) following the delivery by a Purchaser to the Company or the

Transfer Agent of a certificate (or reasonable evidence of issuance by book entry, as applicable) representing Underlying Shares, as applicable,

issued with a restrictive legend, deliver or cause to be delivered to the Purchaser a certificate (or reasonable evidence of issuance

by book entry, as applicable) representing such shares that is free from all restrictive and other legends. The Company may not make any

notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4.1.

Certificates for Underlying Shares subject to legend removal hereunder shall be transmitted by the Transfer Agent to the Purchaser by

crediting the account of the Purchaser’s prime broker with the Depository Trust Company System as directed by the Purchaser. As

used herein, “Standard Settlement Period” means the standard settlement period, expressed in a number of Trading Days,

on the Company’s primary Trading Market with respect to the Common Shares as in effect on the date of delivery of a certificate

(or reasonable evidence of issuance by book entry, as applicable) representing Underlying Shares, as applicable, issued with a restrictive

legend.

(d) The Purchaser agrees

with the Company that the Purchaser will sell any Securities pursuant to either the registration requirements of the Securities Act, including

any applicable prospectus delivery requirements, or an exemption therefrom, and that if Securities are sold pursuant to a Registration

Statement, they will be sold in compliance with the plan of distribution set forth therein, and acknowledges that the removal of the restrictive

legend from certificates (or reasonable evidence of issuance by book entry, as applicable) representing Securities as set forth in this

Section 4.1 is predicated upon the Company’s reliance upon this understanding.

4.2 Acknowledgment of Dilution.

The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding Common Shares, which dilution may

be substantial under certain market conditions. The Company further acknowledges that its obligations under the Transaction Documents,

including, without limitation, its obligation to issue the Underlying Shares pursuant to the Transaction Documents, are unconditional

and absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless of the effect of any such dilution

or any claim the Company may have against the Purchaser and regardless of the dilutive effect that such issuance may have on the ownership

of the other stockholders of the Company.

4.3 Furnishing of Information; Public Information.

Until the time that the Purchaser does not own any Securities, the Company shall use commercially reasonable efforts to maintain the registration

of the Common Shares under Section 12(b) or 12(g) of the Exchange Act and to timely file all reports required to be filed

by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements

of the Exchange Act.

4.4 Integration. The Company shall

not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the

Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration under

the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of the Securities for purposes of

the rules and regulations of any Trading Market such that it would require stockholder approval prior to the closing of such other

transaction unless stockholder approval is obtained before the closing of such subsequent transaction.

4.5 Conversion and Exercise Procedures.

Each of the form of Notice of Exercise included in the Warrants and the form of Notice of Conversion included in the Articles set forth

the totality of the procedures required of the Purchaser in order to exercise the Warrants or convert its Preference Shares. Without limiting

the preceding sentences, no ink-original Notice of Exercise or Notice of Conversion shall be required, nor shall any medallion guarantee

(or other type of guarantee or notarization) of any Notice of Exercise or Notice of Conversion form be required in order to exercise the

Warrants or convert its Preference Shares. No additional legal opinion, other information or instructions shall be required of the Purchaser

to exercise its Warrants or convert its Preference Shares. The Company shall honor exercises of the Purchaser’s Warrants and conversions

of the Purchaser’s Preference Shares and shall deliver Underlying Shares in accordance with the terms, conditions and time periods

set forth in the Transaction Documents.

4.6 Securities Laws Disclosure; Publicity.

Neither the Company nor the Target shall publicly disclose the name of the Purchaser, or include the name of the Purchaser in any filing

with the Commission or any regulatory agency or Trading Market, without the prior written consent of the Purchaser (not to be unreasonably

withheld, delayed or conditioned), except (a) as required by federal securities law or requested by the staff of the Commission

in connection with (i) any filings in connection with the Business Combination, (ii) any registration statement contemplated

by the Registration Rights Agreement and (iii) the filing of final Transaction Documents with the Commission and (b) to the

extent such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Purchaser with prior

notice of such disclosure permitted under this clause (b).

4.7 Stockholder Rights Plan. No

claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that exclusively as a result of the

transactions contemplated by this Agreement the Purchaser is an “Acquiring Person” under any control share acquisition,

business combination, poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in

effect or hereafter adopted by the Company, or that the Purchaser could be deemed to trigger the provisions of any such plan or arrangement,

by virtue of receiving Securities under the Transaction Documents.

4.8 Non-Public Information. The

Company and the Target covenant and agree that neither they, nor any other Person acting on their behalf will provide the Purchaser or

its agents or counsel with any information that constitutes, or the Company and the Target reasonably believe constitutes, material non-public

information, unless prior thereto the Purchaser shall have consented to the receipt of such information and agreed with the Company and

the Target to keep such information confidential. To the extent that the Company, the Target or any of their respective officers, director,

agents, employees or Affiliates delivers any material, non-public information to the Purchaser without the Purchaser’s consent,

the Company and the Target hereby covenant and agree that the Purchaser shall not have any duty of trust or confidentiality to the Company,

the Target or any of their respective officers, directors, agents, employees or Affiliates, or a duty to the Company, the Target or any

of their respective officers, directors, agents, employees or Affiliates not to trade while aware of, such material, non-public information,

provided that the Purchaser shall remain subject to applicable law. To the extent that any notice provided pursuant to any Transaction

Document constitutes, or contains, material, non-public information regarding the Company or the Target, the Company shall if reasonably

practicable simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Company and the Target

understand and confirm that the Purchaser shall be relying on the foregoing covenants in effecting transactions in securities of the Company.

4.9 Use of Proceeds. The Company

shall use the net proceeds from the sale of the Securities hereunder for general corporate and working capital purposes, in the Company’s

exclusive discretion.

4.10 Indemnification.

(a) Subject to the provisions

of this Section 4.10, the Company will indemnify and hold each Purchaser Party harmless from any and all Losses that any such

Purchaser Party may suffer or incur as a result of or relating to any breach of any of the representations, warranties, covenants or agreements

made by the Company in this Agreement or in the other Transaction Documents (unless such Loss is primarily based upon a material breach

of such Purchaser Party’s representations, warranties or covenants under the Transaction Documents or any agreements or understandings

such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws

or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct).

(b) Subject to the provisions

of this Section 4.10, the Target will indemnify and hold each Purchaser Party, harmless from any and all Losses that any such

Purchaser Party may suffer or incur as a result of or relating to any breach of any of the representations and warranties of the Target

Companies found exclusively in Section 3.3, covenants or agreements made by the Target in this Agreement or in the other Transaction

Documents (unless such Loss is primarily based upon a material breach of such Purchaser Party’s representations, warranties or covenants

under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such stockholder or any violations

by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which is finally judicially determined

to constitute fraud, gross negligence or willful misconduct).

of this Section 4.10, the Purchaser will, severally and not jointly, indemnify and hold (i) each Company Party and (ii) each

Target Party, harmless from any and all Losses that any such Company party or Target Party (as applicable) may suffer or incur as a result

of or relating to any breach of any of the representations, warranties, covenants or agreements made by such Purchaser in this Agreement

or in the other Transaction Documents (unless such Loss is primarily based upon a material breach of such Company Party’s or Target

Party’s (as applicable) representations, warranties or covenants under the Transaction Documents or any agreements or understandings

such Company Party or Target Party may have with any such stockholder or any violations by such Company Party or Target Party (as applicable)

of state or federal securities laws or any conduct by such Company Party or Target Party (as applicable) which is finally judicially determined

to constitute fraud, gross negligence or willful misconduct).

(d) If any Action or

Proceeding shall be brought against any Person in respect of which indemnity may be sought pursuant to this Agreement, such Person (the

“Indemnified Party”) shall promptly notify the Person against whom such indemnity may be sought (the “Indemnifying

Party”) in writing, but the omission to notify such Indemnifying Party will not relieve the Indemnifying Party from any liability

that it may have to any Indemnified Party under this Section 4.10 unless, and only to the extent that, such omission results

in the forfeiture of substantive rights or defenses by the Indemnifying Party. The Indemnifying Party shall have the right to assume the

defense thereof with counsel of its own choosing reasonably acceptable to the Indemnified Party. Any Indemnified Party shall have the

right to employ separate counsel in any such Action or Proceeding and participate in the defense thereof, but the fees and expenses of

such counsel shall be at the expense of such Indemnified Party except to the extent that (i) the employment thereof has been specifically

authorized by the Indemnifying Party in writing, (ii) the Indemnifying Party has failed after a reasonable period of time to assume

such defense and to employ counsel or (iii) in such Action or Proceeding there is, in the reasonable opinion of counsel, a material

conflict on any material issue between the position of the Indemnifying Party and the position of such Indemnified Party, in which case

the Indemnifying Party shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Indemnifying

Party shall not be liable for any settlement of any Proceeding effected without its written consent, but if settled with such consent

or if there be a final judgment for the plaintiff, the Indemnifying Party agrees to indemnify the Indemnified Party from and against any

loss or liability by reason of such settlement or judgment. No Indemnifying Party shall, without the prior written consent of the Indemnified

Party, effect any settlement of any pending or threatened Proceeding in respect of which any Indemnified Party is or could have been a

party and indemnity could have been sought hereunder by such Indemnified Party, unless such settlement includes an unconditional release

of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.

4.11 Reservation and Listing of Securities.

(a) Commencing on the

Closing Date, the Company shall maintain a reserve of the Required Minimum from its duly authorized Common Shares for issuance pursuant

to the Transaction Documents in such amount as may then be required to fulfill its obligations in full under the Transaction Documents.

(b) If, on any date

following the Closing Date, the number of authorized but unissued (and otherwise unreserved) Common Shares is less than 100% of (i) the

Required Minimum on such date, minus (ii) the number of Common Shares previously issued pursuant to the Transaction Documents, then

the Board of Directors shall use commercially reasonable efforts to amend the Company’s certificate or articles of incorporation

to increase the number of authorized but unissued Common Shares to at least the Required Minimum at such time (minus the number of Common

Shares previously issued pursuant to the Transaction Documents), as soon as possible and in any event not later than the 75th

day after such date, provided that the Company will not be required at any time to authorize a number of Common Shares greater

than the maximum remaining number of Common Shares that could possibly be issued after such time pursuant to the Transaction Documents.

as applicable: (i) promptly after the Closing Date and in connection with the registration with the Commission of the Underlying

Shares, in the manner required by the principal Trading Market, prepare and file with such Trading Market an additional shares listing

application covering a number of Common Shares at least equal to the Required Minimum on the date of such application, (ii) take

all steps reasonably necessary to cause such Common Shares to be approved for listing or quotation on such Trading Market as soon as practicable

thereafter and to provide to the Purchaser evidence of such listing or quotation and (iii) use commercially reasonable efforts to

maintain the listing or quotation of such Common Shares on any date at least equal to the Required Minimum on such date on such Trading

Market or another Trading Market. The Company agrees to maintain the eligibility of the Common Shares for electronic transfer through

the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to

the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer.

4.12 Certain Transactions and Confidentiality.

The Purchaser covenants that neither it, nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute

any purchases or sales of any of CGC’s securities during the period commencing with the execution of this Agreement and ending at

the Cleanse Time. CGC covenants that the transactions contemplated by this Agreement will be publicly disclosed by CGC (the “Cleanse

Time”) no later than one Business Day following the date of this Agreement. Purchaser covenants that until the Cleanse Time,

it will maintain the confidentiality of the existence and terms of this transaction. As soon as practicable following the Cleanse Time,

but in any event within two hours thereafter, CGC shall inform the Purchaser in writing that it is no longer in possession of material,

non-public information regarding CGC, the Company or the Target. From and after the Cleanse Time, CGC represents to the Purchaser that

it shall have publicly disclosed all material, non-public information, as of immediately prior to the Cleanse Time, delivered to the Purchaser

by CGC, the Company, the Target or any of its officers, directors, employees or agents in connection with the transactions contemplated

by the Transaction Documents. Notwithstanding the foregoing, and notwithstanding anything contained in this Agreement to the contrary,

CGC expressly acknowledges and agrees that, (i) the Purchaser does not make any representation, warranty or covenant hereby that

it will not engage in effecting transactions in any securities of CGC after the Cleanse Time and (ii) the Purchaser shall not be

restricted or prohibited from effecting any transactions in any securities of CGC in accordance with applicable securities laws from and

after the Cleanse Time. Notwithstanding the foregoing, if the Purchaser is a multi-managed investment vehicle whereby separate portfolio

managers manage separate portions of the Purchaser’s assets and the portfolio managers have no direct knowledge of the investment

decisions made by the portfolio managers managing other portions of the Purchaser’s assets, the covenant set forth above shall only

apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities

covered by this Agreement.

4.13 Blue Sky Filings. The Company

shall take such action as the Company shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the Securities

for, sale to the Purchaser at the Closing under applicable securities or “Blue Sky” laws of the states of the United States.

[4.14 Sponsor Accommodation.

Within ten Business Days of the date hereof, the Sponsor shall transfer 800,000 Class A Ordinary Shares (the “Sponsor Accommodation

Shares”) to the Purchaser; provided that the Purchaser hereby agrees that: (a) it shall not, prior to the Closing,

Transfer such Sponsor Accommodation Shares to any other Person (other than as set forth in clause (d) below), (b) it shall

not submit such Sponsor Accommodation Shares for redemption in connection with any extraordinary general meeting of CGC’s shareholders

to approve the transactions contemplated by the Business Combination Agreement or any extension of the deadline to consummate an initial

business combination, (c) it shall vote all Sponsor Accommodation Shares in favor of any proposals put forth by CGC in connection

with any extraordinary general meeting of CGC’s shareholders to approve the transactions contemplated by the Business Combination

Agreement or any extension of the deadline to consummate an initial business combination and (d) in the event the Business Combination

Agreement expires or is terminated or the transactions contemplated thereby are otherwise not consummated (each, a “Termination

Event”), it shall return such Sponsor Accommodation Shares to Sponsor within ten Business Days of such Termination Event. By

virtue of the Registration Statement / Proxy Statement (as defined in the Business Combination Agreement), the issuance at the Closing

of Common Shares in exchange for the Sponsor Accommodation Shares will result in such Common Shares being registered under the Securities

Act, issued without a restrictive legend under the Securities Act and freely tradable by a holder thereof that is not an Affiliate of

the Company. The Company represents, warrants and agrees that, as of the Closing Date, the Sponsor Accommodation shares shall not be

subject to any contractual restrictions on transfer (other than as set forth in the following sentence). From the date that is six months

after the Closing Date until the twenty-first trading day following the date that is six months after the Closing Date, the Purchaser

shall not, directly or indirectly, sell, offer to sell, contract to sell, or otherwise dispose of or enter into any other similar transaction

involving the Sponsor Accommodation Shares).]8

4.15 Subsequent Equity Sales. Except pursuant

to this Agreements, the Other SPAs, the Exchange and the Business Combination Agreement (as in effect on the date hereof), from the date

of this Agreement and ending on the date that is 180 days after the Effective Date, neither CGC nor the Company shall, without the prior

written consent of the Lead Purchaser: (a) issue shares of their capital stock or Capital Stock Equivalents, (b) other than

as required to satisfy the requirements of the Listing Market, effect a reverse stock split, recapitalization, share consolidation, reclassification

or similar transaction affecting any class of their capital stock or (c) file with the Commission a registration statement under

the Securities Act relating to any capital stock or Capital Stock Equivalents, except pursuant to the terms of the Registration Rights

Agreement. Notwithstanding the foregoing, the provisions of this Section 4.15 shall not apply to (i) the issuance of the Securities

hereunder, (ii) the issuance of capital stock or Capital Stock Equivalents upon the conversion, exercise or vesting of any securities

of CGC or the Company, as applicable, outstanding on the date of this Agreement or outstanding pursuant to clause (iii) below, provided

that such securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease the

exercise price or conversion price of such securities (other than in connection with stock splits or combinations) or to extend the term

of such securities, (iii) the issuance of any capital stock or Capital Stock Equivalents pursuant to any stock-based compensation

plans, and (iv) the filing of a registration statement on Form S-8 under the Securities Act to register the offer and sale of

securities on an equity incentive plan or employee stock purchase plan.

4.16 No Prohibited Financing Arrangements.

None of CGC, the Company, the Target or any of their respective Subsidiaries is a party to, or bound by, and none of them has entered

into, authorized, committed or agreed to enter into, any Prohibited Financing Arrangement. From the date of this Agreement and ending

on the date that is 180 days after the Effective Date, none of CGC, the Company or the Target shall, and each of them shall cause its

respective Subsidiaries, the Sponsor and its and their respective controlled Affiliates not to, directly or indirectly, enter into, adopt,

authorize, negotiate, agree or commit to enter into, amend, supplement or otherwise become bound by any Prohibited Financing Arrangement.

4.17 Joinder of the Company. Within 30

days of the date of this Agreement, Target shall cause the Company to adhere to this Agreement by execution of a joinder agreement in

the form attached as Exhibit D and such joinder agreement shall be and remain a valid and binding obligation of the

Company.

4.18 Authorized Share Capital; Redemption.

If, any time the amount of Common Shares issuable upon conversion of the Preferred Shares exceeds the amount permitted under the Company’s

Articles, the board of directors of the Company shall promptly convene a meeting of the shareholders of the Company to increase the authorized

amount of Common Shares to the lesser of the amount of Common Shares issuable upon conversion of the Preferred Shares and the maximum

permitted by applicable Law. The Company shall use commercially reasonable efforts to take, and to cause its applicable corporate bodies

to take, all actions reasonably necessary to permit the Company to effect any redemption of the Preference Shares in accordance with the

Articles, including seeking and maintaining any shareholder or other corporate authorizations required under applicable Law. The Company

shall not take any action principally intended to impair its ability to satisfy any redemption obligation in respect of the Preference

Shares, including by making any dividend, distribution, redemption, repurchase or other payment in respect of any Junior Securities (as

defined in the Articles), at any time when any amount validly due and payable in respect of a redemption of the Preference Shares remains

unpaid; provided that nothing in this Section shall require the Company to effect any redemption or other payment to the extent prohibited

by applicable Law, including applicable Dutch capital maintenance requirements or the absence of sufficient distributable reserves.

[4.19 Lock-up Agreements. The Company shall

not, without the prior written consent of the Lead Purchaser, amend, modify, waive, terminate or fail to enforce any lock-up obligation

as set forth in the Business Combination Agreement.]9

8 For anchor investor

9 For anchor investor

ARTICLE 5

MISCELLANEOUS

5.1 Termination. This Agreement

shall terminate and be void and of no further force and effect, and all rights and obligations of the parties hereunder shall terminate

without any further liability on the part of any party in respect hereof, upon the earlier to occur of (a) the mutual written agreement

of the parties hereto to terminate this Agreement, or (b) the termination (for any reason) of the Business Combination Agreement

by any party to the same. Additionally, (i) the Company may terminate this Agreement with respect to the Purchaser if any of the

conditions set forth in Section 2.3(b) applicable to the Purchaser shall have become incapable of fulfillment, and shall

not have been waived by the Company; and (ii) the Purchaser may terminate this Agreement if (X) any of the conditions set forth

in Section 2.3(a) shall have become incapable of fulfillment, and shall not have been waived by the Purchaser or (Y) the

Closing shall not have occurred on or prior to the date on which the Target is permitted to terminate the Business Combination Agreement

pursuant to Section 8.01(d) of the Business Combination Agreement. Notwithstanding the foregoing, nothing herein will relieve

any party from liability for any intentional breach hereof prior to the time of termination, and each party will be entitled to any remedies

at law or in equity to recover losses, liabilities or damages arising from such intentional breach; provided, that

in the event that the Business Combination Agreement is ever terminated by the Company and/or the Target for any reason, the Purchaser

hereby agrees not to indirectly assert a claim against the Target by funding the Company or any other party to assert any such claim.

5.2 Fees and Expenses. Except as

expressly set forth in the Transaction Documents, each party shall pay the fees and expenses of its advisers, counsel, accountants and

other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and

performance of this Agreement and the Transaction Documents. The Company shall pay all Transfer Agent fees (including, without limitation,

any fees required for same-day processing of any instruction letter delivered by the Company and any conversion notice delivered by a

Purchaser), stamp taxes and other Taxes and duties levied in connection with the delivery of any Securities to the Purchaser.

5.3 Entire Agreement. The Transaction

Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties with respect to the subject

matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which

the parties acknowledge have been merged into such documents, exhibits and schedules.

5.4 Notices. Any and all notices

or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and

effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via email at the e-mail

address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day,

(b) the next Trading Day after the time of transmission, if such notice or communication is delivered via email attachment at the

e-mail address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New

York City time) on any Trading Day, (c) the second (2nd) Trading Day following the

date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom

such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages attached

hereto.

5.5 Amendments; Waivers. No provision

of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment,

by the Company, the Target and the Purchaser or, in the case of a waiver, by the Company, the Target or the Purchaser, as the case may

be, dependent on the party against whom enforcement of any such waived provision is sought. No waiver of any default with respect to any

provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent

default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise

any right hereunder in any manner impair the exercise of any such right.

5.6 Headings. The headings herein

are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions

hereof.

5.7 Successors and Assigns. This

Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. Neither the Company

nor the Target may assign this Agreement or any rights or obligations hereunder without the prior written consent of the other and the

Purchaser (other than by merger). The Purchaser may assign any or all of its rights under this Agreement to any Person to whom the Purchaser

assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities,

by the provisions of the Transaction Documents that apply to the “Purchaser.”

5.8 No Third-Party Beneficiaries..

This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for

the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.10

and this Section 5.8.

5.9 Governing Law. All questions

concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by and construed

and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof.

Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions contemplated

by this Agreement and any other Transaction Documents (other than the Articles) (whether brought against a party hereto or its respective

Affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in any New York

State court or Federal court of the United States of America sitting in New York City in the Borough of Manhattan. Each party hereby irrevocably

submits to the exclusive jurisdiction of any New York State court or Federal court of the United States of America sitting in New York

City in the Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated

hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents, other than the Articles), and

hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction

of any such court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably

waives personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via

registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it

under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing

contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall

commence an Action or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the parties

under Section 4.10, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for

its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such

Action or Proceeding.

5.10 Survival. The representations

and warranties contained in Section 3.1, Section 3.2, Section 3.3 and Section 3.4 herein

shall survive the Closing and the delivery of the Securities.

5.11 Execution. This Agreement may

be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become

effective when counterparts have been signed by each party and delivered to each other party, it being understood that the parties need

not sign the same counterpart. In the event that any signature is delivered by e-mail delivery of a “.pdf” format data file,

such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with

the same force and effect as if such “.pdf” signature page were an original thereof.

5.12 Severability. If any term,

provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable,

the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in

no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ

an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction.

It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions,

covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.

5.13 Rescission and Withdrawal Right.

Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction Documents,

whenever the Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not timely perform

its related obligations within the periods therein provided, then the Purchaser may rescind or withdraw, in its sole discretion from time

to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to its future

actions and rights; provided, however, that, in the case of (x) a rescission of a conversion of the Purchaser’s

Preference Shares, the Purchaser shall be required to return any Common Shares subject to any such rescinded conversion or (y) a

recission of an exercise of a Warrant, the Purchaser shall be required to return any Common Shares subject to any exercise notice concurrently

with the return to the Purchaser of the aggregate exercise price paid to the Company for such shares and the restoration of the Purchaser’s

right to acquire such shares pursuant to the Purchaser’s Warrant (including, issuance of a replacement warrant certificate evidencing

such restored right).

5.14 Replacement of Securities.

If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to

be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor,

a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction.

The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including

customary indemnity) associated with the issuance of such replacement Securities.

5.15 Remedies. In addition to being

entitled to exercise all rights provided herein or granted by law, including recovery of damages, the Purchaser and the Company will be

entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not be adequate compensation

for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby agree to waive and not

to assert in any Action for specific performance of any such obligation the defense that a remedy at law would be adequate. For the avoidance

of doubt, Section 4.10 shall be the exclusive remedy for any Losses resulting from a breach of any of the representations

and warranties contained in ARTICLE 3 of this Agreement, in each case exclusively to the extent such Losses arise during the survival

period of such representations and warranties pursuant to the terms of this Agreement.

5.16 Payment Set Aside. To the extent

that the Company makes a payment or payments to the Purchaser pursuant to any Transaction Document or the Purchaser enforces or exercises

its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently

invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid

or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy

law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part

thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made

or such enforcement or setoff had not occurred.

5.17 Usury. To the extent it may

lawfully do so, the Company hereby agrees not to insist upon or plead or in any manner whatsoever claim, and will resist any and all efforts

to be compelled to take the benefit or advantage of, usury laws wherever enacted, now or at any time hereafter in force, in connection

with any Action or Proceeding that may be brought by the Purchaser in order to enforce any right or remedy under any Transaction Document.

Notwithstanding any provision to the contrary contained in any Transaction Document, it is expressly agreed and provided that the total

liability of the Company under the Transaction Documents for payments in the nature of interest shall not exceed the maximum lawful rate

authorized under applicable law (the “Maximum Rate”), and, without limiting the foregoing, in no event shall any rate

of interest or default interest, or both of them, when aggregated with any other sums in the nature of interest that the Company may be

obligated to pay under the Transaction Documents exceed such Maximum Rate. It is agreed that if the maximum contract rate of interest

allowed by law and applicable to the Transaction Documents is increased or decreased by statute or any official governmental action subsequent

to the date hereof, the new maximum contract rate of interest allowed by law will be the Maximum Rate applicable to the Transaction Documents

from the effective date thereof forward, unless such application is precluded by applicable law. If under any circumstances whatsoever,

interest in excess of the Maximum Rate is paid by the Company to the Purchaser with respect to Indebtedness evidenced by the Transaction

Documents, such excess shall be applied by the Purchaser to the unpaid principal balance of any such Indebtedness or be refunded to the

Company, the manner of handling such excess to be at the Purchaser’s election.

5.18 Liquidated Damages. The Company’s

obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents is a continuing obligation of

the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been paid notwithstanding the fact

that the instrument or security pursuant to which such partial liquidated damages or other amounts are due and payable shall have been

canceled.

5.19 Saturdays, Sundays, Holidays, etc.

If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business

Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.

5.20 Construction. The parties agree

that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents and, therefore,

the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed

in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to share prices and

Common Shares in any Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock

combinations and other similar transactions of the Common Shares that occur after the date of this Agreement. In this Agreement, unless

the context otherwise requires: (i) whenever required by the context, any pronoun used in this Agreement shall include the corresponding

masculine, feminine or neuter forms, and the singular form of nouns, pronouns and verbs shall include the plural and vice versa; (ii) “including”

(and with correlative meaning “include”) means including without limiting the generality of any description preceding or succeeding

such term and shall be deemed in each case to be followed by the words “without limitation”; and (iii) the words “herein”,

“hereto” and “hereby” and other words of similar import in this Agreement shall be deemed in each case to refer

to this Agreement as a whole and not to any particular portion of this Agreement.

5.21 Trust Account Waiver. The Purchaser

hereby acknowledges that, as described in the Company’s prospectus relating to its initial public offering (the “IPO”)

dated May 5, 2022 available at www.sec.gov, the Company has established a trust account (the “Trust Account”)

containing the proceeds of the IPO and from certain private placements occurring simultaneously with the IPO (including interest accrued

from time to time thereon) for the benefit of the Company, its public shareholders and certain other parties. For and in consideration

of the Company entering into this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby

acknowledged, the Purchaser on behalf of itself and each of its affiliates and subsidiaries, and each of its and their employees, agents,

representatives and any other person or entity acting on its and their behalf hereby (a) agrees that it does not now and shall not

at any time hereafter have any right, title, interest or claim of any kind in or to any assets held in the Trust Account, and shall not

make any claim against the Trust Account, arising out or as a result of, in connection with or relating in any way to this Agreement,

and regardless of whether such claim arises based on contract, tort, equity or any other theory of legal liability (any and all such claims

are collectively referred to hereafter as the “Released Claims”), (b) irrevocably waives any Released Claims that

it may have against the Trust Account now or in the future as a result of, or arising out of, this Agreement, and (c) agrees that

it will not seek recourse against the Trust Account as a result of, in connection with or relating in any way to this Agreement; provided,

however, that nothing in this Section 5.21 shall be deemed to limit the Purchaser’s right to distributions from

the Trust Account in accordance with the Company’s memorandum and articles of association in respect of any redemptions by the Purchaser

in respect of Common Shares acquired by any means other than pursuant to this Agreement.

5.22 NO LIABILITY UPON GOOD FAITH TERMINATION.

OTHER THAN WITH RESPECT TO ANY LIABILITIES ARISING PURSUANT TO SECTION 4.10 AND/OR SECTION 5.2 ABOVE, NONE OF

THE COMPANY, TARGET, ANY OF THEIR AFFILIATES, OR ANY OTHER PARTY TO THE BUSINESS COMBINATION AGREEMENT, OR ANY OF THEIR RESPECTIVE OFFICERS,

DIRECTORS, EQUITYHOLDERS, MANAGERS, MEMBERS, ADVISORS OR LEGAL COUNSEL SHALL HAVE ANY LIABILITY (INCLUDING, BUT NOT LIMITED TO, AS A RESULT

OF POTENTIAL LOST PROFITS AND OPPORTUNITIES) TO THE PURCHASER AS A RESULT OF THE TERMINATION OF THIS AGREEMENT AS A RESULT OF THE GOOD

FAITH TERMINATION OF THE BUSINESS COMBINATION AGREEMENT BECAUSE OF A FAILURE OF A CLOSING CONDITION TO BE MET (SOLELY TO THE EXTENT SUCH

FAILURE IS OUTSIDE OF THE CONTROL OF THE TARGET OR THE COMPANY, BUT REGARDLESS OF WHETHER THE BUSINESS COMBINATION AGREEMENT IS TERMINATED

BY THE COMPANY OR TARGET).

5.23 WAIVER OF JURY TRIAL. IN ANY ACTION,

SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO

THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL

BY JURY.

(Signature Pages Follow)

IN WITNESS WHEREOF, the parties hereto have caused

this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.

CARTESIAN GROWTH CORPORATION II

Address for Notice:

505 Fifth Avenue, 15th Floor

By:

New York, New York

Name:

Peter Yu

Title:

Chief Executive Officer

Email: @@@

With a copy to (which shall not constitute notice):

Greenberg Traurig, LLP

One Vanderbilt Avenue

New York, New York 10017

Attn: Adam Namoury

Email: @@@

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE PAGE FOR TARGET FOLLOWS]

IN WITNESS WHEREOF, the parties hereto have caused this Securities

Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.

INOBAT AS

Address for Notice:

Voderady 429

919 42 Voderady

Slovak Republic

Attn: CEO, Marian Bocek

Email: @@@

By:

Name: Marian Bocek

Title: Chief Executive Officer

Email: @@@

With a copy to (which shall not constitute notice):

Dentons US LLP

1221 Avenue of the Americas

New York, New York 10020

Attention: Ilan Katz; Brian Lee; Grant Levine

Email: @@@

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE PAGE FOR SPONSOR FOLLOWS]

IN WITNESS WHEREOF, the parties hereto have caused this Securities

Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.

CGC II SPONSOR LLC

Address for Notice:

505 Fifth Avenue, 15th Floor

New York, New York

By:

Name:

Peter Yu

Title:

President

Email: @@@

With a copy to (which shall not constitute notice):

Greenberg Traurig, LLP

One Vanderbilt Avenue

New York, New York 10017

Attn: Adam Namoury

Email: @@@

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE PAGE FOR PURCHASER FOLLOWS]

IN WITNESS WHEREOF, the undersigned have caused

this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.

Name of Purchaser: _____________________________________________________

Signature of Authorized Signatory of Purchaser: ______________________________

Name of Authorized Signatory: ____________________________________________

Title of Authorized Signatory: _____________________________________________

Email Address of Authorized Signatory: _____________________________________

Address for Notice to Purchaser: ___________________________________________

Address for Delivery of Securities to Purchaser (if not same as address

for notice):

Subscription Amount: $

[Series A] [Series B] Preference Shares:

Warrant Shares:

EIN Number:

ANNEX A-1

Eligibility Representations of Purchaser

This Annex A-1 should be completed and signed by

Purchaser

and constitutes a part of the Securities Purchase Agreement.

A. QUALIFIED INSTITUTIONAL BUYER STATUS (Please check the box, if applicable)

¨ Purchaser is a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act) (a “QIB”)

☐ Purchaser is subscribing for the Purchased Shares as a fiduciary or agent for one or more investor accounts, and each owner of such

account is a QIB.

**OR**

B. ACCREDITED INVESTOR STATUS (Please check the box)

¨ Purchaser is an institutional “accredited investor” (within the meaning of Rule 501(a)(1), (2), (3) or (7) of

Regulation D under the Securities Act) or an entity in which all of the equity holders are accredited investors within the meaning of

Rule 501(a) under the Securities Act, and has marked and initialed the appropriate box below indicating the provision under

which it qualifies as an “accredited investor.”

**OR**

C. ACCREDITED INVESTOR STATUS (Please check the box)

¨ Purchaser is an “accredited investor” (within the meaning of Rule 501(a)(5) or (6) of Regulation D under

the Securities Act).

**AND**

D. AFFILIATE STATUS (Please check the applicable box)

SUBSCRIBER:

is:

is not:

an “affiliate” (as defined in Rule 144

under the Securities Act) of the Company or the Target or acting on behalf of an affiliate of the Company or the Target.

Rule 501(a), in relevant

part, states that an “accredited investor” shall mean any person who comes within any of the below listed categories, or who

the issuer reasonably believes comes within any of the below listed categories, at the time of the sale of the securities to that person.

Purchaser has indicated, by marking and initialing the appropriate box below, the provision(s) below which apply to Purchaser and

under which Purchaser accordingly qualifies as an “accredited investor.”

¨ Any bank as defined in section 3(a)(2) of the Securities Act of 1933 (the “Act”), or any savings and loan

association or other institution as defined in section 3(a)(5)(A) of the Act whether acting in its individual or fiduciary capacity;

any broker or dealer registered pursuant to section 15 of the Securities Exchange Act of 1934; any investment adviser registered pursuant

to section 203 of the Investment Advisers Act of 1940 or registered pursuant to the laws of a state; any investment adviser relying on

the exemption from registering with the Commission under section 203(l) or (m) of the Investment Advisers Act of 1940; any insurance

company as defined in section 2(a)(13) of the Act; any investment company registered under the Investment Company Act of 1940 or a business

development company as defined in section 2(a)(48) of that act; any Small Business Investment Company licensed by the U.S. Small Business

Administration under section 301(c) or (d) of the Small Business Investment Act of 1958; any Rural Business Investment Company

as defined in section 384A of the Consolidated Farm and Rural Development Act;

¨ Any plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political

subdivisions for the benefit of its employees, if such plan has total assets in excess of $5,000,000;

¨ Any Target Benefit Plan within the meaning of the Employee Retirement Income Security Act of 1974 if the investment decision is made

by a plan fiduciary, as defined in section 3(21) of such act, which is either a bank, savings and loan association, insurance company,

or registered investment adviser, or if the Target Benefit Plan has total assets in excess of $5,000,000 or, if a self-directed plan,

with investment decisions made solely by persons that are accredited investors;

¨ Any private business development company as defined in section 202(a)(22) of the Investment Advisers Act of 1940;

¨ Any organization described in section 501(c)(3) of the Internal Revenue Code, corporation, Massachusetts or similar business

trust, partnership, or limited liability company, not formed for the specific purpose of acquiring the securities offered, with total

assets in excess of $5,000,000;

¨ Any natural person whose individual net worth, or joint net worth with that person’s spouse, at the time of his purchase exceeds

$1,000,000. For purposes of calculating a natural person’s net worth: (a) the person’s primary residence must not be

included as an asset; (b) indebtedness secured by the person’s primary residence up to the estimated fair market value of the

primary residence must not be included as a liability (except that if the amount of such indebtedness outstanding at the time of calculation

exceeds the amount outstanding 60 days before such time, other than as a result of the acquisition of the primary residence, the amount

of such excess must be included as a liability); and (c) indebtedness that is secured by the person’s primary residence in

excess of the estimated fair market value of the residence must be included as a liability;

¨ Any natural person who had an individual income in excess of $200,000 in each of the two most recent years or joint income with that

person’s spouse in excess of $300,000 in each of those years and has a reasonable expectation of reaching the same income level

in the current year; or

¨ Any trust with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the securities offered, whose

purchase is directed by a sophisticated person.

This Annex should be completed by Purchaser

and constitutes a part of the Securities Purchase Agreement.

ANNEX A-2

Form of Beneficial Ownership Letter Agreement

[DATE]

InoBat N.V.

[Address]

Attention: [●]

Email: [●]

[Purchaser]

[Address]

Attention: [●]

Email: [●]

Re: Beneficial Ownership Limitation Election Right

Ladies and Gentlemen:

Reference is made to that certain Securities Purchase

Agreement, dated as of July 24, 2026 (as amended, restated, supplemented or otherwise modified from time to time, the “Securities

Purchase Agreement”), by and among Cartesian Growth Corporation II, a Cayman Islands exempted company, InoBat AS, a private

limited company (aksjeselskap) organized under the laws of Norway, CGC II Sponsor LLC, a Cayman Islands limited liability company, InoBat

N.V., a public company with limited liability (naamloze vennootschap) organized under the laws of the Netherlands (the “Company”),

and the purchaser identified on the signature pages thereto (the “Holder”).

The Company and the Holder desire to memorialize

the Holder’s right to elect to be subject to, and the Holder hereby acknowledges that it is bound by, a beneficial ownership limitation

with respect to the conversion of the Company’s [12.0% Series A Cumulative Convertible Preference Shares] [Series B Convertible

Preference Shares], par value EUR 0.12 per share (the “Preference Shares”), held by the Holder, on the terms set forth

in this agreement (this “Agreement”).

Accordingly, for good and valuable consideration,

the receipt and sufficiency of which are hereby acknowledged, the Company and the Holder agree as follows:

1. Definitions

Capitalized terms used but not defined in this Agreement have the meanings

given to them in the Securities Purchase Agreement. As used in this Agreement:

“Affiliate” means with respect

to any specified person, any other person that directly, or indirectly through one or more intermediaries, controls, is controlled by

or is under common control with such specified person, as such terms are used in and construed under Rule 405 under the Securities

Act.

“Attribution Parties” means

the Holder’s Affiliates and any persons acting as a group together with such Holder or any of the Holder’s Affiliates within

the meaning of Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.

“Common Shares” means the common

shares in the capital of the Company, par value EUR [●] per share, and any other class of securities into which such securities

may hereafter be reclassified or changed.

“Commission” means the United

States Securities and Exchange Commission.

“Exchange Act” means the Securities

Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

“Securities Act” means the Securities

Act of 1933, as amended, and the rules and regulations promulgated thereunder.

“Trading Day” means a day on

which the principal Trading Market is open for trading.

“Trading Market” means any of

the following markets or exchanges on which the Common Shares are listed or quoted for trading on the date in question: the NYSE American,

the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange, or any successor

to any of the foregoing.

2. Beneficial Ownership Limitation Election Right

(a) The Holder may notify the Company in writing that it elects to be subject to the provisions of this Section 2. No holder of Preference

Shares shall be subject to this Section 2 unless such holder has made such election.

(b) If such election has been made, the Company shall not effect any conversion of Preference Shares held by such holder and, notwithstanding

the terms of the Preference Shares, such holder shall not have the right to convert all or any part of its Preference Shares, to the extent

that, after giving effect to the conversion specified in the relevant conversion notice, such holder, together with its Attribution Parties,

would beneficially own Common Shares in excess of four point nine per cent (4.9%), nine point nine per cent (9.9%), nineteen point nine

per cent (19.9%) or such other percentage not to exceed nineteen point nine per cent (19.9%) as such holder may specify in its written

election notice or any subsequent written notice to the Company, of the Common Shares then outstanding (the “Beneficial Ownership

Limitation”).

(c) For purposes of determining whether the Beneficial Ownership Limitation would be exceeded, the number of Common Shares beneficially

owned by such holder, its Affiliates and any such group persons shall include the number of Common Shares resulting from the conversion

of the Preference Shares in respect of which such determination is being made, but shall exclude the number of Common Shares which would

result from: (i) the conversion of any remaining Preference Shares held by such holder, its Affiliates or any such group persons

that are not being converted pursuant to the relevant conversion notice; and (ii) the exercise or conversion of any other securities

of the Company held by such holder, its Affiliates or any such group persons that are subject to a limitation on exercise or conversion

analogous to the limitation contained in this Section 2. Except as provided in the preceding sentence, beneficial ownership shall

be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.

(d) To the extent that this Section 2 applies, the determination as to whether any Preference Shares may be converted, and the number

of Preference Shares that may be converted, in each case in relation to other securities beneficially owned by such holder, its Affiliates

and any such group persons, shall be calculated by such holder in its sole discretion, subject always to the Beneficial Ownership Limitation.

The delivery of a conversion notice by such holder shall be deemed to constitute such holder’s determination that the conversion

specified in such conversion notice complies with this Section 2. The Company shall have the right, but no obligation, to verify

or confirm the accuracy of such determination.

(e) Each holder that has elected to be subject to this Section 2 shall be deemed to represent to the Company, each time it delivers

a conversion notice, that such conversion notice does not violate the restrictions set forth in this Section 2. Such holder shall

provide the Company with any information reasonably requested by the Company in connection with this Section 2, in each case to the

extent reasonably required for the Company’s reporting obligations under the Securities Act, the Exchange Act or other applicable

federal or state securities laws or regulations of the United States.

(f) For purposes of this Section 2, in determining the number of outstanding Common Shares, a holder may rely on the number of outstanding

Common Shares stated in the most recent of: (i) the Company’s most recent periodic or annual report filed with the Commission;

(ii) a more recent public announcement by the Company; and (iii) a more recent written notice by the Company or the transfer

agent of the Company setting out the number of Common Shares outstanding. Upon the written or oral request, including by email, of a holder

of Preference Shares, the Company shall, within one Trading Day, confirm in writing to such holder the number of Common Shares then outstanding.

In any case, the number of outstanding Common Shares shall be determined after giving effect to the conversion or exercise of securities

of the Company, including Preference Shares, by such holder, its Affiliates or any such group persons since the date as of which such

number of outstanding Common Shares was reported.

(g) A holder that has elected to be subject to this Section 2 may, by written notice to the Company, from time to time increase or

decrease the Beneficial Ownership Limitation applicable to such holder to a percentage not to exceed nineteen point nine per cent (19.9%),

provided that any increase in the Beneficial Ownership Limitation shall not become effective until the sixty-first (61st) day after the

date on which such notice is delivered to the Company.

(h) In the event that an issuance of Common Shares upon a purported conversion results or would result in the Holder, together with its

Attribution Parties, being deemed to beneficially own, in the aggregate, more than the Beneficial Ownership Limitation, such conversion

shall be deemed null and void and shall be cancelled ab initio.

(i) The provisions of this Section 2 shall be construed and implemented in a manner that gives effect to the intended Beneficial

Ownership Limitation, and the Company and the relevant holder shall make such adjustments in interpretation and implementation as may

be necessary or desirable to correct any provision of this Section 2 that is defective or inconsistent with such intended Beneficial

Ownership Limitation. The limitations contained in this Section 2 shall apply to any successor holder of Preference Shares.

3. Miscellaneous

The undersigned each represents that this agreement

constitutes a valid and legally binding obligation of such person, enforceable against them in accordance with its terms, except to the

extent that enforceability thereof may be limited by applicable bankruptcy, insolvency, reorganization and moratorium laws and other laws

of general application affecting the enforcement of creditors’ rights generally. The terms of Sections 5.4, 5.5, 5.6, 5.7, 5.8 5.9,

5.11, 5.12, 5.19, 5.20 and 5.23 of the Securities Purchase Agreement are incorporated herein by reference and shall apply mutatis mutandis

to this Agreement.

[Signature pages follow]

IN WITNESS WHEREOF, the parties hereto have executed

this Agreement as of the date first written above.

INOBAT N.V.

By:

Name:

Title:

[PURCHASER]

By:

Name:

Title:

EXHIBIT A

Form of Articles

[TO COME]

EXHIBIT B

Form of Amended and Restated Registration

Rights Agreement

FORM OF

AMENDED AND RESTATED

REGISTRATION RIGHTS AGREEMENT

THIS AMENDED AND RESTATED

REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of [●], is made and entered into by and among

Cartesian Growth Corporation II, a Cayman Islands exempted company (“CGC”), InoBat AS, a private limited

company (aksjeselskap) organized under the Laws of Norway (the “Target”), InoBat N.V., a public

company with limited liability (naamloze vennootschap) incorporated under the laws of the Netherlands (the “Company”),

CGC II Sponsor LLC, a Cayman Islands limited liability company (the “Sponsor”), the members of the Sponsor identified

on the signature pages hereto under “Other Sponsor Holders” (such members, together with the Sponsor, the “Sponsor

Holders”), each of the undersigned parties listed on the signature page hereto under “PIPE Holders” (the

“PIPE Holders”), each of the undersigned parties listed on the signature page hereto under “Inobat

Holders” (the “Inobat Holders”) and each of the undersigned parties listed on the signature page hereto

under “Other Holders” (the “Other Holders” and each such party, together with the Sponsor, the Sponsor

Holders, the Inobat Holders and any Person who hereafter becomes a party to this Agreement pursuant to Section 5.2, a “Holder”

and collectively the “Holders”).

RECITALS

WHEREAS, CGC and certain

Sponsor Holders are party to that certain Registration Rights Agreement, dated as of May 5, 2022 (the “Original RRA”);

WHEREAS, the Company

is party to that certain Business Combination Agreement, dated as of July 24, 2026 (as the same may be amended, restated, amended

and restated, supplemented or otherwise modified from time to time, the “Business Combination Agreement” and,

the transactions contemplated thereby, the “Business Combination”);

WHEREAS, prior to the

Closing, the Sponsor owned, in aggregate, (i) 5,649,999 Class A ordinary shares and one Class B ordinary share of CGC and

(ii) 8,900,000 private placement warrants to purchase one Class A ordinary shares of CGC, at an exercise price of $11.50;

WHEREAS, pursuant to

the Business Combination Agreement, on the date hereof: (a) certain shareholders of the Target holding at least 90% of the Targets

common shares contributed such shares to the Company, in exchange for a number of Common Shares of the Company, par value EUR 0.01 per

share (“Common Shares”) equal to the Exchange Ratio (as defined in the Business Combination Agreement); (b) the

Target merged with and into the Company, with the Company surviving the Merger; and (c) Merger Sub merged with and into CGC, with

CGC surviving as a direct wholly-owned subsidiary of the Company;

WHEREAS, on the date

hereof, in connection with the Closing of the Business Combination, the Company issued [●] Common Shares to the Inobat Holders;

WHEREAS, on the date

hereof, the Company issued an additional [●] 12.0% Series A Cumulative Convertible Preference Shares, par value [ ] per share

(the “Series A Preference Shares”), [●] Series B Convertible Preference Shares, par value [

] per share (the “Series B Preference Shares” and, together with the Series A Preference Shares, the

“Preference Shares”) and warrants purchase an aggregate of [●] Common Shares (subject to adjustment),

with each warrant exercisable for one Common Share at an exercise price of $12.00 (the “PIPE Warrants”), to

certain investors pursuant to those certain Securities Purchase Agreements, dated as of [●], by and among the Company and such investors

or other securities purchase agreements regarding the Preference Shares and the PIPE Warrants;

WHEREAS, pursuant to

Section 6.7 of the Original RRA, the provisions, covenants and conditions set forth therein may be amended or modified upon the written

consent of the Company and the Holders (as defined in the Original RRA) (the “Original Holders”) of at least

a majority in interest of the Registrable Securities (as defined in the Original RRA) (the “Original Registrable Securities”)

at the time in question, and the Sponsor Holders party hereto are Original Holders of at least a majority in interest of the Original

Registrable Securities as of the date hereof; and

WHEREAS, in connection

with the consummation of the transactions described above, the Company and the Original Holders desire to amend and restate the Original

RRA in its entirety as set forth herein, and the Company and the Holders desire to enter into this Agreement, pursuant to which the Company

shall grant the Holders certain registration rights with respect to the Registrable Securities (as defined below) on the terms and conditions

set forth in this Agreement.

NOW, THEREFORE,

in consideration of the representations, covenants and agreements contained herein, and certain other good and valuable consideration,

the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:

Article I

DEFINITIONS

1.1 Definitions. The

terms defined in this Article I shall, for all purposes of this Agreement, have the respective meanings set forth below:

“Additional Holder”

shall have the meaning given in Section 5.11.

“Additional Holder

Common Shares” shall have the meaning given in Section 5.11.

“Adverse Disclosure”

shall mean any public disclosure of material non-public information, which disclosure, in the good faith judgment of the Chief Executive

Officer or Chief Financial Officer of the Company or the Board, in each case, after consultation with counsel to the Company, (i) would

be required to be made in any Registration Statement or Prospectus in order for the applicable Registration Statement or Prospectus not

to contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make

the statements contained therein (in the case of any prospectus and any preliminary prospectus, in the light of the circumstances under

which they were made) not misleading, (ii) would not be required to be made at such time if the Registration Statement were not being

filed, declared effective or used, as the case may be, and (iii) the Company has a bona fide business purpose for not making

such information public.

“Agreement”

shall have the meaning given in the Preamble hereto.

“Board” shall

mean the board of directors of the Company.

“Business Combination

Agreement” shall have the meaning given in the Recitals hereto.

“Business Day”

means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York, United States; Amsterdam, the

Netherlands; or Bratislava, Slovakia are authorized or required by law to remain closed.

“Closing”

shall have the meaning given in the Business Combination Agreement.

“Closing Date”

shall have the meaning given in the Business Combination Agreement.

“Commission”

shall mean the U.S. Securities and Exchange Commission.

“Common Shares”

shall have the meaning given in the Recitals hereto.

“Company”

shall have the meaning given in the Preamble hereto and includes the Company’s successors by recapitalization, merger, consolidation,

spin-off, reorganization or similar transaction.

“Competing Registration

Rights” shall have the meaning given in Section 5.7.

“Demanding Holder”

shall have the meaning given in Section 2.1.4.

“Exchange Act”

shall mean the U.S. Securities Exchange Act of 1934, as it may be amended from time to time.

“FINRA”

shall mean the Financial Industry Regulatory Authority, Inc.

“Floor Price”

shall mean $5.00.

“Form F-1

Shelf” shall have the meaning given in Section 2.1.1.

“Form F -3

Shelf” shall have the meaning given in Section 2.1.1.

“Governmental

Authority” means any federal, state, local, foreign or other governmental, quasi-governmental or administrative body, instrumentality,

department or agency or any court, tribunal, administrative hearing body, arbitration panel, commission, or other similar dispute-resolving

panel or body.

“Holder Information”

shall have the meaning given in Section 4.1.2.

“Holders”

shall have the meaning given in the Preamble hereto, for so long as such Person holds any Registrable Securities.

“Inobat Holders”

shall have the meaning given in the Preamble hereto.

“Joinder”

shall have the meaning given in Section 5.11.

“Law”

shall mean any federal, state, local, municipal, foreign or other law, statute, legislation, principle of common law, ordinance, code,

edict, decree, proclamation, treaty, convention, rule, regulation, directive, requirement, writ, injunction, settlement, order or consent

that is or has been issued, enacted, adopted, passed, approved, promulgated, made, implemented or otherwise put into effect by or under

the authority of any Governmental Authority.

“Legal Proceeding”

means any notice of noncompliance or violation, or any claim, demand, charge, action, suit, litigation, audit, settlement, complaint,

stipulation, assessment or arbitration, or any request (including any request for information), inquiry, hearing, proceeding or investigation,

by or before any Governmental Authority.

“Lock-Up Agreement”

means that certain Lock-Up Agreement, dated as of the date hereof, by and among the Company, the Sponsor Holders and the Inobat Holders.

“Lock-Up Period”

shall mean (a) with respect to the Sponsor Holders and their respective Permitted Transferees, the lock-up period specified with

respect to such parties in the Lock-Up Agreement, (b) with respect to the Inobat Holders and their respective Permitted Transferees,

the lock-up period specified with respect to such parties in the Lock-Up Agreement.

“Maximum Number

of Securities” shall have the meaning given in Section 2.1.5.

“Minimum Takedown

Threshold” shall have the meaning given in Section 2.1.4.

“Misstatement”

shall mean an untrue statement of a material fact or an omission to state a material fact required to be stated in a Registration Statement

or Prospectus, or necessary to make the statements in a Registration Statement or Prospectus (in the case of a Prospectus, in the light

of the circumstances under which they were made) not misleading.

“Original Registrable

Securities” shall have the meaning given in the Recitals hereto.

“Original RRA”

shall have the meaning given in the Recitals hereto.

“Other Coordinated

Offering” shall have the meaning given in Section 2.4.1.

“Permitted Transferees”

means persons to whom a holder of Registrable Securities is permitted to transfer such Registrable Securities prior to the expiration

of the applicable Lock-Up Period pursuant to the Lock-Up Agreement.

“Person”

means an individual, corporation, partnership (including a general partnership, limited partnership or limited liability partnership),

limited liability company, association, trust or other entity or organization, including a government, domestic or foreign, or political

subdivision thereof, or an agency or instrumentality thereof.

“Piggyback Registration”

shall have the meaning given in Section 2.2.1.

“PIPE Warrants”

shall have the meaning given in the Recitals hereto.

“Preference Shares”

shall have the meaning given in the Recitals hereto.

“Prospectus”

shall mean the prospectus included in any Registration Statement, as supplemented by any and all prospectus supplements and as amended

by any and all post-effective amendments and including all material incorporated by reference in such prospectus.

“Registrable Security”

shall mean (i) any outstanding Common Shares held by a Holder immediately following the Closing, (ii) any Common Shares that

may be acquired by Holders upon the exercise, conversion or redemption of any other security of the Company or other right to acquire

Common Shares held by a Holder immediately following the Closing, (iii) any outstanding Common Shares or any other equity security

of the Company held by a Holder following the date hereof to the extent that such securities are “restricted securities” (as

defined in Rule 144) or are otherwise held by an “affiliate” (as defined in Rule 144) of the Company and (iv) any

other equity security of the Company issued or issuable with respect to any securities referenced in clause (i), (ii) or

(iii) above by way of a stock dividend or stock split or in connection with a combination of shares, recapitalization, merger,

consolidation, spin-off, reorganization or similar transaction; provided, however, that, as to any particular Registrable Security,

such securities shall cease to be Registrable Securities upon the earliest to occur of the following events: (i) a Registration Statement

with respect to the sale of such securities shall have become effective under the Securities Act and such securities shall have been sold,

transferred, disposed of or exchanged in accordance with such Registration Statement by the applicable Holder to a Person that is not

an “affiliate” (as defined in Rule 144) of the Company and new certificates for such securities not bearing (or book-entry

positions not subject to) a legend restricting further transfer shall have been delivered by the Company and subsequent public distribution

of such securities shall not require registration under the Securities Act; (ii) such securities shall have been otherwise transferred,

new certificates for such securities not bearing (or book-entry positions not subject to) a legend restricting further transfer shall

have been delivered by the Company and subsequent public distribution of such securities shall not require registration under the Securities

Act; (iii) such securities shall have ceased to be outstanding; (iv) such securities may be sold without registration pursuant

to Rule 144 (but with no volume or other restrictions or limitations including as to manner or timing of sale or current public information

requirements); and (v) such securities have been sold to, or through, a broker, dealer or underwriter in a public distribution or

other public securities transaction.

“Registration”

shall mean a registration, including any related Shelf Takedown, effected by preparing and filing a Registration Statement, Prospectus

or similar document in compliance with the requirements of the Securities Act, and the applicable rules and regulations promulgated

thereunder, and such registration statement becoming effective.

“Registration

Expenses” shall mean the documented, out-of-pocket expenses of a Registration, including, without limitation, the following:

(A) all registration,

listing and filing fees (including fees with respect to filings required to be made with FINRA) and any national securities exchange on

which the Common Shares is then listed;

(B) fees and expenses

of compliance with securities or blue sky laws (including reasonable fees and disbursements of counsel for the Underwriters in connection

with blue sky qualifications of Registrable Securities);

telephone and delivery expenses;

(D) reasonable fees and

disbursements of counsel for the Company;

(E) reasonable fees and

disbursements of all independent registered public accountants of the Company incurred specifically in connection with such Registration;

and

(F) reasonable fees and

expenses of one (1) legal counsel selected by the majority in interest of the Demanding Holders in an Underwritten Offering or Other

Coordinated Offering.

“Registration

Statement” shall mean any registration statement that covers Registrable Securities pursuant to the provisions of this Agreement,

including any Shelf, and, in each case, including the Prospectus included in such registration statement, amendments (including post-effective

amendments) and supplements to such registration statement and all exhibits to, and all material incorporated by reference in, such registration

statement.

“Requesting Holders”

shall have the meaning given in Section 2.1.5.

“Rule 144”

shall mean Rule 144 promulgated under the Securities Act, as amended from time to time, or any similar successor rule thereto

that may be promulgated by the Commission.

“Securities Act”

shall mean the U.S. Securities Act of 1933, as amended from time to time.

“Shelf”

shall mean the Form F-1 Shelf, the Form F-3 Shelf, or any Subsequent Shelf Registration, as the case may be.

“Shelf Registration”

shall mean a registration of securities pursuant to a registration statement filed with the Commission in accordance with and pursuant

to Rule 415 promulgated under the Securities Act, as amended from time to time, or any similar successor rule thereto that may

be promulgated by the Commission.

“Shelf Takedown”

shall mean an Underwritten Shelf Takedown or any proposed transfer or sale using a Registration Statement, including a Piggyback Registration.

“Sponsor”

shall have the meaning given in the Preamble hereto.

“Sponsor Holders”

shall have the meaning given in the Preamble hereto.

“Sponsor Majority

Holders” shall mean the Sponsor Holders holding in the aggregate a majority of the Registrable Securities then held by the

Sponsor Holders.

“Subsequent Shelf

Registration” shall have the meaning given in Section 2.1.2.

“Transfer”

shall mean the (i) sale or assignment of, offer to sell, contract or agreement to sell, hypothecation, pledge, grant of any option

to purchase or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent

position or liquidation with respect to or decrease of a call equivalent position within the meaning of Section 16 of the Exchange

Act with respect to, any security, (ii) entry into any swap or other arrangement that transfers to another, in whole or in part,

any of the economic consequences of ownership of any security, whether any such transaction is to be settled by delivery of such securities,

in cash or otherwise, or (iii) public announcement of any intention to effect any transaction specified in clause (i) or

(ii).

“Underwriter”

shall mean a securities dealer who purchases any Registrable Securities as principal in an Underwritten Offering and not as part of such

dealer’s market-making activities.

“Underwritten

Lock-Up Period” shall have the meaning given in Section 2.3.

“Underwritten

Registration” or “Underwritten Offering” shall mean a Registration in which securities of the

Company are sold to an Underwriter in a firm commitment underwriting for distribution to the public.

“Underwritten

Shelf Takedown” shall have the meaning given in Section 2.1.4.

“Withdrawal Notice”

shall have the meaning given in Section 2.1.6.

“Yearly Limit”

shall have the meaning given in Section 2.1.4.

Article II

REGISTRATIONS AND OFFERINGS

2.1 Shelf Registration.

2.1.1 Filing. The Company

shall, subject to Section 3.4, submit or file within 30 days of the Closing Date a Registration Statement for a Shelf Registration

on Form F-1 (the “Form F-1 Shelf”) or, if the Company is eligible to use a Registration Statement

on Form F-3, a Shelf Registration on Form F-3 (the “Form F-3 Shelf”), in each case, covering

the resale of all Registrable Securities (determined as of two (2) business days prior to such submission or filing and assuming

that (i) all Preference Shares are converted into Common Shares at a conversion price equal to the Floor Price and taking into account

payment-in-kind dividends for at least three years from the date of such submission or filing and (ii) all PIPE Warrants are exercised

in full at an exercise price equal to the Floor Price) on a delayed or continuous basis and shall use its commercially reasonable efforts

to have such Shelf declared effective as soon as reasonably practicable after the filing thereof, but no later than the earlier of (a) the

90th calendar day following the filing date thereof if the Commission notifies the Company that it will “review” the Registration

Statement and (b) the tenth (10th) business day after the date the Company is notified

(orally or in writing, whichever is earlier) by the Commission that the Registration Statement will not be “reviewed” or will

not be subject to further review. Such Shelf shall provide for the resale of the Registrable Securities included therein pursuant to any

method or combination of methods legally available to, and requested by, any Holder named therein. Subject to Sections 2.1.3 and

3.4, the Company shall maintain a Shelf in accordance with the terms hereof, and shall prepare and file with the Commission such

amendments, including post-effective amendments, and supplements as may be necessary to keep a Shelf continuously effective, available

for use to permit the Holders named therein to sell their Registrable Securities included therein and in compliance with the provisions

of the Securities Act until such time as there are no longer any Registrable Securities. In the event the Company files a Form F-1

Shelf, the Company shall use its commercially reasonable efforts to convert the Form F-1 Shelf (and any Subsequent Shelf Registration)

to a Form F-3 Shelf as soon as reasonably practicable after the Company is eligible to use Form F-3.

2.1.2 Subsequent Shelf Registration.

If any Shelf ceases to be effective under the Securities Act for any reason at any time while Registrable Securities are still outstanding,

the Company shall, subject to Section 3.4, use its commercially reasonable efforts to, as promptly as is reasonably practicable,

cause such Shelf to again become effective under the Securities Act (including using its commercially reasonable efforts to obtain the

prompt withdrawal of any order suspending the effectiveness of such Shelf), and shall use its commercially reasonable efforts to, as promptly

as is reasonably practicable, amend such Shelf in a manner reasonably expected to result in the withdrawal of any order suspending the

effectiveness of such Shelf or file an additional registration statement as a Shelf Registration (a “Subsequent Shelf Registration”)

registering the resale of all Registrable Securities under such Shelf (determined as of two (2) business days prior to such filing

and assuming that (i) all Preference Shares are converted into Common Shares at a conversion price equal to the Floor Price and taking

into account payment-in-kind dividends for at least three years from the date of such submission or filing and (ii) all PIPE Warrants

are exercised in full at an exercise price equal to the Floor Price), and pursuant to any method or combination of methods legally available

to, and requested by, any Holder named therein. If a Subsequent Shelf Registration is filed, the Company shall use its commercially reasonable

efforts to (i) cause such Subsequent Shelf Registration to become effective under the Securities Act as promptly as is reasonably

practicable after the filing thereof (it being agreed that the Subsequent Shelf Registration shall be an automatic shelf registration

statement (as defined in Rule 405 promulgated under the Securities Act) if the Company is a well-known seasoned issuer (as defined

in Rule 405 promulgated under the Securities Act) at the most recent applicable eligibility determination date) and (ii) keep

such Subsequent Shelf Registration continuously effective, available for use to permit the Holders named therein to sell their Registrable

Securities included therein and in compliance with the provisions of the Securities Act until such time as there are no longer any Registrable

Securities. Any such Subsequent Shelf Registration shall be on Form F-3 to the extent that the Company is eligible to use such form.

Otherwise, such Subsequent Shelf Registration shall be on another appropriate form.

2.1.3 New Registrable Securities.

Subject to Section 3.4, in the event that any Holder holds Registrable Securities that are not registered for resale on a

delayed or continuous basis, the Company shall, upon the written request of such Holder, promptly use its commercially reasonable efforts

to cause the resale of such Registrable Securities to be covered by either, at the Company’s option, any then-available Shelf (including

by means of a post-effective amendment) or a Subsequent Shelf Registration and cause the same to become effective as soon as practicable

after such filing and such Shelf or Subsequent Shelf Registration shall be subject to the terms hereof; provided, however, that

the Company shall only be required to cause such Registrable Securities to be so covered twice per calendar year for each of (i) the

Sponsor Holders, collectively, (ii) the Inobat Holders, collectively, (iii) the PIPE Holders, collectively, and (iv) the

Other Holders, collectively.

2.1.4 Requests for Underwritten

Shelf Takedowns. Subject to Section 3.4, at any time and from time to time when an effective Shelf is on file with the

Commission, any Holder (a “Demanding Holder”) may request to sell all or any portion of its Registrable Securities

in an Underwritten Offering or other coordinated offering that is registered pursuant to the Shelf (each, an “Underwritten

Shelf Takedown”); provided that the Company shall only be obligated to effect an Underwritten Shelf Takedown if such

offering shall include Registrable Securities proposed to be sold by the Demanding Holder, either individually or together with other

Demanding Holders, with a total offering price reasonably expected to exceed, in the aggregate, $25 million (the “Minimum

Takedown Threshold”). All requests for Underwritten Shelf Takedowns shall be made by giving written notice to the Company,

which shall specify the approximate number of Registrable Securities proposed to be sold in the Underwritten Shelf Takedown. Subject to

Section 2.4.4, the Company shall have the right to select the Underwriters for such offering (which shall consist of one or

more reputable nationally recognized investment banks), subject to the initial Demanding Holder’s prior approval (which approval

shall not be unreasonably withheld, conditioned or delayed). Subject to Section 2.4.6, each of (i) the Sponsor Holders,

collectively, (ii) the Inobat Holders, collectively, (iii) the PIPE Holders, and (iv) the Other Holders, collectively,

may demand Underwritten Shelf Takedowns pursuant to this Section 2.1.4 (x) not more than two (2) times in any 12-month

period (the “Yearly Limit”). Notwithstanding anything to the contrary in this Agreement, the Company may effect

any Underwritten Offering pursuant to any then-effective Registration Statement, including a Form F-3, that is then available for

such offering.

2.1.5 Reduction of Underwritten

Offering. If the managing Underwriter or Underwriters in an Underwritten Shelf Takedown, in good faith, advises the Company, the Demanding

Holders and the Holders requesting piggy back rights pursuant to this Agreement with respect to such Underwritten Shelf Takedown (the

“Requesting Holders”) (if any) in writing that the dollar amount or number of Registrable Securities that the

Demanding Holders and the Requesting Holders (if any) desire to sell, taken together with all other Common Shares or other equity securities

that the Company desires to sell and all other Common Shares or other equity securities, if any, that have been requested to be sold in

such Underwritten Offering pursuant to separate written contractual piggy-back registration rights held by any other stockholders who

desire to sell, exceeds the maximum dollar amount or maximum number of equity securities that can be sold in the Underwritten Offering

without adversely affecting the proposed offering price, the timing, the distribution method or the probability of success of such offering

(such maximum dollar amount or maximum number of such securities, as applicable, the “Maximum Number of Securities”),

then the Company shall include in such Underwritten Offering, before including any Common Shares or other equity securities proposed to

be sold by Company or by other holders of Common Shares or other equity securities, the Registrable Securities of the Demanding Holders

and the Requesting Holders (if any) (pro rata, as nearly as practicable, based on the respective number of Registrable Securities

that each Demanding Holder and Requesting Holder (if any) has requested be included in such Underwritten Shelf Takedown and the aggregate

number of Registrable Securities that the Demanding Holders and Requesting Holders (if any) have requested be included in such Underwritten

Shelf Takedown) that can be sold without exceeding the Maximum Number of Securities. To facilitate the allocation of Registrable Securities

in accordance with the above provisions, the Company or the Underwriters may round the number of shares allocated to any Holder to the

nearest 10 Registrable Securities.

2.1.6 Underwritten Shelf

Takedown Withdrawal. Prior to the filing of the applicable “red herring” prospectus or prospectus supplement used for

marketing such Underwritten Shelf Takedown, a majority in interest of the Demanding Holders initiating an Underwritten Shelf Takedown

shall have the right to withdraw from such Underwritten Shelf Takedown for any or no reason whatsoever upon written notification (a “Withdrawal

Notice”) to the Company and the Underwriter or Underwriters (if any) of their intention to withdraw from such Underwritten

Shelf Takedown; provided that any other Demanding Holder(s) may elect to have the Company continue an Underwritten Shelf Takedown

if the Minimum Takedown Threshold would still be satisfied by the Registrable Securities proposed to be sold in the Underwritten Shelf

Takedown by the Demanding Holder(s). If withdrawn, a demand for an Underwritten Shelf Takedown shall constitute a demand for an Underwritten

Shelf Takedown by the withdrawing Demanding Holder for purposes of Section 2.1.4 and shall count toward the Yearly Limit,

unless either (i) the Demanding Holder(s) making the withdrawal has not previously withdrawn any Underwritten Shelf Takedown

or (ii) the Demanding Holder(s) making the withdrawal reimburses the Company for all Registration Expenses with respect to such

Underwritten Shelf Takedown (or, if there is more than one Demanding Holder, a pro rata portion of such Registration Expenses based

on the respective number of Registrable Securities that each Demanding Holder has requested be included in such Underwritten Shelf Takedown);

provided that, if any other Demanding Holder(s) elects to continue an Underwritten Shelf Takedown pursuant to the proviso

in the immediately preceding sentence, such Underwritten Shelf Takedown shall instead count as an Underwritten Shelf Takedown demanded

by such Demanding Holder(s) for purposes of Section 2.1.4 and shall count toward the Yearly Limit. Following the receipt

of any Withdrawal Notice, the Company shall promptly forward such Withdrawal Notice to any other Requesting Holders. Notwithstanding anything

to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with a Shelf

Takedown prior to its withdrawal under this Section 2.1.6, other than if a Demanding Holder elects to pay such Registration

Expenses pursuant to clause (ii) of the second sentence of this Section 2.1.6.

2.2 Piggyback Registration.

2.2.1 Piggyback Rights.

If the Company or any Holder proposes to conduct a registered offering of, or if the Company proposes to file a Registration Statement

under the Securities Act with respect to the Registration of, equity securities, or securities or other obligations exercisable or exchangeable

for, or convertible into equity securities, for its own account or for the account of securityholders of the Company (or by the Company

and by the securityholders of the Company including, without limitation, an Underwritten Shelf Takedown pursuant to Section 2.1),

other than a Registration Statement (or any registered offering with respect thereto) (i) filed in connection with any employee stock

option or other benefit plan, (ii) for an exchange offer or offering of securities solely to the Company’s existing stockholders,

(iii) pursuant to a Registration Statement on Form S-4 (or similar form that relates to a transaction subject to Rule 145

under the Securities Act or any successor rule thereto), (iv) for an offering of debt that is convertible into equity securities

of the Company, (v) for a dividend reinvestment plan, or (vi) a Block Trade or an Other Coordinated Offering (which shall be

subject to Section 2.4), then the Company shall give written notice of such proposed offering to all of the Holders of Registrable

Securities as soon as practicable but not less than ten days before the anticipated filing date of such Registration Statement or, in

the case of an Underwritten Offering pursuant to a Shelf Registration, the applicable “red herring” prospectus or prospectus

supplement used for marketing such offering, which notice shall (A) describe the amount and type of securities to be included in

such offering, the intended method(s) of distribution, and the name of the proposed managing Underwriter or Underwriters, if any,

in such offering, and (B) offer to all of the Holders of Registrable Securities the opportunity to include in such registered offering

such number of Registrable Securities as such Holders may request in writing within five (5) business days after receipt of such

written notice (such Registration, a “Piggyback Registration”). Subject to Section 2.2.2, the Company

shall, in good faith, cause such Registrable Securities to be included in such Piggyback Registration and, if applicable, shall use its

commercially reasonable efforts to cause the managing Underwriter or Underwriters of such Piggyback Registration to permit the Registrable

Securities requested by the Holders pursuant to this Section 2.2.1 to be included therein on the same terms and conditions

as any similar securities of the Company included in such registered offering and to permit the sale or other disposition of such Registrable

Securities in accordance with the intended method(s) of distribution thereof. The inclusion of any Holder’s Registrable Securities

in a Piggyback Registration shall be subject to such Holder’s agreement to enter into an underwriting agreement in customary form

with the Underwriter(s) selected for such Underwritten Offering by the Company.

2.2.2 Reduction of Piggyback

Registration. If the managing Underwriter or Underwriters in an Underwritten Offering that is to be a Piggyback Registration, in good

faith, advises the Company and the Holders of Registrable Securities participating in the Piggyback Registration in writing that the dollar

amount or number of Common Shares or other equity securities that the Company or the Demanding Holders desire to sell, taken together

with (i) the Common Shares or other equity securities, if any, as to which Registration or a registered offering has been demanded

pursuant to separate written contractual arrangements with Persons other than the Holders of Registrable Securities hereunder, (ii) the

Registrable Securities as to which Registration has been requested pursuant to this Section 2.2 and (iii) the Common

Shares or other equity securities, if any, as to which Registration or a registered offering has been requested pursuant to separate written

contractual piggy-back registration rights of Persons other than the Holders of Registrable Securities hereunder, exceeds the Maximum

Number of Securities, then:

(a) if the Registration

or registered offering is undertaken for the Company’s account, the Company shall include in any such Registration or registered

offering (A) first, the Common Shares or other equity securities that the Company desires to sell, which can be sold without exceeding

the Maximum Number of Securities; (B) second, to the extent that the Maximum Number of Securities has not been reached under the

foregoing clause (A), the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant

to Section 2.2.1, pro rata, as nearly as practicable, based on the respective number of Registrable Securities that

each Holder has requested be included in such Underwritten Offering and the aggregate number of Registrable Securities that the Holders

have requested to be included in such Underwritten Offering, which can be sold without exceeding the Maximum Number of Securities; and

(B), the Common Shares or other equity securities, if any, as to which Registration or a registered offering has been requested

pursuant to separate written contractual piggy-back registration rights of Persons other than the Holders of Registrable Securities hereunder,

which can be sold without exceeding the Maximum Number of Securities;

(b) if the Registration

or registered offering is pursuant to a request by Persons other than the Holders of Registrable Securities, then the Company shall include

in any such Registration or registered offering (A) first, the Common Shares or other equity securities, if any, of such requesting

Persons, other than the Holders of Registrable Securities, which can be sold without exceeding the Maximum Number of Securities; (B) second,

to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (A), the Registrable Securities

of Holders exercising their rights to register their Registrable Securities pursuant to Section 2.2.1, pro rata, as

nearly as practicable, based on the respective number of Registrable Securities that each Holder has requested be included in such Underwritten

Offering and the aggregate number of Registrable Securities that the Holders have requested to be included in such Underwritten Offering,

which can be sold without exceeding the Maximum Number of Securities; (C) third, to the extent that the Maximum Number of Securities

has not been reached under the foregoing clauses (A) and (B), the Common Shares or other equity securities that the

Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; and (D) fourth, to the extent that

the Maximum Number of Securities has not been reached under the foregoing clauses (A), (B) and (C), the Common

Shares or other equity securities, if any, as to which Registration or a registered offering has been requested pursuant to separate written

contractual piggy-back registration rights of such Persons other than the Holders of Registrable Securities hereunder, which can be sold

without exceeding the Maximum Number of Securities; and

or registered offering is pursuant to a request by Holder(s) of Registrable Securities pursuant to Section 2.1, then

the Company shall include in any such Registration or registered offering securities in the priority set forth in Section 2.1.5.

2.2.3 Piggyback Registration

Withdrawal. Any Holder of Registrable Securities (other than a Demanding Holder, whose right to withdraw from an Underwritten Shelf

Takedown, and related obligations, shall be governed by Section 2.1.6) shall have the right to withdraw from a Piggyback Registration

for any or no reason whatsoever upon written notification to the Company and the Underwriter or Underwriters (if any) of his, her or its

intention to withdraw from such Piggyback Registration prior to the effectiveness of the Registration Statement filed with the Commission

with respect to such Piggyback Registration or, in the case of a Piggyback Registration pursuant to a Shelf Registration, the filing of

the applicable “red herring” prospectus or prospectus supplement with respect to such Piggyback Registration used for marketing

such transaction. The Company (whether on its own good faith determination or as the result of a request for withdrawal by Persons pursuant

to separate written contractual obligations) may withdraw a Registration Statement filed with the Commission in connection with a Piggyback

Registration at any time prior to the effectiveness of such Registration Statement. Notwithstanding anything to the contrary in this Agreement

(other than Section 2.1.6), the Company shall be responsible for the Registration Expenses incurred in connection with the

Piggyback Registration prior to its withdrawal under this Section 2.2.3.

2.2.4 Unlimited Piggyback

Registration Rights. For purposes of clarity, subject to Section 2.1.6, any Piggyback Registration effected pursuant to

Section 2.2 shall not be counted as a demand for an Underwritten Shelf Takedown under Section 2.1.4 and shall

not count toward the Yearly Limit.

2.3 Market Stand-off.

In connection with any Underwritten Offering of equity securities of the Company (other than a Block Trade or Other Coordinated Offering),

if requested by the managing Underwriter, each Holder that is an executive officer or director of the Company or a Holder in excess of

5.0% of the then-outstanding Common Shares agrees that it shall not Transfer any Common Shares or other equity securities of the Company

(other than those included in such offering pursuant to this Agreement), without the prior written consent of the Company, during the

90-day period (or such shorter time agreed to by the managing Underwriters) beginning on the date of pricing of such offering (the “Underwritten

Lock-Up Period”), except (i) to Permitted Transferees, (ii) as expressly permitted by such lock-up agreement or

(iii) in the event the Underwriters managing the offering otherwise consent in writing. Each Holder agrees to execute a customary

lock-up agreement in favor of the Underwriters to such effect (in each case on substantially the same terms and conditions as all other

Holders). The Company will not be obligated to undertake an Underwritten Shelf Takedown during any Underwritten Lock-Up Period binding

on the Holders, nor will the Company be obligated to include in any Piggyback Registration any Registrable Securities that are then subject

to a “lock-up” agreement.

2.4 Block Trades; Other

Coordinated Offerings.

2.4.1 Notwithstanding any other

provision of this Article II, but subject to Section 3.4, at any time and from time to time when an effective

Shelf is on file with the Commission, if a Demanding Holder wishes to engage in (a) an underwritten registered offering not involving

a “roadshow,” an offer commonly known as a “block trade” (a “Block Trade”) or (b) an

“at the market” or similar registered offering through a broker, sales agent or distribution agent, whether as agent or principal,

(an “Other Coordinated Offering”), in each case, either (x) with an anticipated aggregate offering price

reasonably expected to be at least $25 million or (y) with respect to all remaining Registrable Securities held by the Demanding

Holder, then such Demanding Holder only needs to notify the Company of the Block Trade or Other Coordinated Offering at least five (5) Business

Days prior to the day such offering is to commence and the Company shall as expeditiously as possible use its commercially reasonable

efforts to facilitate such Block Trade or Other Coordinated Offering; provided that the Demanding Holders representing a majority

of the Registrable Securities wishing to engage in the Block Trade or Other Coordinated Offering shall use commercially reasonable efforts

to work with the Company and any Underwriters, brokers, sales agents or placement agents prior to making such request in order to facilitate

preparation of the registration statement, prospectus and other offering documentation related to the Block Trade or Other Coordinated

Offering.

2.4.2 Prior to the filing of

the applicable “red herring” prospectus or prospectus supplement used in connection with a Block Trade or Other Coordinated

Offering, a majority-in-interest of the Demanding Holders initiating such Block Trade or Other Coordinated Offering shall have the right

to submit a Withdrawal Notice to the Company, the Underwriter or Underwriters (if any) and any brokers, sale agents or placement agents

(if any) of their intention to withdraw from such Block Trade or Other Coordinated Offering. Notwithstanding anything to the contrary

in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with a Block Trade or Other Coordinated

Offering prior to its withdrawal under this Section 2.4.2.

2.4.3 Notwithstanding anything

to the contrary in this Agreement, Section 2.2 shall not apply to a Block Trade or Other Coordinated Offering initiated by

a Demanding Holder pursuant to this Agreement.

2.4.4 The Demanding Holder in

a Block Trade or Other Coordinated Offering shall have the right to select the Underwriters and any brokers, sale agents or placement

agents (if any) for such Block Trade or Other Coordinated Offering (in each case, which shall consist of one or more reputable nationally

recognized investment banks).

2.4.5 Subject to Section 2.4.6,

each of (i) the Sponsor Holders, as a group, (ii) the Inobat Holders, as a group, (iii) the PIPE Holders, as a group, and

(iv) the Other Holders, as a group, may demand no more than two (2) Block Trades or Other Coordinated Offerings pursuant to

this Section 2.4 in any twelve (12) month period. For the avoidance of doubt, any Block Trade or Other Coordinated Offering

effected pursuant to this Section 2.4 shall not be counted as a demand for an Underwritten Shelf Takedown pursuant to Section 2.1.4.

2.4.6 Notwithstanding anything

to the contrary in this Agreement, with respect to (i) the Sponsor Holders, as a group, (ii) the Inobat Holders, as a group,

or (iii) the Other Holders, as a group, in no event may the number of Block Trades or Other Coordinated Offerings demanded pursuant

to this Section 2.4 plus the number of Underwritten Shelf Takedowns demanded pursuant to Section 2.1.4 exceed

a total of three (3) demands for such group in any twelve (12) month period.

2.5 Legends. In connection

with any sale or other disposition of the Registrable Securities by a Holder pursuant to Rule 144 promulgated under the Securities

Act (or any successor rule promulgated thereafter by the Commission) and upon compliance by the Holder with the requirements of this

Section 2.5, if requested by the Holder, the Company shall cause the transfer agent for the Registrable Securities (the “Transfer

Agent”) to remove any restrictive legends related to the book entry account holding such Registrable Securities and make

a new, unlegended entry for such book entry shares sold or disposed of without restrictive legends within one (1) trading day of

any such request therefor from the Holder; provided that the Company and the Transfer Agent have timely received from the Holder customary

representations and other documentation reasonably acceptable to the Company and the Transfer Agent in connection therewith. Subject to

receipt from the Holder by the Company and the Transfer Agent of customary representations and other documentation reasonably acceptable

to the Company and the Transfer Agent in connection therewith, the Holder may request that the Company remove any legend from the book

entry position evidencing its Registrable Securities and the Company will, if required by the Transfer Agent, use its commercially reasonable

efforts to cause an opinion of the Company’s counsel be provided, in a form reasonably acceptable to the Transfer Agent, to the

effect that the removal of such restrictive legends in such circumstances may be effected under the Securities Act, following the earliest

of such time as such Registrable Securities (i) are subject to or have been or are about to be sold pursuant to an effective registration

statement or (ii) have been or are about to be sold pursuant to Rule 144 promulgated under the Securities Act (or any successor

rule promulgated thereafter by the Commission). If restrictive legends are no longer required for such Registrable Securities pursuant

to the foregoing, the Company shall, in accordance with the provisions of this section and within one (1) trading day of any request

therefor from the Holder accompanied by such customary and reasonably acceptable representations and other documentation referred to above

establishing that restrictive legends are no longer required, deliver to the Transfer Agent irrevocable instructions that the Transfer

Agent shall make a new, unlegended entry for such book entry shares. The Company shall be responsible for the fees of its Transfer Agent,

its legal counsel and all DTC fees associated with such issuance.

Article III

COMPANY PROCEDURES

3.1 General Procedures.

In connection with any Shelf and/or Shelf Takedown, the Company shall use its commercially reasonable efforts to effect such Registration

to permit the sale of such Registrable Securities in accordance with the intended plan of distribution thereof (and including all manners

of distribution in such Registration Statement as Holders may reasonably request in connection with the filing of such Registration Statement

and as permitted by law, including distribution of Registrable Securities to a Holder’s members, securityholders or partners), and

pursuant thereto the Company shall, as expeditiously as possible:

3.1.1 prepare and file with

the Commission, as soon as reasonably practicable, a Registration Statement with respect to such Registrable Securities and use its commercially

reasonable efforts to cause such Registration Statement to become effective and remain effective until all Registrable Securities have

ceased to be Registrable Securities;

3.1.2 prepare and file with

the Commission such amendments and post-effective amendments to the Registration Statement, and such supplements to the Prospectus, as

may be reasonably requested by any Holder that holds at least five percent (5%) of the Registrable Securities registered on such Registration

Statement or any Underwriter of Registrable Securities or as may be required by the rules, regulations or instructions applicable to the

registration form used by the Company or by the Securities Act or rules and regulations thereunder to keep the Registration Statement

effective until all Registrable Securities covered by such Registration Statement are sold in accordance with the intended plan of distribution

set forth in such Registration Statement or supplement to the Prospectus;

3.1.3 prior to filing a Registration

Statement or Prospectus, or any amendment or supplement thereto, furnish without charge to the Underwriters, if any, and the Holders of

Registrable Securities included in such Registration, and such Holders’ legal counsel, copies of such Registration Statement as

proposed to be filed, each amendment and supplement to such Registration Statement (in each case including all exhibits thereto and documents

incorporated by reference therein), the Prospectus included in such Registration Statement (including each preliminary Prospectus) and

such other documents as the Underwriters and the Holders of Registrable Securities included in such Registration or the legal counsel

for any such Holders may request in order to facilitate the disposition of the Registrable Securities owned by such Holders;

3.1.4 prior to any public offering

of Registrable Securities, use its commercially reasonable efforts to (i) register or qualify the Registrable Securities covered

by the Registration Statement under such securities or “blue sky” laws of such jurisdictions in the United States as the Holders

of Registrable Securities included in such Registration Statement (in light of their intended plan of distribution) may request (or provide

evidence satisfactory to such Holders that the Registrable Securities are exempt from such registration or qualification) and (ii) take

such action necessary to cause such Registrable Securities covered by the Registration Statement to be registered with or approved by

such other governmental authorities as may be necessary by virtue of the business and operations of the Company and do any and all other

acts and things that may be necessary or advisable to enable the Holders of Registrable Securities included in such Registration Statement

to consummate the disposition of such Registrable Securities in such jurisdictions; provided, however, that the Company shall not

be required to qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify or take any action

to which it would be subject to general service of process or taxation in any such jurisdiction where it is not then otherwise so subject;

3.1.5 cause all such Registrable

Securities to be listed on each national securities exchange or automated quotation system on which similar securities issued by the Company

are then listed;

3.1.6 provide a transfer agent

or warrant agent, as applicable, and registrar for all such Registrable Securities no later than the effective date of such Registration

Statement;

3.1.7 advise each seller of

such Registrable Securities, promptly after it shall receive notice or obtain knowledge thereof, of the issuance of any stop order by

the Commission suspending the effectiveness of such Registration Statement or the initiation or threatening of any proceeding for such

purpose, and promptly use its commercially reasonable efforts to prevent the issuance of any stop order or to obtain its withdrawal if

such stop order should be issued;

3.1.8 prior to the filing of

any Registration Statement or Prospectus or any amendment or supplement to such Registration Statement or Prospectus (or such shorter

period of time as (a) may be necessary in order to comply with the Securities Act, the Exchange Act and the rules and regulations

promulgated under the Securities Act or Exchange Act, as applicable or (b) advisable in order to reduce the number of days that sales

are suspended pursuant to Section 3.4), furnish a copy thereof to each seller of such Registrable Securities and its counsel

(excluding any exhibits thereto and any filing made under the Exchange Act that is to be incorporated by reference therein);

3.1.9 notify the Holders at

any time when a Prospectus relating to such Registration Statement is required to be delivered under the Securities Act, of the happening

of any event as a result of which the Prospectus included in such Registration Statement, as then in effect, includes a Misstatement,

and then to correct such Misstatement as set forth in Section 3.4;

3.1.10 in the event of an Underwritten

Offering, a Block Trade, an Other Coordinated Offering, or sale by a broker, placement agent or sales agent that is registered pursuant

to a Registration Statement, permit a representative of the Holders (such representative to be selected by a majority of the participating

Holders), the Underwriters or other financial institutions facilitating such Underwritten Offering, Block Trade, Other Coordinated Offering

or other sale pursuant to such Registration, if any, and any attorney, consultant or accountant retained by such Holders collectively,

Underwriters or other financial institutions to participate, at each such Person’s own expense, in the preparation of the Registration

Statement, and cause the Company’s officers, directors and employees to supply all information reasonably requested by any such

representative, Underwriter, financial institution, attorney, consultant or accountant in connection with the Registration; provided,

however, that such representative, Underwriters or financial institutions agree to confidentiality arrangements, in form and substance

reasonably satisfactory to the Company, prior to the release or disclosure of any such information;

3.1.11 obtain a “comfort”

letter (including a bring-down letter dated as of the date the Registrable Securities are delivered for sale pursuant to such Registration)

from the Company’s independent registered public accountants in the event of an Underwritten Offering, a Block Trade, an Other Coordinated

Offering or a sale by a broker, placement agent or sales agent pursuant to a Registration Statement (subject to such Underwriter or other

financial institution facilitating such offering providing such certification or representation as reasonably requested by the Company’s

independent registered public accountings and the Company’s counsel), in customary form and covering such matters of the type customarily

covered by “comfort” letters as the managing Underwriter or other similar type of sales agent or placement agent may reasonably

request;

3.1.12 in the event of an Underwritten

Offering, a Block Trade, an Other Coordinated Offering or sale by a broker, placement agent or sales agent pursuant to a Registration

Statement, on the date the Registrable Securities are delivered for sale pursuant to such Registration, obtain an opinion and negative

assurance letter, dated such date, of counsel representing the Company for the purposes of such Registration, addressed to the participating

Holders, the broker, placement agent or sales agent, if any, and the Underwriters, if any, covering such legal matters with respect to

the Registration in respect of which such opinion is being given as the participating Holders, broker, placement agent, sales agent, or

Underwriter may reasonably request and as are customarily included in such opinions and negative assurance letters, provided, in each

case, that such participating Holders provide such information to such counsel as is customarily required for, or is reasonably requested

by such counsel for purposes of, such opinion or negative assurance letter;

3.1.13 in the event of any Underwritten

Offering, a Block Trade, an Other Coordinated Offering or sale by a broker, placement agent or sales agent pursuant to a Registration

Statement, enter into and perform its obligations under an underwriting agreement, purchase agreement, sales agreement or placement agreement,

in usual and customary form, with the managing Underwriter or broker, sales agent or placement agent of such offering or sale;

3.1.14 make available to its

security holders, as soon as reasonably practicable, an earnings statement covering the period of at least 12 months beginning with the

first day of the Company’s first full calendar quarter after the effective date of the Registration Statement which satisfies the

provisions of Section 11(a) of the Securities Act and Rule 158 thereunder (or any successor rule promulgated thereafter

by the Commission);

3.1.15 with respect to an Underwritten

Offering pursuant to Section 2.1.4, use its commercially reasonable efforts to make available senior executives of the Company

to participate in customary “road show” presentations that may be reasonably requested by the Underwriter in such Underwritten

Offering; and

3.1.16 otherwise, in good faith,

cooperate reasonably with, and take such customary actions as may reasonably be requested by the Holders participating in such Registration,

consistent with the terms of this Agreement, in connection with such Registration.

Notwithstanding the foregoing, the Company shall

not be required to provide any documents or information to an Underwriter or other sales agent or placement agent if such Underwriter

or other sales agent or placement agent has not then been named with respect to the applicable Underwritten Offering or other offering

involving a registration as an Underwriter or broker, sales agent or placement agent, as applicable.

3.2 Registration Expenses.

The Registration Expenses of all Registrations shall be borne by the Company. It is acknowledged by the Holders that the Holders shall

bear all incremental selling expenses relating to the sale of Registrable Securities, such as Underwriters’ or agents’ commissions

and discounts, brokerage fees, Underwriter marketing costs and, other than as set forth in the definition of “Registration Expenses,”

all reasonable fees and expenses of any legal counsel representing the Holders.

3.3 Requirements for Participation

in Underwritten Offerings. The Holders of Registrable Securities shall provide such information as may reasonably be requested by

the Company, or the managing Underwriter or placement agent or sales agent, if any, in connection with the preparation of any Registration

Statement or Prospectus, including amendments and supplements thereto, in order to effect the registration of any Registrable Securities

under the Securities Act pursuant to Article II and in connection with the Company’s obligation to comply with federal

and applicable state securities Laws. Notwithstanding anything in this Agreement to the contrary, if any Holder does not timely provide

the Company with its requested Holder Information, the Company may exclude such Holder’s Registrable Securities from the applicable

Registration Statement or Prospectus if the Company determines, based on the advice of counsel, that such information is necessary to

effect the registration and such Holder continues thereafter to withhold such information. No Person may participate in any Underwritten

Offering or other coordinated offering for equity securities of the Company pursuant to a Registration initiated by the Company hereunder

unless such Person (i) agrees to sell such Person’s securities on the basis provided in any arrangements approved by the Company

and (ii) timely completes and executes all customary questionnaires, powers of attorney, indemnities, lock-up agreements, underwriting

or other agreements and other customary documents as may be reasonably required under the terms of such arrangements. The exclusion of

a Holder’s Registrable Securities as a result of this Section 3.3 shall not affect the registration of the other Registrable

Securities to be included in such Registration.

3.4 Suspension of Sales;

Adverse Disclosure; Restrictions on Registration Rights.

3.4.1 Upon receipt of written

notice from the Company that a Registration Statement or Prospectus contains a Misstatement, each of the Holders shall forthwith discontinue

disposition of Registrable Securities until he, she or it has received copies of a supplemented or amended Prospectus correcting the Misstatement

(it being understood that the Company hereby covenants to prepare and file such supplement or amendment as soon as practicable after the

time of such notice), or until he, she or it is advised in writing by the Company that the use of the Prospectus may be resumed.

3.4.2 If the filing, initial

effectiveness or continued use of a Registration Statement in respect of any Registration at any time would (i) require the Company

to make an Adverse Disclosure, (ii) require the inclusion in such Registration Statement of financial statements that are unavailable

to the Company for reasons beyond the Company’s control or (iii) in the good faith judgment of the majority of the Board, be

seriously detrimental to the Company, and the majority of the Board concludes as a result that it is essential to defer such filing, initial

effectiveness or continued use at such time, the Company may, upon giving prompt written notice of such action to the Holders (which notice

shall not specify the nature of the event giving rise to such delay or suspension), delay the filing or initial effectiveness of, or suspend

use of, such Registration Statement for the shortest period of time determined in good faith by the Company to be necessary for such purpose.

In the event the Company exercises its rights under this Section 3.4.2, the Holders agree to suspend, immediately upon their

receipt of the notice referred to above, their use of the Prospectus relating to any Registration in connection with any sale or offer

to sell Registrable Securities until such Holder receives written notice from the Company that such sales or offers of Registrable Securities

may be resumed, and in each case maintain the confidentiality of such notice and its contents.

3.4.3 Subject to Section 3.4.4,

if (i) during the period starting with the date 60 days prior to the Company’s good faith estimate of the date of the filing

of, and ending on a date 120 days after the effective date of, a Company-initiated Registration, and provided that the Company continues

to actively employ, in good faith, all commercially reasonable efforts to maintain the effectiveness of the applicable Shelf Registration,

or (ii) if, pursuant to Section 2.1.4, Holders have requested an Underwritten Shelf Takedown and the Company and such

Holders are unable to obtain the commitment of underwriters to firmly underwrite such offering, then, in each case, the Company may, upon

giving prompt written notice of such action to the Holders, delay any other registered offering pursuant to Section 2.1.4.

3.4.4 The right to delay or

suspend any filing, initial effectiveness or continued use of a Registration Statement pursuant to Section 3.4.2 or a registered

offering pursuant to Section 3.4.3 shall be exercised by the Company, in the aggregate, for not more than 90 consecutive calendar

days or more 120 total calendar days in each case, during any 12-month period.

3.5 Reporting Obligations.

As long as any Holder shall own Registrable Securities, the Company, at all times while it shall be a reporting company under the Exchange

Act, covenants to use commercially reasonable efforts to file timely (or obtain extensions in respect thereof and file within the applicable

grace period) all reports required to be filed by the Company after the date hereof pursuant to Section 13(a) or 15(d) of

the Exchange Act. The Company further covenants that it shall take such further action as any Holder may reasonably request, to the extent

required from time to time to enable such Holder to sell Registrable Securities held by such Holder without registration under the Securities

Act within the limitation of the exemptions provided by Rule 144.

Article IV

INDEMNIFICATION AND CONTRIBUTION

4.1 Indemnification.

4.1.1 The Company agrees to

indemnify, to the extent permitted by law, each Holder of Registrable Securities, its officers, directors, agents and each Person who

controls such Holder (within the meaning of the Securities Act) against all losses, claims, damages, liabilities and reasonable and documented

out-of-pocket expenses (including, without limitation, reasonable outside attorneys’ fees) resulting from any untrue or alleged

untrue statement of material fact contained in or incorporated by reference in any Registration Statement, Prospectus or preliminary Prospectus

or any amendment thereof or supplement thereto filed pursuant to this Agreement or any omission or alleged omission of a material fact

required to be stated therein or necessary to make the statements therein not misleading, except insofar as the same are caused by or

contained in any information or affidavit so furnished in writing to the Company by such Holder expressly for use therein. The Company

shall indemnify the Underwriters, their officers and directors and each Person who controls such Underwriters (within the meaning of the

Securities Act) to the same extent as provided in the foregoing with respect to the indemnification of the Holder.

4.1.2 In connection with any

Registration Statement filed pursuant to this Agreement in which a Holder of Registrable Securities is participating, such Holder shall

furnish (or cause to be furnished) to the Company in writing such information and affidavits as the Company reasonably requests for use

in connection with any such Registration Statement or Prospectus (the “Holder Information”) and, to the extent

permitted by law, shall indemnify the Company, its directors, officers and agents and each Person who controls the Company (within the

meaning of the Securities Act) against all losses, claims, damages, liabilities and reasonable and documented out-of-pocket expenses (including,

without limitation, reasonable outside attorneys’ fees) resulting from any untrue or alleged untrue statement of material fact contained

in or incorporated by reference in any Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement

thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein

not misleading, but only to the extent that such untrue statement is contained in (or not contained in, in the case of an omission) any

information or affidavit so furnished in writing by such Holder expressly for use therein; provided, however, that the obligation

to indemnify shall be several, not joint and several, among such Holders of Registrable Securities, and the liability of each such Holder

of Registrable Securities shall be in proportion to and limited to the net proceeds received by such Holder from the sale of Registrable

Securities pursuant to such Registration Statement. The Holders of Registrable Securities shall indemnify the Underwriters, their officers,

directors and each person or entity who controls such Underwriters (within the meaning of the Securities Act) to the same extent as provided

in the foregoing with respect to indemnification of the Company.

4.1.3 Any Person entitled to

indemnification herein shall (i) give prompt written notice to the indemnifying party of any claim with respect to which it seeks

indemnification (provided that the failure to give prompt notice shall not impair any Person’s right to indemnification hereunder

to the extent such failure has not materially prejudiced the indemnifying party) and (ii) unless in such indemnified party’s

reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim, permit

such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such defense

is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party without its

consent (but such consent shall not be unreasonably withheld). An indemnifying party who is not entitled to, or elects not to, assume

the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel (plus one local counsel if necessary

in the reasonable judgment of the indemnified party) for all parties indemnified by such indemnifying party with respect to such claim,

unless in the reasonable judgment of any indemnified party a conflict of interest may exist between such indemnified party and any other

of such indemnified parties with respect to such claim. No indemnifying party shall, without the consent of the indemnified party, consent

to the entry of any judgment or enter into any settlement which cannot be settled in all respects by the payment of money (and such money

is so paid by the indemnifying party pursuant to the terms of such settlement) or which settlement includes a statement or admission of

fault and culpability on the part of such indemnified party or which settlement does not include as an unconditional term thereof the

giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.

4.1.4 The indemnification provided

for under this Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of the indemnified

party or any officer, director or controlling Person of such indemnified party and shall survive the transfer of securities. The Company

and each Holder of Registrable Securities participating in an offering also agrees to make such provisions as are reasonably requested

by any indemnified party for contribution to such party in the event the Company’s or such Holder’s indemnification is unavailable

for any reason.

4.1.5 If the indemnification

provided under Section 4.1 from the indemnifying party is unavailable or insufficient to hold harmless an indemnified party

in respect of any losses, claims, damages, liabilities and out-of-pocket expenses referred to herein, then the indemnifying party, in

lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified party as a result of such

losses, claims, damages, liabilities and out-of-pocket expenses in such proportion as is appropriate to reflect the relative fault of

the indemnifying party and the indemnified party, as well as any other relevant equitable considerations. The relative fault of the indemnifying

party and indemnified party shall be determined by reference to, among other things, whether any action in question, including any untrue

or alleged untrue statement of a material fact or omission or alleged omission to state a material fact, was made by (or not made by,

in the case of an omission), or relates to information supplied by (or not supplied by in the case of an omission), such indemnifying

party or indemnified party, and the indemnifying party’s and indemnified party’s relative intent, knowledge, access to information

and opportunity to correct or prevent such action; provided, however, that the liability of any Holder under this Section 4.1.5

shall be limited to the amount of the net proceeds received by such Holder in such offering giving rise to such liability. The amount

paid or payable by a party as a result of the losses or other liabilities referred to above shall be deemed to include, subject to the

limitations set forth in Sections 4.1.1, 4.1.2 and 4.1.3, any legal or other fees, charges or out-of-pocket expenses

reasonably incurred by such party in connection with any investigation or proceeding. The parties hereto agree that it would not be just

and equitable if contribution pursuant to this Section 4.1.5 were determined by pro rata allocation or by any other

method of allocation, which does not take account of the equitable considerations referred to in this Section 4.1.5. No Person

guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution

pursuant to this Section 4.1.5 from any Person who was not guilty of such fraudulent misrepresentation.

4.2 Waiver of Medallion

Guaranty. The Company agrees to use commercially reasonable efforts to enter into that certain indemnification agreement, substantially

in the form attached as Exhibit B to this Agreement, in favor of Continental Stock Transfer & Trust Company (or any

successor transfer agent or warrant agent of the Company) in connection with the waiver of any requirement to provide a medallion guarantee

in connection with any Transfer of any Common Shares or other equity securities of the Company by any Sponsor Holder, PIPE Holder, or

any of their Permitted Transferees; provided that, in each case, as a prerequisite to the Company’s entry into such indemnification

agreement, such Sponsor Holder or Permitted Transferee enters into an indemnification agreement in favor of the Company.

Article V

MISCELLANEOUS

5.1 Notices. All notices,

consents, waivers and other communications hereunder shall be in writing and shall be deemed to have been duly given when delivered (i) in

person, (ii) by facsimile or other electronic means (including email), with affirmative confirmation of receipt, (iii) one (1) Business

Day after being sent, if sent by reputable, nationally recognized overnight courier service or (iv) three (3) Business Days

after being mailed, if sent by registered or certified mail, pre-paid and return receipt requested, in each case to the applicable party

at the following addresses (or at such other address for a party as shall be specified by like notice). Any notice or communication under

this Agreement must be addressed, if to the Company, to: Inobat N.V., [●], Attention: [●], Email: [●], with a copy (which

shall not constitute notice) to Dentons LLP, [●], Attention: [●], Email: [●]; and, if to any Holder, at such Holder’s

address or contact information as set forth in the Company’s books and records. Any party may change its address for notice at any

time and from time to time by written notice to the other parties hereto, and such change of address shall become effective thirty (30)

days after delivery of such notice as provided in this Section 5.1.

5.2 Assignment; No Third-Party

Beneficiaries.

5.2.1 This Agreement and the

rights, duties and obligations of the Company hereunder may not be assigned or delegated by the Company in whole or in part.

5.2.2 This Agreement and the

rights, duties and obligations of the Holders hereunder may not be assigned or delegated by the Holders in whole or in part; provided,

however, that, subject to Section 5.2.5, a Holder may assign the rights and obligations of such Holder hereunder relating

to particular Registrable Securities in connection with the transfer of such Registrable Securities to a Permitted Transferee of such

Holder (it being understood that no such Transfer shall reduce any rights of the Holder with respect to Registrable Securities still held

by such Holder). A Permitted Transferee receiving Registrable Securities from a Sponsor Holder shall become a Sponsor Holder, a Permitted

Transferee receiving Registrable Securities from a Inobat Holder shall become an Inobat Holder, a Permitted Transferee receiving Registrable

Securities from a PIPE Holder shall become a PIPE Holder, and a Permitted Transferee receiving Registrable Securities from an Other Holder

shall become an Other Holder.

5.2.3 This Agreement and the

provisions hereof shall be binding upon and shall inure to the benefit of each of the parties and its successors and the permitted assigns

of the Holders, which shall include Permitted Transferees.

5.2.4 This Agreement shall not

confer any rights or benefits on any Persons that are not parties hereto, other than as expressly set forth in this Agreement and Section 5.2.

5.2.5 No assignment by any party

hereto of such party’s rights, duties and obligations hereunder shall be binding upon or obligate the Company unless such assignment

is permitted under 5.2.2 and unless and until the Company shall have received (i) written notice of such assignment as provided in

Section 5.1 and (ii) the written agreement of the assignee, in a form reasonably satisfactory to the Company, to be bound

by the terms and provisions of this Agreement (which may be accomplished by an addendum or certificate of joinder to this Agreement).

Any transfer or assignment made other than as provided in this Section 5.2 shall be null and void.

5.3 Counterparts. This

Agreement may be executed and delivered (including by facsimile or other electronic transmission) in one or more counterparts, and by

the different parties hereto in separate counterparts, each of which when executed shall be deemed to be an original but all of which

taken together shall constitute one and the same agreement.

5.4 Governing Law.

This Agreement, and all claims or causes of action based upon, arising out of, or related to this Agreement or the transactions contemplated

hereby, shall be governed by, and construed in accordance with, the Laws of the State of New York, without giving effect to principles

or rules of conflict of Laws to the extent such principles or rules would require or permit the application of Laws of another

jurisdiction.

5.5 Jurisdiction. Any

Legal Proceeding based upon, arising out of or related to this Agreement or the transactions contemplated hereby must be brought in any

New York State court or Federal court of the United States of America sitting in New York City in the Borough of Manhattan, and each of

the parties irrevocably (i) submits to the exclusive jurisdiction of each such court in any such Legal Proceeding, (ii) waives

any objection it may now or hereafter have to personal jurisdiction, venue or to convenience of forum, (iii) agrees that all claims

in respect of the Legal Proceeding shall be heard and determined only in any such court, and (iv) agrees not to bring any Legal Proceeding

arising out of or relating to this Agreement or the transactions contemplated hereby in any other court. Nothing herein contained shall

be deemed to affect the right of any party to serve process in any manner permitted by Law or to commence Legal Proceedings or otherwise

proceed against any other party in any other jurisdiction, in each case, to enforce judgments obtained in any Legal Proceeding, suit or

proceeding brought pursuant to this Section 5.5.

5.6 Waiver of Jury Trial.

EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREBY

IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY, UNCONDITIONALLY AND VOLUNTARILY

WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY ACTION, SUIT OR PROCEEDING DIRECTLY OR INDIRECTLY ARISING

OUT OF OR RELATING TO THIS AGREEMENT OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY.

5.7 Amendments and Modifications.

Upon the written consent of the Company and the Holders of at least a majority in interest of the aggregate Registrable Securities at

the time in question, compliance with any of the provisions, covenants and conditions set forth in this Agreement may be waived, or any

of such provisions, covenants or conditions may be amended or modified; provided, however, that notwithstanding the foregoing,

(i) any amendment hereto or waiver hereof that adversely effects the Sponsor Holders shall also require the written consent of the

Sponsor Majority Holders so long as the Sponsor Holders and their respective affiliates hold, in the aggregate, at least one percent (1%)

of the outstanding Common Shares of the Company and (ii) any amendment hereto or waiver hereof that adversely effects the Lead Purchaser

or its affiliates shall also require the written consent of the Leader Purchaser so long as the Lead Purchaser and its respective affiliates

hold, in the aggregate, at least three percent (3%) of the outstanding Common Shares of the Company; and provided, further,

that any amendment hereto or waiver hereof that adversely affects one Holder, solely in its capacity as a holder of the shares of capital

stock of the Company, in a manner that is materially different from the other Holders (in such capacity) shall require the consent of

the Holder so affected. No course of dealing between any Holder or the Company and any other party hereto or any failure or delay on the

part of a Holder or the Company in exercising any rights or remedies under this Agreement shall operate as a waiver of any rights or remedies

of any Holder or the Company. No single or partial exercise of any rights or remedies under this Agreement by a party shall operate as

a waiver or preclude the exercise of any other rights or remedies hereunder or thereunder by such party.

5.8 Other Registration

Rights. Other than as provided in the Warrant Agreement, dated as of May 5, 2022, between the Company and Continental Stock Transfer &

Trust Company, the Company represents and warrants that no Person, other than a Holder of Registrable Securities, has any right to require

the Company to register any securities of the Company for sale or to include such securities of the Company in any Registration Statement

filed by the Company for the sale of securities for its own account or for the account of any other Person. For

so long as the Sponsor Holders and their respective affiliates hold, in the aggregate, at least five percent (5%) of the outstanding Common

Shares of the Company, the Company hereby agrees and covenants that it will not grant rights to register any Common Shares (or securities

convertible into or exchangeable for Common Shares) pursuant to the Securities Act that are more favorable or senior to those granted

to the Holders hereunder (such rights “Competing Registration Rights”) without the prior written consent of

the Sponsor Majority Holders, not to be unreasonably withheld, delayed or conditioned. For so long as the Lead Purchaser and its respective

affiliates hold, in the aggregate, at least five percent (5%) of the outstanding Common Shares of the Company, the Company hereby agrees

and covenants that it will not grant any Competing Registration Rights without the prior written consent of the Lead Purchaser, not to

be unreasonably withheld, delayed or conditioned. Further, the Company represents and warrants that this Agreement supersedes any

other registration rights agreement or agreement with similar terms and conditions, and in the event of a conflict between any such agreement

or agreements and this Agreement, the terms of this Agreement shall prevail.

5.9 Term. This Agreement

shall terminate upon the earlier of (i) the tenth anniversary of the date of this Agreement and (ii) with respect to any Holder,

the date that such Holder no longer holds any Registrable Securities. The provisions of Article IV shall survive any termination.

5.10 Holder Information.

Each Holder agrees, if requested in writing, to represent to the Company the total number of Registrable Securities held by such Holder

in order for the Company to make determinations hereunder.

5.11 Additional Holders;

Joinder. In addition to Persons who may become Holders pursuant to Section 5.2, subject to the prior written consent of

at least a majority in interest of the aggregate Registrable Securities at the time in question, the Company may make any Person who acquires

Common Shares or rights to acquire Common Shares after the date hereof a party to this Agreement (each such Person, an “Additional

Holder”) by obtaining an executed joinder to this Agreement from such Additional Holder in the form of Exhibit A

attached hereto (a “Joinder”). Such Joinder shall specify the rights and obligations of the applicable Additional

Holder under this Agreement. Upon the execution and delivery and subject to the terms of a Joinder by such Additional Holder, the Common

Shares of the Company then owned, or underlying any rights then owned, by such Additional Holder (the “Additional Holder Common

Shares”) shall be Registrable Securities to the extent provided herein and therein, and such Additional Holder shall be

a Holder under this Agreement with respect to such Additional Holder Common Shares.

5.12 Severability.

In case any provision in this Agreement shall be held invalid, illegal or unenforceable in a jurisdiction, such provision shall be modified

or deleted, as to the jurisdiction involved, only to the extent necessary to render the same valid, legal and enforceable, and the validity,

legality and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby nor shall the validity,

legality or enforceability of such provision be affected thereby in any other jurisdiction. Upon such determination that any term or other

provision is invalid, illegal or incapable of being enforced, the parties will substitute for any invalid, illegal or unenforceable provision

a suitable and equitable provision that carries out, so far as may be valid, legal and enforceable, the intent and purpose of such invalid,

illegal or unenforceable provision.

5.13 Entire Agreement;

Restatement. This Agreement and the documents or instruments referred to herein, including any exhibits and schedules attached hereto,

which exhibits and schedules are incorporated herein by reference, embody the entire agreement and understanding of the parties hereto

in respect of the subject matter contained herein. There are no restrictions, promises, representations, warranties, covenants or undertakings,

other than those expressly set forth or referred to herein or the documents or instruments referred to herein, which collectively supersede

all prior agreements and the understandings among the parties with respect to the subject matter contained herein. Upon the Closing, the

Original RRA shall no longer be of any force or effect.

[Signature Pages Follow]

IN WITNESS WHEREOF, the undersigned

have caused this Agreement to be executed as of the date first written above.

COMPANY:

INOBAT N.V.

InoBat N.V., a public company with limited

liability (naamloze vennootschap)

incorporated under the laws of the Netherlands

By:

Name:

Title:

[Signature Page to Amended and Restated

Registration Rights Agreement]

INOBAT HOLDERS:

[●]

[Signature Page to Amended and Restated

Registration Rights Agreement]

SPONSOR:

CGC II SPONSOR LLC, a Cayman Islands limited liability company

By:

Name:

Title:

By:

Name:

Title:

OTHER SPONSOR HOLDERS:

[●]

By:

Name:

Title:

[●]

By:

Name:

Title:

[Signature Page to Amended and Restated

Registration Rights Agreement]

PIPE HOLDERS:

[●]

[Signature Page to Amended and Restated

Registration Rights Agreement]

OTHER HOLDERS:

[●]

[Signature Page to Amended and Restated

Registration Rights Agreement]

Exhibit A

AMENDED AND RESTATED

REGISTRATION RIGHTS AGREEMENT

JOINDER

The undersigned is executing

and delivering this joinder (this “Joinder”) pursuant to the Amended and Restated Registration Rights Agreement,

dated as of [____], 2026 (as the same may hereafter be amended, the “Registration Rights Agreement”), among

a public company with limited liability (naamloze vennootschap) incorporated under the laws of the Netherlands (the “Company”),

and the other Persons named as parties therein. Capitalized terms used but not otherwise defined herein shall have the meanings provided

in the Registration Rights Agreement.

By executing and delivering

this Joinder to the Company, and upon acceptance hereof by the Company upon the execution of a counterpart hereof, the undersigned hereby

agrees to become a party to, to be bound by and to comply with the Registration Rights Agreement as a Holder of Registrable Securities

in the same manner as if the undersigned were an original signatory to the Registration Rights Agreement as [a Sponsor Holder / a Inobat

Holder / a PIPE Holder / an Other Holder], and the undersigned’s [Common Shares] shall be included as Registrable Securities under

the Registration Rights Agreement to the extent provided therein; provided, however, that the undersigned and its permitted assigns

(if any) shall not have any rights as Holders, and the undersigned’s (and its transferees’) [Common Shares] shall not be included

as Registrable Securities, for purposes of the Excluded Sections.

For purposes of this Joinder,

“Excluded Sections” shall mean [ ].

Accordingly, the undersigned

has executed and delivered this Joinder as of the __________ day of __________, 20__.

Signature of Stockholder

Print Name of Stockholder

Its:

Address:

Agreed

and Accepted as of ____________, 20__

[●]

By:

Name:

Its:

Exhibit B

[●]

[DATE]

Continental Stock Transfer & Trust Company

1 State Street, 30th

Floor

New York, NY 10004

Re: Indemnification in-lieu-of Medallion Signature

Guarantee

To whom it may concern:

This letter is in regards

to the transfer by [CGC II Sponsor LLC / Name of Sponsor Holder] to [ ], of [ ] Common Shares of Inobat N.V. (the “Company”).

Please be advised that the Company authorizes Continental Stock Transfer & Trust Company to process the subject transfer, which

includes securities that have been duly endorsed by the registered holder but do not bear a customary medallion signature guarantee. The

Company agrees to indemnify Continental Stock Transfer & Trust Company against all losses, damages, costs, charges and expenses

that it may in any way sustain, incur, or become liable for by reason related to the above referenced transaction.

I, [●], a duly authorized

officer of the Company, have the authority to execute this indemnification on behalf of the Company.

Very truly yours,

[●]

By:

Name:

Title:

EXHIBIT C

Common Shares Purchase Warrant

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH

THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE

IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND,

ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT

TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE

WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN

CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

INOBAT

N.V.

COMMON SHARE PURCHASE WARRANT

Warrant Shares: [_______]

Initial Exercise Date: [●], [●]

THIS COMMON SHARE PURCHASE WARRANT

(this “Warrant”) certifies that, for value received, [_____________] or its assigns (the “Holder”)

is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after

the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [●],

[●]10 (the “Termination Date”) but not thereafter, to subscribe

for and purchase from InoBat N.V., a public company with limited liability (naamloze vennootschap) incorporated under the laws

of the Netherlands (the “Company”), up to [______] (as subject to adjustment hereunder, the “Warrant Shares”)

Common Shares, par value [ ] per share, of the Company (the “Common Shares”). The purchase price of one Common Share

under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Section 1. Definitions. Capitalized

terms used and not otherwise defined herein shall have the meanings set forth in Schedule A hereto.

Section 2. Exercise.

10 NTD: five years after Initial Exercise Date.

(a)

Exercise of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company (or such other office or agency that the Company may designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the Company), as applicable, of a duly executed PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the “Notice of Exercise”). Not later than the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver to the Company the aggregate Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is available and specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Business Day of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.

(b)

Exercise Price. The exercise price per Common Share under this Warrant shall be $12.00, subject to adjustment hereunder (the “Exercise Price”).

(c)

Cashless Exercise. If at any time after the six (6) month anniversary of the Closing Date, (x) the Warrants Shares issuable upon exercise of this Warrant would be (i) “restricted securities” as defined in Rule 144 or (ii) the Holder is an Affiliate of the Company and (y) there is no effective registration statement registering, or the prospectus contained therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing ((A-B) multiplied by (X)) by (A), where:

(A) =

as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day, (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular trading hours” (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day or (3) executed during “regular trading hours” on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of “regular trading hours” on a Trading Day), or (ii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of “regular trading hours” on such Trading Day;

(B) =

the Exercise Price of this Warrant, as adjusted hereunder; and

(X) =

the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.

Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of

the Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the

Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees not to take any position contrary

to this Section 2(c).

Notwithstanding anything herein to the

contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant to this Section 2(c).

(d)

Mechanics of Exercise.

(i)

Delivery of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system if the Company is then a participant in such system and there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder, and otherwise by physical delivery of a certificate, (or reasonable evidence of issuance by book entry of ownership of the Warrant Shares) registered in the Company’s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the later of (i) the Standard Settlement Period after the delivery to the Company of the Notice of Exercise, and (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company (such date, the “Warrant Share Delivery Date”); provided, however, in any event, the Company shall not be obligated to deliver Warrant Shares until it has received the aggregate Exercise Price therefor. Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received no later than the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, “Standard Settlement Period” means the standard settlement period, expressed in a number of Trading Days, on the Company’s primary Trading Market with respect to the Common Shares as in effect on the date of delivery of the Notice of Exercise.

(ii)

Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.

(iii)

Rescission Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date (subject to receipt of the aggregate Exercise Price for the applicable exercise (other than in the case of a cashless exercise)), then the Holder will have the right to rescind such exercise prior to the delivery of the Warrant Shares.

(iv)

No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.

(v)

Charges, Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares pursuant to the terms of this Warrant.

(vi)

Closing of Books. The Company will not close its shareholder books or records in any manner intended to prevent the timely exercise of this Warrant, pursuant to the terms hereof.

(e)

Holder’s Exercise Limitations. The Holder may notify the Company in writing in the event it elects to be subject to the provisions contained in this Section 2(e); however, the Holder shall not be subject to this Section 2(e) unless he, she or it makes such election. If the election is made, the Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any Persons acting as a group together with the Holder or any of the Holder’s Affiliates within the meaning of Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder (such Persons, “Attribution Parties”)) would beneficially own in excess of 4.9%, 9.9%, 19.9% (or such other amount as the Holder may specify not to exceed 19.9%) (the “Beneficial Ownership Limitation”). For purposes of the foregoing sentence, the number of Common Shares beneficially owned by the Holder, its Affiliates and Attribution Parties shall include the number of Common Shares issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of Common Shares which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company (including, without limitation, any other Common Share Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and, of which portion of this Warrant is exercisable up to the Beneficial Ownership Limitation shall be calculated in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s good faith determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case, subject to the Beneficial Ownership Limitation, and the Company shall have the right, but no obligation, to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder and the Company shall have the right, but no obligation, to verify or confirm the accuracy of such determination. For purposes of this Section 2(e), in determining the number of outstanding Common Shares, a Holder may rely on the number of outstanding Common Shares as reflected in (A) the Company’s most recent periodic or annual report filed

with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of Common Shares outstanding. Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day confirm in writing to the Holder the number of Common Shares then outstanding. In any case, the number of outstanding Common Shares shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding Common Shares was reported. By written notice to the Company, the Holder may from time to time increase or decrease the Beneficial Ownership Limitation to an amount not to exceed 19.9% applicable to the Holder, provided, however, that any such increase in the Beneficial Ownership Limitation will not be effective until the sixty-first (61st) day after such notice is delivered to the Company. In the event that an issuance of Common Shares upon a purported exercise results or would result in the Holder, together with its Attribution Parties, being deemed to beneficially own, in the aggregate, more than the Beneficial Ownership Limitation, such exercise shall be deemed null and void and shall be cancelled ab initio. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.

Section 3.

Certain Adjustments.

(a)

Share Dividends and Splits. If the Company at any time while this Warrant is outstanding: (i) pays a share dividend or otherwise makes a distribution or distributions on shares of its Common Share or any other equity or equity equivalent securities payable in Common Shares (which, for avoidance of doubt, shall not include any Common Shares issued by the Company upon exercise of this Warrant or any cash distributions), (ii) subdivides outstanding Common Shares into a larger number of shares, (iii) combines (including by way of a reverse share split) outstanding Common Shares into a smaller number of shares, or (iv) issues by reclassification of Common Shares any capital shares of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of Common Shares (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of Common Shares outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of shareholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.

(b)

VWAP Reset. If on the twenty-first trading day following the date that is six months after the Closing Date, the VWAP (as defined by Bloomberg) of the Common Shares for the twenty trading period commencing on the date that is six months after the Closing Date (the “Measurement Price”) is less than the Exercise Price then in effect, then the Exercise Price then in effect shall be reduced to an amount equal to the greater of (i) the Measurement Price and (ii) $5.00.

(c)

Adjustment Upon Issuance of Common Share. If and whenever on or after the Closing Date, the Company issues or sells, or in accordance with this Section 3(c) is deemed to have issued or sold, any Common Shares (including the issuance or sale of Common Shares owned or held by or for the account of the Company, but excluding Common Shares issued or sold, or deemed to have been issued or sold, by the Company in connection with any Exempt Issuance) for a consideration per share (the “New Issuance Price”) less than the Exercise Price then in effect (each such issue, sale or deemed issuance or sale, a “Dilutive Issuance”), where the aggregate amount of consideration received by the Company, together with all prior issuances and sales conducted for the purpose of raising capital by the Company on or after the Closing Date that were excluded from this Section 3(c) by this clause, exceeds $500,000, then immediately after such Dilutive Issuance, the Exercise Price then in effect shall be reduced to an amount equal to the New Issuance Price.

For purposes of determining the adjusted

Exercise Price under this Section 3(c), the following shall be applicable:

(i)

Options and Convertible Securities. The consideration per share received by the Company for Common Share deemed to have been issued pursuant to Section 3(c)(ii), relating to Options and Convertible Securities, shall be determined by dividing:

(1)

the total amount, if any, received or receivable by the Company as consideration for the issue of such Options or Convertible Securities, plus the minimum aggregate amount of additional consideration (as set forth in the instruments relating thereto, without regard to any provision contained therein for a subsequent adjustment of such consideration) payable to the Company upon the exercise of such Options or the conversion or exchange of such Convertible Securities, or in the case of Options for Convertible Securities, the exercise of such Options for Convertible Securities and the conversion or exchange of such Convertible Securities, by

(2)

the maximum number of Common Shares (as set forth in the instruments relating thereto, without regard to any provision contained therein for a subsequent adjustment of such number) deemed to be issued pursuant to Section 3(c)(ii) upon the issuance of such Options or Convertible Securities.

(ii)

Deemed Issuance of Options and Convertible Securities.

(1)

If the Company at any time or from time to time shall issue any Options or Convertible Securities or shall fix a record date for the determination of holders of any class of securities entitled to receive any such Options or Convertible Securities, then the maximum number of Common Shares (as set forth in the instrument relating thereto, assuming the satisfaction of any conditions to exercisability, convertibility or exchangeability but without regard to any provision contained therein for a subsequent adjustment of such number) issuable upon the exercise of such Options or, in the case of Convertible Securities and Options therefor, the conversion or exchange of such Convertible Securities, shall be deemed to be outstanding and to have been issued as of the time of such issue or, in case such a record date shall have been fixed, as of the close of business on such record date.

(2)

If the purchase price provided for in any Options, the additional consideration, if any, payable upon the issue, conversion, exercise or exchange of any Convertible Securities, or the rate at which any Convertible Securities are convertible into or exercisable or exchangeable for Common Share increases or decreases at any time, (other than (x) proportional changes in conversion or exercise prices, as applicable, in connection with an event referred to in Section 3(a) above and (y) automatic adjustments to such terms pursuant to anti-dilution or similar provisions of such Option or Convertible Security which are not more favorable to the holder thereof than the anti-dilution and similar provisions set forth herein), the Exercise Price in effect at the time of such increase or decrease shall be adjusted to the Exercise Price, which would have been in effect at such time had such Options or Convertible Securities provided for such increased or decreased purchase price, additional consideration or increased or decreased conversion rate, as the case may be, at the time initially granted, issued or sold. For purposes of this Section 3(c)(ii)(2), if the terms of any Option or Convertible Security that was outstanding as of the Initial Exercise Date are increased or decreased in the manner described in the immediately preceding sentence, then such Option or Convertible Security and the Common Shares deemed issuable upon exercise, conversion or exchange thereof shall be deemed to have been issued as of the date of such increase or decrease. No adjustment pursuant to this Section 3(c)(i)(2) shall be made if such adjustment would result in an increase of the Exercise Price then in effect.

(iii)

Calculation of Consideration Received.

(1)

In case one or more Option is issued in connection with the issue or sale of other securities of the Company, together comprising one integrated transaction, (x) each such Option will be deemed to have been issued for the Option Value of such Option and (y) the other securities issued or sold in such integrated transaction shall be deemed to have been issued or sold for the difference of (I) the aggregate consideration received by the Company less any consideration paid or payable by the Company pursuant to the terms of such other securities of the Company, less (II) the Option Value of each such Options; provided, that, no Common Share shall be deemed to have been issued for less than a fraction of the aggregate consideration received (excluding the minimum aggregate amount of additional consideration (as set forth in the instruments relating thereto, without regard to any provision contained therein for a subsequent adjustment of such consideration) payable to the Company upon the exercise of any such Options, or in the case of Options for Convertible Securities, the exercise of such Options for Convertible Securities and the conversion or exchange of such Convertible Securities) equal to (A) one divided by (B) the total number of Common Shares issued or issuable in the integrated transaction (including the number of shares underlying any Options and Convertible Securities).

(2)

If any Common Shares, Options or Convertible Securities are issued or sold for a consideration other than cash, the amount of such consideration received by the Company will be the fair value of such consideration, except where such consideration consists of publicly traded securities, in which case the amount of consideration received by the Company will be the closing sale price of such publicly traded securities on the date of receipt. If any Common Shares, Options or Convertible Securities are issued to the owners of the non-surviving entity in connection with any merger in which the Company is the surviving entity, the amount of consideration therefor will be deemed to be the fair value of such portion of the net assets and business of the non-surviving entity as is attributable to such Common Shares, Options or Convertible Securities, as the case may be. The fair value of any consideration other than cash or publicly traded securities will be determined jointly by the Company and the holders of a majority in interest of this Warrant and the Other Warrants and then outstanding. If such parties are unable to reach agreement within ten (10) days after the occurrence of an event requiring valuation (the “Valuation Event”), the fair value of such consideration will be determined within five (5) Business Days after the tenth (10th) day following the Valuation Event by an independent, reputable appraiser jointly selected by the Company and the holders of a majority in interest of this Warrant and the Other Warrants then outstanding. The determination of such appraiser shall be final and binding upon all parties absent manifest error and the fees and expenses of such appraiser shall be borne by the Company.

(iv)

Record Date. If the Company takes a record of the holders of Common Shares for the purpose of entitling them (A) to receive a dividend or other distribution payable in Common Shares, Options or in Convertible Securities or (B) to subscribe for or purchase Common Shares, Options or Convertible Securities, then such record date will be deemed to be the date of the issuance or sale of the Common Shares deemed to have been issued or sold upon the declaration of such dividend or the making of such other distribution or the date of the granting of such right of subscription or purchase, as the case may be.

(v)

Expiration or Termination of Options or Convertible Securities. Upon the expiration or termination of any unexercised Option or unconverted or unexchanged Convertible Securities (or portion thereof) which resulted (either upon its original issuance or upon a revision of its terms) in an adjustment to the Exercise Price pursuant to the terms of Section 3(c), the Exercise Price shall be readjusted to such Exercise Price as would have obtained had such Option or Convertible Securities (or portion thereof) never been issued.

(d)

Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above, if at any time after the Initial Exercise Date the Company grants, issues or sells any Common Share Equivalents or rights to purchase shares, warrants, securities or other property pro rata to the record holders of any class of Common Shares (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of Common Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, any applicable Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Common Shares are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that the Holder’s right to participate in any such Purchase Right would result in the Holder exceeding any applicable Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such Common Shares as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding any applicable Beneficial Ownership Limitation). To the extent that the issue price of such Purchase Rights would result in an adjustment of the Exercise Price pursuant to Section 3(c), such adjustment shall not occur to the extent the Holders were granted the right to acquire such Purchase Rights on the applicable terms.

(e)

Pro Rata Distributions. If the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of Common Shares, by way of return of capital or otherwise (including, without limitation, any distribution of cash, shares or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of Common Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, any applicable Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of Common Shares are to be determined for the participation in such Distribution (provided, however, that, to the extent that the Holder’s right to participate in any such Distribution would result in the Holder exceeding any applicable Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any Common Shares as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding any applicable Beneficial Ownership Limitation).

(f)

Fundamental Transaction.

(i)

If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (and all of its subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Shares are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Shares, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Shares or any compulsory share exchange pursuant to which the Common Shares are effectively converted into or exchanged for other securities, cash or property (other than as a result of a share split, combination or reclassification of Common Shares covered by Section 3(a)), or (v) the Company, directly or indirectly, in one or more related transactions consummates a share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires 50% or more of the outstanding Common Shares (not including any Common Shares held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such share purchase agreement or other business combination) or 50% or more of the voting power of the common equity of the Company (each a “Fundamental Transaction”), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of Common Shares of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of Common Shares for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant).

(ii)

For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one Common Share in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Shares are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder’s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value of the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction; provided, that if holders of Common Shares of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders of Common Shares will be deemed to have received Common Shares or ordinary shares of the Successor Entity (which Successor Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within the later of (i) five Business Days of the Holder’s election and (ii) the date of consummation of the Fundamental Transaction.

(iii)

The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(f) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of capital shares of such Successor Entity (or its parent entity) equivalent to the Common Shares acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the Exercise Price hereunder to such capital shares (but taking into account the relative value of the Common Shares pursuant to such Fundamental Transaction and the value of such capital shares, such number of capital shares and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder.

(g)

Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of Common Shares deemed to be issued and outstanding as of a given date shall be the sum of the number of Common Shares (excluding treasury shares, if any) issued and outstanding.

(h)

Number of Warrant Shares. Simultaneously with any adjustment to the Exercise Price pursuant to this Section 3, the number of Warrant Shares that may be purchased upon exercise of this Warrant shall be increased or decreased proportionately so that after such adjustment the aggregate Exercise Price payable hereunder for the adjusted number of Warrant Shares shall be the same as the aggregate Exercise Price in effect immediately prior to such adjustment (without regard to any limitations on exercise contained herein).

(i)

Notice to Holder.

(i)

Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

(ii)

Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Share, (B) the Company shall declare a redemption of the Common Share, (C) the Company shall authorize the granting to all holders of Common Shares rights or warrants to subscribe for or purchase any capital shares of any class or of any rights, (D) the approval of any shareholders of the Company shall be required in connection with any reclassification of the Common Share, any consolidation or merger to which the Company (or any of its subsidiaries) is a party, any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Shares are converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Shares of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Shares of record shall be entitled to exchange their Common Shares for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided, that, notwithstanding the foregoing, any notice delivery requirement hereunder shall also be deemed satisfied by filing or furnishing such communication with the Commission via the EDGAR system; provided, further, that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided to the Holder in accordance with the terms of this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 6-K, unless determined by the Company that such filing would be harmful to the Company at such time, in which case the Company shall file such 6-K as soon as is reasonably practicable in its discretion. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

(j)

Voluntary Adjustment By Company. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of this Warrant, subject to the prior written consent of the Holder, reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of directors of the Company.

(k)

Most Favored Nation. If, at any time while

this Warrant is outstanding, the Company modifies, waives or amends any provision of any Other Warrant, or otherwise agrees to grant any

holder of any Other Warrant any term, right, preference or privilege, in each case, that is more favorable to such holder than the corresponding

term, right, preference or privilege applicable to the Holder under this Warrant, then the Company shall promptly, and in any event within

five (5) Business Days, deliver written notice thereof to the Holder, together with a reasonably detailed description of such more

favorable term, right, preference or privilege and a copy of the relevant amendment, waiver, agreement or other documentation, if any.

Upon the Holder’s written election delivered

to the Company no later than ten (10) Business Days thereafter, this Warrant shall be deemed automatically amended to incorporate

such more favorable term, right, preference or privilege, mutatis mutandis, effective as of the date such term, right, preference or privilege

became effective with respect to such Other Warrant, without any further action by the Company or the Holder. The Company shall, upon

the Holder’s request, execute and deliver such amendments, confirmations or other instruments as the Holder may reasonably request

to evidence the foregoing.

Section 4.

Transfer of Warrant.

(a)

Transferability. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

(b)

New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Initial Exercise Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto, and if applicable, shall reflect any adjustment to the Exercise Price prior to the date of such transfer or exchange.

(c)

Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

(d)

Transfer Restrictions. This Warrant and the Warrant Shares may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of this Warrant or the Warrant Shares other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of the Holder or in connection with a pledge in connection with a bona fide margin account with a registered broker-dealer or other loan with a financial institution that is an “accredited investor” as defined in Rule 501(a) under the Securities Act or other loan secured by this Warrant or the Warrant Shares, the Company may require the transferor to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of this Warrant or the Warrant Shares under the Securities Act.

(e)

Representation by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to sales registered or exempted under the Securities Act.

Section 5.

Miscellaneous.

(a)

No Rights as Shareholder Until Exercise. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.

(b)

Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any share certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or share certificate, if mutilated, the Company will make and deliver a new Warrant or share certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or share certificate.

(c)

Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business Day.

(d)

Authorized Shares.

(i)

The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Shares a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant (without regard to any limitation on exercise set forth herein and assuming an Exercise Price equal to the lower of (i) $5.00 and (ii) the Exercise Price then in effect). The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Shares may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

(ii)

Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its Articles or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.

(iii)

Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.

(e)

Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Warrant (whether brought against a party hereto or its respective Affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in any New York State court or Federal court of the United States of America sitting in New York City in the Borough of Manhattan. Each party hereby irrevocably submits to the exclusive jurisdiction of any New York State court or Federal court of the United States of America sitting in New York City in the Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of this Warrant), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of this Warrant, then, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.

(f)

Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.

(g)

Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other provision of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

(h)

Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via email at the e-mail address as set forth on the signature pages attached hereto, or to such other address as the Company or the Holder may indicate by a notice delivered to the other from time to time, at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered via email attachment at the e-mail address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto, or to such other address as the Company or the Holder may indicate by a notice delivered to the other from time to time.

(i)

Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Shares or as a shareholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.

(j)

Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

(k)

Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.

(l)

Amendment. This Warrant may be modified, waived or amended or the provisions hereof waived with the written consent of the Company and the Holder.

(m)

Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

(n)

Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

********************

(Signature Page Follows)

IN WITNESS WHEREOF, the parties hereto have caused

this Common Share Purchase Warrant to be duly executed by their respective authorized signatories as of the date first indicated above.

INOBAT N.V..

Address for Notice:

By:

Name:

Title:

Email:

With a copy to (which shall not constitute notice):

IN WITNESS WHEREOF, the undersigned have caused

this Common Share Purchase Warrant to be duly executed by their respective authorized signatories as of the date first indicated above.

Name of Purchaser:

Signature of Authorized Signatory of Purchaser:

Name of Authorized Signatory:

Title of Authorized Signatory:

Email Address of Authorized Signatory:

Address for Notice to Purchaser:

Address for Delivery of Securities to Purchaser (if not same as address

for notice):

Warrant Shares:

EIN Number:

SCHEDULE A

“Action” means any action,

suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the applicable party, threatened against

or affecting the applicable party or any of its properties before or by any court, arbitrator, governmental or administrative agency or

regulatory authority (federal, state, county, local or foreign).

“Affiliate” means any Person

that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person,

as such terms are used in and construed under Rule 405 under the Securities Act.

“Black Scholes Value” means

the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the “OV” function on Bloomberg determined

as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest

rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable

contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of 100%

and the 100 day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the

Trading Day immediately following the public announcement of the applicable contemplated Fundamental Transaction, (C) the underlying

price per share used in such calculation shall be the greater of (i) the sum of the price per share being offered in

cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the highest

VWAP during the period beginning on the Trading Day immediately preceding the announcement of the applicable Fundamental Transaction (or

the consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder’s request pursuant

to this Section 3(f), (D) a remaining option time equal to the time between the date of the public announcement of the

applicable Fundamental Transaction and the Termination Date and (E) a zero cost of borrow.

“Bloomberg” means Bloomberg

L.P.

“Business Combination” means

the transactions contemplated by the Business Combination Agreement.

“Business Combination Agreement”

means that certain Business Combination Agreement, dated as of July 24, 2026, by and among Cartesian Growth Corporation II, a Cayman

Islands exempted company, InoBat AS, a private limited company (aksjeselskap) organized under the laws of Norway, the Company,

and InoBat Cayman Merger Sub, a Cayman Islands exempted company.

“Business Day” means any day

other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by law to remain

closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required

by law to remain closed due to “stay at home,” “shelter-in-place,” “non-essential employee” or any

other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so

long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally

are open for use by customers on such day.

“Closing Date” means the Trading

Day on which the Business Combination is consummated.

“Common Share Equivalents”

means any securities of the Company which would entitle the holder thereof to acquire at any time Common Share, including, without limitation,

any debt, preferred share, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable

for, or otherwise entitles the holder thereof to receive, Common Share, and any securities of the Company that when paired with one or

more other securities of the Company or another entity entitles the holder thereof to receive, Common Share.

“Convertible Securities” means

any shares or securities (other than Options) directly or indirectly convertible into or exercisable or exchangeable for, or which otherwise

entitles the holder thereof to acquire, any Common Shares and any securities of the Company that when paired with one or more other securities

of the Company or another entity entitles the holder thereof to receive, Common Share.

“Exempt Issuance” means the

issuance of (a) any securities of the Company to employees, officers or directors, consultants, contractors, vendors or other agents

of the Company pursuant to any share or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board

of Directors or a majority of the members of a committee of non-employee directors established for such purpose for services rendered

to the Company, (b) securities upon the exercise or exchange of or conversion of any securities issued pursuant to the Purchase Agreements

or the Business Combination Agreement and/or other securities exercisable or exchangeable for or convertible into Common Shares issued

and outstanding on the Closing Date, provided that such securities have not been amended since the Closing Date to increase the number

of such securities or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection

with share splits or combinations and automatic adjustments to such terms pursuant to anti-dilution or similar provisions of such securities

which are not more favorable to the holder thereof than the anti-dilution and similar provisions set forth herein) or to extend the term

of such securities, (c) the Underlying Shares, and (d) securities issued pursuant to any merger, acquisition or strategic transaction

or partnership approved by a majority of the directors of the Company, provided that (i) such securities are issued as “restricted

securities” (as defined in Rule 144) or are issued pursuant to an effective registration statement pursuant to the Securities

Act and (ii) any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries,

an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company

additional benefits in addition to the investment of funds, but any such Exempt Issuance shall not include a transaction in which the

Company is issuing securities (i) primarily for the purpose of raising capital, including an at-the-market offering, or (ii) to

an entity whose primary business is investing in securities.

“Options” means any rights,

warrants or options to subscribe for or purchase Common Shares or Convertible Securities.

“Option Value” means the value

of an Option based on the Black-Scholes Option Pricing model obtained from the “OV” function on Bloomberg determined as of

(A) the Trading Day prior to the public announcement of the issuance of the applicable Option, if the issuance of such Option is

publicly announced or (B) the Trading Day immediately following the issuance of the applicable Option if the issuance of such Option

is not publicly announced, for pricing purposes and reflecting (i) a risk-free interest rate corresponding to the U.S. Treasury rate

for a period equal to the remaining term of the applicable Option as of the applicable date of determination, (ii) an expected volatility

equal to the greater of 100% and the 100 day volatility obtained from the HVT function on Bloomberg as of (A) the Trading

Day immediately following the public announcement of the applicable Option if the issuance of such Option is publicly announced or (B) the

Trading Day immediately following the issuance of the applicable Option if the issuance of such Option is not publicly announced, (iii) the

underlying price per share used in such calculation shall be the highest weighted average price of the Common Shares during the period

beginning on the Trading Day prior to the execution of definitive documentation relating to the issuance of the applicable Option and

ending on (A) the Trading Day immediately following the public announcement of such issuance, if the issuance of such Option is publicly

announced or (B) the Trading Day immediately following the issuance of the applicable Option if the issuance of such Option is not

publicly announced, (iv) a zero cost of borrow and (v) a 360 day annualization factor, provided, however, in case any

Option is issued in connection with the issue or sale of other securities of the Company, together comprising one integrated transaction,

in no event shall the Option Value exceed a fraction of the aggregate consideration received (excluding the minimum aggregate amount of

additional consideration (as set forth in the instruments relating thereto, without regard to any provision contained therein for a subsequent

adjustment of such consideration) payable to the Company upon the exercise of such Options, or in the case of Options for Convertible

Securities, the exercise of such Options for Convertible Securities and the conversion or exchange of such Convertible Securities) equal

to (1) the number of Common Shares underlying such Option divided by (2) the total number of Common Shares issued or issuable

in the integrated transaction (including the number of shares underlying such Option).

“Other Warrants” means the

other Common Share purchase warrants, with substantially the same terms as this Warrant, with an initial exercise price of $12.00 per

share, issued on the Initial Exercise Date.

“Person” means an individual

or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock

company, government (or an agency or subdivision thereof) or other entity of any kind.

“Proceeding” means an action,

claim, suit, investigation or proceeding, whether commenced or threatened.

“Purchase Agreements” means

the several Securities Purchase Agreements, between the Company and certain original holders of Common Share purchase warrants, with an

initial exercise price of $12.00 per share, issued on the Initial Exercise Date, as amended, modified or supplemented from time to time

in accordance with its terms.

“Registration Rights Agreement”

means the Amended and Restated Registration Rights Agreement among the Company, the initial Holder of this Warrant and the other parties

thereto.

“Trading Day” means a day on

which the principal Trading Market is open for trading.

“Trading Market” means any

of the following markets or exchanges on which the Common Shares are listed or quoted for trading on the date in question: the NYSE American,

the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or any successors

to any of the foregoing).

“Transaction Documents” means

this Warrant, the Other Warrants and the Registration Rights Agreement, and all exhibits and schedules thereto.

“Transfer Agent” means Continental

Stock Transfer & Trust Company, the current transfer agent of the Company, and any successor transfer agent of the Company.

“Underlying Shares” means the

Common Shares issuable upon conversion of the Company’s 12.0% Series A Cumulative Convertible Preference Shares or Series B

Convertible Preference Shares or exercise of this Warrant or the Other Warrants.

“VWAP” means, for any date,

the price determined by the first of the following clauses that applies: (a) if the Common Shares are then listed or quoted on a

Trading Market, the daily volume weighted average price of the Common Shares for the 20 Trading Day preceding such date (or the nearest

preceding date) on the Trading Market on which the Common Shares are then listed or quoted as reported by Bloomberg (based on a Trading

Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market,

the volume weighted average price of the Common Shares for the 20 Trading Days preceding such date (or the nearest preceding date) on

OTCQB or OTCQX as applicable, (c) if the Common Shares are not then listed or quoted for trading on OTCQB or OTCQX and if prices

for the Common Shares are then reported in The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting

prices), the average of the highest closing bid price per share and the lowest closing ask price per share of the Common Shares for the

20 Trading Days preceding such date, or (d) in all other cases, the fair market value of a Common Share as determined by an independent

appraiser selected in good faith by the holders of a majority in interest of this Warrant and the Other Warrants then outstanding, and

reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

EXHIBIT A

NOTICE OF EXERCISE

To:

Attn:

Email:

(1) The undersigned hereby

elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and

tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

(2) Payment shall take

the form of (check applicable box):

in lawful money of the United States; or

if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in

subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless

exercise procedure set forth in subsection 2(c).

(3) Please issue said Warrant

Shares in the name of the undersigned or in such other name as is specified below:

The Warrant Shares shall be delivered to the following

DWAC Account Number:

[(4) Accredited Investor.

The undersigned is an “accredited investor” as defined in Regulation D promulgated under the Securities Act of 1933, as amended.]

[SIGNATURE OF HOLDER]

Name of Investing Entity:

Signature of Authorized Signatory of Investing Entity:

Name of Authorized Signatory:

Title of Authorized Signatory:

Date:

EXHIBIT B

ASSIGNMENT FORM

(To assign the foregoing

Warrant, execute this form and supply required information. Do not use this form to purchase shares.)

FOR VALUE RECEIVED, the foregoing

Warrant and all rights evidenced thereby are hereby assigned to

Name:

(Please Print)

Address:

(Please Print)

Phone Number:

Email Address:

Dated: _______________ __, ______

Holder’s Signature:

Holder’s Address:

EXHIBIT D

Form of SPA Joinder

Reference is made to the Securities Purchase Agreement, dated as of

[●], 2026 (the “SPA”), by and among, inter alios, Cartesian Growth Corporation II, InoBat AS and the Purchaser

party thereto. Capitalized terms used but not defined herein have the meanings set forth in the SPA.

The undersigned, InoBat N.V., hereby joins the SPA as the “Company”

and agrees to be bound by all provisions of the SPA applicable to the Company as if it were an original signatory thereto.

This SPA may be executed in counterparts and by electronic signature

and shall be governed by the governing law applicable to the SPA.

Dated: [●], 2026

INOBAT B.V.

By:

Name:

Title:

Annex to A to Securities Purchase Agreement

Draft of the articles of association of InoBat

N.V. prepared and updated by Dentons Notary dated July 24, 2026, who is also attending the incorporation of InoBat B.V. and its subsequent

conversion and restatement if its articles

Governance included is based on the two-tier

system (but can be amended to one tier system in view of listing)

In this translation an attempt has been made

to be as literal as possible without jeopardizing the overall continuity. Inevitably, differences may occur in translation, and if so,

by law the Dutch text will govern

ARTICLES OF ASSOCIATION

1 Definitions (for convenience sake the following definitions

are listed in alphabetical order not necessarily in the order of the Dutch original)

1.1 In these Articles of Association:

(a) Accrued Dividend means: a dividend on a Series A Preference Share that has accrued but not

yet been paid, as referred to in Article 34.

(b) Accrued Value means: as of any date and with respect to each Series A Preference Share: the

sum of (i) the Stated Value; plus (ii) the aggregate amount of all PIK Dividends on such Series A Preference Share that

have been added to the Accrued Value; plus (iii) on each Dividend Compounding Date, all Cash Dividends that have accrued on such

Series A Preference Share but have not been paid and have not yet been added to the Accrued Value; in each case subject to appropriate

adjustment for any share split, share consolidation or similar recapitalisation affecting the Series A Preference Shares.

Book 2, of the Company.

(d) Annual Accounts (Jaarrekening) means: the balance sheet, the profit and loss account and

the explanatory notes thereon.

(e) Annual EBITDA means EBITDA for the four (4) most recently ended consecutive fiscal quarters

of the Company for which financial statements have been published; provided that, any fiscal quarter ending more than sixty (60) days

prior to the date of determination shall be deemed a fiscal quarter for which financial statements have been published, whether or not

such financial statements have in fact been published as of such date of determination.

(f) Annual Rate means: twelve percent (12%) per annum of the Accrued Value in respect of a PIK Dividend,

and ten percent (10%) per annum of the Accrued Value in respect of a Cash Dividend; provided that if, on the second anniversary (or any

subsequent anniversary) of the Issue Date, the Company's Annual EBITDA equals or exceeds fifty million United States Dollars (USD 50,000,000.00),

the Annual Rate shall be reduced with effect from that date to ten percent (10%) in respect of a PIK Dividend and eight percent (8%) in

respect of a Cash Dividend.

(g) Available Proceeds means: in connection with a Deemed Liquidation Event, the consideration received

by the Company or any Group Company in respect of that Deemed Liquidation Event, less:

(i) liabilities retained by the Company or any Group Company in connection with the assets, undertaking or

technology transferred, sold or licensed pursuant to that Deemed Liquidation Event;

(ii) taxes, costs, fees and expenses incurred or reasonably expected to be incurred in connection with that

Deemed Liquidation Event, any redemption pursuant to Article 39.8 or any subsequent dissolution and winding-up of the Company; and

(iii) such amounts as the Board of Managing Directors, acting in good faith, determines are required to satisfy

or make reasonable provision for the liabilities of the Company and its Group Companies,

(iv) together with any other assets of the Company lawfully available for distribution to Shareholders or for

the acquisition or redemption of Preference Shares, in each case subject to Articles 10 and 33.1 and applicable law.

(h) Board of Managing Directors (bestuur) means: the Body of the Company controlling the management

of the Company’s business within the meaning of Book 2.

(i) Board of Supervisory Directors (Raad van Commissarissen) means: the Body of the Company

supervising the policy of the Board of Managing Directors and the general course of affairs of the Company and of the business connected

with it.

(j) Body of the Company (Vennootschapsorgaan) means: the General Meeting, the Board of Supervisory

Directors or the Board of Managing Directors.

(k) Book 2 (Boek 2) means: Book 2 of the Dutch Civil Code.

(l) Business Day means: a day (other than a Saturday or Sunday) on which commercial banks are generally

open for business in Amsterdam, the Netherlands, the City of New York, United States or Bratislava, Slovakia.

(m) Cancellable Preference Shares means: Preference Shares in respect of which the Accrued Value, together

with all accrued and unpaid dividends thereon, has been repaid in full, and which may accordingly be cancelled pursuant to Article 11.

(n) Cash Dividend means: a dividend on the Series A Preference Shares paid in cash, as further

described in Article 34.

(o) Conversion Price means: the price per Common Share at which a Preference Share may be converted

into Common Shares pursuant to Article 36, being twelve United States Dollars (USD 12.00) as at the Issue Date), as adjusted

from time to time in accordance with Article 35.5;

(p) CEO means: the Company’s chief executive officer, which title may be granted to a member

of the Board of Managing Directors in accordance with article 14.3.

(q) Chairperson (Voorzitter) means: the chairperson of the Board of Supervisory Directors.

(r) Common Shares means: the common shares in the capital of the Company.

(s) Company (Vennootschap) means: the company governed by these Articles of Association.

(t) Conflict of Interest (Tegenstrijdig Belang) means: the interest of a Managing Director or

Supervisory Director that conflicts with the interest of the Company and the business connected with it within the meaning of Dutch law.

(u) Convertible Securities means: any securities or other instruments that are directly or indirectly

convertible into, exchangeable for or exercisable for Common Shares, other than those in existence on the Issue Date.

(v) Dependent Company (Afhankelijke Maatschappij) means: a dependent company, of the Company

within the meaning of Section 152 of Book 2.

(w) Deemed Liquidation Event means, unless the Required Holders otherwise consent in writing:

(i) a merger, legal merger, consolidation, demerger, reorganisation, compulsory share exchange or other transaction

or series of related transactions as a result of which:

(A) the Shareholders immediately

prior to such transaction or series of transactions cease to hold, directly or indirectly, a majority of the voting rights in the surviving,

acquiring or resulting entity; or

(B) all or substantially all of

the Shares are converted into, exchanged for or otherwise become entitled to receive cash, securities or other property;

(ii) the sale, transfer, lease, exclusive licence or other disposal, in a single transaction or series of related

transactions, of all or substantially all of the assets, business, undertaking or intellectual property of the Company and its Subsidiaries,

taken as a whole; or

(iii) any other transaction or series of related transactions having substantially the same economic effect

as a transaction described in paragraph (a) or (b),

provided that a transaction effected

solely for the purpose of changing the jurisdiction of incorporation or legal form of the Company, and pursuant to which the economic

and voting interests of the Shareholders remain substantially unchanged, shall not constitute a Deemed Liquidation Event.

(x) Dividend Compounding Date means: the first (1) day of [June] and the first (1) day of

[December] of each calendar year.

(y) Dutch Corporate Governance Code means: the code of conduct referred to in Section 391, paragraph

5 of Book 2.

(z) EBITDA means: for any period, the net income (or net loss, as applicable) as reported in the Company's

consolidated financials for such period plus, in each case to the extent deducted in computing net income (or added in computing net loss):

(a) interest or financial expense or income; (b) income tax expenses, benefits or credits; (c) depreciation; and (d) amortisation,

in each case calculated in accordance with IFRS;

(aa) Exempt Issuances means: (i) issuances of Common Shares or rights to subscribe for Common Shares

to employees, managing directors, supervisory directors or consultants of the Company or a Group Company pursuant to a share incentive

plan or compensation programme; (ii) issuances in connection with an acquisition or strategic transaction approved by the Board of

Managing Directors; (iii) conversions of Preference Shares pursuant to Article 35; (iv) issuances upon exercise of the

Issue Date Warrants; and (v) issuances pursuant to a rights issue in respect of which the pre-emptive right has not been excluded.

(bb) Floor Price means: five United States Dollars (USD 5.00) per Common Share, as adjusted for

any share split, share consolidation, reclassification or similar transaction occurring after the Issue Date, being the minimum Conversion

Price which no adjustment shall reduce the Conversion Price.

(cc) General Meeting (Algemene Vergadering) means: the Body of the Company formed by its Shareholders,

and also meetings of that body.

(dd) Group Company (Groepsmaatschappij) means: a legal entity, a company or a partnership which

is economically united in one group, within the meaning of Section 24b of Book 2 with the Company.

(ee) IFRS means: means the International Financial Reporting Standards as issued by the International

Accounting Standards Board.

(ff) Indemnified Officer (Gevrijwaarde Fuctionaris) means: a current or former Managing Director

or Supervisory Director and such other current of former officer or employee of the Company or a Group Company, as determined by the Board

of Managing Directors.

(gg) Issue Date means: the date of first issuance of any Preference Shares.

(hh) Issue Date Warrants means: the rights to subscribe for Common Shares granted to subscribers for

Preference Shares on the Issue Date.

(ii) Junior Securities means: the Common Shares and any other class of shares ranking junior to the

Preference Shares as to dividend rights and rights on a liquidation or winding-up.

(jj) Managing Director (Directeur) means: a managing director of the Company within the meaning

of Book 2.

(kk) Option means: any right, option or warrant to subscribe for, acquire or otherwise receive Common

Shares or Convertible Securities, other than Warrants.

(ll) Option Value means: in respect of an Option issued together with one or more other securities as

part of an integrated transaction, the fair value of that Option as of the date of issuance, determined by the Board of Managing Directors

acting reasonably and in good faith, subject to Article 35.5(c)(iii)(c).

(mm) Permitted Bond Financing means: (i) the issuance by the Company of non-dilutive, non-convertible

bonds (that carry no warrant, option or other equity-linked right) in the Nordic bond market (a “Nordic Bond”) in an aggregate

principal amount not exceeding thirty million United States Dollars (USD 30,000,000.00) (or the equivalent in Norwegian Krone (NOK),

Swedish Krona (SEK), Euro (EUR) or any other currency, determined as of the issue date) and occurring prior to the incurrence or guarantee

of other financial indebtedness pursuant to Section 17.3(b) (other than financial indebtedness that is fully paid off and satisfied

within 5 Business Days of the adoption of these Articles) and (ii) any refinancing, replacement, renewal or extension of such a Nordic

Bond; provided that the aggregate outstanding principal amount is not increased (other than by accrued interest, fees, costs and premium

and reasonable refinancing expenses).

(nn) PIK Dividend means: a dividend on a Series A Preference Share that is not paid in cash but

in kind by increasing the Accrued Value of such Series A Preference Share, as further described in Article 34.

(oo) Preference Shares means: the Series A Preference Shares and the Series B Preference Shares.

(pp) Preference Share Liquidation Amount means: in respect of a Preference Share, the aggregate amount

that the holder of that Preference Share would be entitled to receive under Article 39.6 if the Company were dissolved and wound

up immediately following the relevant Deemed Liquidation Event, determined on the basis of the Available Proceeds and the Conversion Price

then in effect.

(qq) Record Date (Registratiedatum) means: the date of registration for a General Meeting as

provided by law.

(rr) Restricted Right (Beperkt Recht) means: a right of usufruct within the meaning of Part 8

of Book 3 of the Dutch Civil Code, or a right of pledge within the meaning of Part 9 of Book 3 of the Dutch Civil Code.

(ss) Required Holders means: the holders of a majority of the issued and outstanding Preference Shares,

for so long as at least twenty percent (20%) of the Preference Shares issued as of the Issue Date remain outstanding.

(tt) Series A Preference Shares means: the twelve percent (12%) Series A cumulative convertible

preference Shares in the capital of the Company having the rights, preferences and privileges as set forth in these Articles and identified

in the Shareholders' Register and on any share certificate by the letters P-A.

(uu) Series B Preference Shares means: the Series B convertible preference Shares in the capital

of the Company having the rights, preferences and privileges as set forth in these Articles and identified in the Shareholders' Register

and on any share certificate by the letters P-B.

(vv) Share Delivery Date means: in relation to a conversion of Preference Shares, the last day on which

the Company is required to deliver the resulting Common Shares pursuant to Article 35.3(b).

(ww) Share Premium Reserve means: a reserve which the Company records in its books for amounts paid

on Shares in excess of the par value thereof; in as much as these Articles provide that only holders of a particular class of Shares are

entitled to a Share Premium Reserve, this reserve shall be recorded with the letter(s), as stated in Article 4, of that particular

class of Shares.

(xx) Shares (Aandelen) means: both the Common Shares and the Preference Shares.

(yy) Shareholder (Aandeelhouder) means: both the holder of Common Shares and the holder of Preference

Shares.

(zz) Shareholders Register (Register van Aandeelhouders) means: the register setting out the

names and addresses of all Shareholders and holders of a Restricted Right within the meaning of Section 85 of Book 2.

(aaa) Stated Value means: one hundred and twenty United States Dollars (USD 120.00) per Preference

Share.

(bbb) Subsidiary (Dochtermaatschappij) means: a subsidiary, within the meaning of Section 24a

of Book 2, of the Company.

(ccc) Supervisory Director (Commissaris) means: a supervisory director of the Company within the

meaning of Book 2.

(ddd) Trading Day means: a day on which the principal Trading Market is open for business or, if the

Common Shares are not listed on a Trading Market but are listed or quoted on OTCQB Venture Market or the OTCQX Best Market, a day on which

such market is open for business.

(eee) Trading Market means: any of the following markets or exchanges on which the Common Shares are

listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq

Global Select Market or the New York Stock Exchange (or any successors to any of the foregoing).

(fff) VWAP means: for any date, the price determined by the first of the following clauses that applies:

(a) if the Common Shares are then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Shares

for the twenty (20) Trading Days preceding such date, or the nearest preceding date, on the Trading Market on which the Common Shares

are then listed or quoted, as reported by Bloomberg L.P., based on a Trading Day from nine hours and thirty minutes ante meridiem (9:30

a.m.) (New York City time) to four hours and two minutes post meridiem (4:02 p.m.) (New York City time); (b) if the Common Shares

are not listed on a Trading Market but are listed or quoted on the OTCQB Venture Market or the OTCQX Best Market, the volume weighted

average price of the Common Shares for the twenty (20) Trading Days preceding such date, or the nearest preceding date, on the OTCQB Venture

Market or the OTCQX Best Market, as applicable; (c) if the Common Shares are not then listed or quoted for trading on a Trading Market

or the OTCQB Venture Market or the OTCQX Best Market and prices for the Common Shares are then reported in the Pink Open Market, or a

similar organisation or agency succeeding to its functions of reporting prices, the average of the highest closing bid price and the lowest

closing ask price of the Common Shares for the twenty (20) Trading Days preceding such date; and (d) in all other cases, the fair

market value of a Common Share as determined by an independent appraiser selected in good faith by the holders of a majority in interest

of the Preference Shares then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the

Company.

1.2 Except as otherwise required by law, the expressions "written" and "in writing" used

in these Articles of Association include: communications sent by telegraph, telex, telefax or any other means of an electronic communication

system which is readable and printable. The written form requirement will be met if the document is recorded electronically.

1.3 Save where the context shows otherwise or as evidently otherwise intended, words or expressions in the

singular shall include the plural and vice versa.

1.4 Save where the context shows otherwise or as evidently other intended, referents in the masculine form

shall include the feminine form and vice versa.

2 Name. Registered Office

2.1 The Company is a limited liability company under Dutch law (naamloze vennootschap) and its name

is: InoBat N.V.

2.2 The Company has its registered office in Amsterdam, The Netherlands.

2.3 The Company may have branch offices elsewhere, also in and outside The Netherlands.

3 Objects

3.1 The objects for which the Company is established are:

(a) to, either alone or jointly with others, acquire and dispose of affiliations or other interests in legal

entities, companies and enterprises, and to collaborate with and to manage such legal entities, companies or enterprises;

(b) to acquire, manage, turn to account, encumber and dispose of any property - including intellectual property

rights - and to invest capital;

Group Companies and/or Affiliates, as well as to draw or to procure the drawing of money loans;

(d) to enter into agreements whereby the Company commits itself as guarantor or severally liable co-debtor,

or grants security or declares itself jointly or severally liable with or for others, particularly - but not exclusively - to the benefit

of companies as referred to above under clause (d) above, all this subject to the provision in article 3.2;

(e) for purposes not related to the conduct of its business to make periodic payments for or towards pension

funds or other objectives;

(f) to do all such things as are incidental or may be conducive to the above objects or any of them.

3.2 The Company may not grant security, give price guarantees, commit itself in any other way or declare itself

jointly or severally liable with or for others with a view to enabling third parties to take or acquire Shares or depository receipts

issued therefore. This prohibition applies equally to the Company's Subsidiaries.

3.3 The Company and its Subsidiaries may not provide loans with a view to subscription for or acquisition

of Shares or depositary receipts for Shares in the Company's capital by others, unless the Board of Managing Directors resolves to do

so and Section 98c of Book 2 is observed.

3.4 Article 3.2 and 3.3 do not apply if Shares or depositary receipts for Shares are subscribed for or

acquired by or for employees of the Company or of a Group Company.

4 Capital

4.1 The authorised share capital of the Company amounts to [ ] divided into:

(a) [ ] Common Shares, having a par value of twelve eurocents (EUR 0.12) each;

(b) [ ] Series A Preference Shares, each having a par value of twelve eurocents (EUR 0.12); and

5 Shares. Restricted Rights

5.1 All Shares shall be registered shares. The Company may issue share certificates for Shares in a form approved

by the Board of Managing Directors. The Series A Preference Shares shall be identified by the letter: P-A. The Series B Preference

Shares shall be identified by the letter: P-B. The Board of Managing Directors may number the Shares in consecutive order, starting from

number 1. Subject to the provision in the preceding sentence the Board of Managing Directors may change the numbering of the Shares. Shares

may be encumbered with a Restricted Right.

6 Transfer of Shares. Exercise of Shareholders' Rights

6.1 Unless the laws of The Netherlands provide or allow otherwise, the transfer of Shares requires a deed

executed for that purpose.

6.2 Save in case the Company itself has been a party to the transaction, the rights attached to the Shares

concerned may not be exercised until the transaction has been acknowledged by the Company or until the deed has been served upon the Company

in compliance with the provisions of Section 86b of Book 2, or until the transaction has been acknowledged by the Company by the

registration thereof in the Shareholder’s Register.

6.3 The acknowledgement is effected by such deed or otherwise in the manner provided by law.

6.4 For as long as the Common Shares are admitted to trading on a Trading Market, the laws of the State of

New York shall apply to the property law aspects of the Shares reflected in the register administered by the relevant transfer agent,

without prejudice to Sections 10:140 and 10:141 of the Dutch Civil Code.

7 Addresses. Shareholders Register

7.1 Shareholders, pledgees and usufructuaries of Shares must supply their addresses and other particulars

to the Company in writing. Any consequences of not doing so in a timely and correct manner are borne by the party concerned.

7.2 The Board of Managing Directors shall keep a Shareholders Register. Part of the Shareholders Register

may be kept outside The Netherlands to comply with applicable local law or pursuant to stock exchange rules.

8 Issuance of Shares

8.1 The Company may only issue Shares pursuant to a resolution of the General

Meeting or of another Body of the Company in case such Body of the Company is designated to do so by a resolution of the General Meeting

for a fixed period, not exceeding five years. Such designation shall specify the number of Shares that may be issued. The designation

may be extended, from time to time, for periods not exceeding five years. Unless such designation provides otherwise, it may not be withdrawn.

For as long as and to the extent that another Body of the Company has been authorized to resolve to issue shares, the General Meeting

shall not have this authority.

8.2 The number of authorised Preference Shares may not be increased without the prior consent of the holders

of at least fifty per cent (50%) of the then issued and outstanding Preference Shares at a combined class meeting of the Class A

Preference Shares and the Class B Preference Shares, voting (each) as a single class.

8.3 Within eight days following a resolution by the General Meeting to issue

Shares or to designate another Body of the Company, the Company shall file the full text of such resolution at the Trade Register

of the Dutch Chamber of Commerce.

8.4 The provisions of the preceding paragraphs of this Article 8 shall apply mutatis mutandis to the

granting of rights to subscribe for Shares, but shall not apply to the issue of Shares to a person who exercises a previously-acquired

right to subscribe for Shares.

8.5 The issuance of Shares requires a deed executed for that purpose to which the Company and each person

to whom Shares are issued are parties, except as otherwise provided or allowed by Dutch law and notwithstanding Article 6.4.

8.6 The Company may not subscribe for Shares.

8.7 On subscription for a Share, payment must be made for its par value and, in addition, if the Share is

subscribed at a higher amount, the difference between such amounts. It may be agreed that part, such part not to exceed three fourths

of the par value of the Shares, may remain unpaid until the Company makes a call in respect of the monies unpaid on the Shares. Such arrangement

may only be agreed prior to the resolution to issue Shares and requires the approval of the Body of the Company which has the power to

pass the resolution for the issuance concerned.

8.8 Parties who professionally place shares for their own account may be allowed by virtue of an agreement

to pay up less than the par value of the Shares they subscribe for, under the proviso that at least ninety-four percent (94%) of this

amount is paid up in cash ultimately upon subscription for such Shares.

8.9 Payment in a currency other than the euro may only be made with the Company’s consent. In the event

such a payment is made, the payment obligation is satisfied for the amount of in euro for which the paid amount can be freely exchanged.

Without prejudice to the last sentence of Section 80a, paragraph 3, Book 2, the date of payment determines the exchange rate.

8.10 Calls upon the Shareholders in respect of any monies unpaid on their Shares shall be made by the Board

of Managing Directors.

8.11 The Body of the Company which has the power to resolve to issue Shares may resolve that payment on Shares

shall be made by some other means than payment in cash.

8.12 The Company shall maintain three Share Premium Reserves. A Share Premium Reserve to which only the holders

of Common Shares shall be entitled, a Share Premium Reserve P-A to which only the holders of Series A Preference Shares shall be

entitled, and a Share Premium Reserve P-B to which only the holders of Series B Preference Shares shall be entitled. Any resolution

to make a distribution to the debit of a Share Premium Reserve or to convert (a part of) a Share Premium Reserve into share capital can

only be taken by the General Meeting with the prior approval of the class meeting of Shareholders who are entitled to the Share Premium

Reserve concerned.

9 Pre-emptive Rights

9.1 Save as otherwise provided by law, at the issuance of Common Shares each holder of Common Shares shall

have a pre-emptive right pro rata to the total amount of the Common Shares held by him on the date of the resolution to issue Common Shares.

At the issue of Common Shares no pre-emptive right shall vest in holders of Preference Shares.

9.2 If at the issuance of Common Shares any Shareholder fails to exercise, or does not exercise on time or

in full, his pre-emptive right, the pre-emptive right in respect of the Common Shares so becoming available shall enure to the benefit

of the other holders of Common Shares in the proportion described in Article 9.1.

9.3 Save as otherwise provided by law, at the issuance of Preference Shares each holder of Preference Shares

shall have a pre-emptive right pro rata to the total amount of the Preference Shares held by him on the date of the resolution to issue

Preference Shares. At the issue of Preference Shares no pre-emptive right shall vest in holders of Common Shares.

9.4 If at the issuance of Preference Shares any holder of such Preference Shares fails to exercise, or does

not exercise on time or in full, his pre-emptive right, the pre-emptive right in respect of the Preference Shares so becoming available

shall enure to the benefit of the other Shareholders in the proportion described in Article 9.3.

9.5 In deviation of Article 9.1 and 9.2, Shareholders do not have pre-emptive rights in respect of:

(a) Shares issued against non-cash contribution; or

(b) Shares issued to employees of the Company or of a Group Company.

9.6 The Company will announce an issuance of Shares with pre-emptive rights and the period during which such

pre-emption rights may be exercised in the Dutch State Gazette, as well as in a Dutch daily newspaper distributed nationally, unless the

announcement is sent in writing to all shareholders at the addresses submitted by them.

9.7 Pre-emption rights may be exercised for a period of at least two weeks after the date of announcement

in the Dutch State Gazette or after the announcement was sent to the Shareholders.

9.8 If as a result of the ratio between the Shareholders' respective holdings one or several of the Shares

to be issued cannot be allotted to a Shareholder or Shareholders, said Share(s) shall be allotted to the Shareholders by ballot.

9.9 The General Meeting may, each time in respect of one particular issuance of Shares, resolve to limit or

to exclude the pre-emptive right to subscribe for Shares.

If at a General Meeting at which a proposal

to limit or exclude the pre-emptive right to subscribe for Shares comes up for discussion and less than one half of the issued capital

is represented, a resolution to limit or exclude the pre-emptive right may only be adopted by at least two-thirds of the votes cast.

Any proposal to limit or exclude the

pre-emptive right must contain a written explanation of the reasons for the proposal and the choice of the proposed price of issue.

The pre-emptive right may also be limited

or excluded by another Body of the Company if such Body of the Company by resolution of the General Meeting has been designated for a

period not exceeding five years as the Body of the Company having the power to limit or exclude pre-emptive subscription rights.

Such designation may be renewed for

subsequent periods not exceeding five years each.

Unless the terms of the designation

provide otherwise, it cannot be revoked. For as long as and to the extent that other Body of the Company has been authorized to resolve

to limit or exclude pre-emption rights, the General Meeting shall not have this authority.

Within

eight days following a resolution by the General Meeting to limit or exclude the pre-emptive right or to designate the Board of Managing

Directors, the Company shall file the full text of such resolution at the Trade Register of the Dutch Chamber of Commerce.

9.10 A Share issuance at which Shareholders may exercise a pre-emptive right and the period during which said

right is to be exercised shall be announced by the Company to all Shareholders. The pre-emptive right may be exercised during the period

to be determined by the Body of the Company authorized to issue Shares, that period to be at least two weeks from the day following the

date of dispatch of the announcement.

9.11 The provisions of the preceding paragraphs of this Article 9 shall mutatis mutandis apply to the

grant of rights to take Shares, but do not apply in respect of issuing Shares to a party exercising a previously acquired right to subscribe

for Shares.

10 Acquisition by the Company of Shares, the transfer thereof

and the Creation of Restricted Rights on Shares held by the Company

10.1 Any acquisition by the Company of Shares that have not been paid-up in part

or in full shall be null and void.

10.2 Unless it concerns Shares that have been acquired by the Company by way of universal succession, the Company

- provided that the General Meeting has given the Board of Managing Directors authorisation for this purpose - may acquire fully paid-up

Shares, otherwise than for no consideration, provided that the Company's equity capital, reduced by the acquisition price, is not less

than the sum of the issued and paid-up capital and the reserves to be maintained pursuant to the law or the Articles of Association.

10.3 For the purpose of Article 10.2, the amount of the equity capital as shown in the most recently adopted

balance sheet shall be the determining factor, reduced by the acquisition price of the Shares, the amount of loans as referred in Section 98c

paragraph 2 Book 2 and any payments from profit or reserves to others which may have become due by the Company and its Subsidiaries since

the date of the balance sheet. If more than six months of a financial year have passed without the Annual Accounts having been adopted,

the acquisition of Shares under Article 10.2 shall not be permitted.

10.4 The authorisation of the General Meeting, referred to in Article 10.2, which shall be valid for a

maximum of five years only, must specify how many Shares are permitted to be acquired, the manner in which they may be acquired and the

permitted upper and lower limits of the price.

10.5 Any acquisition of Shares made in breach of the provisions of Article 10.2 shall be null and void.

The Managing Directors shall be severally liable to the bona fide transferor who suffers loss as a result of the voidness.

10.6 The Body of the Company which has the power to resolve to issue Shares shall also have the power to resolve:

(a) to transfer Shares held by the Company;

(b) to enter into contracts whereby the Company is committed to transfer

Shares held by it.

10.7 The word Shares where used in this Article 10 shall include depository receipts issued therefore.

11 Reduction of Capital

11.1 The General Meeting may resolve to reduce the issued capital by cancelling Shares or by reducing the par

value of all Shares, or by reducing the par value of only the Common Shares or only the Preference Shares, by amending the Articles of

Association. In that resolution the Shares to which it relates must be specified and provisions for its implementation must be included.

11.2 The General Meeting may only pass a resolution to reduce the par value of any class of Shares after having

obtained the prior approval of the class meeting of holders of the class of Shares concerned.

11.3 A resolution to cancel Shares may only relate to Shares which are held by the Company itself, to Shares

of which the depository receipts issued therefor are held by the Company, or to the Cancellable Preference Shares.

11.4 Any reduction of the par value of Shares without redemption and without release of the obligation to pay

up must be made pro rata to all Shares of the same class. Such pro rata requirement may be waived if all Shareholders of the class concerned

so agree.

11.5 Any partial repayment on Shares or release of the obligation to pay up is possible only on the implementation

of a resolution to reduce the par value of such Shares. Such repayment or release must be made pro rata to all Shares of the same class.

The pro rata requirement may be waived if all Shareholders of the class concerned so agree.

11.6 A resolution for reduction of capital shall require a majority of at least two thirds of the votes cast,

if less than one half of the issued capital is represented at the General Meeting.

11.7 The notice calling the General Meeting at which a resolution as referred to in this Article 11 is

to be passed shall state the purpose of the reduction of capital and the manner of implementation thereof. The provisions of Articles

39.2 and 39.3 shall apply mutatis mutandis.

11.8 The Company shall file the resolutions referred to in this Article 11

at the Trade Register of the Dutch Chamber of Commerce and shall publish a notice of the filing in a national Dutch daily newspaper.

In addition, Section 100 Book 2 applies.

12 Joint Ownership

If a Share, a Restricted Right on a

Share or a depository receipt is held by more than one person jointly, the Company may require such joint holders to give one person a

written power of attorney to represent them against the Company.

13 Transferabilty of Shares

The transfer of Shares is not restricted

in any way.

14 Board of Managing Directors

14.1 The business and affairs of the Company shall be managed by a Board of Managing Directors consisting of

one or more Managing Directors. The number of Managing Directors shall be determined by the Board of Supervisory Directors.

14.2 Only natural persons shall be eligible for appointment as a Managing Director.

14.3 The Board of Supervisory Directors will appoint one of the Managing Directors as CEO. The Board of Supervisory

Directors may dismiss the CEO, provided however that the CEO that is dismissed in such a manner may continue to hold office as a Managing

Director, without the title CEO.

14.4 The Managing Directors shall be appointed by the General Meeting.

14.5 The appointment of Managing Directors will occur on the basis of a nomination

by the Board of Supervisory Directors made with due regard to the rules and principles in the Company’s diversity policy

for the composition of the Board of Managing Directors and the Board of Supervisory Directors. The General Meeting may at any time resolve

that such nomination has a non-binding character, which resolution is adopted by a majority of two thirds of the votes cast, which votes

represent more than half of the issued capital of the Company. After a resolution that a nomination is non-binding, the Board of Supervisory

Directors will issue a new nomination, again made with due regard to the rules and principles in the Company’s diversity policy

for the composition of the Board of Managing Directors and the Board of Supervisory Directors. In the event that the nomination comprises

one candidate for a vacancy, such resolution to nominate the single candidate will result in the appointment of such candidate, unless

the nomination is resolved to be non-binding. A second meeting as referred to in Section 120, paragraph 3, Book 2, cannot be convened.

14.6 At a General Meeting, a resolution to appoint a Managing Director can only be passed in respect of candidates

whose names are stated for that purpose in the agenda of that General Meeting or the explanatory notes thereto.

14.7 Managing Directors may be suspended and/or removed from office by the General Meeting at any time. Before

consulting the General Meeting on the intended dismissal, the Managing Director concerned shall be given the opportunity, to account for

his conduct at a General Meeting. For that purpose he may have himself assisted by a legal adviser. A resolution of the General Meeting

to suspend or dismiss a Managing Director requires a majority of at least two thirds of the votes cast representing more than half of

the Company’s issued capital, unless such resolution is adopted at the proposal of the Board of Supervisory Directors. A second

meeting as referred to in Section 120, paragraph 3, Book 2, cannot be convened.

14.8 A Managing Director’s suspension shall terminate if within three months after the effective date

of his suspension the General Meeting has not passed a resolution to remove him from office or to lift or to extend his suspension. The

period of extension of a Managing Director’s suspension may not exceed three months from the date on which the resolution to extend

the suspension was passed.

14.9 A resolution of the General Meeting to suspend a Managing Director or to extend a Managing Director’s

suspension or to remove a Managing Director from office must be passed by a majority of at least two thirds of the votes cast, that majority

to represent more than half of the issued capital.

A proposal to suspend a Managing Director,

or to extend a Managing Director’s suspension or to remove a Managing Director from office cannot be put forward for discussion

at a second General Meeting as defined in Section 120 of Book 2 if the part of the issued capital required by virtue of this Article was

not represented at the preceding General Meeting.

14.10 The Board of Supervisory Directors shall have the power to suspend a Managing Director. If a Managing

Director has been suspended by the Board of Supervisory Directors:

(a) the General Meeting shall have the power to extend or to lift the suspension at any time;

(b) the suspended Managing Director’s account for his conduct, as referred to in Article 14.7,

shall be given at the General Meeting.

14.11 The General Meeting shall determine the Company’s policy concerning the compensation of the Board

of Managing Directors with due observance of the relevant statutory requirements.

14.12 The compensation of Managing Directors shall be determined by the Board of Supervisory Directors with

due observance of the policy referred to in Article 14.11.

14.13 The Board of Supervisory Directors will submit proposals concerning compensation arrangements for the

Board of Managing Directors in the form of Common Shares or rights to subscribe for Common Shares to the General Meeting for approval.

This proposal must at least include the number of Common Shares or rights to subscribe for Common Shares that may be awarded to the Board

of Managing Directors and which criteria apply for such awards or changes thereto.

15 Duties and Powers of the Managing Directors. Managing Directors'

ceasing to hold office or Inability to Act

15.1 Save any restrictions under the Articles of Association, the Board of Managing Directors shall control

and manage the Company's business and affairs.

15.2 Each Managing Director shall be answerable to the Company for a proper discharge of his duties of office.

15.3 The Board of Managing Directors shall adopt management board rules with due observance of these Articles

of Association. Such rules may contain variations from the provisions of Article 15.4. These rules may contain provisions

defining which particular duties shall be assigned to each of the Managing Directors. However, such division of duties shall not derogate

from the joint responsibility of all Managing Directors for the whole of the management.

15.4 Meetings of a Board of Managing Directors consisting of several members shall be held as frequently as

any Managing Director may wish. Meetings will be held in Amsterdam, the Netherlands, unless the Board of Managing Directors explicitly

determined otherwise. Each Managing Director shall have the power to call a Board Meeting, provided that written notice of such meeting,

stating the subjects to be discussed and voted upon, is given to each of the other Managing Directors. The term of notice shall be at

least three days, not including the date of dispatch of the notice and the date of the meeting. In special cases the term of notice may

be reduced, provided that all Managing Directors in office agree thereto. At any duly convened meeting resolutions may be passed on all

subjects announced in the notice of that meeting, irrespective of the number of Managing Directors present at the meeting in person or

by proxy.

15.5 Each Managing Director may be represented at Board Meetings by another Managing Director of the Company

acting by virtue of a power of attorney issued in writing. The power of attorney may only concern one specifically designated meeting

stated therein.

15.6 In a meeting of the Board of Managing Directors each Managing Director is allowed to cast one vote in

the decision-making, subject to Article 15.8.

15.7 Invalid votes, blank votes and abstentions shall not be counted as votes cast. Managing Directors who

casted an invalid or blank vote or who abstained from voting shall be taken into account when determining the number of Managing Directors

who are present or represented at a meeting of the Board of Managing Directors.

15.8 If the Board of Managing Directors consists of several members, resolutions of the Board of Managing Directors

shall require an absolute majority of the votes cast. If the voting for and against a proposal is equally divided, the CEO will have a

casting vote, provided the CEO cannot cast more votes than the other Managing Directors jointly. Otherwise, the applicable resolution

is not adopted.

15.9 Meetings of the Board of Managing Directors may be held through audio-communication means, save if one

or more Managing Directors objects to such manner of holding a meeting.

15.10 All resolutions which the Managing Directors can pass at a Board Meeting may also be passed outside a

meeting, whether or not using electronic means of communication, provided all Managing Directors are familiar with the resolution to be

passed and each of them approves this manner of decision-making and that the resolution be passed by the majority of votes required under

these Articles of Association. A resolution thus taken must be recorded in writing by the Managing Directors concerned. Said document

shall be kept at the office of the Company and shall be open to the inspection of any Managing Director.

15.11 In the event that one or several Managing Directors cease to hold office or are unable to act, the other

or remaining Managing Directors or the only other or remaining Managing Director shall be temporarily in charge of the management of the

Company. In the event that all Managing Directors or the sole Managing Director cease(s) to hold office or are unable to act, the

person (to be) designated thereto by the Board of Supervisory Directors, whether or not from its midst, shall be temporarily entrusted

with the management of the Company. Failing such designation by the Board of Supervisory Directors said person shall be designated by

the General Meeting; the General Meeting is completely free in this designation. The provisions of these Articles of Association concerning

the Board of Managing Directors and the Managing Director(s) individually shall apply mutatis mutandis to that person. Furthermore,

that person shall be required to call a General Meeting as soon as possible, which General Meeting may decide on the appointment of one

or several new Managing Directors.

15.12 A Managing Director shall be considered to be unable to act within the meaning of Article 15.11:

a. during the existence of a vacancy on the Board of Managing Directors, including as a result of:

(i) his death;

(ii) his dismissal by the General Meeting, other than at the proposal of the Board of Supervisory Directors;

(iii) his voluntary resignation before his term of office has expired;

(iv) not being reappointed by the General Meeting, notwithstanding a (binding) nomination to that effect by

the Board of Supervisory Directors,

provided that the Board of Supervisory

Directors may always decide to decrease the number of Managing Directors such that a vacancy no longer exists; or

b. during his suspension; or

c. in a period during which the Company has not been able to contact him (including as a result of illness),

provided that such period lasted longer than five consecutive days (or such other period as determined by the Board of Supervisory Directors

on the basis of the facts and circumstances at hand).

15.13 A Managing Director shall not participate in the deliberations and decision-making of the Board of Managing

Directors on a matter in relation to which he has a direct or indirect personal interest which conflicts with the interests of the Company

and of the business connected with it. If, as a result thereof, no resolution can be passed by the Board of Managing Directors, the resolution

shall be passed by the Board of Supervisory Directors.

15.14 The Board of Managing Directors and the Board of Supervisory Directors shall provide to the General Meeting

all such information as it may request, unless doing so would conflict with a material interest of the Company.

16 Representation

16.1 The Board of Managing Directors shall represent the Company. The power to represent the Company shall

also vest in the CEO individually, as well as in two other Managing Directors, acting jointly.

The Board of Managing Directors is,

when consisting of several members, authorised to issue powers of attorney authorising one or more Managing Directors to represent the

Company within the scope of said power of attorney.

16.2 The Board of Managing Directors may give power of attorney to one or several persons and may alter or

revoke such power of attorney.

17 Restrictions in the authority to manage

17.1 Any resolution of the Board of Managing Directors involving a significant change in the identity or character

of the Company, including at least the events listed in Section 107a of Book 2 requires the approval of the General Meeting.

17.2 In addition, the prior approval of the Board of Supervisory Directors is required for the following resolutions

of the Board of Managing Directors:

(a) the making of a proposal to the General Meeting concerning:

(i) the issue of Shares or the granting of rights to subscribe for Shares;

(ii) the limitation or exclusion of pre-emption rights;

(iii) the designation or granting of an authorisation as referred to in Articles 8.1, 8.3, 9.8, 9.10, 10.2 and

10.4, respectively;

(iv) the reduction of the Company’s issued share capital;

(v) the making of a distribution from the Company’s profits or reserves;

(vi) the determination that all or part of a distribution, instead of being made in cash, shall be made in

the form of Shares or in the form of assets;

(vii) the amendment of these Articles of Association;

(viii) the entering into of a merger or demerger;

(ix) the instruction of the Board of Managing Directors to apply for the Company’s bankruptcy;

(x) the Company’s dissolution;

(b) the issue of Shares or the granting of rights to subscribe for Shares;

(d) the acquisition of Shares by the Company in its own capital, including the determination of the value

of a non-cash consideration for such an acquisition;

(e) the drawing up or amendment of the management rules referred to in Article 15.3;

(f) the performance of the legal acts described in Article 17.1 and 17.6;

(g) the charging of amounts to be paid up on Shares against the Company’s reserves;

(h) the making of an interim distribution; and

(i) such other resolutions of the Board of Managing Directors as the Board of Supervisory Directors shall

have specified in a resolution to that effect and notified to the Board of Managing Directors.

17.3 For so long as the condition in the definition of Required Holders is satisfied, the following resolutions

of the Board of Managing Directors shall require the prior approval of the combined class meeting of Class A Preference Shares and

the Class B Preference Shares, voting (each) as a single class:

(a) entering into any transaction with an Affiliate of the Company, other than:

(i) the issuance of shares or awards to eligible participants pursuant to a share incentive or compensation

plan;

(ii) employment or consulting arrangements with members of the Board of Managing Directors; or

(iii) transactions approved in accordance with the Company's related party transaction policy as required by

the applicable provisions of the Dutch Corporate Governance Code; or

(b) incurring or guaranteeing any financial indebtedness, other than equipment leases or trade payables arising

in the ordinary course of business, in an aggregate outstanding amount in excess of two (2.0) times EBITDA, calculated on a

trailing twelve-month basis as of the last day of the most recently ended fiscal period for which financial statements have

been published; provided that (i) the Preference Shares shall not be treated as indebtedness for the purpose of this calculation,

and (ii) the prior written consent required by this paragraph (b) shall be deemed to have been given in respect of the

incurrence of the Permitted Bond Financing (which shall, for the avoidance of doubt, be included in the calculation of aggregate

financial indebtedness for the purpose of any subsequent incurrence).

17.4 The absence of any consent required pursuant to this Article 17.1, 17.2 and 17.3 shall not affect

the power of representation referred to in Article 16.1. The Board of Managing Directors shall, before passing any resolution referred

to in this Article 17.3, notify the holders of Preference Shares in writing of the proposed resolution with reasonable prior notice

to enable the Required Holders to respond.

17.5 The Board of Supervisory Directors may determine that also other resolutions of the Board of Managing

Directors than those specified in Article 17.2 shall be subject to its prior approval, provided that the Board of Supervisory Directors

shall carefully describe such resolutions and notify the Board of Managing Directors accordingly.

17.6 The Board of Managing Directors may resolve to perform as well as perform the transactions identified

in Section 94 of Book 2.

17.7 The Board of Managing Directors must follow the directions given by the Board of Supervisory Directors

with respect to the general lines of the financial, social, economic and personnel policies to be pursued.

18 BOARD OF SUPERVISORY DIRECTORS - COMPOSITION

18.1 The Company has a Board of Supervisory Directors consisting of one or more Supervisory Directors. The

Board of Supervisory Directors shall be composed of natural persons.

18.2 The Board of Supervisory Directors shall determine the number of Supervisory Directors.

18.3 The Board of Supervisory Directors shall elect a Supervisory Director to be the Chairperson. The Board

of Supervisory Directors may dismiss the Chairperson, provided that the Supervisory Director so dismissed shall subsequently continue

his term of office as a Supervisory Director without having the title of Chairperson.

18.4 Where a Supervisory Director is no longer in office or is unable to act, he may be replaced temporarily

by a person whom the Board of Supervisory Directors has designated for that purpose and, until then, the other Supervisory Director(s) shall

be charged with the supervision of the Company. Where all Supervisory Directors are no longer in office or are unable to act, the supervision

of the Company shall be attributed to the former Supervisory Director who most recently ceased to hold office as the Chairperson, provided

that he is willing and able to accept that position, who may designate one or more other persons to be charged with the supervision of

the Company (instead of, or together with, such former Supervisory Director). The person(s) charged with the supervision of the Company

pursuant to the previous sentence shall cease to hold that position when the General Meeting has appointed one or more persons as Supervisory

Director(s). Article 15.12 applies mutatis mutandis.

19 BOARD OF SUPERVISORY DIRECTORS - APPOINTMENT, SUSPENSION AND

DISMISSAL

19.1 The General Meeting shall appoint the Supervisory Directors and may at any time suspend or dismiss any

Supervisory Director.

19.2 The General Meeting can only appoint a Supervisory Director upon a binding nomination by the Board of

Supervisory Directors made with due regard to the rules and principles in the Company’s diversity policy for the composition

of the Board of Managing Directors and the Board of Supervisory Directors as made by the Board of Supervisory Directors and the profile

for the composition of the Board of Supervisory Directors. The General Meeting may at any time resolve to render such nomination to be

non-binding by a majority of at least two thirds of the votes cast representing more than half of the issued share capital. If a nomination

is rendered non-binding, a new nomination shall be made by the Board of Supervisory Directors. A second meeting as referred to in Section 120

paragraph 3 of Book 2 cannot be convened.

19.3 Upon the making of a nomination for the appointment of a Supervisory Director, the following information

shall be provided with respect to the candidate:

(a) his age and profession;

(b) the aggregate par value of the Shares held by him;

of a Supervisory Director;

(d) the names of any entities of which he is already a supervisory director or a non-executive director; if

these include entities that form part of the same group, a specification of the group’s name shall suffice.

The nomination must be supported by reasons. In the case

of a reappointment, the manner in which the candidate has fulfilled his duties as a Supervisory Director shall be taken into account.

19.4 At a General Meeting, a resolution to appoint a Supervisory Director can only be passed in respect of

candidates whose names are stated for that purpose in the agenda of that General Meeting or in the explanatory notes thereto.

19.5 A resolution of the General Meeting to suspend or dismiss a Supervisory Director shall require a majority

of at least two thirds of the votes cast representing more than half of the issued share capital, unless the resolution is passed at the

proposal of the Board of Supervisory Directors. A second meeting as referred to in Section 120 paragraph 3 of Book 2 cannot be convened.

19.6 If a Supervisory Director is suspended and the General Meeting does not resolve to dismiss him within

three months from the date of such suspension, the suspension shall lapse.

20 BOARD OF SUPERVISORY DIRECTORS - DUTIES AND ORGANISATION

20.1 The Board of Supervisory Directors is charged with the supervision of the policy of the Board of Managing

Directors and the general course of affairs of the Company and of the business connected with it. The Board of Supervisory Directors shall

provide the Board of Managing Directors with advice. In performing their duties, Supervisory Directors shall be guided by the interests

of the Company and of the business connected with it.

20.2 The Board of Managing Directors shall provide the Board of Supervisory Directors with the information

necessary for the performance of its tasks in a timely fashion. At least once a year, the Board of Managing Directors shall inform the

Board of Supervisory Directors in writing of the main features of the strategic policy, the general and financial risks and the administration

and control system of the Company.

20.3 The Board of Supervisory Directors shall draw up Supervisory Board rules concerning its organisation,

decision-making and other internal matters, with due observance of these Articles of Association. In performing their duties, the Supervisory

Directors shall act in compliance with these rules.

20.4 The Board of Supervisory Directors shall establish the committees which the Company is required to have

and otherwise such committees as are deemed to be appropriate by the Board of Supervisory Directors. The Board of Supervisory Directors

shall draw up (and/or include in the Supervisory Board rules) rules concerning the organisation, decision-making and other internal

matters of its committees.

21 BOARD OF SUPERVISORY DIRECTORS - DECISION-MAKING

21.1 Without prejudice to Article 21.5, each Supervisory Director may cast one vote in the decision-making

of the Board of Supervisory Directors.

21.2 A Supervisory Director can be represented by another Supervisory Director holding a written proxy for

the purpose of the deliberations and the decision-making of the Board of Supervisory Directors.

21.3 Resolutions of the Board of Supervisory Directors shall be passed, irrespective of whether this occurs

at a meeting or otherwise, by simple majority of the votes cast unless the Supervisory Board rules provide differently.

21.4 Invalid votes, blank votes and abstentions shall not be counted as votes cast. Supervisory Directors who

casted an invalid or blank vote or who abstained from voting shall be taken into account when determining the number of Supervisory Directors

who are present or represented at a meeting of the Board of Supervisory Directors.

21.5 Where there is a tie in any vote of the Board of Supervisory Directors, the Chairperson shall have a casting

vote, provided that the Chairperson cannot cast more votes than the other Supervisory Directors together. Otherwise, the relevant resolution

shall not have been passed.

21.6 A Supervisory Director shall not participate in the deliberations and decision-making of the Board of

Supervisory Directors on a matter in relation to which he has a direct or indirect personal interest which conflicts with the interests

of the Company and of the business connected with it. If, as a result thereof, no resolution can be passed by the Board of Supervisory

Directors, the resolution may nevertheless be passed by the Board of Supervisory Directors as if none of the Supervisory Directors has

a conflict of interests as described in the previous sentence.

21.7 Meetings of the Board of Supervisory Directors can be held through audio-communication facilities, unless

a Supervisory Director objects thereto.

21.8 Resolutions of the Board of Supervisory Directors may, instead of at a meeting, be passed in writing,

provided that all Supervisory Directors are familiar with the resolution to be passed and none of them objects to this decision-making

process. Articles 21.1 through 21.6 apply mutatis mutandis.

22 BOARD OF SUPERVISORY DIRECTORS - COMPENSATION

The General Meeting may grant a compensation to the Supervisory

Directors.

23 INDEMNITY

23.1 The Company shall indemnify and hold harmless each of its Indemnified Officers against:

(a) any financial losses or damages incurred by such Indemnified Officer; and

(b) any expense reasonably paid or incurred by such Indemnified Officer

in connection with any threatened, pending or completed suit, claim, action or legal proceedings of a civil, criminal, administrative

or other nature, formal or informal, in which he becomes involved,

to the extent this relates to his current or former position

with the Company and/or a Group Company and in each case to the extent permitted by applicable law.

23.2 No indemnification shall be given to an Indemnified Officer:

(a) if a competent court or arbitral tribunal has established, without having (or no longer having) the possibility

for appeal, that the acts or omissions of such Indemnified Officer that led to the financial losses, damages, expenses, suit, claim, action

or legal proceedings as described in Article 23.1 are of an intentional unlawful nature (being acts or omissions which are considered

to constitute malice, gross negligence, intentional recklessness and/or serious culpability attributable to such Indemnified Officer);

(b) to the extent that his financial losses, damages and expenses are covered under insurance and the relevant

insurer has settled, or has provided reimbursement for, these financial losses, damages and expenses (or has irrevocably undertaken to

do so);

brought to enforce indemnification to which he is entitled pursuant to these Articles of Association, pursuant to an agreement between

such Indemnified Officer and the Company which has been approved by the Board of Managing Directors or pursuant to insurance taken out

by the Company for the benefit of such Indemnified Officer;

(d) for any financial losses, damages or expenses incurred in connection with a settlement of any proceedings

effected without the Company’s prior consent.

23.3 The Board of Managing Directors may stipulate additional terms, conditions and restrictions in relation

to the indemnification referred to in Article 23.1.

24 General Meeting - Notice and Venue of the General Meeting

24.1 General Meetings shall be held as frequently as the Board of Managing Directors or any Managing Director

or the Board of Supervisory Directors or any Supervisory Director may wish. The power to call the General Meeting shall vest in the Board

of Managing Directors, in each Managing Director individually, in the Board of Supervisory Directors and in each Supervisory Director

individually.

24.2 The Board of Managing Directors must call a General Meeting:

(a) if one or several Shareholders jointly representing at least the part of the Company’s share capital

provided by law so request the Board of Managing Directors, that request to specify the subjects to be discussed and voted upon;

(b) within three months after the Board of Managing Directors has considered

it plausible that the equity capital of the Company has decreased to an amount equal to or less than one-half of the paid and called up

part of the capital to discuss any potential measures.

This obligation shall apply mutatis

mutandis to the Board of Supervisory Directors.

If the General Meeting is not held within

six weeks after the request referred to under (a), the applicants themselves may call the General Meeting - with due observance of the

applicable provisions of the law and the Articles of Association - without for that purpose requiring authorisation from the President

of the District Court. The provisions of Article 24.3 shall apply mutatis mutandis to the procedure of calling a General Meeting

referred to in the preceding sentence.

24.3 Notice of the General Meeting must be given to each Shareholder and to everyone in whom the right to attend

General Meetings is vested. The term of notice must be at least fifteen clear days before the date on which the meeting is held. Notice

shall be given by means of letters specifying the venue and the date of the meeting and the hour at which it shall begin. The subjects

to be discussed and voted upon at the meeting shall be listed in the letters or shall be announced to the Shareholders by separate letters

sent within the term set for giving notice. Shareholders may also be convened by an electronic communication system in accordance with

Section 113, paragraph 4, of Book 2. Persons who are given notice of the General Meeting and who jointly represent at least the part

of the issued share capital of the Company prescribed by law for this purpose, may have the Board of Managing Directors or the Board of

Supervisory Directors place on the agenda any subjects which such persons wish to be discussed and voted upon at the meeting, provided

that they shall inform the Board of Managing Directors or the Board of Supervisory Directors of such subjects no later than thirty (30)

days before the date on which the meeting intended for their discussion shall be held. Any announcements which by law or pursuant to the

Articles of Association must be addressed to the General Meeting may be inserted in the letters of notice of the General Meeting.

24.4 Persons with the right to attend General Meetings who wish to exercise their rights as described in Articles

24.2 and 24.3 should first consult the Board of Managing Directors. If the intended exercise of such rights might result in a change to

the Company’s strategy, including by dismissing one or more Managing Directors or Supervisory Directors, the Board of Managing Directors

shall be given the opportunity to invoke a reasonable period to respond to such intention. Such period shall not exceed the term stipulated

by Dutch law and/or the Dutch Corporate Governance Code for that purpose. The person(s) with the right to attend General Meetings

concerned should respect the response time stipulated by the Board of Managing Directors. If invoked, the Board of Managing Directors

shall use such response period for further deliberation and constructive consultation, in any event with the person(s) with the right

to attend General Meetings concerned, and shall explore the alternatives. At the end of the response time, the Board of Managing Directors

shall report on this consultation and the exploration of alternatives to the General Meeting. This shall be supervised by the Board of

Supervisory Directors. The response period may be invoked only once for any given General Meeting and shall not apply in the situations

stipulated by Dutch law and/or the Dutch Corporate Governance Code for that purpose.

24.5 If the term of notice has not been observed or if notice has not been given or has not been served in

the appropriate manner, resolutions may nevertheless be validly passed, also on subjects which were not announced or the announcement

of which had not been made in the prescribed manner, provided that any such resolution be passed unanimously at a General Meeting at which

the entire issued capital is represented.

24.6 General Meetings shall be held in the municipality where the Company's registered office is situated or

in The Hague, Rotterdam, or at Schiphol Airport in the municipality of Haarlemmermeer. Entirely without prejudice to the provisions of

Article 24.5, any resolution passed at a General Meeting held elsewhere - in or outside The Netherlands - shall be valid only if

the entire issued capital is represented.

25 Admittance to and ChairPERSONship of the General Meeting

25.1 The Shareholders and everyone in whom the right to attend General Meetings is vested, have admittance

to the General Meeting. Save any Managing Director and/or any Supervisory Director who has been suspended, the Managing Directors and

the Supervisory Directors also are entitled to admittance, as is any person who has been invited by the chairperson of the meeting concerned

to attend the General Meeting or any part of that meeting.

25.2 If a Shareholder or anyone in whom the rights to attend General Meetings is vested, wishes to attend a

General Meeting by proxy he must issue a written power of attorney for that purpose, which must be presented to the chairperson of the

meeting concerned.

25.3 The General Meeting shall be chaired by the Chairperson or by the CEO or by the person designated thereto

by the Board of Supervisory Directors, whether or not from its midst. If the Chairperson and the CEO are absent and the Board of Supervisory

Directors has not designated another person as aforesaid, the General Meeting itself shall appoint its chairperson.

25.4 The conclusion of the chairperson of the meeting concerned, pronounced by him at the meeting, as to the

result of any vote shall be decisive. This applies also to the content of any resolution passed, to the extent that the vote taken related

to a proposal not recorded in writing. However, if immediately after the pronouncement of such conclusion that conclusion is called into

question, another vote shall be taken if so desired by the majority at the meeting or - if the original vote was not taken on a poll or

by a secret ballot - by any person present who is entitled to vote. Such new vote shall override the legal consequences of the original

vote.

25.5 Unless an official record of the business done at the meeting is drawn up by a notary or unless the chairperson

of the relevant meeting himself wishes to keep the minutes, such chairperson shall designate a person charged with keeping the minutes.

The minutes shall be confirmed by the General Meeting at the same meeting or at a subsequent meeting, in evidence of which the minutes

shall be signed by the chairperson and the Secretary of the meeting at which the minutes were confirmed. If the General Meeting, the Board

of Supervisory Directors or the Board of Managing Directors resolves to instruct a notary to draw up an official record of the proceedings

at a General Meeting, or if one or several Shareholders jointly representing at least one tenth of the issued capital so decide, the Board

of Managing Directors shall instruct a notary to draw up such official record. The cost of the notarial record shall be borne by the Company.

25.6 The Board of Managing Directors shall keep a minute book in which the confirmed minutes of each General

Meeting shall be entered and in which shall further be inserted a copy of each notarial record made of any General Meeting. The minute

book shall be open to the inspection of the Shareholders and to everyone in whom the right to attend General Meetings is vested at the

registered office of the Company. Upon request any Shareholder and anyone in whom the right to attend General Meetings is vested, shall

be issued a copy of or an extract from the minutes of any General Meeting, at a charge not exceeding cost.

25.7 Each Shareholder is entitled to attend the General Meeting in person or by written proxy by means of an

electronic communication system and to address the meeting and exercise the voting right there. Holders of fractional shares which collectively

constitute the par value of a share shall exercise these rights collectively, whether through one of them or through the holder of a written

proxy.

25.8 For the purposes of Article 25.7 above, it is mandatory that the Shareholder may be identified by

means of such electronic communication system, that he may follow the transaction at the meeting directly and exercise the voting right.

25.9 The Board of Managing Directors may subject the use of such electronic communication system to certain

conditions which will be announced in the convocation.

25.10 The Board of Managing Directors can also decide that votes cast through electronic means of communication

or by means of a letter prior to the General Meeting are considered to be votes that are cast during the General Meeting. These votes

shall not be cast prior to the Record Date.

25.11 For the purpose of Articles 25.7 up to and including 25.10, those who have voting rights and/or the right

to attend General Meetings on the Record Date and are recorded as such in a register designated by the Board of Managing Directors shall

be considered to have those rights, irrespective of whoever is entitled to the Shares or depository receipts at the time of the General

Meeting. Unless Dutch law requires otherwise, the Board of Managing Directors is free to determine, when convening a General Meeting,

whether the previous sentence applies.

25.12 Each person with the right to attend General Meetings must notify the Company in writing of his identity

and his intention to attend the General Meeting. This notice must be received by the Company ultimately on the seventh day prior to the

General Meeting, unless indicated otherwise when such General Meeting is convened. Persons with the right to attend General Meetings that

have not complied with this requirement may be refused entry to the General Meeting.

26 Voting rights. Decision-making

26.1 Each Share carries the right to cast one vote.

26.2 At the General Meeting no votes can be cast for Shares which are held by the Company or Subsidiaries,

nor for depository receipts issued for Shares which are held by the Company or Subsidiaries. Usufructuaries and pledgees of Shares which

belong to the Company or Subsidiaries shall not, however, be excluded from the right to vote if the usufruct or pledge was created before

the Shares concerned came to be held by the Company or a Subsidiary. The Company or a Subsidiary cannot cast votes for Shares in respect

of which the Company or the Subsidiary possesses a pledge or usufruct.

26.3 For the purpose of determining to which extent Shareholders cast votes, are present or are represented,

or to which extent the share capital is represented, the Shares in respect of which no votes can be cast shall not be taken into account.

26.4 Unless the law or these Articles of Association stipulate a larger majority,

all resolutions of the General Meeting shall be passed by an absolute majority of the votes cast. Subject to any provision of mandatory

Dutch law and any higher quorum requirement stipulated by these articles of association, if and for as long as the Company is subject

under applicable securities law or applicable exchange rules to the requirement that the General Meeting can only pass certain resolutions

if a certain part of the Company's issued capital is represented at such General Meeting, then such quorum as determined under such securities

law or such exchange rules shall apply to such resolutions and a second meeting as referred to in Section 120, paragraph 3,

Book 2 cannot be convened.

26.5 Blank votes, invalid votes and abstentions shall not be counted as votes cast.

26.6 Votes on business matters - including proposals for suspension, dismissal or removal of persons - shall

be taken by voice, but votes on the election of persons shall be taken by secret ballot, unless the chairperson decides a different method

of voting and none of the persons present at the meeting object to such different method of voting.

26.7 If at the election of persons the voting for and against the proposal is equally divided, another vote

shall be taken at the same meeting; if again the votes are equally divided, then - without prejudice to the provision in the next following

sentence of this Article 27.7 - a drawing of lots shall decide. If at an election of persons the vote is taken between more than

two candidates and none of the candidates receive the absolute majority of votes, another vote - where necessary after an interim vote

and/or a drawing of lots - shall be taken between the two candidates who have received the largest number of votes in their favour.

If the voting for and against any other

proposal than as first referred to in this Article 27.7 is equally divided, that proposal shall be rejected.

26.8 If pursuant to the Articles of Association the validity of a resolution depends also upon the part of

the issued capital represented at the meeting and if such quorum is not present at the meeting, then - unless elsewhere in these Articles

of Association the contrary is provided with respect to any subject specifically mentioned there - a second meeting may be called and

held at which such resolution may be passed irrespective of the part of the issued capital represented at that meeting.

The notice calling the second meeting

must state that and pursuant to which provision a resolution may be passed at that meeting irrespective of the part of the issued capital

represented at that meeting.

Notice calling the second meeting shall

not be given until after the end of the first meeting. The second meeting must be held within six weeks after the first meeting.

27 Decision-making outside a Meeting

27.1 Unless the Company has cooperated with the issuance of depositary receipts for Shares in its capital,

any resolution which Shareholders entitled to vote can pass at a General Meeting may also be passed by them outside a meeting, provided

that anyone having the right to attend General Meetings approve this manner of decision making. The approval to the manner of decision

making and the votes may be submitted by electronic means of communication. The members of the Board of Managing Directors and the Board

of Supervisory Directors will be allowed to give their advice prior to the decision making.

27.2 In case of decision making outside a meeting, the votes are cast in writing. The written form requirement

will be met provided the resolution is recorded in writing or in electronic form getting out the manner each Shareholder votes and provided

such resolution is undersigned by each person having the right to attend General Meetings.

28 GENERAL MEETING - SPECIAL RESOLUTIONS

28.1 Subject to Article 17.2, the following resolutions can only be passed by the General Meeting at the

proposal of the Board of Managing Directors:

(a) the issue of Shares or the granting of rights to subscribe for Shares;

(b) the limitation or exclusion of pre-emption rights;

10.4, respectively;

(d) the reduction of the Company’s issued share capital;

(e) the making of a distribution from the Company’s profits or reserves;

(f) the making of a distribution in the form of Shares or in the form of assets, instead of in cash;

(g) the amendment of these Articles of Association;

(h) the entering into of a merger or demerger;

(i) the instruction to the Board of Supervisory Directors to apply for the Company’s bankruptcy; and

(j) the Company’s dissolution.

28.2 For so long as the condition in the definition of Required Holders is satisfied, the following resolutions

of the General Meeting and/or the Board of Managing Directors, shall require the prior written approval of the Required Holders at a combined

class meeting of Series A Preference Shares and the Series B Preference Shares, voting (each) as a single class:

(a) the issuance of Shares or granting of rights to subscribe for Shares, to the extent that the securities

to be issued constitute or would rank senior to or pari passu with the Preference Shares as to dividend rights or liquidation preference,

or increase the number of authorised Preference Shares;

(b) the amendment of these Articles of Association, to the extent that such amendment materially and adversely

affects the powers, preferences or rights attached to the Preference Shares;

(d) the making of a distribution from the Company’s profits or reserves, or the making of a distribution

in the form of Shares or in the form of assets, instead of in cash, on any class of shares constituting Junior Securities prior to the

payment in full of all Accrued Dividends on the Preference Shares, other than repurchases of shares at cost from former employees or consultants

upon cessation of their employment or services pursuant to an equity incentive plan of the Company.

28.3 A resolution of the General Meeting referred to in this Article 28.2 that is passed without the prior

consent of the Required Holders shall be null and void (nietig). The Board of Managing Directors shall ensure that notice of any

General Meeting at which any such resolution is proposed to be passed is given to the holders of Preference Shares in accordance with

Article 24.3, and shall include in such notice confirmation of whether the prior consent of the Required Holders has been obtained

or is being sought concurrently.

28.4 A matter which pursuant to articles 24.2 and/or 24.3 has been included in the convening notice or announced

in the same manner by or at the request of one or more Shareholders or anyone having the right to attend General Meetings shall not be

considered to have been proposed by the Board of Managing Directors for purposes of article 28.1, unless the Board of Managing Directors

has expressly indicated that it supports the discussion of such matter in the agenda of the General Meeting concerned or in the explanatory

notes thereto.

29 Class Meetings

29.1 The provisions of this Article 29 apply to every class of Shares issued and outstanding in the capital

of the Company, including the Common Shares, the Series A Preference Shares, the Series B Preference Shares and to any class

of Shares that may in the future be issued in the capital of the Company.

29.2 The Board of Managing Directors, as well as one or more holders of Shares of a particular class who jointly

represent at least one-tenth of the capital issued and outstanding in the form of that class, are each authorised to convene a class meeting

of holders of that class. The notice period shall be at least seven clear days before the day of the meeting.

29.3 Admittance to a class meeting shall be given to:

(a) the holders of Shares of the relevant class;

(b) the holders of depository receipts issued for Shares of that class with the concurrence of the Company;

(d) every Managing Director and every Supervisory Director; and

(e) any other person who has received an invitation to attend.

29.4 A class meeting may adopt resolutions if Shareholders of the relevant class holding more than half of

the total issued capital of that class are present or represented. If a quorum is not present, a second meeting shall be convened at which

no quorum requirement applies. Unless these Articles of Association or mandatory law require a larger majority, resolutions of a class

meeting shall require an absolute majority of the votes cast. Where a resolution of a class meeting is required as a condition for a resolution

of the General Meeting that itself requires a two-thirds majority, the same two-thirds majority shall apply at the class meeting.

29.5 The approval of a class meeting required under these Articles shall not be required if all Shareholders

of the relevant class have given their prior written consent to the matter set forth for approval at such class meeting.

29.6 Without prejudice to the foregoing, the provisions of Articles 24 through 27 of these Articles of Association

shall apply mutatis mutandis to class meetings.

30 Financial Year. Annual Accounts

30.1 The financial year of the Company shall be the calendar year.

30.2 Each year within five months after the end of the Company's financial year, save where this term is extended

by a maximum of five months by the General Meeting on account of special circumstances, the Board of Managing Directors shall draw up

Annual Accounts and a management report on that financial year. To these documents shall be added the particulars referred to in Section 392

paragraph 1 of Book 2. The Annual Accounts shall be signed by each of the Managing Directors and each of the Supervisory Directors. If

the signature of any of the Managing Directors and/or any Supervisory Directors is missing, this and the reason for such absence shall

be stated.

30.3 The Company shall ensure that the Annual Accounts and the management report and the particulars added

by virtue of Section 392 Book 2 shall be available at the registered office of the Company as soon as possible but not later than

as from the date of notice calling the General Meeting intended for the discussion and approval thereof. Shareholders or other persons

with the right to attend General Meetings may inspect said documents at the business office of the Company and obtain copies thereof free

of charge.

31 Auditor

31.1 The General Meeting shall give a certified public accountant or other expert within the meaning of Section 393

of Book 2 - both referred to herein as the "Expert" - or, as the case may be, an organisation in which such Experts work

together, instruction to audit the Annual Accounts. If the General Meeting fails to give such instruction the Board of Supervisory Directors

or - if it fails to give such instruction - the Board of Managing Directors shall be authorised and required to do so. The General Meeting

may at any time revoke the instruction as first referred to in this Article 30.1 and give it to another Expert.

31.2 The Expert shall report on his audit to the Board of Managing Directors and to the Board of Supervisory

Directors and shall set out the result of his audit in a certificate.

31.3 In cases in which the law so permits, the instruction referred to in Article 30.1 may be dispensed

with or the instruction may be given to another person than the Expert referred to therein.

32 Annual Meeting. Adoption of Annual Accounts

32.1 Each year at least one General Meeting shall be held, that meeting to be held within six months after

the end of the Company's last expired financial year; this General Meeting is referred to hereinafter as the Annual Meeting. The

agenda of the Annual Meeting shall contain at least the following subjects:

(a) if an annual report on the past financial year is required: discussion of the annual report;

(b) adoption of the Annual Accounts of the past financial year;

any loss sustained in that financial year is to be cleared.

32.2 The subjects listed in Article 32.1 need not be stated in the agenda of the Annual Meeting if the

term for preparing the Annual Accounts has been extended or if a proposal to extend said term is on the agenda.

32.3 The Annual Accounts shall be adopted by the General Meeting. Said adoption shall not constitute a release

from liability of the Managing Directors and the Supervisory Directors.

32.4 If an auditor's certificate on the Annual Accounts is required and if the General Meeting has not had

the opportunity of inspecting that certificate, the Annual Accounts cannot be adopted unless the other, added particulars include a statement

giving a lawful reason for the absence of the certificate.

32.5 If the Annual Accounts are adopted after they have been amended, copies of the amended Annual Accounts

may be obtained by the Shareholders and everyone in whom the right to attend General Meetings is vested free of charge.

33 DISTRIBUTIONS - GENERAL

33.1 A distribution can only be made to the extent that the Company’s equity exceeds the amount of the

paid up and called up part of its capital plus the reserves which must be maintained by law.

33.2 The Board of Managing Directors may resolve to make interim distributions, provided that it appears from

interim accounts to be prepared in accordance with Section 105 paragraph 4 Book 2 that the requirement referred to in Article 33.1

has been met.

33.3 The parties entitled to a distribution shall be the relevant Shareholders, usufructuaries and pledgees,

as the case may be, at a date to be determined by the Board of Managing Directors for that purpose. This date shall not be earlier than

the date on which the distribution was announced.

33.4 The General Meeting may resolve, subject to Article 28, that all or part of a distribution, instead

of being made in cash, shall be made in the form of Shares or in the form of the Company’s assets.

33.5 A distribution shall be payable on such date and, if it concerns a distribution in cash, in such currency

or currencies as determined by the Board of Managing Directors. If it concerns a distribution in the form of the Company’s assets,

the Board of Managing Directors shall determine the value attributed to such distribution for purposes of recording the distribution in

the Company’s accounts with due observance of applicable law (including the applicable accounting principles).

33.6 A claim for payment of a distribution shall lapse after five years have expired after the distribution

became payable.

33.7 For the purpose of calculating the amount or allocation of any distribution, Shares held by the Company

in its own capital shall not be taken into account. No distribution shall be made to the Company in respect of Shares held by the Company

in its own capital.

34 Ranking and Distributions. Profits, Reserves and Priority

34.1 The Preference Shares shall rank senior to all Junior Securities and, except as set forth in Article 34.2

and 39.6, the Class A Preference Shares and the Class B Preference Shares shall rank pari passu to each other, in each case

as to:

(a) the right to receive dividends and other distributions of profits or reserves; and

(b) the right to participate in distributions of cash or assets upon any liquidation, dissolution or winding-up

of the Company, whether voluntary or involuntary.

34.2 Subject to Article 33.1, the freely distributable reserves shown in the Company's annual accounts

in respect of a financial year shall be appropriated as follows, and in the following order of priority:

(a) First: out of the freely distributable reserves, a dividend shall first be paid on the Series A Preference

Shares at the Annual Rate on the Accrued Value of each Series A Preference Share (the Preference Dividend), to the extent

the Company is permitted to make such payment pursuant to Article 33.1.

Dividends on each Series A Preference

Share shall be cumulative and shall accrue daily from and after the Issue Date, compounding on a semi-annual basis on each Dividend Compounding

Date, whether or not earned or declared. Each Preference Dividend so accrued (an Accrued Dividend) shall be paid, at the election

of the Board of Managing Directors, either:

(i) in cash (a Cash Dividend); or

(ii) in kind, by increasing the Accrued Value of such Series A Preference

Share by the amount of such accrued dividend (a PIK Dividend).

For the avoidance of doubt, the cumulative

nature of the Preference Dividend means that Accrued Dividends shall accumulate and be carried forward regardless of whether they have

been earned or declared, subject at all times to Article 33.1. A PIK Dividend that solely increases the Accrued Value is not a distribution

for the purposes of Section 105 of Book 2 at the time of accrual; the distribution test of Article 33.1 applies only upon any

subsequent Cash Dividend payment or redemption giving effect to that increased Accrued Value.

(b) Second: the Company shall not declare, pay or set aside any dividend or distribution on Preference Shares

(other than the Series A Preference Shares), Common Shares or any other Junior Securities (other than dividends on Common Shares

payable solely in Common Shares) unless the holders of all outstanding Series A Preference Shares shall first receive, or simultaneously

receive, an amount per Series A Preference Share at least equal to the sum of: (i) all Accrued Dividends then outstanding and

not previously paid; and (ii) in the case of a dividend on Common Shares, the dividend per Series A Preference Share that would

be payable on an as-converted basis in accordance with Article 34.2(d) below.

to pay the Preference Dividend in full, or if Article 33.1 prevents full payment, the unpaid amount shall be carried forward cumulatively.

In each subsequent financial year, until the holders of Series A Preference Shares have received in full all arrears of the Preference

Dividend together with the Preference Dividend accrued for the then-current financial year: (i) no distribution shall be made on

any Junior Securities; and (ii) no amounts shall be added to free reserves beyond what is required by law.

(d) Fourth: subject to Articles 35 (Conversion) and 34.2(b), holders of Preference Shares shall be entitled

to receive, on an as-converted basis, any dividend paid on Common Shares (other than Accrued Dividends), in the same form and at the same

time as such dividend is paid on the Common Shares. The number of Common Shares into which each Preference Share is deemed converted for

this purpose shall be calculated by dividing the Accrued Value of such Preference Share by the Conversion Price then in effect.

(e) Fifth: the Board of Managing Directors shall determine what part of the remaining profits, after application

of sub-paragraphs (a) through (d) above, shall be added to the Company's reserves.

(f) Sixth: subject to Article 28.1(e), the profits remaining after sub-paragraphs (a) through (e) above

shall be at the disposal of the General Meeting for distribution on the Common Shares.

34.3 Subject to Article 33.1, a distribution of profits shall be made after the adoption of the Annual

Accounts that show that such distribution is permitted.

34.4 The Board of Managing Directors may resolve to make interim distributions, provided that:

(a) interim accounts prepared in accordance with Section 105 paragraph 4 of Book 2 demonstrate that the

requirement of Article 33.1 has been satisfied; and

(b) all Accrued Dividends on the Series A Preference Shares in respect of the then-current financial

year (calculated on a time-proportionate basis to the proposed distribution date) have been paid in full or, in the case of a PIK Dividend

election, credited in full to the Accrued Value of each Series A Preference Share.

34.5 Subject to Article 33.1, the General Meeting is authorised to resolve to make a distribution from

the Company's reserves, provided that no distribution may be made to the debit of the Share Premium Reserve of a class of Preference Shares

(and the Share Premium Reserve of the relevant class of Preference Shares may not be used, released, converted or otherwise applied in

a manner adverse to the holders of such Preference Shares) without the prior approval of the relevant class meeting of Shareholders who

are entitled to the Share Premium Reserve concerned.

34.6 The Board of Managing Directors may resolve to charge amounts to be paid up on Shares against the Company's

reserves, irrespective of whether those Shares are issued to existing Shareholders, provided that no such charge may be made to the debit

of the Share Premium Reserve of a class of Preference Shares (and the Share Premium Reserve of the relevant class of Preference Shares

may not be used, released, converted or otherwise applied in a manner adverse to the holders of such Preference Shares) without the prior

approval of the relevant class meeting of Shareholders who are entitled to the Share Premium Reserve concerned.

35 Conversion of Preference Shares

35.1 Each Preference Share shall be convertible, at any time and from time to time from and after the Issue

Date, at the option of the holder thereof, into that number of whole Common Shares determined by dividing the Accrued Value of such Preference

Share by the Conversion Price then in effect.

35.2 The initial Conversion Price shall be twelve United States Dollars (USD 12.00) per Common Share,

subject to adjustment in accordance with Article 35.5.

35.3 Mechanics of Conversion:

(a) A holder wishing to convert Preference Shares shall deliver a written conversion notice to the Company

specifying the number of Preference Shares to be converted and the intended date of conversion.

(b) Not later than the number of settlement days comprising the standard settlement period on the principal

stock exchange on which the Common Shares are listed as of the date of delivery of the conversion notice, the Company shall deliver to

the converting holder the number of Common Shares resulting from such conversion, which shall be free of transfer restrictions following

the earlier of (i) the first anniversary of the Issue Date and (ii) the effective date of any applicable registration or admission

to trading.

to which a holder would otherwise be entitled, the Company shall, at its election, either pay a cash adjustment equal to such fraction

multiplied by the Conversion Price or round up to the next whole Common Share.

(d) Preference Shares converted into Common Shares shall be cancelled and shall not be reissued. All rights

with respect to converted Preference Shares shall terminate upon conversion, save for the right to receive Common Shares.

35.4 The Company shall at all times reserve and keep available out of its authorised

Common Shares, for the sole purpose of conversion of Preference Shares, not less than such number of Common Shares as shall be required

for the conversion of all then-outstanding Preference Shares, assuming a Conversion Price equal to the Floor Price. In case of a shortage

of authorised Common Shares for the purpose as described before, the Board of Managing Directors will call a General Meeting so that within

a term of seventy-five (75) calendar days a resolution can be passed to amend the Articles to increase the authorised capital of the Company.

In case the term ends a calendar day which is not a Business Day, the term is extended to the next Business Day.

35.5 Adjustments to Conversion Price:

(a) If the Company at any time while Preference Shares are outstanding (i) pays a share dividend or makes

a distribution payable in Common Shares, (ii) subdivides outstanding Common Shares into a larger number of shares, (iii) combines

outstanding Common Shares into a smaller number of shares, or (iv) issues shares by way of reclassification, then the Conversion

Price and the Floor Price shall each be adjusted by multiplying them by a fraction of which the numerator is the number of Common Shares

issued and outstanding immediately before such event and the denominator is the number of Common Shares issued and outstanding immediately

after such event.

(b) If, on the twenty-first trading day following the date that is six months after the Issue Date, the VWAP

of the Common Shares (the Measurement Price) is less than the Conversion Price then in effect, the Conversion Price shall be reduced

to an amount equal to the greater of (i) the Measurement Price and (ii) the Floor Price.

issues or sells Common Shares (excluding Exempt Issuances) for a consideration per share (the New Issuance Price) less than the

Conversion Price then in effect, and the aggregate consideration received by the Company in connection with all such issuances for the

purpose of raising capital on or after the Issue Date exceeds five hundred thousand United States Dollars (USD 500,000.00) (a Dilutive

Issuance), then immediately after such issuance the Conversion Price shall be reduced to an amount equal to the New Issuance Price.

For the purposes of this Article 35.5(c):

(i) Options and Convertible Securities

The consideration per Common Share

received or receivable by the Company in respect of Common Shares issued or deemed issued pursuant to an Option or Convertible Security

shall be determined by dividing:

(A)   the

aggregate amount received or receivable by the Company as consideration for the issuance of the relevant Options or Convertible Securities,

plus the minimum aggregate amount of additional consideration payable to the Company upon:

(1)   exercise

of the Options;

(2)   conversion

or exchange of the Convertible Securities; or

(3)   in

the case of Options to acquire Convertible Securities, exercise of the Options and subsequent conversion or exchange of the Convertible

Securities,

in each case without giving effect

to any provision providing for a subsequent adjustment of such consideration; by

(B)   the

maximum number of Common Shares issuable upon exercise, conversion or exchange, determined without giving effect to any provision providing

for a subsequent adjustment of that number.

(ii) Deemed issuance of Options and Convertible Securities

(A)   If

the Company issues an Option or Convertible Security, the maximum number of Common Shares issuable upon exercise, conversion or exchange

thereof shall be deemed to have been issued at the time the Option or Convertible Security is issued. Where the Company fixes a record

date for determining the persons entitled to receive an Option or Convertible Security, the deemed issuance shall occur at the close of

business on that record date. The number of Common Shares deemed issued shall be determined assuming satisfaction of any conditions to

exercise, conversion or exchange, but without giving effect to any provision providing for a subsequent adjustment of that number.

(B)   If

at any time:

(1) the purchase

or exercise price under an Option;

(2) the additional

consideration payable upon issuance, conversion, exercise or exchange of a Convertible Security; or

(3) the rate at which a

Convertible Security is convertible into or exchangeable or exercisable for Common Shares, is increased or decreased, the Conversion

Price shall be recalculated to the Conversion Price that would have been in effect had the amended terms applied when the Option or

Convertible Security was initially issued.

(B) shall not apply to:

(1) proportionate adjustments

resulting from an event described in Article 35.5(a); or

(2)   automatic

anti-dilution adjustments that are no more favourable to the holder of the relevant Option or Convertible Security than the adjustments

provided for in this Article 35.5.

(D) If the terms of an Option or

Convertible Security outstanding on the Issue Date are subsequently amended in a manner described in paragraph (B), that Option or Convertible

Security and the Common Shares issuable upon its exercise, conversion or exchange shall be deemed issued on the date of the amendment.

(E) No adjustment under this Article 35.5(c)(ii) shall

increase the Conversion Price.

(iii) Calculation of consideration

(A)   Where

one or more Options are issued together with other securities as part of a single integrated transaction:

(1) each

Option shall be deemed issued for its Option Value; and

(2) the other securities shall

be deemed issued for the aggregate consideration received or receivable by the Company in the integrated transaction, less:

(a) any consideration

paid or payable by the Company pursuant to the terms of those other securities; and

(b) the aggregate

Option Value of the Options issued in the transaction.

(B) If Common Shares, Options or

Convertible Securities are issued or sold for cash, the consideration shall be the net cash proceeds received or receivable by the Company.

Convertible Securities are issued or sold for consideration other than cash:

(1) publicly traded securities

shall be valued at their VWAP on the date on which they are received or become receivable by the Company; and

(2) all other

consideration shall be valued at its fair market value.

(D) If Common Shares, Options

or Convertible Securities are issued to the shareholders or other equity holders of a non-surviving or acquired entity in connection

with a merger, acquisition, legal merger, demerger or similar transaction, the consideration shall be the fair market value of the portion

of the net assets and business acquired by the Company that is reasonably attributable to the relevant Common Shares, Options or Convertible

Securities.

(E) The fair market value of any

consideration referred to in paragraph (C)(2) or (D) shall be determined jointly by the Company and the Required Holders. If

they do not agree within ten (10) Business Days after the event requiring valuation, the fair market value shall be determined by

an independent, reputable appraiser jointly appointed by the Company and the Required Holders. If they fail to agree on an appraiser within

a further five (5) Business Days, the appraiser shall, at the request of either party, be appointed by the president of the Royal

Netherlands Institute of Chartered Accountants or its successor organisation.

The appraiser shall act as an expert

and not as an arbitrator. Its determination shall, absent manifest error, be final and binding, and its reasonable fees and expenses shall

be borne by the Company.

(iv) No duplication: No issuance or deemed issuance shall result in more than one adjustment of the Conversion

Price. Upon the expiry, cancellation or termination of an Option or Convertible Security without all underlying Common Shares having been

issued, the Conversion Price shall not be increased unless and only to the extent expressly approved by the Required Holders through a

class meeting of Class A Preference Shares and the Class B Preference Shares, voting (each) as a single class.

(d) If the Company effects any merger, consolidation, sale of all or substantially all of its assets, compulsory

share exchange or similar transaction pursuant to which Common Shares are converted into or exchanged for other securities, cash or property

(each a Fundamental Transaction), then upon any subsequent conversion of Preference Shares, the holder shall have the right to

receive, for each Common Share that would have been issuable upon conversion immediately prior to such Fundamental Transaction, the same

consideration receivable by a holder of Common Shares as a result of such Fundamental Transaction (the Alternate Consideration).

35.6 Subject only to mandatory applicable law and the receipt of a valid conversion notice in accordance with

Article 35.3(a), the Company’s obligation to issue and deliver Common Shares upon conversion of Preference Shares shall be

absolute and unconditional, irrespective of:

(a) any act or omission of the relevant holder in enforcing its rights;

(b) any waiver or consent relating to these Articles of Association or any agreement between the Company and

that holder;

have against that holder or any of its Affiliates;

(d) any actual or alleged breach by that holder or any other person of an obligation owed to the Company or

any Group Company; or

(e) any actual or alleged violation of law by that holder or any person associated or affiliated with it.

The delivery of Common Shares shall

not constitute a waiver of any claim that the Company may have against the relevant holder.

35.7 The Company may not refuse or delay a conversion on the basis of a claim described in Article 35.6,

unless:

(a) a competent court has issued an immediately enforceable injunction or order restraining or prohibiting

the relevant conversion, following notice to the relevant holder and an opportunity for that holder to be heard; and

(b) to the extent permitted by applicable law, the Company has provided security, in a form reasonably satisfactory

to the relevant holder, in an amount equal to one hundred fifty percent (150%) of the Accrued Value of the Preference Shares subject to

the injunction or order.

Such security shall remain in place

until the underlying dispute has been finally resolved and shall be available to satisfy any final judgment or award in favour of the

holder.

35.8 In the absence of an injunction or order satisfying Article 35.7, the Company shall issue and deliver

the applicable Common Shares and any cash payable in respect of fractional Common Shares following receipt of a valid conversion notice.

35.9 If the Company fails to deliver the Common Shares resulting from a conversion by the tenth (10th) Trading

Day after the applicable Share Delivery Date, the Company shall pay to the relevant holder, in cash, as a contractual penalty and without

prejudice to Article 35.10, for each five thousand United States Dollars (USD 5,000.00) of Accrued Value being converted:

(a) twenty-five United States Dollars (USD 25.00) for each Trading Day commencing on the eleventh (11th) Trading

Day after the Share Delivery Date;

(b) fifty United States Dollars (USD 50.00) for each Trading Day commencing on the third (3rd) Trading Day

after the payments under paragraph (a) begin to accrue; and

Day after the payments under paragraph (a) begin to accrue,

in each case until the Common Shares

have been delivered or the holder has withdrawn or rescinded the relevant conversion notice.

The payments provided for in this Article 35.9

shall not constitute the holder’s exclusive remedy. Subject to applicable law, the holder may seek specific performance, injunctive

relief and compensation for losses exceeding the amounts paid under paragraphs (a) through (c) above, provided that there shall

be no double recovery in respect of the same loss.

35.10 Notice of specified corporate actions

(a) If the Company proposes to:

(i) declare or make a dividend or other distribution, in cash, Shares or other assets, on the Common Shares;

(ii) acquire, redeem or cancel Common Shares, other than an acquisition in the ordinary course pursuant to

an employee share plan;

(iii) grant to all or substantially all holders of Common Shares any rights, Options or warrants to subscribe

for or acquire Shares or other securities;

(iv) effect or submit for approval any reclassification of the Common Shares, legal merger, demerger, consolidation,

compulsory share exchange, Fundamental Transaction or sale or transfer of all or substantially all of the assets of the Company and its

Subsidiaries, taken as a whole; or

(v) resolve upon, apply for or otherwise commence the voluntary or involuntary dissolution, liquidation, winding-up,

bankruptcy or suspension of payments of the Company,

the Company shall give written notice

to each holder of Preference Shares at the address, including any electronic address, recorded for that holder in the Shareholders Register.

(b) The notice shall be given at least twenty (20) calendar days before the applicable record date, effective

date or expected completion date and shall state, as applicable:

(i) the date on which the relevant record is to be taken;

(ii) if no record date is to be fixed, the date as of which the holders entitled to the relevant dividend,

distribution, acquisition, redemption, rights, Options or warrants are to be determined;

(iii) the expected effective or completion date of the relevant reclassification, merger, demerger, consolidation,

share exchange, Fundamental Transaction, sale, transfer, dissolution, liquidation or winding-up;

(iv) the date as of which holders of Common Shares are expected to become entitled to receive or exchange their

Common Shares for securities, cash or other property;

(v) a reasonably detailed description of the material terms of the proposed action and the consideration payable

or distributable in connection with it; and

(vi) the manner in which the proposed action is expected to affect the rights of the holders of Preference

Shares, including their conversion rights and any proposed adjustment to the Conversion Price.

invalidate the relevant corporate action, but shall not prejudice:

(i) any conversion right of a holder of Preference Shares;

(ii) any claim arising from the Company’s failure to comply with this Article 35.10; or

(iii) any right of the holders of Preference Shares under Articles 28, 35, 37 or 39.

(d) Each holder of Preference Shares shall remain entitled to convert all or any portion of its Preference

Shares during the period commencing on the date of the notice and ending on the effective or completion date of the relevant action, unless

conversion is prohibited by mandatory applicable law or by an immediately enforceable order of a competent court.

(e) To the extent the notice contains inside information or other non-public price-sensitive information,

its delivery and any public disclosure shall be made in compliance with applicable securities laws and the rules of the relevant

Trading Market. The Company shall not withhold or delay the notice solely because it contains such information, except to the extent a

delay is permitted by applicable law, in which case the notice shall be delivered as soon as the lawful basis for delay ceases to apply.

36 [Reserved].

37 Redemption of Preference Shares

37.1 Subject to this Article and to Articles 10.2, 10.3 and 33.1, the Company may in its sole discretion

redeem all or a portion of the outstanding Preference Shares at the following redemption prices per Preference Share:

(a) In the case of Series A Preference Shares:

(i) Issue Date to first anniversary: one hundred fifty percent (150%) of Accrued Value;

(ii) First to second anniversary: one hundred forty percent (140%) of Accrued Value;

(iii) Second to third anniversary: one hundred thirty percent (130%) of Accrued Value;

(iv) Third to fourth anniversary: one hundred twenty percent (120%) of Accrued Value;

(v) Fourth to fifth anniversary: one hundred ten percent (110%) of Accrued Value; and

(vi) Fifth anniversary onwards: one hundred percent (100%) of Accrued Value; and

(b) In the case of Series B Preference Shares:

(i) Issue Date to first anniversary: one hundred fifty percent (150%) of Stated Value;

(ii) First to second anniversary: one hundred forty percent (140%) of Stated Value;

(iii) Second to third anniversary: one hundred thirty percent (130%) of Stated Value;

(iv) Third to fourth anniversary: one hundred twenty percent (120%) of Stated Value;

(v) Fourth to fifth anniversary: one hundred ten percent (110%) of Stated Value; and

(vi) Fifth anniversary onwards: one hundred percent (100%) of Stated Value.

37.2 The Company shall provide not less than fifteen (15) days' prior written notice to each holder of Preference

Shares of the intended redemption, specifying the number of Preference Shares to be redeemed, the redemption date and the applicable redemption

price. Each holder shall remain entitled to convert all or a portion of its Preference Shares at any time during the fifteen (15)-day

period commencing on the date of such notice through the applicable redemption date.

37.3 Subject to Articles 10 and 33.1 and applicable law, if at any time after the fifth (5th) anniversary of

the Issue Date, a holder delivers to the Company a written notice demanding redemption of all or part of such holder's Preference Shares,

the Company shall redeem the relevant Preference Shares at a price per share equal to, in the case of Series A Preference Shares,

the Accrued Value, and, in the case of Series B Preference Shares, the Stated Value (in each case, as applicable, the Redemption

Price). The Company shall apply all of its available assets to such redemption until the Redemption Price has been paid in full.

37.4 If any portion of the Redemption Price has not been paid within five (5) Business Days following

the applicable redemption date, interest on such unpaid amount shall accrue at a rate equal to the lesser of (i) twenty-four percent

(24%) per annum and (ii) the maximum rate permitted under Dutch law.

37.5 Upon redemption of any Preference Shares, all rights with respect to such shares shall immediately terminate,

except the right of the holder to receive the applicable redemption price. Redeemed Preference Shares shall constitute Cancellable Preference

Shares and shall be cancelled in accordance with Article 11.

38 Amendment of the Articles of Association. Merger. Division

38.1 Notwithstanding Article 26.1 and 28.1, a resolution to amend the Articles of Association or a resolution

for a merger or division in the terms of Part 7 of Book 2 may be passed by the General Meeting only by a majority of at least two

thirds of the votes cast; that majority must represent more than half of the issued capital; provided, that no amendment of these Articles

may adversely affect the rights of the holders of a class of Preference Shares without the prior approval of a class meeting of such Preference

Shares.

38.2 If a proposal to amend the Articles of Association is to be made to the General Meeting, this must be

stated in the notice calling the General Meeting. The persons giving such notice must at the same time deposit a copy of that proposal,

containing the verbatim text of the proposed amendment, at the business office of the Company for inspection by the Shareholders and everyone

in whom the right to attend General Meetings is vested. Failing this no resolution can be validly passed on the proposal unless the requirements

set out in Article 24.5 have been fulfilled.

38.3 From the day of deposit of the proposal to amend the Articles of Association and until the end of the

General Meeting at which that proposal will be discussed and voted upon, the Shareholders and everyone in whom the right to attend General

Meetings is vested, must be given the opportunity to obtain copies of that proposal. The copies shall be issued free of charge.

39 Dissolution and Winding up

39.1 The General Meeting has the power to resolve to dissolve the Company, provided with due observance of

the requirements set out in Articles 28.1(j) and 28.2(c).

39.2 In the event of its voluntary dissolution the Company shall continue in existence for such period of time

as the liquidation of its assets and liabilities may require.

39.3 In any document issued and notice served by the Company in the course of its winding up the words: "in

liquidation" must be added to its name.

39.4 Unless otherwise resolved by the General Meeting or unless otherwise provided by law, the Managing Directors

of the Company shall be the liquidators of the Company under the supervision of the Supervisory Directors.

39.5 The reports and statements relating to the dissolution and the winding up

as required by law shall be filed by the liquidators at the Trade Register of the Dutch Chamber of Commerce.

39.6 The surplus assets remaining after all the Company's liabilities have been satisfied shall be distributed

as follows:

(a) First: to the holders of Preference Shares, an amount per Preference Share equal to the greater of:

(i) one hundred per cent (100%) of the Accrued Value of such Preference Share (including all Accrued Dividends,

as applicable); or

(ii) such amount per Preference Share as would have been payable had all Preference Shares been converted into

Common Shares pursuant to Article 35 immediately prior to the liquidation, dissolution or winding-up, calculated at the Conversion

Price then in effect;

together

with the balance, if any, of the Share Premium Reserve allocated to the Preference Shares. If the available assets are insufficient

to pay the full amount under (i) or (ii) (as applicable), the holders of Preference Shares shall share pro rata in the available

assets in proportion to their respective entitlements.

(b) Second: to the holders of Common Shares the paid-up par value of their Common Shares together with the

balance, if any, of the Share Premium Reserve allocated to the Common Shares;

remaining surplus shall be distributed to the holders of Preference Shares and holders of Common Shares pro rata, treating all Preference

Shares as converted into Common Shares at the Conversion Price then in effect.

Each distribution referred to in this

Article 39.6 shall be made in proportion to the amount of paid-up par value of the relevant Shares held by each Shareholder.

39.7 After completion of the winding up, during the safe-keeping period prescribed by law the books, records

and other data carriers of the dissolved Company shall remain in the custody of the person whom the liquidators have appointed for that

purpose in writing.

39.8 Deemed Liquidation Events

(a) If a Deemed Liquidation Event occurs and the Company has not been dissolved within ninety (90) days after

its completion, the Company shall, no later than the ninetieth (90th) day following completion of that Deemed Liquidation Event, give

written notice to each holder of Preference Shares:

(i) describing the material terms of the Deemed Liquidation Event and the consideration received or receivable

in connection with it;

(ii) setting out the Company’s good-faith calculation of the Available Proceeds and the Preference Share

Liquidation Amount; and

(iii) advising the holders of Preference Shares of their rights under this Article 39.8 and the procedure

and time limits for exercising those rights.

(b) If the Required Holders so request by written notice delivered to the Company no later than one hundred

twenty (120) days after completion of the Deemed Liquidation Event, the Company shall, on the one hundred fiftieth (150th) day after completion

of the Deemed Liquidation Event, apply the Available Proceeds to acquire or redeem all outstanding Preference Shares at a price per Preference

Share equal to the Preference Share Liquidation Amount.

permitted by Articles 10 and 33.1 and applicable law. To the extent that the Available Proceeds or the amount lawfully available are insufficient

to acquire or redeem all outstanding Preference Shares in full:

(i) the Company shall acquire or redeem the maximum number or portion of Preference Shares that it may lawfully

acquire or redeem;

(ii) the amount applied shall be allocated among the holders of Preference Shares pro rata in proportion to

the respective Preference Share Liquidation Amounts that would have been payable to them if all Preference Shares had been acquired or

redeemed in full; and

(iii) the Company shall acquire or redeem the remaining Preference Shares, or unpaid portions thereof, as soon

as and to the maximum extent that it may lawfully do so.

(d) Until the obligations under this Article 39.8 have been satisfied in full, the Company shall not,

and shall procure that its Subsidiaries do not, expend, transfer or otherwise dissipate any consideration received in connection with

the Deemed Liquidation Event, except:

(i) to discharge liabilities, taxes, costs, fees and expenses taken into account in determining the Available

Proceeds;

(ii) in the ordinary course of business consistent with past practice and as reasonably necessary to preserve

the value of the Company and its Subsidiaries; or

(iii) with the prior consent of the Required Holders through a class meeting of Class A Preference Shares

and the Class B Preference Shares, voting (each) as a single class.

(e) Preference Shares acquired or redeemed pursuant to this Article 39.8 shall constitute Cancellable

Preference Shares and shall be cancelled in accordance with Article 11. Article 37.6 shall apply mutatis mutandis.

39.9 Valuation of non-cash consideration

(a) If any part of the Available Proceeds consists of property other than cash, the value of that property

shall be its fair market value as at the date on which it was received or became receivable by the Company or the relevant Group Company.

(b) The fair market value shall be determined as follows:

(i) securities listed or quoted on a Trading Market and not subject to restrictions on transfer or marketability

shall be valued at their VWAP as at the relevant valuation date;

(ii) securities subject to investment letters, lock-ups or other restrictions on free marketability, other

than restrictions arising solely from a holder’s status as an affiliate or former affiliate, shall be valued at the value determined

under paragraph (i), less an appropriate discount reflecting those restrictions; and

(iii) all other property shall be valued by the Board of Managing Directors acting reasonably and in good faith.

ten (10) Business Days after receiving notice of it, the fair market value shall be determined by an independent, reputable appraiser

jointly appointed by the Company and the Required Holders. If they fail to agree on an appraiser within five (5) Business Days, the

appraiser shall, at the request of either party, be appointed by the president of the Royal Netherlands Institute of Chartered Accountants

or its successor organisation.

(d) The appraiser shall act as an expert and not as an arbitrator. Its determination shall, absent manifest

error, be final and binding. The Company shall bear the appraiser’s reasonable fees and expenses.

39.10 If the Company is dissolved following a Deemed Liquidation Event, Articles 39.1 through 39.6 shall apply,

provided that any amount previously paid to a holder of Preference Shares pursuant to Article 39.8 shall be credited against the

amount otherwise payable to that holder pursuant to Article 39.6, so that no holder receives more than the aggregate amount to which

it is entitled under those Articles.

40 Federal forum provision

40.1 Except as otherwise consented into writing by the Company, the sole and exclusive forum of any complaint

asserting a cause of action arising under the United States Securities Act of 1933, as amended, to the fullest extent permitted by applicable

law, shall be the federal district courts of the United States of America.

EX-99.1 — EXHIBIT 99.1

EX-99.1

Filename: tm2621302d1_ex99-1.htm · Sequence: 6

Exhibit 99.1

FOR IMMEDIATE RELEASE

InoBat

and Cartesian Growth Corporation II

Announce

Business Combination Agreement

Accelerate Expansion of Battery Energy Storage Systems

· InoBat has contracted or delivered 875 MWh of utility-scale battery energy storage systems (“BESS”)

across Europe

· InoBat is positioning its platform to support the rapidly growing power demand from AI infrastructure

and hyperscale data centers

· Business combination connects leading European manufacturer with Nasdaq and US institutional capital

· Combination provides $77.5 million in a committed PIPE and has no further cash conditions

· Combination values InoBat at $1.265 billion (~€1.1 billion) on a pre-money, pre-merger basis,

including strategic- and EBITDA-based earnouts

27 July 2026 — InoBat AS (“InoBat”),

a leading European battery energy storage systems and battery technology company, and Cartesian Growth Corporation II (“Cartesian

II”), a special purpose acquisition company (OTCPK: RENEF), today announced that they have entered into a definitive business combination

agreement (“BCA”).

The business combination (“Combination”)

values InoBat at $1.265 billion (approximately €1.1 billion) on a pre-money, pre-merger basis, including consideration tied to the

achievement of strategic and financial milestones. The Combination also includes $77.5 million in new capital committed by institutional

investors and InoBat’s current shareholders. There is no minimum-cash condition to closing.

“This

agreement is a defining moment for InoBat,” said Marian Boček, Co-Founder and Chief Executive Officer of InoBat. “Demand

for electricity is rising as data center and AI infrastructure expands, and the operators building that infrastructure need reliable,

large-scale energy storage. AI runs on computing; computing runs on power. InoBat has built a cash-generative BESS business serving industrial

customers today, and we are now scaling that platform to further reinforce our position in

advanced energy infrastructure for AI. A successful Nasdaq listing would provide us with access to the world’s deepest capital markets,

which we believe would give us the resources and transatlantic reach to further accelerate our growth, expand manufacturing capacity,

strengthen and advance our programs, including our next-generation sodium-ion energy storage technology, and reinforce our position as

a leading advanced energy storage company.”

Electricity demand from data centers and AI infrastructure

is expected to support continued investment in grid modernization and energy storage. Centered in its assembly facility in Voderady, Slovakia, InoBat

serves industrial and utility customers through its BESSMONT platform, which has delivered or contracted 875 MWh of utility-scale battery

energy storage capacity, with a long pipeline of prospective projects. The company is also positioning its platform to support data center

and AI-related infrastructure that requires resilient, flexible power to meet the growing global demand from hyperscalers. In parallel, InoBat

is advancing next-generation sodium-ion battery technology with strategic partners, providing a differentiated and geopolitically resilient

chemistry designed to complement lithium-ion for battery applications, including energy storage systems.

“InoBat is almost uniquely well-situated

to address growing demand for battery storage in a world of heightened attention to supply chain security,” noted Peter Yu,

Chairman and CEO of Cartesian II. “With industrial partners such as Clarios and Altris, and strategic investors including Gotion,

Rio Tinto, and Amara Raja, we believe InoBat will play a critical role in the battery ecosystem.”

The proposed Combination is expected to close

in late 2026, subject to customary closing conditions. Additional information about the proposed Combination will be provided in a Current

Report on Form 8-K filed by Cartesian II with the Securities and Exchange Commission (the “SEC”) concurrently with this

announcement. Following the closing of the Combination, InoBat is expected to trade on Nasdaq under the ticker symbol “INBT.”

Advisors

Dentons is acting as legal counsel to InoBat.

Greenberg Traurig LLP and Hillbridges, s.r.o. are acting as legal counsel to Cartesian II.

About InoBat

InoBat is a European battery energy storage systems

manufacturer and cell development platform, headquartered in Slovakia. Through its BESSMONT product line, InoBat designs, manufactures,

and deploys utility-scale BESS from its production facility in Voderady, Slovakia, serving industrial and utility customers and positioning

for rising power demand from data centers and AI infrastructure. InoBat is also advancing a strategic partnership with Clarios and Altris

on next-generation cell technology and participates in a gigafactory joint venture with Gotion High-Tech, supporting European battery

supply chain localization. InoBat is an IPCEI awardee. Strategic shareholders include Rio Tinto, Amara Raja, Gotion High-Tech / Volkswagen

Group, Slovak Investment Holding (SZRB Group), Across Finance and IPM Group. For more information, visit www.inobat.eu.

About Cartesian Growth Corporation II

Cartesian Growth Corporation II (OTCPK: RENEF)

is a blank check company organized for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, or

similar business combination with one or more businesses or entities. Cartesian II is an affiliate of Cartesian Capital Group, LLC, a

global private equity firm and registered investment adviser headquartered in New York City. For more information, visit www.cartesiangrowth.com.

Forward-Looking Statements

This communication includes forward-looking statements

within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform

Act of 1995, as amended. Forward-looking statements generally are accompanied by words such as “believe,” “may,”

“will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,”

“should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,”

“future,” “outlook,” “plans,” “expects,” “estimated,” “is expected,”

“budget,” “scheduled,” “forecasts,” “targets,” “projects,” “contemplates,”

and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking

statements may include, but are not limited to, statements regarding estimates and forecasts of financial and performance metrics and

projections of market opportunity, including demand for energy storage from data centers and artificial intelligence; the PIPE financing,

expected cash proceeds, earnout consideration, and other business milestones; the gigafactory joint venture and related supply chain localization;

the anticipated benefits of a transatlantic platform and Nasdaq listing; the potential benefits of the proposed Combination; and expectations

relating to the proposed Combination and related transactions. These statements are based on various assumptions and on the current expectations

of InoBat’s and Cartesian II’s management and are not predictions of actual performance. Actual events and circumstances are

difficult or impossible to predict and may differ from assumptions. These forward-looking statements are subject to a number of risks

and uncertainties, including changes in domestic and foreign business, market, financial, political, and legal conditions; the inability

of the parties to successfully or timely consummate the proposed Combination; the failure to realize the anticipated benefits of the proposed

Combination; the ability of the combined company to meet U.S. stock exchange listing standards; the pace and scale of energy storage demand

from data center and artificial intelligence operators; the level of redemptions by Cartesian II’s public shareholders and the resulting

impact on cash proceeds; the ability to successfully consummate the PIPE financing; global economic and political conditions; the occurrence

of any event that could give rise to termination of the BCA; and additional risks set forth in Cartesian II’s filings with the SEC.

Additional information on these and other factors that may cause actual results and Cartesian II’s performance to differ materially

is included in Cartesian II’s periodic reports filed with the SEC, including, but not limited to, Cartesian II’s Annual Report

on Form 10-K for the year ended December 31, 2025, including those factors described under the heading “Risk Factors”

therein, and Cartesian II's subsequent Quarterly Reports on Form 10-Q. Copies of Cartesian II’s filings with the SEC are available

publicly on the SEC’s website at www.sec.gov or may be obtained by contacting Cartesian II. If any of these risks materialize, actual

results could differ materially from those implied by these forward-looking statements. Readers are cautioned not to place undue reliance

upon any forward-looking statements, which speak only as of the date made. Neither InoBat nor Cartesian II undertakes any obligation to

update or revise these forward-looking statements, whether as a result of new information, future events or otherwise, except as required

by law.

Important Additional Information will be Filed with the SEC

This communication does not constitute an offer

to sell or the solicitation of an offer to buy any securities or constitute a solicitation of any vote or approval.

In connection with the proposed Combination, Cartesian

II intends to file with the SEC a preliminary proxy statement/prospectus and will mail a definitive proxy statement/prospectus and other

relevant documentation to Cartesian II’s stockholders. This document does not contain all the information that should be considered

concerning the proposed Combination. It is not intended to form the basis of any investment decision or any other decision in respect

of the proposed Combination. Cartesian II’s stockholders and other interested persons are advised to read, when available, the preliminary

proxy statement/prospectus and any amendments thereto, and the definitive proxy statement/prospectus in connection with the solicitation

of proxies for the special meeting to be held to approve the transactions contemplated by the proposed Combination because these materials

will contain important information about InoBat, Cartesian II, and the proposed transactions. The definitive proxy statement/prospectus

will be mailed to Cartesian II’s stockholders as of a record date to be established for voting on the proposed Combination when

it becomes available. Stockholders will also be able to obtain a copy of the preliminary proxy statement/prospectus and the definitive

proxy statement/prospectus once they are available, without charge, at the SEC’s website at www.sec.gov, or by directing a written

request to: Cartesian Growth Corporation II, 505 Fifth Avenue, 15th Floor, New York, New York 10017.

Participants in the Solicitation

InoBat, Cartesian II, and their respective directors

and executive officers may be considered participants in the solicitation of proxies with respect to the potential transaction described

in this communication under the rules of the SEC. Information about the directors and executive officers of Cartesian II is set forth

in Cartesian II’s filings with the SEC. Information regarding other persons who may, under the rules of the SEC, be deemed

participants in the solicitation of the stockholders in connection with the potential transaction, and a description of their interests,

will be set forth in the proxy statement/prospectus filed with the SEC when available. These documents can be obtained free of charge

from the sources indicated above.

Media and Investor Contacts

contact@cartesiangrowth.com

GRAPHIC

Filename: tm2621302d1_ex10-3sp3img001.jpg · Sequence: 10

Binary file (3055 bytes)

Download tm2621302d1_ex10-3sp3img001.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 12

v3.26.1

Cover

Jul. 24, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Jul. 24, 2026

Entity File Number

001-41378

Entity Registrant Name

Cartesian Growth Corporation II

Entity Central Index Key

0001889112

Entity Tax Identification Number

00-0000000

Entity Incorporation, State or Country Code

Entity Address, Address Line One

505 Fifth Avenue

Entity Address, Address Line Two

15th Floor

Entity Address, City or Town

New York

Entity Address, State or Province

Entity Address, Postal Zip Code

10017

City Area Code

212

Local Phone Number

461-6363

Written Communications

true

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Entity Emerging Growth Company

true

Elected Not To Use the Extended Transition Period

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 7A

-Section B

-Subsection 2

+ Details

Name:

dei_EntityExTransitionPeriod

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration